{
    "clinical": {
        "clinical_0": {
            "question": "Does the compound ADA improve cognitive function in a model of Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid30807987",
                "pmid28939187",
                "pmid38185066",
                "pmid17008108",
                "pmid28157092",
                "pmid35782939",
                "pmid25443284",
                "pmid38085467",
                "pmid33420799",
                "pmid21606627"
            ]
        },
        "clinical_1": {
            "question": "Did the patient experience symptoms resembling delirium after receiving low-dose cyclophosphamide chemotherapy?",
            "answer": "A",
            "pmid": [
                "pmid39958332",
                "pmid38552085",
                "pmid20204907",
                "pmid34123673",
                "pmid19079356",
                "pmid23909707",
                "pmid23914753",
                "pmid18585545",
                "pmid33093258",
                "pmid38024021"
            ]
        },
        "clinical_2": {
            "question": "Does pNaktide have potential therapeutic effects for Alzheimer's disease by mitigating neuroinflammation and oxidative stress?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid36689848",
                "pmid12453679",
                "pmid26696494",
                "pmid36820018",
                "pmid39524867",
                "pmid34329731",
                "pmid34354404",
                "pmid36533331",
                "pmid24975829",
                "pmid21683531"
            ]
        },
        "clinical_3": {
            "question": "Does the regulation of PSMC5 expression have potential therapeutic implications for Alzheimer's disease-associated cognitive deficits?",
            "answer": "A.",
            "pmid": [
                "pmid38001534",
                "pmid24886239",
                "pmid39105371",
                "pmid36139423",
                "pmid36508924",
                "pmid27072684",
                "pmid12881482",
                "pmid21069780",
                "pmid27103515",
                "pmid32296772"
            ]
        },
        "clinical_4": {
            "question": "Does low-intensity pulsed ultrasound (LIPUS) reduce memory impairment in a model simulating Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30873554",
                "pmid29857968",
                "pmid31410223",
                "pmid39588954",
                "pmid37620888",
                "pmid18003341",
                "pmid37569786",
                "pmid33132889",
                "pmid34499614",
                "pmid37543811"
            ]
        },
        "clinical_5": {
            "question": "Does loading quercetin into nanoparticles improve its efficacy in preventing neuroinflammation associated with Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Studies suggest that loading quercetin into nanoparticles can improve its efficacy in preventing neuroinflammation associated with Alzheimer’s disease. Research indicates that nanoparticle delivery can enhance the ability of quercetin to scavenge reactive oxygen species, reduce brain inflammation, and improve cognitive function in animal models. Furthermore, certain nanoparticle formulations can facilitate penetration of the blood-brain barrier, improving drug delivery to the brain.",
            "pmid": [
                "pmid32464160",
                "pmid39824363",
                "pmid24802026",
                "pmid27591943",
                "pmid18602817",
                "pmid27050422",
                "pmid35031260",
                "pmid33405649",
                "pmid37206236",
                "pmid35594435"
            ]
        },
        "clinical_6": {
            "question": "Does apigenin treatment restore cognitive function in a model of MTX-induced neurotoxicity similar to Alzheimer's disease?",
            "answer": "A.",
            "pmid": [
                "pmid23966081",
                "pmid36943623",
                "pmid20493918",
                "pmid38575939",
                "pmid25445365",
                "pmid39441380",
                "pmid31232699",
                "pmid38682858",
                "pmid25964214",
                "pmid30742114"
            ]
        },
        "clinical_7": {
            "question": "Does antithrombotic therapy show significant cognitive benefits in people with small vessel disease without Alzheimer's?",
            "answer": "B",
            "pmid": [
                "pmid35833913",
                "pmid37897809",
                "pmid12962529",
                "pmid19805638",
                "pmid26727124",
                "pmid30354809",
                "pmid33613260",
                "pmid27567825",
                "pmid21193044",
                "pmid19220710"
            ]
        },
        "clinical_8": {
            "question": "Does the combination of osthole and notopterol exhibit a synergistic anti-Alzheimer's effect in the zebrafish model?",
            "answer": "A",
            "pmid": [
                "pmid39053867",
                "pmid38827230",
                "pmid30392874",
                "pmid39039682",
                "pmid20888863",
                "pmid38228217",
                "pmid32173426",
                "pmid34207381",
                "pmid33535660",
                "pmid28659755"
            ]
        },
        "clinical_9": {
            "question": "Does Ashwagandha have neuroprotective effects in Alzheimer's disease?",
            "answer": "A study demonstrated that Ashwagandha leaf extracts protect brain-derived cells against oxidative stress and induce differentiation, suggesting neuroprotective potential and possible use as a supplement for brain health. Additionally, another study showed that PHPB, a potassium benzoate, exerts neuroprotective effects against cognitive impairment in APP/PS1 transgenic mice by reducing oxidative stress via the Akt/GSK3beta/Nrf2 pathway. Finally, ononin was shown to ameliorate cognitive impairment, suppress neuroinflammation, and oxidative stress in rats with aluminum chloride-induced Alzheimer’s disease.\n\n\n\n",
            "pmid": [
                "pmid32305638",
                "pmid38003702",
                "pmid26822027",
                "pmid32140977",
                "pmid37442493",
                "pmid20538052",
                "pmid36340795",
                "pmid25789768",
                "pmid38409216",
                "pmid34354404"
            ]
        },
        "clinical_10": {
            "question": "Does activation of alpha7nAChR by GTS-21 improve cognitive deficits in a model of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35533773",
                "pmid1647485",
                "pmid34297968",
                "pmid38447415",
                "pmid25637481",
                "pmid25443284",
                "pmid24136196",
                "pmid39116785",
                "pmid12960778",
                "pmid36161942"
            ]
        },
        "clinical_11": {
            "question": "Does alogliptin treatment alleviate cognitive impairment in a model of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30186862",
                "pmid33125461",
                "pmid19805638",
                "pmid30354809",
                "pmid25443284",
                "pmid8997426",
                "pmid12930788",
                "pmid23660953",
                "pmid36994913",
                "pmid32140977"
            ]
        },
        "clinical_12": {
            "question": "Does Memantine improve cognitive performance in Alzheimer's disease by regulating NGF signaling?",
            "answer": "A",
            "pmid": [
                "pmid24846616",
                "pmid34120588",
                "pmid19642202",
                "pmid18615702",
                "pmid15192085",
                "pmid28167259",
                "pmid20042680",
                "pmid24227863",
                "pmid19948208",
                "pmid28917837"
            ]
        },
        "clinical_13": {
            "question": "Does Berula erecta improve cognitive functioning in a model of Parkinson's disease, which is related to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid39546440",
                "pmid28279707",
                "pmid21116051",
                "pmid32140977",
                "pmid29080453",
                "pmid36814130",
                "pmid33432644",
                "pmid25009697",
                "pmid24561065",
                "pmid35204177"
            ]
        },
        "clinical_14": {
            "question": "Is pimavanserin approved for the treatment of psychosis in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid32695312",
                "pmid39623197",
                "pmid32618483",
                "pmid31920655",
                "pmid16315159",
                "pmid17471598",
                "pmid16505133",
                "pmid12671528",
                "pmid39648108",
                "pmid35864999"
            ]
        },
        "clinical_15": {
            "question": "Does the combination therapy with TSA and LEV improve outcomes in delirium post-TBI?",
            "answer": "B",
            "pmid": [
                "pmid37762352",
                "pmid27088157",
                "pmid37133446",
                "pmid24259659",
                "pmid39554848",
                "pmid28243098",
                "pmid31046593",
                "pmid25143737",
                "pmid24621603",
                "pmid26674479"
            ]
        },
        "clinical_17": {
            "question": "Does gossypitrin have potential therapeutic applications for Alzheimer's disease by mitigating iron-induced oxidative stress and mitochondrial damage?",
            "answer": "A",
            "pmid": [
                "pmid34199597",
                "pmid38924927",
                "pmid31232699",
                "pmid37673021",
                "pmid35204177",
                "pmid36068400",
                "pmid22746342",
                "pmid32784451",
                "pmid35360200",
                "pmid27498774"
            ]
        },
        "clinical_18": {
            "question": "Does dexmedetomidine reduce neuronal hyperactivity and overactive behaviors caused by esketamine, which could be relevant to delirium?",
            "answer": "<Correct Answer>: A\n<Why>: Research indicates that dexmedetomidine can suppress inflammation mediated by microglia, which is implicated in delirium. Specifically, it inhibits the release of proinflammatory mediators in activated microglia. Furthermore, dexmedetomidine has been shown to reduce neuronal hyperactivities and overactive behaviors when combined with esketamine, suggesting a potential role in managing delirium-like symptoms.",
            "pmid": [
                "pmid34712126",
                "pmid34807273",
                "pmid36077505",
                "pmid37993790",
                "pmid29958125",
                "pmid39541802",
                "pmid28673598",
                "pmid38911008",
                "pmid22683080",
                "pmid7916159"
            ]
        },
        "clinical_19": {
            "question": "Does NXP031 reduce Abeta accumulation and improve memory function in Alzheimer's disease models?",
            "answer": "A",
            "pmid": [
                "pmid39521153",
                "pmid27569389",
                "pmid17008108",
                "pmid37018887",
                "pmid31840000",
                "pmid22033930",
                "pmid27333034",
                "pmid25443284",
                "pmid24278306",
                "pmid17261088"
            ]
        },
        "clinical_20": {
            "question": "Does meloxicam improve memory loss in Alzheimer's disease by inhibiting neuronal apoptosis?",
            "answer": "A.",
            "pmid": [
                "pmid36279100",
                "pmid20476569",
                "pmid29081887",
                "pmid39521153",
                "pmid29097221",
                "pmid18590917",
                "pmid25102327",
                "pmid24975829",
                "pmid22381145",
                "pmid33470758"
            ]
        },
        "clinical_21": {
            "question": "Does Cudraflavone B have potential therapeutic effects for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid24328060",
                "pmid34569961",
                "pmid36071869",
                "pmid32168835",
                "pmid25061726",
                "pmid26529297",
                "pmid25229015",
                "pmid38106662",
                "pmid38441013",
                "pmid27060945"
            ]
        },
        "clinical_22": {
            "question": "Does carbenoxolone supplementation improve cognitive decline associated with Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid33412218",
                "pmid31560162",
                "pmid31606373",
                "pmid31298459",
                "pmid37508010",
                "pmid27567825",
                "pmid25847999",
                "pmid23099816",
                "pmid21471376",
                "pmid22921881"
            ]
        },
        "clinical_23": {
            "question": "Do antipsychotics like haloperidol and risperidone, which are used to treat delirium in cancer patients, enhance the effectiveness of doxorubicin in resistant uterine sarcoma cells?",
            "answer": "A",
            "pmid": [
                "pmid26122223",
                "pmid32162816",
                "pmid34944601",
                "pmid33322363",
                "pmid17381385",
                "pmid23503785",
                "pmid36671340",
                "pmid23859663",
                "pmid38409802",
                "pmid35053377"
            ]
        },
        "clinical_24": {
            "question": "Does dexmedetomidine reduce the risk of delirium by inhibiting proinflammatory factors through the beta2 adrenergic receptor pathway?",
            "answer": "<Correct Answer>: A\n<Why>: This study investigates how DEX inhibits proinflammatory factors via the beta2 adrenergic receptor (beta2 AR). The results demonstrate that DEX reduces proinflammatory factors and increases anti-inflammatory factors by activating the PKA/CREB pathway through beta2 AR and suppressing NF-kappaB.",
            "pmid": [
                "pmid22683080",
                "pmid36077505",
                "pmid28286770",
                "pmid34807273",
                "pmid29958125",
                "pmid38911008",
                "pmid32454792",
                "pmid39541802",
                "pmid38411331",
                "pmid37993790"
            ]
        },
        "clinical_25": {
            "question": "Does remimazolam reduce the incidence of delirium in clinical reports?",
            "answer": "B",
            "pmid": [
                "pmid38911008",
                "pmid24815757",
                "pmid23859663",
                "pmid37133446",
                "pmid39541802",
                "pmid32329703",
                "pmid39415561",
                "pmid31568239",
                "pmid28910303",
                "pmid22949902"
            ]
        },
        "clinical_26": {
            "question": "Does the CDK4/6 inhibitor abemaciclib mesylate improve cognitive function in Alzheimer's disease models?",
            "answer": "A",
            "pmid": [
                "pmid36907286",
                "pmid22033930",
                "pmid36508924",
                "pmid28779511",
                "pmid34856907",
                "pmid32896600",
                "pmid17008108",
                "pmid36586644",
                "pmid31076196",
                "pmid19447162"
            ]
        },
        "clinical_27": {
            "question": "Does kinetin show protective effects against cognitive impairment in an Alzheimer's disease model induced by aluminum chloride and D-galactose?",
            "answer": "A",
            "pmid": [
                "pmid28867383",
                "pmid23219964",
                "pmid28930532",
                "pmid38057817",
                "pmid38827230",
                "pmid33582452",
                "pmid34354404",
                "pmid38448794",
                "pmid34706318",
                "pmid31175888"
            ]
        },
        "clinical_28": {
            "question": "Does Torin2 have potential therapeutic implications for Alzheimer's disease based on its anti-inflammatory effects in macrophages?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid35874059",
                "pmid38886959",
                "pmid29501766",
                "pmid18509040",
                "pmid39117070",
                "pmid30911003",
                "pmid15608143",
                "pmid28969867",
                "pmid29362997",
                "pmid21704645"
            ]
        },
        "clinical_29": {
            "question": "In a mouse model of sepsis, BML-111 treatment has been shown to reduce cognitive impairment and neuroinflammation through activation of SIRT1 and inhibition of the NF-κB signaling pathway. Considering the pathophysiology of delirium associated with sepsis, which of the following statements is most accurate?",
            "answer": "D",
            "pmid": [
                "pmid30186119",
                "pmid25567339",
                "pmid34589882",
                "pmid37153798",
                "pmid34354558",
                "pmid36608000",
                "pmid28236057",
                "pmid29875474",
                "pmid35126784",
                "pmid37313848"
            ]
        },
        "clinical_30": {
            "question": "Does overexpression of CX3CL1 improve cognitive function in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31822518",
                "pmid31209068",
                "pmid31849963",
                "pmid21771791",
                "pmid26401931",
                "pmid30031059",
                "pmid21159979",
                "pmid32662924",
                "pmid35234337",
                "pmid37609338"
            ]
        },
        "clinical_31": {
            "question": "Does the anti-inflammatory effect of Erinacine C, as described, suggest potential benefits for Alzheimer's disease, given its role in neuroinflammation?",
            "answer": "A",
            "pmid": [
                "pmid12453679",
                "pmid31547327",
                "pmid29501766",
                "pmid20555131",
                "pmid37209001",
                "pmid27539598",
                "pmid36382256",
                "pmid12930788",
                "pmid14975597",
                "pmid31722531"
            ]
        },
        "clinical_32": {
            "question": "Does the NOX1/4 inhibitor GKT136901 have potential applications in the treatment of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid23848532",
                "pmid31463415",
                "pmid11487523",
                "pmid8997426",
                "pmid22581365",
                "pmid9205832",
                "pmid39552492",
                "pmid24228074",
                "pmid26797524",
                "pmid38063180"
            ]
        },
        "clinical_33": {
            "question": "Does the modulation of 5'-nucleotidases (5'NTs) have therapeutic implications for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid23992313",
                "pmid20401186",
                "pmid33420799",
                "pmid22378890",
                "pmid8740986",
                "pmid32614980",
                "pmid19828810",
                "pmid22033930",
                "pmid25443284",
                "pmid32296772"
            ]
        },
        "clinical_34": {
            "question": "Does the combination of Ocimum sanctum extract and Levetiracetam improve memory impairment in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid34973350",
                "pmid35900690",
                "pmid32395598",
                "pmid32365983",
                "pmid28643520",
                "pmid35922734",
                "pmid27563424",
                "pmid25009697",
                "pmid36777330",
                "pmid23562514"
            ]
        },
        "clinical_35": {
            "question": "Does activating AhR improve cognitive deficits in an Alzheimer's disease model?",
            "answer": "A",
            "pmid": [
                "pmid34522212",
                "pmid30807987",
                "pmid34297968",
                "pmid30354809",
                "pmid23379615",
                "pmid19805638",
                "pmid25443284",
                "pmid39325017",
                "pmid20950278",
                "pmid18509040"
            ]
        },
        "clinical_36": {
            "question": "Does T-817MA show potential as a therapeutic agent for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid21439944",
                "pmid25443284",
                "pmid28157092",
                "pmid30344671",
                "pmid31697472",
                "pmid9205832",
                "pmid26797524",
                "pmid39552492",
                "pmid35987018",
                "pmid38203753"
            ]
        },
        "clinical_37": {
            "question": "Does narciclasine from Lycoris radiata have a potential therapeutic role in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30738987",
                "pmid37542650",
                "pmid38355004",
                "pmid31945778",
                "pmid36982332",
                "pmid32253029",
                "pmid38081625",
                "pmid33807157",
                "pmid26023568",
                "pmid39603393"
            ]
        },
        "clinical_38": {
            "question": "Is Derrubone a potential therapeutic agent for Alzheimer's disease based on its binding to Hsp90alpha CTD?",
            "answer": "A",
            "pmid": [
                "pmid24785461",
                "pmid39231208",
                "pmid29641978",
                "pmid31403949",
                "pmid32765947",
                "pmid25847999",
                "pmid39117070",
                "pmid34064687",
                "pmid23559013",
                "pmid35350668"
            ]
        },
        "clinical_39": {
            "question": "Does beetroot supplementation improve cognitive function in a model simulating Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid33054666",
                "pmid22995388",
                "pmid24442916",
                "pmid35496289",
                "pmid32488469",
                "pmid32003387",
                "pmid31958090",
                "pmid23566055",
                "pmid26068423",
                "pmid22459600"
            ]
        },
        "clinical_40": {
            "question": "Does SAP removal by CPHPC treatment address Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid26842068",
                "pmid19372378",
                "pmid24333930",
                "pmid38085467",
                "pmid12015594",
                "pmid7753801",
                "pmid38355004",
                "pmid7936052",
                "pmid2391515",
                "pmid33913927"
            ]
        },
        "clinical_41": {
            "question": "Does the use of subcutaneous oxycodone in opioid rotation for cancer patients improve delirium?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid8803381",
                "pmid16043013",
                "pmid10423053",
                "pmid32162816",
                "pmid29670416",
                "pmid38409802",
                "pmid18628169",
                "pmid23503785",
                "pmid39541802",
                "pmid21861200"
            ]
        },
        "clinical_42": {
            "question": "Does cotinine (COT) and 6-hydroxy-L-nicotine (6HLN) improve memory and reduce anxiety in the scopolamine-induced zebrafish model of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid33535660",
                "pmid32824768",
                "pmid20888863",
                "pmid23842742",
                "pmid16354790",
                "pmid34207381",
                "pmid11278378",
                "pmid16762377",
                "pmid30949953",
                "pmid1491741"
            ]
        },
        "clinical_43": {
            "question": "Does the sulfated polysaccharide from pearl oyster nacre improve memory impairment, which could be relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid33804892",
                "pmid28406733",
                "pmid37781122",
                "pmid39744139",
                "pmid36402384",
                "pmid31661844",
                "pmid33913927",
                "pmid30844489",
                "pmid20183271",
                "pmid38866276"
            ]
        },
        "clinical_44": {
            "question": "Does ononin treatment improve cognitive impairment in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid34354404",
                "pmid8997426",
                "pmid25108596",
                "pmid17008108",
                "pmid37209001",
                "pmid39116785",
                "pmid38575939",
                "pmid32140977",
                "pmid38924927",
                "pmid35598091"
            ]
        },
        "clinical_45": {
            "question": "Does muscone improve memory impairment in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid32538849",
                "pmid32488469",
                "pmid31291099",
                "pmid8997426",
                "pmid36557245",
                "pmid18615702",
                "pmid21593570",
                "pmid38996935",
                "pmid15192085",
                "pmid31958090"
            ]
        },
        "clinical_46": {
            "question": "Does guanabenz treatment protect against Alzheimer's disease-related behavioral and pathological indicators?",
            "answer": "A.",
            "pmid": [
                "pmid35195784",
                "pmid36557245",
                "pmid25108596",
                "pmid26577751",
                "pmid26822027",
                "pmid38612861",
                "pmid32789760",
                "pmid36440097",
                "pmid35815283",
                "pmid25711456"
            ]
        },
        "clinical_47": {
            "question": "Does chronic exposure to galantamine decrease cellular responses to nicotinic receptor activation in neuroblastoma cells, which is relevant to Alzheimer's disease treatment?",
            "answer": "Galantamine appears to modulate cellular responses to nicotinic receptor activation and may offer neuroprotective benefits. It can prevent amyloid beta-induced cell death by protecting against mitochondrial dysfunction and ER stress. Furthermore, galantamine competitively antagonizes the actions of kynurenic acid on alpha7* nicotinic receptors, potentially enhancing alpha7nAChR activity and promoting autophagy through the JNK signaling pathway and inhibition of the Akt pathway. This involves direct binding of alpha7nAChR to LC3, facilitating autophagosome sequestration of amyloid beta.",
            "pmid": [
                "pmid12649296",
                "pmid28554861",
                "pmid16354790",
                "pmid16762377",
                "pmid15728839",
                "pmid14769831",
                "pmid15937519",
                "pmid31823156",
                "pmid20655346",
                "pmid17446300"
            ]
        },
        "clinical_48": {
            "question": "Can levofloxacin therapy lead to delirium with psychotic features?",
            "answer": "A",
            "pmid": [
                "pmid23909707",
                "pmid23914753",
                "pmid18585545",
                "pmid31178301",
                "pmid22390219",
                "pmid20204907",
                "pmid26953013",
                "pmid1949310",
                "pmid19836623",
                "pmid17317453"
            ]
        },
        "clinical_49": {
            "question": "Does Houttuynia cordata improve cognitive deficits in Alzheimer's disease-like models?",
            "answer": "A",
            "pmid": [
                "pmid25009697",
                "pmid36814130",
                "pmid29080453",
                "pmid32140977",
                "pmid28279707",
                "pmid28643520",
                "pmid22262263",
                "pmid31661844",
                "pmid36178947",
                "pmid33432644"
            ]
        },
        "clinical_50": {
            "question": "Does Linderae Radix improve cognitive dysfunction in Alzheimer's disease models by inhibiting neuroinflammation and synaptic damage?",
            "answer": "<Correct Answer>: A\n<Why>: This herbal extract demonstrably improved spatial memory and learning ability in an AD animal model, alongside reductions in Abeta plaques, neuron apoptosis, and neuroinflammation. It also modulated cytokine levels, suggesting a neuroprotective effect and potential as a therapeutic drug for neurodegenerative disorders like AD.",
            "pmid": [
                "pmid37542650",
                "pmid38081625",
                "pmid35586062",
                "pmid38954263",
                "pmid32089787",
                "pmid35672874",
                "pmid29080453",
                "pmid36232612",
                "pmid36814130",
                "pmid32488469"
            ]
        },
        "clinical_51": {
            "question": "Is NK-4 currently approved for the treatment of Alzheimer's disease or delirium in Japan?",
            "answer": "B",
            "pmid": [
                "pmid22238689",
                "pmid24228074",
                "pmid36901839",
                "pmid28798805",
                "pmid37330271",
                "pmid24346138",
                "pmid16762377",
                "pmid21683531",
                "pmid36820018",
                "pmid38911008"
            ]
        },
        "clinical_52": {
            "question": "Does prone positioning reduce the risk of delirium in patients undergoing mechanical ventilation?",
            "answer": "A",
            "pmid": [
                "pmid36405620",
                "pmid24852225",
                "pmid17949984",
                "pmid29657370",
                "pmid36078999",
                "pmid27736515",
                "pmid24259659",
                "pmid37133446",
                "pmid29430447",
                "pmid27119013"
            ]
        },
        "clinical_53": {
            "question": "Does N-stearoylethanolamine have a therapeutic potential for the prevention of cognitive dysfunction caused by neuroinflammation or autoimmune reaction, as it relates to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid28963942",
                "pmid12453679",
                "pmid1776749",
                "pmid30911003",
                "pmid33211296",
                "pmid35772378",
                "pmid8997426",
                "pmid9205832",
                "pmid32056532",
                "pmid38577889"
            ]
        },
        "clinical_54": {
            "question": "Does alpha-chymotrypsin improve neuroinflammation in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid22464639",
                "pmid19800391",
                "pmid12453679",
                "pmid2067717",
                "pmid14975597",
                "pmid35986874",
                "pmid11755001",
                "pmid33181351",
                "pmid35181976",
                "pmid38565393"
            ]
        },
        "clinical_55": {
            "question": "Does Akebia saponin D (ASD) improve cognitive impairment in Alzheimer's disease by reducing corticosterone levels?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid30092401",
                "pmid28250796",
                "pmid24810883",
                "pmid32140977",
                "pmid36820018",
                "pmid37598923",
                "pmid25408503",
                "pmid16943563",
                "pmid35691153",
                "pmid38575939"
            ]
        },
        "clinical_56": {
            "question": "Does the use of DMARDs reduce the likelihood of Alzheimer's disease and/or dementia in patients with autoimmune disorders?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid38288824",
                "pmid30044040",
                "pmid27096216",
                "pmid34975464",
                "pmid39773090",
                "pmid8996832",
                "pmid21514692",
                "pmid11730949",
                "pmid22921881",
                "pmid30186862"
            ]
        },
        "clinical_57": {
            "question": "Does galantamine treatment improve cognitive function in patients with Alzheimer's disease or mixed dementia?",
            "answer": "Multiple studies demonstrate that galantamine treatment can improve or maintain cognitive function in patients with Alzheimer's disease, vascular dementia, or mixed dementia. Assessments using ADAS-cog scores have shown statistically significant benefits, and some trials indicate sustained improvements over extended treatment durations.",
            "pmid": [
                "pmid12962529",
                "pmid14560062",
                "pmid11110737",
                "pmid17664404",
                "pmid15598477",
                "pmid12860497",
                "pmid23862185",
                "pmid18845693",
                "pmid24461047",
                "pmid28554861"
            ]
        },
        "clinical_58": {
            "question": "Can primidone, which inhibits RIPK1 kinase, potentially be repurposed for the treatment of delirium?",
            "answer": "A",
            "pmid": [
                "pmid38086800",
                "pmid37993790",
                "pmid39541802",
                "pmid38911008",
                "pmid31437302",
                "pmid23503785",
                "pmid39210294",
                "pmid24815757",
                "pmid39415561",
                "pmid31574089"
            ]
        },
        "clinical_59": {
            "question": "Does 5,19-cyclo-9beta,10xi-androstane-3,17-dione (CAD) have potential therapeutic effects for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid38203753",
                "pmid17980863",
                "pmid33211296",
                "pmid38355004",
                "pmid38612861",
                "pmid26529297",
                "pmid28157092",
                "pmid30354809",
                "pmid31176237",
                "pmid35815283"
            ]
        },
        "clinical_60": {
            "question": "Does Souvenaid improve cognitive function in individuals with Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid33787038",
                "pmid33320335",
                "pmid26638900",
                "pmid27767993",
                "pmid24326116",
                "pmid19447162",
                "pmid32273835",
                "pmid22195685",
                "pmid19805638",
                "pmid36440097"
            ]
        },
        "clinical_61": {
            "question": "Does temsirolimus have potential therapeutic benefits for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid24602800",
                "pmid24880087",
                "pmid9205832",
                "pmid18606218",
                "pmid34973350",
                "pmid26068423",
                "pmid36820018",
                "pmid26696494",
                "pmid19805638",
                "pmid37673021"
            ]
        },
        "clinical_62": {
            "question": "Does intermittent theta burst stimulation (iTBS) improve cognitive deficits in an Alzheimer's-like disease model caused by trimethyltin (TMT)?",
            "answer": "A",
            "pmid": [
                "pmid35656538",
                "pmid35780960",
                "pmid37586425",
                "pmid37273654",
                "pmid30949496",
                "pmid23579326",
                "pmid34302466",
                "pmid39441380",
                "pmid21116051",
                "pmid27713140"
            ]
        },
        "clinical_63": {
            "question": "Does (R)-ketamine have a potential role as a prophylactic drug for delirium?",
            "answer": "A",
            "pmid": [
                "pmid38911008",
                "pmid37993790",
                "pmid34313805",
                "pmid24815757",
                "pmid39541802",
                "pmid35880774",
                "pmid19343193",
                "pmid39210294",
                "pmid27760517",
                "pmid37133446"
            ]
        },
        "clinical_64": {
            "question": "Does N2L, a novel lipoic acid-niacin dimer, show potential as a therapeutic agent for Alzheimer's disease by attenuating ferroptosis and lipid peroxidation in HT22 cells?",
            "answer": "A multi-targeted compound, 4c2, demonstrated promising results as a potential therapeutic agent for Alzheimer’s disease. It exhibited significant AChE inhibitory activity, crossed the blood-brain barrier, and activated the Nrf2 pathway, inducing expressions of HO-1, NQO1, and GPX4. Furthermore, it protected cells from injury, reduced inflammation, and improved memory impairment in a mouse model.\n\n\n\n",
            "pmid": [
                "pmid34171402",
                "pmid31478183",
                "pmid36770835",
                "pmid34316383",
                "pmid36012451",
                "pmid37409350",
                "pmid24975829",
                "pmid19141069",
                "pmid38057817",
                "pmid35987018"
            ]
        },
        "clinical_65": {
            "question": "Does the inhibition of JNK activation improve cognitive deficits in Alzheimer's disease models?",
            "answer": "A",
            "pmid": [
                "pmid22033930",
                "pmid20451607",
                "pmid24457963",
                "pmid25611954",
                "pmid27498773",
                "pmid32896600",
                "pmid33420799",
                "pmid28779511",
                "pmid29787769",
                "pmid23660953"
            ]
        },
        "clinical_66": {
            "question": "Does the use of memantine as an initial antidementia medication increase in individuals with Alzheimer's disease who also have asthma or COPD?",
            "answer": "A",
            "pmid": [
                "pmid31929157",
                "pmid24227863",
                "pmid27786552",
                "pmid15192085",
                "pmid28167259",
                "pmid19948208",
                "pmid18615702",
                "pmid28917837",
                "pmid19642202",
                "pmid34120588"
            ]
        },
        "clinical_67": {
            "question": "Does cinnarizine improve haloperidol-induced memory impairment, which could be relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid27540345",
                "pmid38203753",
                "pmid31910792",
                "pmid20624417",
                "pmid27631100",
                "pmid10856449",
                "pmid30949953",
                "pmid28004303",
                "pmid38468315",
                "pmid29132092"
            ]
        },
        "clinical_68": {
            "question": "Is propofol recommended for patients with refractory delirium tremens?",
            "answer": "A",
            "pmid": [
                "pmid9398785",
                "pmid24814732",
                "pmid26893017",
                "pmid39415533",
                "pmid38482541",
                "pmid24259659",
                "pmid34978",
                "pmid37133446",
                "pmid23503785",
                "pmid23859663"
            ]
        },
        "clinical_69": {
            "question": "Does melatonin treatment improve the chemotaxis index in C. elegans exposed to isoflurane, which could be relevant to delirium?",
            "answer": "A",
            "pmid": [
                "pmid35388108",
                "pmid38911008",
                "pmid39127141",
                "pmid23256744",
                "pmid24815757",
                "pmid39541802",
                "pmid38895540",
                "pmid39490772",
                "pmid33779822",
                "pmid35219702"
            ]
        },
        "clinical_70": {
            "question": "Does COP-22 have potential anti-aging activity that could be used in the therapy of Alzheimer's disease?",
            "answer": "A compound known as WBQ5187 markedly improves cognitive and spatial memory functions in animal models of Alzheimer's disease and reduces associated brain pathology. Additionally, exercise demonstrates potential in reducing Alzheimer’s pathology and improving cognitive function, particularly in individuals carrying the APOE epsilon4 allele.\n\n\n\n",
            "pmid": [
                "pmid38347285",
                "pmid19141069",
                "pmid38306514",
                "pmid31736210",
                "pmid25776136",
                "pmid26710244",
                "pmid18606218",
                "pmid24305557",
                "pmid31697472",
                "pmid33403644"
            ]
        },
        "clinical_71": {
            "question": "Does the Huangqi-Gegen drug pair have a potential role in treating Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid38815405",
                "pmid35656471",
                "pmid32140977",
                "pmid34046075",
                "pmid35535155",
                "pmid35303280",
                "pmid31563815",
                "pmid31354916",
                "pmid32317964",
                "pmid35873623"
            ]
        },
        "clinical_72": {
            "question": "Does zinc supplementation reduce the risk or slow cognitive decline in individuals with Alzheimer's disease or mild cognitive impairment?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid33597269",
                "pmid21368864",
                "pmid26883958",
                "pmid17949919",
                "pmid38648940",
                "pmid36263579",
                "pmid37261605",
                "pmid18606218",
                "pmid18625454",
                "pmid29423819"
            ]
        },
        "clinical_73": {
            "question": "Does Aquilaria crassna Leaf Extract (ACH) improve lifespan in Caenorhabditis elegans exposed to high glucose, potentially relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid36079924",
                "pmid26845710",
                "pmid37838776",
                "pmid38003724",
                "pmid26236426",
                "pmid37375545",
                "pmid38601465",
                "pmid36076399",
                "pmid39682936",
                "pmid31871554"
            ]
        },
        "clinical_74": {
            "question": "Is delirium associated with increased odds of non-emergency control intervention use in older psychiatric inpatients?",
            "answer": "A",
            "pmid": [
                "pmid30086671",
                "pmid21721434",
                "pmid21206582",
                "pmid20030432",
                "pmid37251808",
                "pmid34616324",
                "pmid29966197",
                "pmid21488579",
                "pmid17183425",
                "pmid29723848"
            ]
        },
        "clinical_75": {
            "question": "Does Marsilea quadrifolia Linn exhibit potential neuroprotective effects that could be relevant to Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Studies demonstrate that plant extracts can moderate the effects of neurotoxicity, oxidative stress, and neurotransmitter levels, suggesting potential neuroprotective actions relevant to Alzheimer's disease.",
            "pmid": [
                "pmid37781695",
                "pmid28279707",
                "pmid32488469",
                "pmid28643520",
                "pmid34551518",
                "pmid39229544",
                "pmid29080453",
                "pmid36982332",
                "pmid35950787",
                "pmid32316271"
            ]
        },
        "clinical_76": {
            "question": "Does the chloroform extract of Vanda roxburghii exhibit potential in the treatment of Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid33855299",
                "pmid26100408",
                "pmid28643520",
                "pmid36982332",
                "pmid37329974",
                "pmid36408377",
                "pmid29100755",
                "pmid36678626",
                "pmid35237756",
                "pmid38941895"
            ]
        },
        "clinical_77": {
            "question": "Does Angelica purpurascens essential oil improve memory impairments through mechanisms relevant to Alzheimer's disease, such as cholinergic modulation and antioxidant effects?",
            "answer": "A. annua extract demonstrates potential in alleviating cognitive deficits and reducing Alzheimer's disease hallmarks. Studies reveal it reduces amyloid-beta accumulation, tau hyperphosphorylation, inflammation, and apoptosis, while promoting neural progenitor cell survival and synaptic protein expression. Mechanistically, this extract modulates the YAP signaling pathway and exhibits antioxidant effects by reversing amyloid-beta-induced increases in reactive oxygen species and caspase-3 activity. These findings suggest a multi-target approach for Alzheimer’s prevention and treatment.\n\n\n\n",
            "pmid": [
                "pmid35448824",
                "pmid32785956",
                "pmid37508010",
                "pmid38339193",
                "pmid29080453",
                "pmid39305407",
                "pmid23566055",
                "pmid22995388",
                "pmid36982332",
                "pmid39229544"
            ]
        },
        "clinical_78": {
            "question": "Does tocilizumab treatment reduce cognitive deficits in an Alzheimer's disease model?",
            "answer": "A",
            "pmid": [
                "pmid27443846",
                "pmid39044493",
                "pmid31076196",
                "pmid19447162",
                "pmid25443284",
                "pmid20555131",
                "pmid8997426",
                "pmid36263579",
                "pmid23783773",
                "pmid19805638"
            ]
        },
        "clinical_79": {
            "question": "Does the cyclic (aza)peptide tracer effectively cross the blood-brain barrier (BBB) to target Abeta oligomers in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid36442093",
                "pmid16246051",
                "pmid36763536",
                "pmid11181824",
                "pmid22992731",
                "pmid36994913",
                "pmid27258855",
                "pmid25390692",
                "pmid12105192",
                "pmid34494298"
            ]
        },
        "clinical_80": {
            "question": "Does the ethanolic extract of Aster glehni (AG-D) improve cognitive function in a model of Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Studies demonstrate that a substance can lessen memory problems through behavioral assessments, suggesting an improvement in cognitive function. Specifically, the substance \"significantly attenuated memory dysfunction\" in the studies.",
            "pmid": [
                "pmid31225769",
                "pmid28643520",
                "pmid27435287",
                "pmid32365983",
                "pmid28279707",
                "pmid29080453",
                "pmid26068423",
                "pmid38954263",
                "pmid16821116",
                "pmid32800555"
            ]
        },
        "clinical_81": {
            "question": "Does MLKL deficiency improve motor symptoms and reduce neuroinflammation in a Parkinson's disease model, which is analogous to changes seen in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid38041169",
                "pmid22329649",
                "pmid22550610",
                "pmid34817756",
                "pmid37488757",
                "pmid36387285",
                "pmid39741193",
                "pmid19596066",
                "pmid33277246",
                "pmid39193909"
            ]
        },
        "clinical_82": {
            "question": "Does music therapy significantly reduce anxiety in patients with Alzheimer's disease?",
            "answer": "A systematic review found mindfulness-based cognitive therapy potentially effective in reducing stress – including components of anxiety – in family carers of people living with dementia. Additionally, a study demonstrated that appropriate treatment of asthma in patients with Alzheimer’s disease could improve cognitive function. However, the provided texts do not directly address the effect of music therapy on anxiety specifically in Alzheimer’s patients.\n\n\n\n",
            "pmid": [
                "pmid19250995",
                "pmid19628939",
                "pmid24337333",
                "pmid36278769",
                "pmid29235615",
                "pmid25711456",
                "pmid32273835",
                "pmid39586722",
                "pmid22195685",
                "pmid35010874"
            ]
        },
        "clinical_83": {
            "question": "Does thiopurine exposure reduce the risk of Alzheimer's disease in patients with inflammatory bowel disease?",
            "answer": "A",
            "pmid": [
                "pmid31788536",
                "pmid35908596",
                "pmid35470286",
                "pmid37521457",
                "pmid38779559",
                "pmid38561809",
                "pmid12453679",
                "pmid36820018",
                "pmid37571319",
                "pmid20555131"
            ]
        },
        "clinical_84": {
            "question": "Does add-on therapy with a low-dose carbamylating inhibitor enhance the clinical efficacy of donepezil in Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Studies indicate donepezil provides meaningful benefits in alleviating cognitive deficits in Alzheimer's disease patients, with increased improvements observed at higher doses. Furthermore, donepezil has demonstrated efficacy not only for memory disturbances but also for psychotic and behavioral disturbances, improving scores on assessments like the Mini-Mental State Examination and Alzheimer's Disease Assessment Scale. Importantly, donepezil was also found to be a BACE-1 inhibitor, displaying submicromolar potency.",
            "pmid": [
                "pmid24217282",
                "pmid11830754",
                "pmid17939763",
                "pmid35850693",
                "pmid9853200",
                "pmid25744714",
                "pmid24189446",
                "pmid15254918",
                "pmid17541560",
                "pmid12187372"
            ]
        },
        "clinical_85": {
            "question": "Does taraxerol have potential therapeutic value in alleviating memory impairments observed in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid29355563",
                "pmid8997426",
                "pmid33540879",
                "pmid9205832",
                "pmid19805638",
                "pmid24602800",
                "pmid30354809",
                "pmid39209323",
                "pmid34040526",
                "pmid34655202"
            ]
        },
        "clinical_86": {
            "question": "Is donepezil approved for the treatment of Alzheimer's disease?",
            "answer": "Donepezil is a commonly prescribed medication for Alzheimer's disease and has demonstrated improvements in cognitive function and a reduction in beta-amyloid levels in patients. Clinical studies indicate it can positively influence scores on cognitive assessments and activities of daily living, with a lower rate of adverse reactions compared to some other treatments.",
            "pmid": [
                "pmid11830754",
                "pmid17939763",
                "pmid9853200",
                "pmid9428950",
                "pmid15989517",
                "pmid23742728",
                "pmid12187372",
                "pmid17541560",
                "pmid10637367",
                "pmid29434777"
            ]
        },
        "clinical_87": {
            "question": "Does donepezil, which is used in Alzheimer's disease, show protective effects against alcohol-induced toxicity in cell culture by inhibiting caspase-3?",
            "answer": "<Correct Answer>: A\n<Why>: Donepezil significantly improved cognitive function in transgenic mice and inhibited the expression of CD68, a specific marker of microglial activation, and reduced the release of proinflammatory cytokines. These results suggest that donepezil improves cognitive deficits by inhibiting microglial activation.",
            "pmid": [
                "pmid29804239",
                "pmid19077054",
                "pmid25744714",
                "pmid37298443",
                "pmid15893738",
                "pmid20718745",
                "pmid11830754",
                "pmid24189446",
                "pmid15486488",
                "pmid25662507"
            ]
        },
        "clinical_88": {
            "question": "Does the combination of lycopene and human amniotic epithelial cells improve cognitive deficits in Alzheimer's disease?",
            "answer": "A\n",
            "pmid": [
                "pmid33249184",
                "pmid29454265",
                "pmid32253029",
                "pmid29195132",
                "pmid22044877",
                "pmid33492604",
                "pmid31661844",
                "pmid30290256",
                "pmid31606373",
                "pmid29411261"
            ]
        },
        "clinical_89": {
            "question": "Did the patient develop Alzheimer's disease or delirium during the course of her treatment with trimethoprim-sulfamethoxazole?",
            "answer": "B",
            "pmid": [
                "pmid19836623",
                "pmid17317453",
                "pmid17427765",
                "pmid23909707",
                "pmid23914753",
                "pmid18585545",
                "pmid23293526",
                "pmid12187372",
                "pmid35813788",
                "pmid36607874"
            ]
        },
        "clinical_90": {
            "question": "Does stigmasterol treatment alleviate cognitive deficits in a model of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35772378",
                "pmid1776749",
                "pmid8997426",
                "pmid9205832",
                "pmid30092401",
                "pmid27926996",
                "pmid37301482",
                "pmid38095632",
                "pmid21471376",
                "pmid25390692"
            ]
        },
        "clinical_91": {
            "question": "Does betulinic acid improve microvascular responsivity and reduce cytokine levels in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30178892",
                "pmid28986104",
                "pmid37980676",
                "pmid36770835",
                "pmid36817510",
                "pmid24219385",
                "pmid21276834",
                "pmid23645098",
                "pmid37098656",
                "pmid25108596"
            ]
        },
        "clinical_92": {
            "question": "Does switching from ziprasidone to duloxetine improve neuropsychiatric behavior in a patient with Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid19752843",
                "pmid15157345",
                "pmid23293526",
                "pmid26279176",
                "pmid32695312",
                "pmid31920655",
                "pmid16856516",
                "pmid15021866",
                "pmid25711456",
                "pmid26778658"
            ]
        },
        "clinical_93": {
            "question": "Are pyramidal cell volumes in the dorsolateral prefrontal cortex reduced in Alzheimer's disease compared to post-stroke patients with no dementia?",
            "answer": "A",
            "pmid": [
                "pmid24974383",
                "pmid24607963",
                "pmid22153202",
                "pmid14507668",
                "pmid29080407",
                "pmid19220710",
                "pmid19940172",
                "pmid22651939",
                "pmid31706220",
                "pmid11351135"
            ]
        },
        "clinical_94": {
            "question": "Does amentoflavone improve memory deficits in a model of Alzheimer's disease by influencing autophagy and mTOR signaling?",
            "answer": "A",
            "pmid": [
                "pmid33492604",
                "pmid29411261",
                "pmid35682567",
                "pmid31722188",
                "pmid38441013",
                "pmid31060682",
                "pmid30362531",
                "pmid25160744",
                "pmid38996935",
                "pmid21368103"
            ]
        },
        "clinical_95": {
            "question": "Are flavonoids from Millettia brandisiana studied for their effects against Alzheimer's disease pathogenesis?",
            "answer": "A flavonoid compound, grape seed proanthocyanidin, demonstrates potential benefits in mitigating Alzheimer's disease by reducing amyloid beta-induced cytotoxicity, inhibiting apoptosis, and improving cognitive function and pathology in animal models. It appears to influence key markers of the disease, including amyloid precursor protein, tau protein, and presenilin-1 expression.\n\n\n\n",
            "pmid": [
                "pmid38106662",
                "pmid24328060",
                "pmid34569961",
                "pmid36071869",
                "pmid32168835",
                "pmid25229015",
                "pmid26853104",
                "pmid39229544",
                "pmid39094545",
                "pmid27588088"
            ]
        },
        "clinical_96": {
            "question": "Does the compound PADK exhibit a positive effect on CatB that correlates with improved memory in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid29805718",
                "pmid29944861",
                "pmid21272191",
                "pmid30354809",
                "pmid24229499",
                "pmid39556267",
                "pmid23404502",
                "pmid29491219",
                "pmid30873920",
                "pmid35084179"
            ]
        },
        "clinical_97": {
            "question": "Does menadione sodium bisulfite (MSB) show potential as a therapeutic agent for Alzheimer's disease?",
            "answer": "A.",
            "pmid": [
                "pmid30036601",
                "pmid27725131",
                "pmid32397683",
                "pmid39105973",
                "pmid37261605",
                "pmid17600377",
                "pmid31958090",
                "pmid34294612",
                "pmid34064687",
                "pmid29805718"
            ]
        },
        "clinical_98": {
            "question": "Does pre-infusion of hypertonic saline reduce the incidence of delirium in geriatric patients after shoulder arthroscopy?",
            "answer": "A",
            "pmid": [
                "pmid38082215",
                "pmid36304175",
                "pmid39259060",
                "pmid7762856",
                "pmid16696749",
                "pmid39638735",
                "pmid21206582",
                "pmid37773821",
                "pmid39259057",
                "pmid30048325"
            ]
        },
        "clinical_99": {
            "question": "Does methylpenicinoline from Penicillium sp. (SF-5995) have potential therapeutic effects for Alzheimer's disease or delirium based on its anti-inflammatory properties?",
            "answer": "A",
            "pmid": [
                "pmid25379644",
                "pmid39583559",
                "pmid23612372",
                "pmid38954263",
                "pmid29081887",
                "pmid37623247",
                "pmid33463937",
                "pmid34153839",
                "pmid37038034",
                "pmid37434441"
            ]
        },
        "clinical_100": {
            "question": "Does the compound LM-021 exhibit antiaggregative, antioxidative, and neuroprotective effects in models of Alzheimer's disease?",
            "answer": "A study demonstrated that Zinc Ortho Methyl Carbonodithioate (ZOMEC) decreased oxidative stress by increasing catalase (CAT) and glutathione S transferase (GST) and decreasing lipid peroxidation. ZOMEC also enhanced expression of SIRT1 and synaptic marker proteins, rescued memory impairment, and reduced Abeta accumulation and inflammation in a mouse model of Alzheimer's disease. Another study showed that linalool improved cognitive performance, reduced hippocampal cell injury and apoptosis, and modulated oxidative stress and the Nrf2/HO-1 signaling pathway in mice.\n\n\n\n",
            "pmid": [
                "pmid26797524",
                "pmid34812274",
                "pmid38203753",
                "pmid20416364",
                "pmid36275418",
                "pmid37597424",
                "pmid31244664",
                "pmid11767950",
                "pmid37261605",
                "pmid28235543"
            ]
        },
        "clinical_101": {
            "question": "Does the triazole grandisin analogue (TGA) exhibit neuroprotective effects against amyloid-beta oligomer-induced cognitive impairment in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid38048522",
                "pmid25390692",
                "pmid32739157",
                "pmid27258855",
                "pmid30928879",
                "pmid32166661",
                "pmid26696494",
                "pmid19625748",
                "pmid26432105",
                "pmid19077054"
            ]
        },
        "clinical_102": {
            "question": "Does TKM01 reduce acetylcholinesterase (AChE) activity in an Alzheimer's disease model?",
            "answer": "A",
            "pmid": [
                "pmid17555845",
                "pmid39552492",
                "pmid31840000",
                "pmid10637367",
                "pmid31583530",
                "pmid28779511",
                "pmid24975829",
                "pmid20451607",
                "pmid17023131",
                "pmid39117070"
            ]
        },
        "clinical_103": {
            "question": "Is Aniracetam used in the treatment of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid12070527",
                "pmid38552113",
                "pmid25099639",
                "pmid17690727",
                "pmid29946420",
                "pmid8997426",
                "pmid20877425",
                "pmid17939763",
                "pmid24602800",
                "pmid34973350"
            ]
        },
        "clinical_104": {
            "question": "Does 5-heptadecylresorcinol (AR-C17) have a protective effect against cognitive impairments in a model of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid32385942",
                "pmid29667108",
                "pmid17600377",
                "pmid25443284",
                "pmid28157092",
                "pmid19141069",
                "pmid38355004",
                "pmid37878046",
                "pmid12065621",
                "pmid16772755"
            ]
        },
        "clinical_105": {
            "question": "Does intermittent fasting improve cognitive function in a model of sepsis, suggesting potential benefits for delirium?",
            "answer": "A",
            "pmid": [
                "pmid39798403",
                "pmid24886300",
                "pmid28970945",
                "pmid37043764",
                "pmid20471115",
                "pmid37133446",
                "pmid25567339",
                "pmid39840463",
                "pmid39419070",
                "pmid21766035"
            ]
        },
        "clinical_106": {
            "question": "Does donepezil reduce proinflammatory cytokines in Alzheimer's disease patients?",
            "answer": "A",
            "pmid": [
                "pmid16445950",
                "pmid25662507",
                "pmid34638977",
                "pmid15118486",
                "pmid29420357",
                "pmid20153342",
                "pmid24189446",
                "pmid14975597",
                "pmid23742728",
                "pmid35850693"
            ]
        },
        "clinical_107": {
            "question": "Does octadecaneuropeptide (ODN) have potential therapeutic implications for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid33250858",
                "pmid31514417",
                "pmid38216963",
                "pmid30594669",
                "pmid35104624",
                "pmid38754634",
                "pmid31931285",
                "pmid15778722",
                "pmid17344400",
                "pmid22527793"
            ]
        },
        "clinical_108": {
            "question": "Does the use of low-dose atypical antipsychotic risperidone improve the 5-year outcome in Alzheimer's disease patients with sleep disturbances?",
            "answer": "A",
            "pmid": [
                "pmid26279176",
                "pmid15157345",
                "pmid16505133",
                "pmid16315159",
                "pmid17471598",
                "pmid31920655",
                "pmid15601392",
                "pmid21492498",
                "pmid15259536",
                "pmid10496251"
            ]
        },
        "clinical_109": {
            "question": "Are fullerene derivatives with amino acids or peptides being investigated for the treatment of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35051749",
                "pmid35628525",
                "pmid24222914",
                "pmid26829126",
                "pmid19141069",
                "pmid38203753",
                "pmid25596491",
                "pmid26362358",
                "pmid19625748",
                "pmid21272191"
            ]
        },
        "clinical_110": {
            "question": "Is lithium more cost-effective than aducanumab for treating cognitive decline in patients with mild cognitive impairment or Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35961514",
                "pmid38253184",
                "pmid26402004",
                "pmid28880358",
                "pmid38657568",
                "pmid25018109",
                "pmid36275418",
                "pmid10664610",
                "pmid34497504",
                "pmid37897809"
            ]
        },
        "clinical_111": {
            "question": "Does nabilone show anti-inflammatory effects in agitated patients with Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31547752",
                "pmid31338476",
                "pmid12453679",
                "pmid31322567",
                "pmid25711456",
                "pmid14975597",
                "pmid23585364",
                "pmid12930788",
                "pmid15118486",
                "pmid37336148"
            ]
        },
        "clinical_112": {
            "question": "Does Captopril show greater effectiveness than Perindopril in preventing Alzheimer's disease-like pathology induced by aluminium chloride?",
            "answer": "A",
            "pmid": [
                "pmid35243060",
                "pmid25290208",
                "pmid20627092",
                "pmid21593435",
                "pmid21981801",
                "pmid38448794",
                "pmid19805638",
                "pmid30354809",
                "pmid28930532",
                "pmid38057817"
            ]
        },
        "clinical_113": {
            "question": "Does apicidin improve learning and memory impairments in a model of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid36708130",
                "pmid23966081",
                "pmid25108596",
                "pmid31087219",
                "pmid28852940",
                "pmid36382256",
                "pmid37209001",
                "pmid31291099",
                "pmid21069780",
                "pmid21272191"
            ]
        },
        "clinical_114": {
            "question": "Does the inhibition of tau aggregation by the three Aspergillus nidulans secondary metabolites have potential therapeutic implications for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid24414310",
                "pmid34009955",
                "pmid39583559",
                "pmid25822288",
                "pmid37038034",
                "pmid21605038",
                "pmid21782947",
                "pmid30542264",
                "pmid28546539",
                "pmid33320518"
            ]
        },
        "clinical_115": {
            "question": "Does donepezil improve cognitive deficits in a patient with neurosyphilis, similar to its use in Alzheimer's disease?",
            "answer": "A drug therapy combined with donepezil can decrease Abeta levels and improve cognitive functions. Studies demonstrate donepezil improves cognitive performance in various tests, such as the Mini-Mental State Examination and the Morris water maze, and can reduce hippocampal and neocortical caspase-3 activity. These improvements are linked to the inhibition of microglial activation and the reduction of proinflammatory cytokines.",
            "pmid": [
                "pmid26166240",
                "pmid27131829",
                "pmid23742728",
                "pmid24189446",
                "pmid26778658",
                "pmid15254918",
                "pmid29434777",
                "pmid24401551",
                "pmid25662507",
                "pmid12187372"
            ]
        },
        "clinical_116": {
            "question": "Does donepezil, a medication used for Alzheimer's disease, increase collagen 1 expression in mesenchymal stroma cells in an ovine osteoporosis model?",
            "answer": "A",
            "pmid": [
                "pmid30179213",
                "pmid35850693",
                "pmid25662507",
                "pmid25450366",
                "pmid32937955",
                "pmid34582845",
                "pmid31913348",
                "pmid25744714",
                "pmid34638977",
                "pmid19077054"
            ]
        },
        "clinical_117": {
            "question": "Do Spiroisoxazoline (SIO) alkaloids represent a potential new structural manifold for lead-discovery of new therapeutics for treatment of Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Research indicates that certain alkaloids can directly impact Alzheimer's disease pathology, potentially offering new avenues for therapeutic development. Studies have identified pathways related to amyloid beta and tau, as well as synaptic function, as targets for these compounds.",
            "pmid": [
                "pmid36095307",
                "pmid34153839",
                "pmid31087219",
                "pmid28852940",
                "pmid37005850",
                "pmid26797524",
                "pmid33867926",
                "pmid33807157",
                "pmid33991608",
                "pmid31669775"
            ]
        },
        "clinical_118": {
            "question": "Does xanthoceraside have potential therapeutic effects for Alzheimer's disease based on its protective effects in SH-SY5Y cells?",
            "answer": "A",
            "pmid": [
                "pmid24810883",
                "pmid23909924",
                "pmid23966052",
                "pmid28744803",
                "pmid20183271",
                "pmid21735075",
                "pmid23562514",
                "pmid32141445",
                "pmid22102154",
                "pmid29081887"
            ]
        },
        "clinical_119": {
            "question": "Does (m)RVD-hemopressin have a potential therapeutic application in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid37971633",
                "pmid32241604",
                "pmid33171279",
                "pmid31730791",
                "pmid35455468",
                "pmid30354809",
                "pmid30344671",
                "pmid38886959",
                "pmid19805638",
                "pmid28274813"
            ]
        },
        "clinical_120": {
            "question": "Does L-serine improve cognitive dysfunction in an ALS/PDC model that presents symptoms analogous to Alzheimer's-like dementia?",
            "answer": "A",
            "pmid": [
                "pmid36142514",
                "pmid30476904",
                "pmid30824685",
                "pmid22869752",
                "pmid35416570",
                "pmid1776749",
                "pmid31520071",
                "pmid16837104",
                "pmid20555131",
                "pmid25443284"
            ]
        },
        "clinical_121": {
            "question": "Does cytokine signaling in CAR-T cell therapy have a known relationship with delirium?",
            "answer": "<Correct Answer>: A\n<Why>: Cytokine signaling can contribute to neurotoxicity, a complication of CAR-T cell therapy. This neurotoxicity can manifest as neurological dysfunction, aligning with delirium symptoms. Therefore, a relationship exists between cytokine signaling in CAR-T cell therapy and neurological complications resembling delirium.",
            "pmid": [
                "pmid37649721",
                "pmid34192631",
                "pmid24557038",
                "pmid20309566",
                "pmid37851904",
                "pmid17467406",
                "pmid39210294",
                "pmid28769556",
                "pmid35791660",
                "pmid35871757"
            ]
        },
        "clinical_122": {
            "question": "Does the UCNPs-LMB/VQIVYK nanosystem inhibit Tau aggregation to reduce neurotoxicity in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid37103297",
                "pmid21228179",
                "pmid36562884",
                "pmid37269953",
                "pmid32814048",
                "pmid36198316",
                "pmid21605038",
                "pmid32591533",
                "pmid32366836",
                "pmid35662233"
            ]
        },
        "clinical_123": {
            "question": "Does the aqueous extract of Ziziphus jujuba exhibit antiamnesic effects comparable to donepezil, a standard drug for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid34194520",
                "pmid34422074",
                "pmid35922734",
                "pmid24244815",
                "pmid24886882",
                "pmid34973350",
                "pmid32316271",
                "pmid28643520",
                "pmid35900690",
                "pmid28275781"
            ]
        },
        "clinical_124": {
            "question": "Does memantine, a drug used for Alzheimer's disease, have a protective effect against cartilage destruction in osteoarthritis?",
            "answer": "A",
            "pmid": [
                "pmid28545202",
                "pmid24227863",
                "pmid28917837",
                "pmid28167259",
                "pmid19642202",
                "pmid20042680",
                "pmid34120588",
                "pmid19948208",
                "pmid18615702",
                "pmid15192085"
            ]
        },
        "clinical_125": {
            "question": "Does the extract POEE from Marapuama reduce cognitive impairment in an Alzheimer's disease model?",
            "answer": "A",
            "pmid": [
                "pmid20739160",
                "pmid36982332",
                "pmid26068423",
                "pmid36777330",
                "pmid31661844",
                "pmid28279707",
                "pmid32488469",
                "pmid28643520",
                "pmid29190943",
                "pmid32316271"
            ]
        },
        "clinical_126": {
            "question": "Does xanthoceraside improve cognitive impairment in Alzheimer's disease by promoting neurogenesis?",
            "answer": "A",
            "pmid": [
                "pmid28744803",
                "pmid24810883",
                "pmid23562514",
                "pmid23909924",
                "pmid21735075",
                "pmid20183271",
                "pmid23966052",
                "pmid32141445",
                "pmid35781783",
                "pmid38355004"
            ]
        },
        "clinical_127": {
            "question": "Does remifentanil reduce the occurrence of delirium in mechanically ventilated patients?",
            "answer": "A",
            "pmid": [
                "pmid28910303",
                "pmid18577171",
                "pmid24259659",
                "pmid24852225",
                "pmid38911008",
                "pmid35726401",
                "pmid39541802",
                "pmid29958125",
                "pmid37133446",
                "pmid23503785"
            ]
        },
        "clinical_128": {
            "question": "Does Deacetyl Ganoderic Acid F (DeGA F) have potential therapeutic effects for conditions associated with neural inflammation, such as Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31892211",
                "pmid39625499",
                "pmid33821438",
                "pmid34798773",
                "pmid26965310",
                "pmid33178186",
                "pmid12453679",
                "pmid32583667",
                "pmid23645098",
                "pmid32480240"
            ]
        },
        "clinical_129": {
            "question": "Does nervonic acid have the potential to be developed as an antioxidant drug for the prevention and early therapy of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid37823115",
                "pmid33431776",
                "pmid39603393",
                "pmid36639003",
                "pmid25847999",
                "pmid38203753",
                "pmid31945778",
                "pmid28630497",
                "pmid26529297",
                "pmid36770835"
            ]
        },
        "clinical_130": {
            "question": "Does Lonicera japonica polysaccharide (LJP) improve learning and memory impairments associated with Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid32954750",
                "pmid31661844",
                "pmid30844489",
                "pmid36193798",
                "pmid29190943",
                "pmid33913927",
                "pmid27534446",
                "pmid30290256",
                "pmid29865080",
                "pmid35586051"
            ]
        },
        "clinical_131": {
            "question": "Does the behavioral variant of Alzheimer's disease show reduced attention to salient facial features compared to typical Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid36268579",
                "pmid37672106",
                "pmid30088784",
                "pmid26017202",
                "pmid27056068",
                "pmid2694529",
                "pmid30820047",
                "pmid22495348",
                "pmid11483593",
                "pmid9425904"
            ]
        },
        "clinical_132": {
            "question": "Does cabergoline's neuroprotective effect against oxidative stress suggest a potential role in treating Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid24914776",
                "pmid31945778",
                "pmid15948179",
                "pmid35195784",
                "pmid24975829",
                "pmid22186599",
                "pmid29411261",
                "pmid28250796",
                "pmid34354404",
                "pmid26797524"
            ]
        },
        "clinical_133": {
            "question": "Does the use of amlodipine in Alzheimer's dementia patients reduce the risk of ischaemic stroke compared to other calcium channel blockers?",
            "answer": "A",
            "pmid": [
                "pmid32854138",
                "pmid15582745",
                "pmid25068540",
                "pmid27512890",
                "pmid33327915",
                "pmid12962529",
                "pmid19805638",
                "pmid16399208",
                "pmid37897809",
                "pmid26727124"
            ]
        },
        "clinical_134": {
            "question": "Does the core sequence of PIF compete for insulin/amyloid beta in insulin degrading enzyme, potentially offering a treatment for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30338033",
                "pmid15590928",
                "pmid29132916",
                "pmid39481143",
                "pmid27320287",
                "pmid26444774",
                "pmid30422705",
                "pmid26895791",
                "pmid17496198",
                "pmid22829447"
            ]
        },
        "clinical_135": {
            "question": "Does trametinib, a MEK1/2 inhibitor, reduce amyloid beta (Abeta) deposition in a model of Alzheimer's Disease?",
            "answer": "A",
            "pmid": [
                "pmid35948663",
                "pmid27567806",
                "pmid20119496",
                "pmid29327084",
                "pmid24269024",
                "pmid22992731",
                "pmid25303711",
                "pmid26696494",
                "pmid26883430",
                "pmid19642202"
            ]
        },
        "clinical_136": {
            "question": "Does the ethanolic extract of D. moldavica leaves (EEDM) show potential for treating Alzheimer's disease based on its effects in scopolamine-induced cognitive impairment studies?",
            "answer": "<Correct Answer>: A\n<Why>: Studies demonstrate that herbal medicines with multiple actions can improve cognitive function in Alzheimer’s disease. Bugu-M, a multi-herbal extract, mitigated amyloid-beta-evoked toxicity and prevented cognitive impairment in mice, suggesting potential for delaying disease progression. Similarly, another study found that a specific extract significantly attenuates scopolamine-induced memory impairment, indicating a promising therapeutic effect on cognitive function.\n\n\n\n",
            "pmid": [
                "pmid32035879",
                "pmid29100755",
                "pmid28643520",
                "pmid32488469",
                "pmid38954263",
                "pmid26068423",
                "pmid32316271",
                "pmid29081887",
                "pmid34973350",
                "pmid36777330"
            ]
        },
        "clinical_137": {
            "question": "Does prazosin improve behavioral symptoms in patients with Alzheimer disease experiencing agitation and aggression?",
            "answer": "A",
            "pmid": [
                "pmid19700947",
                "pmid25711456",
                "pmid35864999",
                "pmid16856516",
                "pmid11087767",
                "pmid32695312",
                "pmid39623197",
                "pmid39648108",
                "pmid17897735",
                "pmid34864088"
            ]
        },
        "clinical_138": {
            "question": "Does the pro-drug peptide (PDp) exhibit neuroprotective effects against Alzheimer's disease in vitro?",
            "answer": "A",
            "pmid": [
                "pmid30958369",
                "pmid28714389",
                "pmid27995757",
                "pmid21346312",
                "pmid18442091",
                "pmid17459354",
                "pmid12105192",
                "pmid36994913",
                "pmid18403590",
                "pmid17261088"
            ]
        },
        "clinical_139": {
            "question": "Does donepezil treatment affect cholesterol levels in Alzheimer's disease patients?",
            "answer": "<Correct Answer>: A\n<Why>: Research indicates donepezil is therapeutically efficacious for Alzheimer’s disease and exhibits convenient pharmacokinetic properties, suggesting its continued importance in treatment for the foreseeable future. While studies show a correlation between cholesterol metabolism and Alzheimer’s, there is no information provided regarding the effect of donepezil on cholesterol levels.",
            "pmid": [
                "pmid28861608",
                "pmid14599705",
                "pmid30680019",
                "pmid29434777",
                "pmid27131829",
                "pmid11830754",
                "pmid23742728",
                "pmid17939763",
                "pmid12187372",
                "pmid30878503"
            ]
        },
        "clinical_140": {
            "question": "Does the compound ZLWH-23 show potential as a drug lead for Alzheimer's disease treatment?",
            "answer": "A novel series of harmine derivatives, including compound ZLWH-23, exhibit significant anti-acetylcholinesterase activity and selective inhibition of butyrylcholinesterase and glycogen synthase kinase-3beta. Molecular studies suggest stable interactions with these enzymes, and the compound demonstrates efficient reduction of tau hyperphosphorylation, indicating potential as a drug lead for Alzheimer's disease therapy.\n\n\n\n",
            "pmid": [
                "pmid26797524",
                "pmid37261605",
                "pmid38010470",
                "pmid38203753",
                "pmid30344671",
                "pmid25596491",
                "pmid36411758",
                "pmid31697472",
                "pmid19625748",
                "pmid34995924"
            ]
        },
        "clinical_141": {
            "question": "Does the presence of cerebral amyloid angiopathy (CAA) correlate with reduced NEP activity in Alzheimer's disease patients?",
            "answer": "A",
            "pmid": [
                "pmid17021406",
                "pmid21382117",
                "pmid17591969",
                "pmid12387451",
                "pmid22482447",
                "pmid19319544",
                "pmid35851991",
                "pmid25368578",
                "pmid38405347",
                "pmid16328515"
            ]
        },
        "clinical_142": {
            "question": "Does the combined treatment of MC5523 and LiCl improve neuroprotection and reduce side effects in the treatment of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30513908",
                "pmid36411758",
                "pmid36275418",
                "pmid25018109",
                "pmid37762479",
                "pmid17406652",
                "pmid34497504",
                "pmid34856907",
                "pmid38203753",
                "pmid31541651"
            ]
        },
        "clinical_143": {
            "question": "Does TRPC3 suppression improve memory deficits in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid39345364",
                "pmid29660945",
                "pmid33998138",
                "pmid34302466",
                "pmid32061032",
                "pmid39209323",
                "pmid33420799",
                "pmid30362958",
                "pmid25443284",
                "pmid27713140"
            ]
        },
        "clinical_144": {
            "question": "Does the use of angiotensin II-inhibiting antihypertensive medications increase the risk of Alzheimer's disease in patients with colorectal cancer compared to angiotensin II-stimulating medications?",
            "answer": "A",
            "pmid": [
                "pmid37215552",
                "pmid19805638",
                "pmid30354809",
                "pmid38685540",
                "pmid21451506",
                "pmid20627092",
                "pmid39584306",
                "pmid10490699",
                "pmid32854138",
                "pmid30186862"
            ]
        },
        "clinical_145": {
            "question": "Is QS-21 used in therapeutic vaccines for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31182297",
                "pmid37947289",
                "pmid31839610",
                "pmid21975314",
                "pmid24950335",
                "pmid31697472",
                "pmid30264333",
                "pmid31923845",
                "pmid32092796",
                "pmid39117070"
            ]
        },
        "clinical_146": {
            "question": "Is donepezil, an acetylcholinesterase inhibitor, also found to inhibit BACE-1 and thus potentially beneficial for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid17541560",
                "pmid10637367",
                "pmid11830754",
                "pmid15989517",
                "pmid17939763",
                "pmid9853200",
                "pmid25744714",
                "pmid19077054",
                "pmid9428950",
                "pmid30709653"
            ]
        },
        "clinical_147": {
            "question": "Does the hydroxylated form of docosahexaenoic acid (DHA-H) improve survival and motor function in a model of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid28284721",
                "pmid24374316",
                "pmid18037281",
                "pmid31677009",
                "pmid21606627",
                "pmid35782939",
                "pmid26965310",
                "pmid23645098",
                "pmid19423322",
                "pmid12065621"
            ]
        },
        "clinical_148": {
            "question": "Does Piper wallichii's petroleum ether fraction (PPF) exhibit anti-Alzheimer's disease effects in Caenorhabditis elegans?",
            "answer": "A",
            "pmid": [
                "pmid37327643",
                "pmid32413539",
                "pmid38003724",
                "pmid38373507",
                "pmid39682936",
                "pmid24909620",
                "pmid29709515",
                "pmid28119052",
                "pmid27474225",
                "pmid37838776"
            ]
        },
        "clinical_149": {
            "question": "Does Triticum aestivum L. (TAL) have neuroprotective effects against beta-amyloid-induced cell death and memory impairments in Alzheimer's disease?",
            "answer": "A growing body of literature supports the concept that certain compounds may be potential candidates for use in treating age-related neurodegeneration, including Alzheimer’s disease. Studies have demonstrated that specific compounds can attenuate beta-amyloid-induced cell damage, enhance signaling pathways, and reduce tau phosphorylation and apoptosis. Furthermore, these compounds have been shown to improve spatial learning and memory in mouse models of Alzheimer’s disease.",
            "pmid": [
                "pmid19441012",
                "pmid38363611",
                "pmid38455162",
                "pmid25229015",
                "pmid23833520",
                "pmid37114959",
                "pmid29100755",
                "pmid32140977",
                "pmid26068423",
                "pmid29865080"
            ]
        },
        "clinical_150": {
            "question": "Does early initiation of donepezil treatment improve outcomes for patients with geriatric depression and Alzheimer's disease?",
            "answer": "Donepezil is a clinically effective and well-tolerated once-daily treatment for the symptoms of mild to moderate Alzheimer’s disease. It improves cognitive performance and stabilizes functional abilities by increasing acetylcholine levels in the brain. Clinical trials have demonstrated statistically significant improvements in cognition, as measured by scales like the Alzheimer’s Disease Assessment Scale. The drug exhibits good safety and tolerability, with a convenient pharmacokinetic profile for prescription.\n\n\n\n",
            "pmid": [
                "pmid30037778",
                "pmid19528519",
                "pmid25919986",
                "pmid27790242",
                "pmid23742728",
                "pmid15254918",
                "pmid11830754",
                "pmid12187372",
                "pmid9853200",
                "pmid17939763"
            ]
        },
        "clinical_151": {
            "question": "Does Callicarpa kwangtungensis Chun (CK) improve cognitive function in Alzheimer's disease (AD) models?",
            "answer": "A",
            "pmid": [
                "pmid39586557",
                "pmid29080453",
                "pmid32140977",
                "pmid28279707",
                "pmid36349022",
                "pmid25009697",
                "pmid30844489",
                "pmid36814130",
                "pmid31661844",
                "pmid28643520"
            ]
        },
        "clinical_152": {
            "question": "Does flufenamic acid inhibit the activation of the NLRP3 inflammasome in microglia, thereby offering a potential treatment for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35474599",
                "pmid38565393",
                "pmid23686772",
                "pmid28003153",
                "pmid36799439",
                "pmid34478813",
                "pmid32929691",
                "pmid36018189",
                "pmid25621771",
                "pmid29743866"
            ]
        },
        "clinical_153": {
            "question": "Can the disruption of gut microbiota caused by treatments like Acyclovir contribute to delirium?",
            "answer": "A",
            "pmid": [
                "pmid20309566",
                "pmid25567339",
                "pmid32760124",
                "pmid37313848",
                "pmid33648701",
                "pmid24557038",
                "pmid38895540",
                "pmid32592865",
                "pmid39355007",
                "pmid39419070"
            ]
        },
        "clinical_154": {
            "question": "Is hypophosphatemia associated with neurotoxicity symptoms resembling delirium in CD19-targeted CAR T-cell therapy?",
            "answer": "A",
            "pmid": [
                "pmid36259217",
                "pmid35042236",
                "pmid36006611",
                "pmid35871757",
                "pmid28049548",
                "pmid33763368",
                "pmid38566855",
                "pmid29311807",
                "pmid36078999",
                "pmid38937571"
            ]
        },
        "clinical_155": {
            "question": "Does imatinib methanesulfonate reduce hippocampal amyloid-beta and restore cognitive function in a model of Alzheimer's disease following repeated endotoxin exposure?",
            "answer": "A",
            "pmid": [
                "pmid23665252",
                "pmid27320209",
                "pmid31134481",
                "pmid27567806",
                "pmid22982445",
                "pmid34589882",
                "pmid28346227",
                "pmid20555131",
                "pmid39476996",
                "pmid19798641"
            ]
        },
        "clinical_156": {
            "question": "Does Armillaria mellea polysaccharides (AMPS) improve cognitive function in Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: This substance demonstrated improvements in cognition and histopathological changes in a mouse model of the disease, reduced amyloid beta deposition, and downregulated pro-inflammatory cytokines and glial cell activation. These findings suggest a neuroprotective effect and improvement in cognitive function. Therefore, the answer is yes.",
            "pmid": [
                "pmid29081887",
                "pmid38866276",
                "pmid35924065",
                "pmid33432644",
                "pmid30290256",
                "pmid33913927",
                "pmid32800555",
                "pmid29080453",
                "pmid37781122",
                "pmid30844489"
            ]
        },
        "clinical_157": {
            "question": "Does donepezil treatment protect against doxorubicin-induced chemobrain by reducing Alzheimer's disease-associated lesions?",
            "answer": "<Correct Answer>: A\n<Why>: Studies demonstrate donepezil improves cognitive function in transgenic mice and rats with induced cognitive impairment. These improvements are associated with reduced microglial activation, decreased proinflammatory cytokines, and increased BDNF expression. Donepezil also attenuates neurodegeneration and restores synapse density in the cortex and hippocampus.",
            "pmid": [
                "pmid34312765",
                "pmid27131829",
                "pmid24189446",
                "pmid20718745",
                "pmid24401551",
                "pmid19077054",
                "pmid23742728",
                "pmid25662507",
                "pmid16772755",
                "pmid31913348"
            ]
        },
        "clinical_158": {
            "question": "Does the compound 4v inhibit Abeta42-induced cytotoxicity and show potential for Alzheimer's disease treatment?",
            "answer": "A",
            "pmid": [
                "pmid19141069",
                "pmid22238689",
                "pmid28131834",
                "pmid22992731",
                "pmid16246051",
                "pmid16805796",
                "pmid36442093",
                "pmid27258855",
                "pmid36724966",
                "pmid31402645"
            ]
        },
        "clinical_159": {
            "question": "What was the outcome of the patient's treatment regarding delirium and Behcet's disease symptoms?",
            "answer": "B",
            "pmid": [
                "pmid27579169",
                "pmid16840933",
                "pmid26953013",
                "pmid669496",
                "pmid37133446",
                "pmid12766698",
                "pmid36078999",
                "pmid25567339",
                "pmid20204907",
                "pmid39541802"
            ]
        },
        "clinical_160": {
            "question": "What was the primary outcome measure in the AMARANTH and DAYBREAK-ALZ trials for assessing lanabecestat's efficacy in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid31764959",
                "pmid11110737",
                "pmid27767993",
                "pmid24326116",
                "pmid24461047",
                "pmid9853200",
                "pmid20202480",
                "pmid18363842",
                "pmid34064687",
                "pmid34294612"
            ]
        },
        "clinical_161": {
            "question": "What is the relationship between cholinergic drugs used for treating neuroleptic-induced tardive dyskinesia and Alzheimer's disease?",
            "answer": "D",
            "pmid": [
                "pmid12137608",
                "pmid24217282",
                "pmid2694529",
                "pmid33540879",
                "pmid38502289",
                "pmid1491741",
                "pmid8997426",
                "pmid37701892",
                "pmid16762377",
                "pmid18577377"
            ]
        },
        "clinical_162": {
            "question": "What is the effect of ethyl pyruvate on the neurotoxicity induced by aluminum chloride in an in vitro model of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid32030557",
                "pmid25434488",
                "pmid17004365",
                "pmid23219964",
                "pmid33582452",
                "pmid28930532",
                "pmid38448794",
                "pmid38228217",
                "pmid2725861",
                "pmid38057817"
            ]
        },
        "clinical_163": {
            "question": "How does the BQCA-SA-P80-NP conjugate improve therapeutic outcomes in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid35423107",
                "pmid25443284",
                "pmid25390692",
                "pmid23017601",
                "pmid24141082",
                "pmid38006681",
                "pmid31839610",
                "pmid35048805",
                "pmid36817510",
                "pmid21272191"
            ]
        },
        "clinical_164": {
            "question": "How does the use of QU-SA-5HTM-PA-PLGA nanoparticles contribute to the management of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid33405649",
                "pmid29113362",
                "pmid27591943",
                "pmid28630497",
                "pmid33042734",
                "pmid35307993",
                "pmid39805185",
                "pmid37206236",
                "pmid37947289",
                "pmid37103297"
            ]
        },
        "clinical_165": {
            "question": "What was the effect of nicergoline on the ADAS-Cog score in Alzheimer's disease patients?",
            "answer": "The available literature suggests that while current treatments for early Alzheimer’s disease, such as acetylcholine esterase inhibitors, have limited efficacy, alternative approaches focusing on N-methyl-D-aspartate receptor function and oxidative stress may offer potential biomarkers for diagnosis and treatment response. Studies have evaluated the efficacy of galantamine, rivastigmine, and donepezil on cognitive scores and cholinesterase levels, highlighting varying pharmacological effects among these inhibitors. However, there is no information provided regarding the effect of nicergoline on the ADAS-Cog score.\n\n\n\n",
            "pmid": [
                "pmid29568940",
                "pmid11687175",
                "pmid9205832",
                "pmid30906380",
                "pmid15882840",
                "pmid39325017",
                "pmid25243157",
                "pmid11110737",
                "pmid19199870",
                "pmid34294612"
            ]
        },
        "clinical_166": {
            "question": "How does the combined formulation of Ramipril and Black Seed Oil (BSO) address the therapeutic management of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid34064687",
                "pmid39305407",
                "pmid36145341",
                "pmid36500385",
                "pmid37598923",
                "pmid26529297",
                "pmid34973350",
                "pmid36232612",
                "pmid38612861",
                "pmid28821008"
            ]
        },
        "clinical_167": {
            "question": "What is the potential benefit of combining low doses of lupeol and metformin in the management of dementia, particularly in Alzheimer's disease (AD) type?",
            "answer": "C",
            "pmid": [
                "pmid38842663",
                "pmid30958364",
                "pmid32580040",
                "pmid34283253",
                "pmid39441380",
                "pmid37483818",
                "pmid37597424",
                "pmid33335556",
                "pmid30186862",
                "pmid25018109"
            ]
        },
        "clinical_168": {
            "question": "What effect does pranlukast have on cognitive deficits associated with Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid24229499",
                "pmid30354809",
                "pmid19805638",
                "pmid20627092",
                "pmid8997426",
                "pmid22982445",
                "pmid24269024",
                "pmid8128843",
                "pmid27916702",
                "pmid39044493"
            ]
        },
        "clinical_169": {
            "question": "How might the inclusion of evodiamine in hydroxypropyl-beta-cyclodextrin (HP-beta-CD) affect Alzheimer's disease treatment?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid29883380",
                "pmid21278785",
                "pmid27458481",
                "pmid37329974",
                "pmid21272191",
                "pmid38203753",
                "pmid31730791",
                "pmid26696494",
                "pmid21276834",
                "pmid30563837"
            ]
        },
        "clinical_170": {
            "question": "How does breviscapine combined with BMSCs treatment affect Abeta deposition in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid35048805",
                "pmid32144518",
                "pmid24219385",
                "pmid34116571",
                "pmid26696494",
                "pmid25303711",
                "pmid36907286",
                "pmid24184877",
                "pmid26883430",
                "pmid25390692"
            ]
        },
        "clinical_171": {
            "question": "What effect did donepezil treatment have on the gray matter volume in the hippocampus of Alzheimer's disease patients?",
            "answer": "Donepezil treatment led to significantly increased volumes in the hippocampus compared to untreated patients.",
            "pmid": [
                "pmid27131829",
                "pmid18070217",
                "pmid27647493",
                "pmid29434777",
                "pmid23742728",
                "pmid24189446",
                "pmid31913348",
                "pmid25662507",
                "pmid24401551",
                "pmid25266713"
            ]
        },
        "clinical_172": {
            "question": "What is the effect of ETA receptor antagonists on cognitive impairment caused by amyloid-beta in a model of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid21116051",
                "pmid12930788",
                "pmid25390692",
                "pmid15817521",
                "pmid18509040",
                "pmid28157092",
                "pmid23379615",
                "pmid36586644",
                "pmid26271288",
                "pmid11741404"
            ]
        },
        "clinical_173": {
            "question": "What effect does vanillin have on memory deficits in a scopolamine-induced model of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid38941895",
                "pmid36408377",
                "pmid37329974",
                "pmid33171279",
                "pmid32056532",
                "pmid1776749",
                "pmid30949953",
                "pmid37971633",
                "pmid38468315",
                "pmid20627092"
            ]
        },
        "clinical_174": {
            "question": "What was the primary symptom observed in the patient following pembrolizumab therapy that was associated with delirium?",
            "answer": "B",
            "pmid": [
                "pmid36626467",
                "pmid20204907",
                "pmid39958332",
                "pmid34123673",
                "pmid26953013",
                "pmid23909707",
                "pmid23914753",
                "pmid19079356",
                "pmid18585545",
                "pmid19836623"
            ]
        },
        "clinical_175": {
            "question": "What effect does vinpocetine have on memory and learning impairment in an Alzheimer's disease model induced by Abeta peptide?",
            "answer": "B",
            "pmid": [
                "pmid31991177",
                "pmid11200083",
                "pmid31175888",
                "pmid36927298",
                "pmid34706318",
                "pmid39521153",
                "pmid24229499",
                "pmid17008108",
                "pmid25596671",
                "pmid18400893"
            ]
        },
        "clinical_176": {
            "question": "What effect does IRL-1620, an endothelin receptor type B agonist, have on Alzheimer's disease (AD) in experimental models?",
            "answer": "B",
            "pmid": [
                "pmid24561065",
                "pmid29947531",
                "pmid21116051",
                "pmid28274813",
                "pmid21193044",
                "pmid12383957",
                "pmid25443284",
                "pmid30354809",
                "pmid28939187",
                "pmid20627092"
            ]
        },
        "clinical_177": {
            "question": "What effect does SS31 have on Alzheimer's disease progression in early-stage AD?",
            "answer": "B",
            "pmid": [
                "pmid24059318",
                "pmid37018887",
                "pmid36620941",
                "pmid33991608",
                "pmid23226438",
                "pmid10817927",
                "pmid30820047",
                "pmid34366829",
                "pmid37108607",
                "pmid9737546"
            ]
        },
        "clinical_178": {
            "question": "What is a potential benefit of using B6-RES-OPC-HA nanoparticles in the treatment of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid28630497",
                "pmid37206236",
                "pmid33042734",
                "pmid38747495",
                "pmid35307993",
                "pmid37103297",
                "pmid29113362",
                "pmid39805185",
                "pmid39281976",
                "pmid33405649"
            ]
        },
        "clinical_179": {
            "question": "How does mindfulness-based stress reduction (MBSR) therapy impact outcomes in cirrhosis patients and their caregivers, particularly in relation to Alzheimer's disease or delirium?",
            "answer": "A recent study demonstrated that music therapy can improve anxiety and depression in patients with mild to moderate Alzheimer’s disease. Furthermore, research indicates that music therapy can benefit both Alzheimer’s patients and their caregivers by improving symptoms and reducing caregiver burden. Differences in the etiology and presentation of delirium have been noted when occurring in patients with underlying dementia, with systemic infection often linked to delirium superimposed on dementia and metabolic disturbances associated with delirium alone.\n\n\n\n",
            "pmid": [
                "pmid28749453",
                "pmid35010874",
                "pmid25154985",
                "pmid20471115",
                "pmid35017578",
                "pmid27567825",
                "pmid37133446",
                "pmid37566435",
                "pmid36278769",
                "pmid19628939"
            ]
        },
        "clinical_180": {
            "question": "What therapeutic approach does MRZ-99030 represent for Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid25634238",
                "pmid24223757",
                "pmid20154710",
                "pmid19625748",
                "pmid31060682",
                "pmid22344941",
                "pmid32892233",
                "pmid17939763",
                "pmid35195784",
                "pmid25368578"
            ]
        },
        "clinical_181": {
            "question": "What is the primary outcome measure used to assess the effectiveness of premedication in preventing emergence delirium in children undergoing strabismus surgery?",
            "answer": "<Correct Answer>: A\n<Why>: The study evaluated the effectiveness of intranasal dexmedetomidine-esketamine premedication in reducing emergence delirium compared to esketamine alone and dexmedetomidine alone in children undergoing tonsillectomy and/or adenoidectomy. While the specific scale used isn’t mentioned, the primary focus is on reducing the incidence of emergence delirium.",
            "pmid": [
                "pmid32976205",
                "pmid27635747",
                "pmid37128675",
                "pmid33045022",
                "pmid37133446",
                "pmid36203819",
                "pmid39464168",
                "pmid36224337",
                "pmid27119013",
                "pmid38911008"
            ]
        },
        "clinical_182": {
            "question": "What is a key factor that makes ANAVEX 2-73 (blarcamesine) an intriguing candidate for Rett syndrome treatment, based on its profile in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31704481",
                "pmid28587858",
                "pmid23293526",
                "pmid20950278",
                "pmid36430502",
                "pmid23379615",
                "pmid35671352",
                "pmid31966420",
                "pmid34502373",
                "pmid37598923"
            ]
        },
        "clinical_183": {
            "question": "What effect does reducing the levels of KIF5B have on memory impairment in Alzheimer's disease models?",
            "answer": "B",
            "pmid": [
                "pmid36387285",
                "pmid25443284",
                "pmid28939187",
                "pmid36533331",
                "pmid19447162",
                "pmid31840000",
                "pmid29491219",
                "pmid22033930",
                "pmid20555131",
                "pmid37264981"
            ]
        },
        "clinical_184": {
            "question": "What is the effect of donepezil on homocysteine (Hcy) levels and dyssomnia in Alzheimer's disease patients?",
            "answer": "Donepezil is generally well tolerated, with most adverse events being mild, transient, and cholinergic in nature. It's approved for treating mild to moderate Alzheimer's disease and may have potential applications in other conditions like dementia with Lewy bodies, and sleep disorders. Studies have shown it can improve cognitive functions and decrease beta-amyloid levels in the peripheral blood.",
            "pmid": [
                "pmid30680019",
                "pmid24189446",
                "pmid28861608",
                "pmid27647493",
                "pmid15601392",
                "pmid25744714",
                "pmid35850693",
                "pmid11830754",
                "pmid18070217",
                "pmid29434777"
            ]
        },
        "clinical_185": {
            "question": "What effect did methylene blue have on neurotoxicity in a zebrafish model for tauopathies, specifically in relation to Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid20381619",
                "pmid24462887",
                "pmid38228217",
                "pmid33687726",
                "pmid19363289",
                "pmid38827230",
                "pmid26852117",
                "pmid27258855",
                "pmid39039682",
                "pmid33535660"
            ]
        },
        "clinical_186": {
            "question": "What is the protective effect of Housefly (Musca domestica) Larvae powder (HL) against Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid30540319",
                "pmid35530205",
                "pmid29745345",
                "pmid28284721",
                "pmid32321934",
                "pmid39833898",
                "pmid36814130",
                "pmid16821116",
                "pmid38003724",
                "pmid30290256"
            ]
        },
        "clinical_187": {
            "question": "In Alzheimer's disease, where was aluminum consistently detected?",
            "answer": "C",
            "pmid": [
                "pmid17004365",
                "pmid2725861",
                "pmid38057817",
                "pmid34209820",
                "pmid23052602",
                "pmid30820047",
                "pmid11730949",
                "pmid11958858",
                "pmid29053874",
                "pmid15486488"
            ]
        },
        "clinical_188": {
            "question": "What category size affects verbal fluency in Alzheimer's patients?",
            "answer": "C",
            "pmid": [
                "pmid15010242",
                "pmid37672106",
                "pmid26017202",
                "pmid27272392",
                "pmid27781389",
                "pmid16286547",
                "pmid33301871",
                "pmid25820930",
                "pmid18562794",
                "pmid34665329"
            ]
        },
        "clinical_189": {
            "question": "What brain changes are described as examples of aging and Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid2893306",
                "pmid35093614",
                "pmid29977201",
                "pmid38077352",
                "pmid33597269",
                "pmid11483593",
                "pmid30820047",
                "pmid24336108",
                "pmid9425904",
                "pmid17215356"
            ]
        },
        "clinical_190": {
            "question": "What changes occur in cortical mean diffusivity (MD) in early Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid29080407",
                "pmid22651939",
                "pmid9878757",
                "pmid2893306",
                "pmid17215356",
                "pmid27056068",
                "pmid26923404",
                "pmid29053874",
                "pmid11958858",
                "pmid30820047"
            ]
        },
        "clinical_191": {
            "question": "Which brain region correlates with ideomotor and dressing apraxia in Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid9605726",
                "pmid7916770",
                "pmid38958450",
                "pmid27195475",
                "pmid8239309",
                "pmid2900051",
                "pmid11276052",
                "pmid38972885",
                "pmid17080199",
                "pmid22495348"
            ]
        },
        "clinical_192": {
            "question": "Which animals are proposed as natural, non-transgenic models for Alzheimer's disease research?",
            "answer": "<Correct Answer>: C\n<Why>: Research indicates that chick embryos and dogs possess enzymatic machinery for processing APP that closely resembles that of humans, suggesting their potential as natural, non-transgenic models for Alzheimer's disease research. Additionally, a recent study established an Alzheimer's disease model in zebrafish using okadaic acid, providing a time and cost-efficient option for drug discovery.",
            "pmid": [
                "pmid19355852",
                "pmid38228217",
                "pmid38827230",
                "pmid33687726",
                "pmid20881126",
                "pmid25443284",
                "pmid27474225",
                "pmid25529196",
                "pmid10550330",
                "pmid30392874"
            ]
        },
        "clinical_193": {
            "question": "What differences in outcome were observed between men and women with Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid20733307",
                "pmid37330146",
                "pmid35708851",
                "pmid39497354",
                "pmid33301871",
                "pmid33715827",
                "pmid30820047",
                "pmid23715905",
                "pmid23052602",
                "pmid9425904"
            ]
        },
        "clinical_194": {
            "question": "How does chronic kidney disease affect cognitive impairment in Alzheimer's disease mice?",
            "answer": "C",
            "pmid": [
                "pmid27916702",
                "pmid12881482",
                "pmid36894557",
                "pmid33597269",
                "pmid38241837",
                "pmid21799251",
                "pmid38996935",
                "pmid39736370",
                "pmid17215356",
                "pmid37597424"
            ]
        },
        "clinical_195": {
            "question": "How does dual tasking affect postural sway in preclinical Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid38554257",
                "pmid9605726",
                "pmid36396271",
                "pmid17851237",
                "pmid38395200",
                "pmid32273835",
                "pmid25820930",
                "pmid17215356",
                "pmid37108607",
                "pmid30820047"
            ]
        },
        "clinical_196": {
            "question": "What two main factors affect support for Iranian older spousal caregivers of people with Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid39097934",
                "pmid30820047",
                "pmid20733307",
                "pmid38554257",
                "pmid28269768",
                "pmid9425904",
                "pmid1908231",
                "pmid27060961",
                "pmid17537576",
                "pmid12059037"
            ]
        },
        "clinical_197": {
            "question": "What condition can share cognitive decline and a positive Amyloid-PET scan with Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid38405347",
                "pmid37123373",
                "pmid25820930",
                "pmid19940172",
                "pmid30820047",
                "pmid28243073",
                "pmid17803977",
                "pmid9425904",
                "pmid25351853",
                "pmid37108607"
            ]
        },
        "clinical_198": {
            "question": "Which brain area shows decreased diffusivity potentially indicating early Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid22651939",
                "pmid29080407",
                "pmid19319544",
                "pmid24607963",
                "pmid14507668",
                "pmid11276052",
                "pmid20202480",
                "pmid25820930",
                "pmid7916770",
                "pmid10095092"
            ]
        },
        "clinical_199": {
            "question": "Which delirium subtypes are associated with shorter survival periods in terminally ill patients?",
            "answer": "Biomarkers reflecting systemic inflammation and astrocyte/glial activation are linked to longer delirium duration, increased severity, and in-hospital mortality. A high blood urea nitrogen to creatinine ratio is associated with hypoactive delirium. Clinical characteristics and risk factors for delirium differ between demented and non-demented elderly inpatients, with demented patients being vulnerable to delirium at lower levels of medical acuity.",
            "pmid": [
                "pmid26397939",
                "pmid37133446",
                "pmid29657370",
                "pmid37610551",
                "pmid20471115",
                "pmid37566435",
                "pmid31770149",
                "pmid36078999",
                "pmid17183425",
                "pmid37851904"
            ]
        },
        "clinical_200": {
            "question": "Which cognitive tests correlate with functional decline in both Parkinson's and Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid17851237",
                "pmid37246509",
                "pmid39781717",
                "pmid37521457",
                "pmid21488579",
                "pmid34217798",
                "pmid39476996",
                "pmid36291338",
                "pmid38241837",
                "pmid25318543"
            ]
        },
        "clinical_201": {
            "question": "What pathology is linked to iatrogenic Alzheimer's disease in growth hormone recipients?",
            "answer": "C\n",
            "pmid": [
                "pmid38287166",
                "pmid17080199",
                "pmid16943563",
                "pmid32444869",
                "pmid18525129",
                "pmid33737172",
                "pmid22495348",
                "pmid18516051",
                "pmid31442405",
                "pmid10817926"
            ]
        },
        "clinical_202": {
            "question": "What functional domains were identified as highly relevant for assessment in early Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid33250792",
                "pmid23558480",
                "pmid36396271",
                "pmid18363842",
                "pmid7533559",
                "pmid37672106",
                "pmid11351135",
                "pmid7916770",
                "pmid33466666",
                "pmid33446646"
            ]
        },
        "clinical_203": {
            "question": "What role do home healthcare nurses play in delirium?",
            "answer": "C",
            "pmid": [
                "pmid19114784",
                "pmid36520371",
                "pmid28673598",
                "pmid31574089",
                "pmid30142098",
                "pmid33648701",
                "pmid25567339",
                "pmid20030432",
                "pmid35815182",
                "pmid7211434"
            ]
        },
        "clinical_204": {
            "question": "What data types were used to identify conversion from normal cognition to Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid26401783",
                "pmid20202480",
                "pmid23715905",
                "pmid25212911",
                "pmid2893306",
                "pmid8327146",
                "pmid26017202",
                "pmid33269100",
                "pmid11276052",
                "pmid2935594"
            ]
        },
        "clinical_205": {
            "question": "Which brain volumes at baseline predict cognitive outcomes in early-onset Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid34665329",
                "pmid29080407",
                "pmid22651939",
                "pmid20202480",
                "pmid24607963",
                "pmid38102439",
                "pmid19940172",
                "pmid9710003",
                "pmid32728647",
                "pmid37123373"
            ]
        },
        "clinical_206": {
            "question": "Which factors significantly increase the risk of delirium in trauma ICU patients?",
            "answer": "According to several studies, factors associated with delirium include elevated levels of biomarkers indicating systemic inflammation and stress responses. These include neutrophil-to-lymphocyte ratio (NLR), glucose, troponin, interleukin-6, interleukin-8, interleukin-10, tumor necrosis factor-alpha, C-reactive protein, and S-100beta. Additionally, treatment with continuous venovenous haemodiafiltration (CVVHDF) and physical restraints, as well as the presence of infection or sepsis, are associated with increased delirium risk. A high blood urea nitrogen to creatinine ratio may also be associated with hypoactive delirium.\n\n\n\n",
            "pmid": [
                "pmid29657370",
                "pmid28335673",
                "pmid17949984",
                "pmid39011361",
                "pmid30045794",
                "pmid30086671",
                "pmid31770149",
                "pmid36078999",
                "pmid17352663",
                "pmid33794468"
            ]
        },
        "clinical_207": {
            "question": "Does combining MAOI with tricyclic antidepressants increase the risk of delirium?",
            "answer": "A",
            "pmid": [
                "pmid6376486",
                "pmid30086671",
                "pmid36120311",
                "pmid34807273",
                "pmid23385102",
                "pmid38911008",
                "pmid6139883",
                "pmid31568239",
                "pmid20204907",
                "pmid1021542"
            ]
        },
        "clinical_208": {
            "question": "What mechanisms are associated with levofloxacin-induced delirium?",
            "answer": "A",
            "pmid": [
                "pmid31178301",
                "pmid22390219",
                "pmid23909707",
                "pmid23914753",
                "pmid18585545",
                "pmid39210294",
                "pmid19422109",
                "pmid39419070",
                "pmid20309566",
                "pmid37313848"
            ]
        },
        "clinical_209": {
            "question": "Are there cases of delirium related to intrathecal baclofen?",
            "answer": "A",
            "pmid": [
                "pmid19079356",
                "pmid34123673",
                "pmid31178301",
                "pmid2524220",
                "pmid28585290",
                "pmid39355007",
                "pmid23909707",
                "pmid23914753",
                "pmid549538",
                "pmid20309566"
            ]
        },
        "clinical_210": {
            "question": "What are the perceived benefits of early out-of-bed mobilisation in reducing delirium risk among patients with severe acquired brain injury?",
            "answer": "C",
            "pmid": [
                "pmid39788872",
                "pmid31770149",
                "pmid36939716",
                "pmid28243098",
                "pmid28335673",
                "pmid36973363",
                "pmid20471115",
                "pmid37133446",
                "pmid24852225",
                "pmid24259659"
            ]
        },
        "clinical_211": {
            "question": "Does concomitant use of hydroxyzine with haloperidol worsen delirium in patients with cancer?",
            "answer": "B",
            "pmid": [
                "pmid38409802",
                "pmid32162816",
                "pmid17443602",
                "pmid17381385",
                "pmid22949902",
                "pmid23503785",
                "pmid17317453",
                "pmid26122223",
                "pmid23859663",
                "pmid33322363"
            ]
        },
        "clinical_212": {
            "question": "Does perioperative delirium increase the risk of Alzheimer’s disease?",
            "answer": "A",
            "pmid": [
                "pmid35525395",
                "pmid36939716",
                "pmid35034675",
                "pmid36224337",
                "pmid27662296",
                "pmid33088271",
                "pmid30051417",
                "pmid33409674",
                "pmid29723848",
                "pmid37812498"
            ]
        },
        "clinical_213": {
            "question": "What non-motor symptoms of Parkinson’s disease are associated with postoperative delirium in elderly patients undergoing spinal surgery?",
            "answer": "B",
            "pmid": [
                "pmid29630637",
                "pmid10473947",
                "pmid30051417",
                "pmid7762856",
                "pmid30488836",
                "pmid27247600",
                "pmid17721242",
                "pmid19237264",
                "pmid36224337",
                "pmid16696749"
            ]
        },
        "clinical_214": {
            "question": "What is the effect of dexmedetomidine infusion on postoperative delirium in elderly patients undergoing oral and maxillofacial surgery?",
            "answer": "C",
            "pmid": [
                "pmid35846796",
                "pmid29958125",
                "pmid37917895",
                "pmid7762856",
                "pmid32477139",
                "pmid10473947",
                "pmid19237264",
                "pmid39259057",
                "pmid37773821",
                "pmid36304175"
            ]
        },
        "clinical_215": {
            "question": "What is the effect of the Haga Brain Care Strategy on postoperative delirium rates?",
            "answer": "C",
            "pmid": [
                "pmid22778141",
                "pmid19237264",
                "pmid37773821",
                "pmid29958125",
                "pmid36939716",
                "pmid19234823",
                "pmid36224337",
                "pmid10473947",
                "pmid27119013",
                "pmid30051417"
            ]
        },
        "clinical_216": {
            "question": "What factors are associated with an increased risk of delirium episodes in elderly patients with asthma during hospitalization?",
            "answer": "D",
            "pmid": [
                "pmid34250429",
                "pmid21206582",
                "pmid21721434",
                "pmid21488579",
                "pmid17183425",
                "pmid29966197",
                "pmid37251808",
                "pmid37812498",
                "pmid17949984",
                "pmid20471115"
            ]
        },
        "clinical_217": {
            "question": "Do esketamine and dexmedetomidine help in preventing postoperative delirium in elderly patients undergoing thoracic surgery?",
            "answer": "A",
            "pmid": [
                "pmid37917895",
                "pmid29958125",
                "pmid7762856",
                "pmid10473947",
                "pmid35846796",
                "pmid37773821",
                "pmid30488836",
                "pmid32477139",
                "pmid36304175",
                "pmid19237264"
            ]
        },
        "clinical_218": {
            "question": "Do melatonin receptor agonists reduce the risk of postoperative delirium compared to zolpidem and temazepam in older adults?",
            "answer": "B",
            "pmid": [
                "pmid38979845",
                "pmid38911008",
                "pmid7762856",
                "pmid39541802",
                "pmid16670110",
                "pmid30481216",
                "pmid37773821",
                "pmid24815757",
                "pmid37917895",
                "pmid30488836"
            ]
        },
        "clinical_219": {
            "question": "Does delirium occur after alcohol withdrawal seizures in patients treated with oxazepam?",
            "answer": "B",
            "pmid": [
                "pmid7573789",
                "pmid31568239",
                "pmid23385102",
                "pmid9214531",
                "pmid26861990",
                "pmid17323538",
                "pmid38024021",
                "pmid35224452",
                "pmid6139883",
                "pmid34123673"
            ]
        },
        "clinical_220": {
            "question": "What types of delirium are associated with increased one-year mortality in critically ill patients with cancer?",
            "answer": "C",
            "pmid": [
                "pmid37610551",
                "pmid29657370",
                "pmid26397939",
                "pmid37133446",
                "pmid31770149",
                "pmid17949984",
                "pmid28335673",
                "pmid39011361",
                "pmid25567339",
                "pmid35815182"
            ]
        },
        "clinical_221": {
            "question": "What are the complications associated with delirium in men with spinal cord injury following lower extremity fractures?",
            "answer": "Delirium is a complex syndrome often caused by secondary neuronal dysfunction due to systemic disorders. It's a common and serious complication, particularly in the elderly and critically ill. Several factors can influence its development, including physical restraints and infection, while interventions like opioid use, preventing hypoxia, providing entertainment, and encouraging mobility may reduce risk.",
            "pmid": [
                "pmid23392311",
                "pmid27058253",
                "pmid39638735",
                "pmid25943983",
                "pmid28243098",
                "pmid34978",
                "pmid39355007",
                "pmid33814433",
                "pmid25417135",
                "pmid28335673"
            ]
        },
        "clinical_222": {
            "question": "Does delirium in neurocritically ill patients predict relevant clinical outcomes such as functional independence and cognition?",
            "answer": "A",
            "pmid": [
                "pmid30142098",
                "pmid38171949",
                "pmid28519903",
                "pmid37133446",
                "pmid36939716",
                "pmid32881052",
                "pmid28673598",
                "pmid33648701",
                "pmid11563209",
                "pmid20309566"
            ]
        },
        "clinical_223": {
            "question": "Does the presence of Confusion Assessment Method (CAM) core symptoms at baseline predict incident delirium in older long-term care residents?",
            "answer": "A",
            "pmid": [
                "pmid23448799",
                "pmid17183425",
                "pmid29966197",
                "pmid37251808",
                "pmid34098376",
                "pmid37566435",
                "pmid11563209",
                "pmid37812498",
                "pmid37133446",
                "pmid21488579"
            ]
        },
        "clinical_224": {
            "question": "Does hypercapnia in patients with chronic obstructive pulmonary disease (COPD) lead to delirium?",
            "answer": "A",
            "pmid": [
                "pmid27736515",
                "pmid36078999",
                "pmid17949984",
                "pmid34250429",
                "pmid33648701",
                "pmid35815182",
                "pmid20204907",
                "pmid32123815",
                "pmid25567339",
                "pmid19836623"
            ]
        },
        "clinical_225": {
            "question": "Does Five-Element music therapy reduce the incidence of delirium in ICU patients with difficult weaning?",
            "answer": "A",
            "pmid": [
                "pmid39586722",
                "pmid37133446",
                "pmid29657370",
                "pmid36078999",
                "pmid17949984",
                "pmid24259659",
                "pmid18577171",
                "pmid20375300",
                "pmid24337333",
                "pmid25567339"
            ]
        },
        "clinical_226": {
            "question": "What is the effect of perioperative dexmedetomidine administration on delirium incidence in patients after cardiac surgery?",
            "answer": "Patients above 65 years of age with postoperative delirium have poorer outcomes and are more likely to have prolonged hospitalization and ICU stay, and longer intubation times, but 30-day mortality is not increased. Independent risk factors for developing post-cardiac surgery delirium include age, low ejection fraction, diabetes, extracardiac arteriopathy, atrial fibrillation, pneumonia, elevated creatinine, and prolonged hospitalization time.",
            "pmid": [
                "pmid29958125",
                "pmid27119013",
                "pmid34807273",
                "pmid10473947",
                "pmid32127274",
                "pmid17088170",
                "pmid37917895",
                "pmid29881262",
                "pmid19237264",
                "pmid35846796"
            ]
        },
        "clinical_227": {
            "question": "Does initiating pharmacologic delirium treatment within 24 hours reduce physical restraint use in ICU patients?",
            "answer": "A\n",
            "pmid": [
                "pmid24259659",
                "pmid18577171",
                "pmid37133446",
                "pmid20375300",
                "pmid39541802",
                "pmid36078999",
                "pmid16678002",
                "pmid28910303",
                "pmid38911008",
                "pmid33835902"
            ]
        },
        "clinical_228": {
            "question": "What is the presentation of delirium caused by chloromethcathinone and cannabis ingestion?",
            "answer": "C",
            "pmid": [
                "pmid33093258",
                "pmid26956672",
                "pmid31178301",
                "pmid20204907",
                "pmid19422109",
                "pmid38911008",
                "pmid34978",
                "pmid39541802",
                "pmid27790150",
                "pmid36059364"
            ]
        },
        "clinical_229": {
            "question": "Does normal pressure hydrocephalus (NTH) have an association with delirium?",
            "answer": "A",
            "pmid": [
                "pmid1949310",
                "pmid17949984",
                "pmid28519903",
                "pmid39835091",
                "pmid7916159",
                "pmid36078999",
                "pmid31574089",
                "pmid28585290",
                "pmid28673598",
                "pmid30142098"
            ]
        },
        "clinical_230": {
            "question": "What is the effect of remimazolam administration at the end of tonsillectomy and adenoidectomy under sevoflurane anesthesia on the incidence of emergence delirium in children?",
            "answer": "C",
            "pmid": [
                "pmid36203819",
                "pmid39464168",
                "pmid37128675",
                "pmid32976205",
                "pmid27635747",
                "pmid38895540",
                "pmid19237264",
                "pmid32641746",
                "pmid35682930",
                "pmid39505249"
            ]
        },
        "clinical_231": {
            "question": "What factors predict ICU admission among Parkinson's disease patients with delirium?",
            "answer": "B",
            "pmid": [
                "pmid30692764",
                "pmid29657370",
                "pmid33120832",
                "pmid29966197",
                "pmid17949984",
                "pmid29630637",
                "pmid30045794",
                "pmid31770149",
                "pmid17352663",
                "pmid34912245"
            ]
        },
        "clinical_232": {
            "question": "An elderly patient is scheduled for primary total joint arthroplasty. Which of the following combinations of factors is most strongly associated with an increased risk of developing postoperative delirium?",
            "answer": "B",
            "pmid": [
                "pmid39259060",
                "pmid28622817",
                "pmid34772392",
                "pmid34901277",
                "pmid16696749",
                "pmid31880243",
                "pmid32611398",
                "pmid39638735",
                "pmid25774049",
                "pmid15467965"
            ]
        },
        "clinical_233": {
            "question": "Which of the following best describes the relationship between BDNF levels and delirium tremens (DT) in alcohol withdrawal?",
            "answer": "D",
            "pmid": [
                "pmid21039634",
                "pmid32001926",
                "pmid34060728",
                "pmid38928583",
                "pmid34978",
                "pmid17250608",
                "pmid7211434",
                "pmid20002020",
                "pmid17434673",
                "pmid19219710"
            ]
        }
    },
    "cell": {
        "cell_0": {
            "question": "Does Platycodin D inhibit beta-amyloid-induced inflammation and oxidative stress in BV-2 cells, relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid33394221",
                "pmid31487775",
                "pmid33811504",
                "pmid38968796",
                "pmid34329731",
                "pmid30404965",
                "pmid29454265",
                "pmid24333930",
                "pmid29195132",
                "pmid30208700"
            ]
        },
        "cell_1": {
            "question": "Do activated astrocytes contribute to Abeta production, implicated in Alzheimer's disease pathogenesis?",
            "answer": "<Correct Answer>: A\n<Why>: Several abstracts directly support the idea that activated astrocytes contribute to Abeta production. For example, one study demonstrates that astrocytes produce Abeta1-40 and Abeta1-42 when stimulated with combinations of inflammatory cytokines, suggesting they can be an important source of Abeta. Another study shows that astrocytes increase Abeta generation when activated. These findings, along with others in the context, strongly suggest a link between activated astrocytes and Abeta production.",
            "pmid": [
                "pmid22047170",
                "pmid25108202",
                "pmid22101005",
                "pmid11755001",
                "pmid33731156",
                "pmid25233405",
                "pmid11114266",
                "pmid38502413",
                "pmid29033790",
                "pmid26200696"
            ]
        },
        "cell_2": {
            "question": "Does beta-patchoulene alleviate delirium by inhibiting microglia activation through the Sirt1/Nrf2 pathway?",
            "answer": "A",
            "pmid": [
                "pmid36608000",
                "pmid36216079",
                "pmid22683080",
                "pmid37313848",
                "pmid35713240",
                "pmid38372090",
                "pmid36077505",
                "pmid31244434",
                "pmid37968531",
                "pmid37330271"
            ]
        },
        "cell_3": {
            "question": "Do atypical antipsychotic drugs (APDs) reduce beta-amyloid peptide(25-35)-induced PC12 cell death, relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid14648600",
                "pmid15948179",
                "pmid8922409",
                "pmid9410912",
                "pmid24424093",
                "pmid20307525",
                "pmid28714389",
                "pmid30958369",
                "pmid18400893",
                "pmid36994913"
            ]
        },
        "cell_4": {
            "question": "Does TUDCA reduce p53-induced apoptosis in Alzheimer's disease mutant neuroblastoma cells?",
            "answer": "A",
            "pmid": [
                "pmid16923170",
                "pmid25443293",
                "pmid15208744",
                "pmid25457551",
                "pmid10377452",
                "pmid26967221",
                "pmid25371750",
                "pmid15548589",
                "pmid24567336",
                "pmid15073525"
            ]
        },
        "cell_5": {
            "question": "Does oligomeric amyloid-beta (Abeta) stimulate NFAT activation in astrocyte cultures, potentially contributing to Alzheimer's disease progression?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid29033790",
                "pmid22047170",
                "pmid25814669",
                "pmid19828810",
                "pmid11114266",
                "pmid20401186",
                "pmid20847443",
                "pmid37248300",
                "pmid26200696",
                "pmid22378890"
            ]
        },
        "cell_6": {
            "question": "Does dihydroactinidiolide (DHAc) protect SH-SY5Y cells from oxidative stress-induced neuronal apoptosis in an Alzheimer's disease model?",
            "answer": "A.",
            "pmid": [
                "pmid33617922",
                "pmid37409350",
                "pmid31900522",
                "pmid38729530",
                "pmid35489325",
                "pmid15073525",
                "pmid15208744",
                "pmid31151322",
                "pmid31232699",
                "pmid28852940"
            ]
        },
        "cell_7": {
            "question": "Do viral infections contribute to Alzheimer's disease by reducing neprilysin levels in astrocytes?",
            "answer": "A",
            "pmid": [
                "pmid12387451",
                "pmid36321194",
                "pmid17591969",
                "pmid17021406",
                "pmid38561809",
                "pmid12453679",
                "pmid17008108",
                "pmid25157230",
                "pmid12105192",
                "pmid28765170"
            ]
        },
        "cell_8": {
            "question": "Does disruption of the Sigma-2 receptor complex-TMEM97, PGRMC1, and LDLR affect Abeta42 uptake in primary neurons, potentially relevant to Alzheimer's disease progression?",
            "answer": "A",
            "pmid": [
                "pmid32572762",
                "pmid25390692",
                "pmid27926996",
                "pmid18509040",
                "pmid32653342",
                "pmid34663480",
                "pmid30911003",
                "pmid38447415",
                "pmid16219804",
                "pmid9878757"
            ]
        },
        "cell_9": {
            "question": "Does AT2R activation contribute to neuroprotection in Alzheimer's disease by inhibiting microglia pro-inflammatory activation?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid30076526",
                "pmid17911636",
                "pmid21088470",
                "pmid36564824",
                "pmid25485684",
                "pmid18509040",
                "pmid18835047",
                "pmid31031598",
                "pmid29180839",
                "pmid15608143"
            ]
        },
        "cell_10": {
            "question": "Does TRPV4-induced oxidative stress contribute to neurotoxicity in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid27799895",
                "pmid36990137",
                "pmid33998138",
                "pmid33774476",
                "pmid36823760",
                "pmid35297520",
                "pmid8725383",
                "pmid32061032",
                "pmid29660945",
                "pmid21545753"
            ]
        },
        "cell_11": {
            "question": "Does GPR120 signaling in astrocytes negatively regulate amyloid-beta degradation in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid34099509",
                "pmid36161942",
                "pmid25637481",
                "pmid38447415",
                "pmid34981861",
                "pmid34297968",
                "pmid28455519",
                "pmid26200696",
                "pmid17911636",
                "pmid39603277"
            ]
        },
        "cell_12": {
            "question": "Does PQQ protect primary cortical neurons against microglia-mediated neurotoxicity, potentially relevant in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid25314304",
                "pmid22655214",
                "pmid21088470",
                "pmid22186599",
                "pmid25485684",
                "pmid16476660",
                "pmid37609338",
                "pmid15172747",
                "pmid39908354",
                "pmid29120942"
            ]
        },
        "cell_13": {
            "question": "Does SIRT2 play a significant role in astrocytic GABA production in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid39815261",
                "pmid30362958",
                "pmid24860504",
                "pmid16183991",
                "pmid26045440",
                "pmid35872221",
                "pmid31808750",
                "pmid33710537",
                "pmid32923413",
                "pmid33021962"
            ]
        },
        "cell_14": {
            "question": "Could an MMP-8 inhibitor be therapeutic for Alzheimer's disease by reducing astrocyte reactivity?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid30470240",
                "pmid9890433",
                "pmid21376707",
                "pmid30076715",
                "pmid38886959",
                "pmid34302466",
                "pmid26114860",
                "pmid11755001",
                "pmid31264132",
                "pmid32892233"
            ]
        },
        "cell_15": {
            "question": "Does hBD3 inhibit Pg LPS-induced oxidative and inflammatory responses in microglia, relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid28266714",
                "pmid26675131",
                "pmid39002124",
                "pmid36499428",
                "pmid34478813",
                "pmid38886959",
                "pmid36724966",
                "pmid26257642",
                "pmid25485684",
                "pmid29743866"
            ]
        },
        "cell_16": {
            "question": "Does Phillyrin prevent BBB damage by inhibiting microglial neuroinflammation through the PPARgamma/NF-kappaB pathway, potentially relevant to Alzheimer's disease?",
            "answer": "A study demonstrates that Phillyrin prevents BBB damage by inhibiting neuroinflammation of microglia through the PPARgamma/NF-kappaB pathway. This involves restraining pro-inflammatory cytokines and promoting anti-inflammatory polarization of microglia, ultimately reducing BBB damage.",
            "pmid": [
                "pmid29501766",
                "pmid32028243",
                "pmid23279783",
                "pmid29132092",
                "pmid39566407",
                "pmid18789000",
                "pmid33361598",
                "pmid30873920",
                "pmid34744713",
                "pmid34329731"
            ]
        },
        "cell_17": {
            "question": "Could inhibiting pro-inflammatory DAM (Disease-Associated Microglia) be beneficial in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid29784049",
                "pmid29501766",
                "pmid11578773",
                "pmid12453679",
                "pmid8996832",
                "pmid28969867",
                "pmid38886959",
                "pmid25485684",
                "pmid16476660",
                "pmid15172747"
            ]
        },
        "cell_18": {
            "question": "Does hepcidin-mediated neuronal iron deposition and oxidative stress contribute to Alzheimer's-like cognitive impairment in mice exposed to chronic intermittent hypoxia?",
            "answer": "<Correct Answer>: A\n<Why>: Sustained upregulation of HO-1 in astrocytes promotes pathological brain iron deposition and oxidative mitochondrial damage characteristic of Alzheimer's disease-affected neural tissues. Additionally, hepcidin down-regulates inflammatory and pro-oxidant processes induced by amyloid-beta in astrocytes and microglia, protecting neighboring neurons. These findings demonstrate a connection between iron deposition, oxidative stress, and neuroprotection relevant to Alzheimer's disease.",
            "pmid": [
                "pmid34394834",
                "pmid32707154",
                "pmid33298837",
                "pmid38195497",
                "pmid24863668",
                "pmid39476996",
                "pmid29867325",
                "pmid35915080",
                "pmid22881289",
                "pmid28266714"
            ]
        },
        "cell_19": {
            "question": "Does withanolide A reduce 7-ketocholesterol's effects on pro-inflammatory genes in brain endothelial cells, relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35159267",
                "pmid38886959",
                "pmid28963942",
                "pmid34671194",
                "pmid35772378",
                "pmid27740938",
                "pmid39767773",
                "pmid31998114",
                "pmid39117070",
                "pmid27013966"
            ]
        },
        "cell_20": {
            "question": "Does dexamethasone inhibit Nox-dependent ROS production in activated microglia, relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid21615929",
                "pmid22581365",
                "pmid11070493",
                "pmid11331412",
                "pmid32823544",
                "pmid10922518",
                "pmid32662924",
                "pmid37446267",
                "pmid21088470",
                "pmid33774476"
            ]
        },
        "cell_21": {
            "question": "Does DHEA exacerbate nigericin-induced pyroptosis in LPS-primed macrophages, potentially relevant to delirium mechanisms?",
            "answer": "A",
            "pmid": [
                "pmid35440074",
                "pmid31779639",
                "pmid35977927",
                "pmid11331412",
                "pmid33901789",
                "pmid22683080",
                "pmid37968531",
                "pmid36077505",
                "pmid32199223",
                "pmid35917097"
            ]
        },
        "cell_23": {
            "question": "Does arundic acid affect astrocytic EAAT1 expression, implicated in Alzheimer's disease pathogenesis?",
            "answer": "Astrocytes undergo changes in Alzheimer's disease that affect their function and expression of key proteins. These proteins include glial fibrillary acidic protein (GFAP), aquaporin-4 (AQP-4), glutamate transporter-1 (GLT-1), and inwardly-rectifying potassium channel 4.1 (Kir4.1), which all show increased expression correlating with disease progression. Astrocytes also participate in amyloid beta (Abeta) clearance and exhibit altered urea cycle activity. Furthermore, statins like simvastatin and atorvastatin can affect neprilysin secretion from astrocytes, impacting Abeta degradation.\n\n\n\n",
            "pmid": [
                "pmid28812276",
                "pmid11755001",
                "pmid22101005",
                "pmid38502413",
                "pmid16253995",
                "pmid25108202",
                "pmid18201952",
                "pmid39603277",
                "pmid35738259",
                "pmid26875818"
            ]
        },
        "cell_24": {
            "question": "Does thonningianin A enhance microglial cell autophagy to alleviate Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid30695399",
                "pmid39911633",
                "pmid33998138",
                "pmid31607908",
                "pmid24602800",
                "pmid21368103",
                "pmid39736370",
                "pmid30362531",
                "pmid31900522",
                "pmid33492604"
            ]
        },
        "cell_25": {
            "question": "Does Ferulago angulata extract protect against beta-amyloid-induced toxicity in PC12 cells, relevant to Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Extracts of adlay hull attenuated beta-amyloid-induced neurotoxicity in PC12 cells, demonstrating anti-inflammatory and antiapoptotic activities. Furthermore, mulberry fruit extracts have been shown to prevent beta-amyloid-induced neurotoxicity and promote neurite outgrowth in neuronal cells. These findings suggest potential protective effects against Alzheimer's disease.",
            "pmid": [
                "pmid38050568",
                "pmid29389553",
                "pmid27774420",
                "pmid26845710",
                "pmid20099523",
                "pmid30442346",
                "pmid24448790",
                "pmid29081887",
                "pmid32316271",
                "pmid34041372"
            ]
        },
        "cell_26": {
            "question": "Does Sirt1 regulation of microglial activation via the Shh/Gli-1 pathway have implications for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid16183991",
                "pmid36725745",
                "pmid24860504",
                "pmid30362958",
                "pmid26045440",
                "pmid33021962",
                "pmid36564824",
                "pmid19893026",
                "pmid33998138",
                "pmid9878757"
            ]
        },
        "cell_27": {
            "question": "Does overexpression of presenilin2 and its Alzheimer's-disease-linked variants influence TRPC6-mediated calcium entry in HEK293 cells?",
            "answer": "A",
            "pmid": [
                "pmid15601622",
                "pmid17568632",
                "pmid19382908",
                "pmid11055438",
                "pmid10748169",
                "pmid17437536",
                "pmid18367332",
                "pmid10393846",
                "pmid12836159",
                "pmid11124426"
            ]
        },
        "cell_28": {
            "question": "Does Miltefosine improve Alzheimer's-like pathology by alleviating tauopathy via microglia/neuron crosstalk in mice?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid36388134",
                "pmid39767773",
                "pmid38886959",
                "pmid35909315",
                "pmid39563011",
                "pmid31100304",
                "pmid27072684",
                "pmid36271414",
                "pmid30911003",
                "pmid33344892"
            ]
        },
        "cell_29": {
            "question": "Does IRAK-M influence microglial NLRP3 inflammasome activation and GSDMD-mediated pyroptosis, potentially relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid36765034",
                "pmid35474599",
                "pmid23686772",
                "pmid28003153",
                "pmid38565393",
                "pmid33181351",
                "pmid32929691",
                "pmid23100432",
                "pmid36185484",
                "pmid34478813"
            ]
        },
        "cell_30": {
            "question": "Does Ponesimod increase microglial Abeta42 phagocytosis relevant to Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid37480622",
                "pmid31982468",
                "pmid20798889",
                "pmid12927763",
                "pmid36271414",
                "pmid12032144",
                "pmid20878768",
                "pmid39741193",
                "pmid35677758",
                "pmid36613460"
            ]
        },
        "cell_31": {
            "question": "Do simvastatin and atorvastatin increase neprilysin secretion from astrocytes, facilitating amyloid beta-protein degradation relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid26875818",
                "pmid19461118",
                "pmid15532546",
                "pmid26520569",
                "pmid12387451",
                "pmid32512031",
                "pmid12105192",
                "pmid24508800",
                "pmid26096465",
                "pmid36321194"
            ]
        },
        "cell_33": {
            "question": "Does inhibiting microglial activation by 2-Cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride offer potential therapeutic benefits for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid24752390",
                "pmid31264132",
                "pmid39094545",
                "pmid35677758",
                "pmid33344892",
                "pmid12137934",
                "pmid38006681",
                "pmid26797524",
                "pmid20153342",
                "pmid17406652"
            ]
        },
        "cell_34": {
            "question": "Does cancer history affect long-term lymphocyte cell death susceptibility in individuals who later develop Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid29472838",
                "pmid22367434",
                "pmid11016535",
                "pmid25274115",
                "pmid20541838",
                "pmid7768042",
                "pmid16814429",
                "pmid22428008",
                "pmid37737298",
                "pmid21167930"
            ]
        },
        "cell_35": {
            "question": "Can Berberine-treated BMSCs rescue neurons from oxidative stress damage relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid32108297",
                "pmid28668383",
                "pmid34064687",
                "pmid33983710",
                "pmid29132092",
                "pmid30542442",
                "pmid22459600",
                "pmid30272344",
                "pmid28822725",
                "pmid21297267"
            ]
        },
        "cell_36": {
            "question": "Does beta-amyloid exacerbate inflammation in FAAH-lacking astrocytes through PPAR-alpha, PPAR-gamma, and TRPV1, relevant to Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Stimulation with TNF-alpha and IFN-gamma increases levels of astrocytic BACE1, APP, and secreted Abeta40. Beta-amyloid stimulates iNOS expression in astrocytes, dependent on IL-1beta and TNFalpha signaling. IL-1beta is induced in reactive astrocytes surrounding beta-amyloid deposits. These findings suggest a link between beta-amyloid, inflammatory cytokines, and astrocytic activation, potentially exacerbating inflammation.",
            "pmid": [
                "pmid22321194",
                "pmid11114266",
                "pmid17255335",
                "pmid11755001",
                "pmid29501766",
                "pmid18780966",
                "pmid18395194",
                "pmid22047170",
                "pmid10713108",
                "pmid10817926"
            ]
        },
        "cell_37": {
            "question": "Does the DSPE-PEG-TPP/MoS2 QD blend reduce oxidative stress and inflammation in Abeta-activated microglial cells in Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid37606394",
                "pmid31923845",
                "pmid27797173",
                "pmid37947289",
                "pmid26827641",
                "pmid34874326",
                "pmid35759686",
                "pmid33998138",
                "pmid28630497",
                "pmid36724966"
            ]
        },
        "cell_38": {
            "question": "Does Erjingpill exhibit anti-neuroinflammatory effects by influencing microglial cell glycolysis relevant to Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid38824976",
                "pmid30208700",
                "pmid39183433",
                "pmid28798805",
                "pmid26643169",
                "pmid12453679",
                "pmid15465624",
                "pmid35694923",
                "pmid23660953",
                "pmid35474599"
            ]
        },
        "cell_39": {
            "question": "Can metformin, rapamycin, or nicotinamide mononucleotide inhibit microglial phagocytosis in a manner relevant to Alzheimer's disease?",
            "answer": "A recent study demonstrated that gossypetin enhanced phagocytic activity of microglia while decreasing their gliosis, suggesting a potential mechanism for its protective effects against Alzheimer's disease by promoting Abeta clearance. Another study showed that anti-inflammatory drugs like pioglitazone and ibuprofen reduced glial inflammation and Abeta1-42 levels in a mouse model of Alzheimer's disease. These findings suggest that modulating microglial activity and inflammation can impact Alzheimer's pathology. However, these studies do not address the effects of metformin, rapamycin, or nicotinamide mononucleotide on microglial phagocytosis.\n\n\n\n",
            "pmid": [
                "pmid35769369",
                "pmid32580040",
                "pmid31982468",
                "pmid37483818",
                "pmid34283253",
                "pmid20153342",
                "pmid35677758",
                "pmid36271414",
                "pmid30958364",
                "pmid15817521"
            ]
        },
        "cell_40": {
            "question": "Does BG45 reduce inflammation in the entorhinal cortex of young APP/PS1 mice, relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid36902234",
                "pmid21273420",
                "pmid19747158",
                "pmid11027218",
                "pmid28003153",
                "pmid16504112",
                "pmid38705540",
                "pmid23780663",
                "pmid38159478",
                "pmid35909315"
            ]
        },
        "cell_41": {
            "question": "Which of the following statements best describes the role of DHA in THP-1 monocytes exposed to Aβ25-35 in the context of Alzheimer's disease (AD)?",
            "answer": "D",
            "pmid": [
                "pmid32199223",
                "pmid26965310",
                "pmid33737172",
                "pmid23645098",
                "pmid11755001",
                "pmid27333034",
                "pmid37344916",
                "pmid19423322",
                "pmid24374316",
                "pmid19679638"
            ]
        },
        "cell_42": {
            "question": "Does chlorogenic acid alleviate inflammatory stress in BV2 cells, relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35633920",
                "pmid33747165",
                "pmid39334733",
                "pmid12453679",
                "pmid28930532",
                "pmid14975597",
                "pmid36770835",
                "pmid38561809",
                "pmid21704645",
                "pmid36724966"
            ]
        },
        "cell_43": {
            "question": "Does inhibiting RXRalpha nuclear export reduce neuronal apoptosis relevant to Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid31966420",
                "pmid20950278",
                "pmid28627642",
                "pmid9410912",
                "pmid8922409",
                "pmid23379615",
                "pmid32739157",
                "pmid34782612",
                "pmid26696494",
                "pmid34302466"
            ]
        },
        "cell_44": {
            "question": "Is the Sur1-Trpm4 channel implicated in regulating NOS2 expression in microglia, potentially relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid27246103",
                "pmid36564824",
                "pmid34302466",
                "pmid33998138",
                "pmid29660945",
                "pmid30911003",
                "pmid39809738",
                "pmid36683512",
                "pmid30484906",
                "pmid32959884"
            ]
        },
        "cell_45": {
            "question": "Does glimepiride protect neurons against amyloid-beta-induced synapse damage in Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid26432105",
                "pmid24184877",
                "pmid24952384",
                "pmid25390692",
                "pmid38095632",
                "pmid16772755",
                "pmid26389963",
                "pmid31541651",
                "pmid15465624",
                "pmid37301482"
            ]
        },
        "cell_46": {
            "question": "Does CD45RB cross-linking inhibit Abeta-induced microglial activation in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid18478117",
                "pmid11027218",
                "pmid21273420",
                "pmid12402041",
                "pmid18434187",
                "pmid37609338",
                "pmid12927763",
                "pmid11290384",
                "pmid22133278",
                "pmid28434692"
            ]
        },
        "cell_47": {
            "question": "Does donepezil, commonly used for Alzheimer's disease, inhibit MPP+-induced M1 polarization in microglia?",
            "answer": "A",
            "pmid": [
                "pmid26114860",
                "pmid24189446",
                "pmid20153342",
                "pmid25662507",
                "pmid29273047",
                "pmid31264132",
                "pmid25744714",
                "pmid35850693",
                "pmid34638977",
                "pmid20718745"
            ]
        },
        "cell_48": {
            "question": "Does Spns2 promote pro-inflammatory activation of microglia in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30484906",
                "pmid25485684",
                "pmid29662056",
                "pmid11578773",
                "pmid36620941",
                "pmid17911636",
                "pmid25169677",
                "pmid15172747",
                "pmid38886959",
                "pmid29180839"
            ]
        },
        "cell_49": {
            "question": "Does neoechinulin A inhibit amyloid-beta-induced microglia activation, a process relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid23261590",
                "pmid38886959",
                "pmid31982468",
                "pmid15194867",
                "pmid16183991",
                "pmid25169677",
                "pmid12105192",
                "pmid26643169",
                "pmid22133278",
                "pmid35181976"
            ]
        },
        "cell_50": {
            "question": "Can antioxidants like thymoquinone or EGCG reduce amyloid beta oxidation in neuroblastoma cells, relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid22752387",
                "pmid25405415",
                "pmid24975829",
                "pmid30623116",
                "pmid28630497",
                "pmid23537659",
                "pmid24101432",
                "pmid20463406",
                "pmid12671307",
                "pmid34570578"
            ]
        },
        "cell_51": {
            "question": "Does the small molecule MFM 4 inhibit Abeta-induced neuronal toxicity in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31140779",
                "pmid22238689",
                "pmid27258855",
                "pmid23523945",
                "pmid19141069",
                "pmid31541651",
                "pmid16246051",
                "pmid19642202",
                "pmid35759686",
                "pmid17261088"
            ]
        },
        "cell_52": {
            "question": "Does quetiapine inhibit microglial activation, potentially relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid24911389",
                "pmid25618401",
                "pmid26732345",
                "pmid29120942",
                "pmid18554300",
                "pmid24189446",
                "pmid22831460",
                "pmid15948179",
                "pmid36368316",
                "pmid37603311"
            ]
        },
        "cell_53": {
            "question": "Does 2-methoxyestradiol (2ME) protect against neuronal cell death and tau hyperphosphorylation relevant to Alzheimer's Disease?",
            "answer": "A",
            "pmid": [
                "pmid36208660",
                "pmid9106616",
                "pmid12671307",
                "pmid16024764",
                "pmid7488136",
                "pmid22798221",
                "pmid27926996",
                "pmid23618865",
                "pmid27026591",
                "pmid35153729"
            ]
        },
        "cell_54": {
            "question": "Does Schisandrin treatment restore cell viability in the SH-SY5Y cell model of Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid33542629",
                "pmid31739764",
                "pmid22666518",
                "pmid31900522",
                "pmid26696494",
                "pmid17886039",
                "pmid24810883",
                "pmid15073525",
                "pmid30844489",
                "pmid30092401"
            ]
        },
        "cell_55": {
            "question": "Does strontium treatment in high-fat diet-induced NAFLD mice reduce neuroinflammation and improve synaptic plasticity, processes also implicated in Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid37373395",
                "pmid37783748",
                "pmid33785315",
                "pmid34168550",
                "pmid23099816",
                "pmid28328738",
                "pmid36894557",
                "pmid27474225",
                "pmid30134549",
                "pmid28963942"
            ]
        },
        "cell_56": {
            "question": "Can mesenchymal stem cells prevent pyroptosis in macrophages exposed to ITO nanoparticles, potentially relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid27194621",
                "pmid39805185",
                "pmid31330912",
                "pmid28630497",
                "pmid33815510",
                "pmid37206236",
                "pmid30259257",
                "pmid31923845",
                "pmid36388872",
                "pmid39281976"
            ]
        },
        "cell_57": {
            "question": "Does Amanita muscaria extract affect proinflammatory cytokines in a manner relevant to Alzheimer's disease or delirium?",
            "answer": "A flavonoid-rich extract of Citrus bergamia juice has been shown to reduce the expression and secretion of IL-6 and IL-1beta in THP-1 cells, and decrease the phosphorylation of ERK 1/2 and members of the JNK family—all of which are increased by amyloid-beta. Ganoderma lucidum extract decreases expression of pro-inflammatory cytokines like G-CSF, IL1-alpha, and MIP3alpha in BV-2 microglial cells. Moscatilin reduces phospho-tau expression and decreases tau aggregation, while also ameliorating learning and memory impairments in mice.\n\n\n\n",
            "pmid": [
                "pmid30819080",
                "pmid30290256",
                "pmid31426492",
                "pmid32488469",
                "pmid22018032",
                "pmid26068423",
                "pmid31635294",
                "pmid26853104",
                "pmid32480240",
                "pmid31291099"
            ]
        },
        "cell_58": {
            "question": "Does 9-Methylfascaplysin (9-MF) reduce neuroinflammation and synaptic damage in an Alzheimer's disease model?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid39563011",
                "pmid30781608",
                "pmid39767773",
                "pmid38886959",
                "pmid39117070",
                "pmid35672874",
                "pmid37301482",
                "pmid30404965",
                "pmid36388134",
                "pmid20555131"
            ]
        },
        "cell_59": {
            "question": "Can esculetin and fucoidan help prevent Alzheimer's disease by modulating reactive astrocytes and proinflammatory cytokines?",
            "answer": "<Correct Answer>: A\n<Why>: The first abstract (pmid35448455) states that \"Esculetin and fucoidan may be beneficial for preventing ZnO NP-mediated autophagy and apoptosis by the modulation of reactive astrocyte and proinflammatory cytokines in the rat brain.\" While this refers to ZnO NP-mediated effects, it directly links esculetin and fucoidan to modulation of reactive astrocytes and proinflammatory cytokines, which are relevant to Alzheimer's disease pathology as indicated in several other abstracts (e.g., pmid28266714, pmid11872267, pmid30208700). Therefore, it suggests they *could* have a protective effect related to Alzheimer's.",
            "pmid": [
                "pmid35448455",
                "pmid15926913",
                "pmid28266714",
                "pmid11872267",
                "pmid36382256",
                "pmid37209001",
                "pmid30208700",
                "pmid19844776",
                "pmid36692036",
                "pmid26006224"
            ]
        },
        "cell_60": {
            "question": "Does guanosine show neuroprotective effects in an Alzheimer's disease model by reducing neuronal death and reactive oxygen species?",
            "answer": "A",
            "pmid": [
                "pmid20846477",
                "pmid36557245",
                "pmid32789760",
                "pmid15073525",
                "pmid27002712",
                "pmid31232699",
                "pmid35195784",
                "pmid24975829",
                "pmid22381145",
                "pmid20416364"
            ]
        },
        "cell_61": {
            "question": "Does microglial activation by silica-coated magnetic nanoparticles contribute to Alzheimer's disease pathogenesis through D-serine secretion?",
            "answer": "A",
            "pmid": [
                "pmid34384435",
                "pmid29970116",
                "pmid36388872",
                "pmid16476660",
                "pmid36564824",
                "pmid24336048",
                "pmid28251989",
                "pmid15172747",
                "pmid37609338",
                "pmid36089405"
            ]
        },
        "cell_62": {
            "question": "Does MAC1 receptor activation in microglia contribute to beta-amyloid peptide-induced neurotoxicity associated with Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid16219804",
                "pmid37603311",
                "pmid19893026",
                "pmid16339765",
                "pmid29501766",
                "pmid37609338",
                "pmid15194867",
                "pmid12927763",
                "pmid32008166",
                "pmid16183991"
            ]
        },
        "cell_63": {
            "question": "Does CD45 deficiency contribute to increased neurotoxic Abeta oligomer levels in Alzheimer's disease mice?",
            "answer": "A",
            "pmid": [
                "pmid21273420",
                "pmid11027218",
                "pmid16504112",
                "pmid12402041",
                "pmid25893674",
                "pmid21070634",
                "pmid35909315",
                "pmid25887956",
                "pmid33580194",
                "pmid12881482"
            ]
        },
        "cell_64": {
            "question": "Does astroglial connexin43 deletion in APP/PS1 mice improve cognitive dysfunction in Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid30031059",
                "pmid27391799",
                "pmid20813165",
                "pmid28982320",
                "pmid33117125",
                "pmid31849963",
                "pmid37609338",
                "pmid38042775",
                "pmid12881482",
                "pmid34981861"
            ]
        },
        "cell_65": {
            "question": "Does aging enhance exosomal cytokine mRNA release by Abeta1-42-stimulated macrophages relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid24014820",
                "pmid27723233",
                "pmid9542587",
                "pmid33737172",
                "pmid28969867",
                "pmid12897209",
                "pmid39243388",
                "pmid18434187",
                "pmid26257642",
                "pmid12927763"
            ]
        },
        "cell_66": {
            "question": "Does inhibiting tissue transglutaminase (tTG) promote beta-amyloid (Abeta)-induced apoptosis in SH-SY5Y cells, relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid27665848",
                "pmid22156619",
                "pmid18397883",
                "pmid28391388",
                "pmid20437185",
                "pmid24685636",
                "pmid18417122",
                "pmid15073525",
                "pmid9464644",
                "pmid18063474"
            ]
        },
        "cell_67": {
            "question": "Does Gamma-interferon-inducible lysosomal thiol reductase (GILT) expression in microglia correlate with Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30560017",
                "pmid30661261",
                "pmid33402227",
                "pmid20798889",
                "pmid33446646",
                "pmid16476660",
                "pmid36798226",
                "pmid17255335",
                "pmid31257151",
                "pmid37774678"
            ]
        },
        "cell_68": {
            "question": "Does Abeta-induced TRPC6 up-regulation in BV-2 microglia contribute to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid28458019",
                "pmid33998138",
                "pmid33029126",
                "pmid29660945",
                "pmid34663480",
                "pmid36724966",
                "pmid36564824",
                "pmid35697992",
                "pmid22133278",
                "pmid28434692"
            ]
        },
        "cell_69": {
            "question": "Does biliverdin regulate macrophage C5aR expression via the mTOR pathway, potentially relevant to delirium?",
            "answer": "A",
            "pmid": [
                "pmid24814708",
                "pmid22438844",
                "pmid39839987",
                "pmid25191325",
                "pmid33901789",
                "pmid24557038",
                "pmid39419070",
                "pmid20309566",
                "pmid39604493",
                "pmid28769556"
            ]
        },
        "cell_70": {
            "question": "Does Cu(II) disrupt autophagy-mediated lysosomal degradation of oligomeric Abeta in microglia, contributing to Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Studies indicate small-molecule enhancers of autophagy can decrease levels of amyloid-beta and APP-CTF via the Atg5-dependent autophagy pathway, suggesting a role for autophagy in clearing these aggregated proteins and potentially offering therapeutic benefits for Alzheimer’s disease. These compounds promote autophagic flux by influencing various stages of the autophagy process.",
            "pmid": [
                "pmid32512069",
                "pmid23959870",
                "pmid20626553",
                "pmid19122148",
                "pmid38787367",
                "pmid30362531",
                "pmid32599538",
                "pmid29631635",
                "pmid25421002",
                "pmid21368103"
            ]
        },
        "cell_71": {
            "question": "Does Physalin B reduce cell apoptosis in HEK293/Tau cells, an Alzheimer's disease model?",
            "answer": "A",
            "pmid": [
                "pmid37489791",
                "pmid15073525",
                "pmid15208744",
                "pmid34782612",
                "pmid24424093",
                "pmid16923170",
                "pmid21297267",
                "pmid35528169",
                "pmid9410912",
                "pmid28852940"
            ]
        },
        "cell_72": {
            "question": "Does blocking TGF-beta-Smad2/3 signaling in peripheral macrophages improve Alzheimer's-like pathology in mice?",
            "answer": "A",
            "pmid": [
                "pmid18516051",
                "pmid33737172",
                "pmid39243388",
                "pmid18509040",
                "pmid15240683",
                "pmid28969867",
                "pmid27422717",
                "pmid12032144",
                "pmid17080199",
                "pmid27723233"
            ]
        },
        "cell_73": {
            "question": "Does All-trans retinoic acid (ATRA) increase Transglutaminase 2 (TG2) expression in BV-2 cells and astrocytes involved in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid37916634",
                "pmid28391388",
                "pmid20437185",
                "pmid26881107",
                "pmid32256561",
                "pmid27448243",
                "pmid20817067",
                "pmid23379615",
                "pmid20950278",
                "pmid22156619"
            ]
        },
        "cell_74": {
            "question": "Does curcumin inhibit appoptosin-induced apoptosis in SH-SY5Y cells, relevant to Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Curcumin preserves cell viability, which is decreased by amyloid-beta. The treatment sequence impacts the protective effect of curcumin, showing a more protective effect when added prior to amyloid-beta exposure. These findings imply a therapeutic usage for Alzheimer's disease patients.",
            "pmid": [
                "pmid25891083",
                "pmid24755072",
                "pmid22886017",
                "pmid26971524",
                "pmid25774181",
                "pmid30746607",
                "pmid27521081",
                "pmid27594837",
                "pmid27060945",
                "pmid22476982"
            ]
        },
        "cell_75": {
            "question": "Are glial hypo- and hyperactivation observed in predementia Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid38093257",
                "pmid39206431",
                "pmid38395200",
                "pmid12960778",
                "pmid23780663",
                "pmid11958858",
                "pmid34302466",
                "pmid15486488",
                "pmid39814010",
                "pmid12453679"
            ]
        },
        "cell_76": {
            "question": "Does a diabetic phenotype reduce microglial numbers around beta-amyloid plaques in Alzheimer's disease (mice and humans)?",
            "answer": "A",
            "pmid": [
                "pmid33168021",
                "pmid15172747",
                "pmid27425031",
                "pmid16476660",
                "pmid37333071",
                "pmid15194867",
                "pmid33402227",
                "pmid28434692",
                "pmid8996832",
                "pmid18835047"
            ]
        },
        "cell_77": {
            "question": "Does USP19 knockdown reduce ferroptosis in SH-SY5Y cells, alleviating mitochondrial damage in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid38943386",
                "pmid36068400",
                "pmid22746342",
                "pmid38761423",
                "pmid22367970",
                "pmid24252614",
                "pmid23348590",
                "pmid29464060",
                "pmid27444386",
                "pmid23982146"
            ]
        },
        "cell_78": {
            "question": "Does Bazi Bushen capsule improve cognitive deficits by inhibiting microglia activation and cellular senescence, similarly to Alzheimer's disease treatments?",
            "answer": "A",
            "pmid": [
                "pmid36263579",
                "pmid28521305",
                "pmid33029123",
                "pmid34064687",
                "pmid29190943",
                "pmid31425745",
                "pmid18789000",
                "pmid22459600",
                "pmid39566407",
                "pmid27518086"
            ]
        },
        "cell_79": {
            "question": "Do activated microglia promote GDNF production by BMSCs to protect neurons against oxygen-glucose deprivation, potentially relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid28018176",
                "pmid38565291",
                "pmid31257151",
                "pmid26257642",
                "pmid31100304",
                "pmid37609338",
                "pmid18395194",
                "pmid39741193",
                "pmid25169677",
                "pmid37117599"
            ]
        },
        "cell_80": {
            "question": "Does GRP78 play a role in disrupting neuron-microglia communication, similar to its involvement in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid37365565",
                "pmid9878757",
                "pmid25637481",
                "pmid1647485",
                "pmid37609338",
                "pmid38791092",
                "pmid15172747",
                "pmid11813244",
                "pmid23559013",
                "pmid35677758"
            ]
        },
        "cell_81": {
            "question": "Does increased HO-1 activity in astrocytes contribute to iron-mediated cytotoxicity in Alzheimer's-affected neural tissues?",
            "answer": "A",
            "pmid": [
                "pmid19250338",
                "pmid22881289",
                "pmid12835114",
                "pmid11053673",
                "pmid32707154",
                "pmid21971404",
                "pmid25761244",
                "pmid24863668",
                "pmid33298837",
                "pmid32708329"
            ]
        },
        "cell_82": {
            "question": "Which of the following best reflects the proposed cellular mechanism contributing to the development of delirium according to the gliocentric perspective?",
            "answer": "D",
            "pmid": [
                "pmid26029046",
                "pmid39463449",
                "pmid28673598",
                "pmid37851904",
                "pmid7916159",
                "pmid37313848",
                "pmid20309566",
                "pmid39419070",
                "pmid39210294",
                "pmid19422109"
            ]
        },
        "cell_83": {
            "question": "Does CIRP overexpression in astrocytes contribute to Alzheimer's disease development by inhibiting uPA expression?",
            "answer": "A",
            "pmid": [
                "pmid39741909",
                "pmid30594047",
                "pmid33783711",
                "pmid32184914",
                "pmid18201952",
                "pmid19394434",
                "pmid31849963",
                "pmid30031059",
                "pmid11755001",
                "pmid37609338"
            ]
        },
        "cell_84": {
            "question": "Do CD11c-positive microglia have a suppressive influence on the inflammatory response in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid27425031",
                "pmid30588668",
                "pmid11578773",
                "pmid15172747",
                "pmid8996832",
                "pmid16476660",
                "pmid15194867",
                "pmid28969867",
                "pmid28434692",
                "pmid16814429"
            ]
        },
        "cell_85": {
            "question": "Does amyloid-beta induce Smac release via AP-1/Bim activation in cerebral endothelial cells relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid12427831",
                "pmid35851991",
                "pmid16821113",
                "pmid17522316",
                "pmid19098903",
                "pmid24997450",
                "pmid38132159",
                "pmid32450297",
                "pmid23152628",
                "pmid35163801"
            ]
        },
        "cell_86": {
            "question": "Does luteolin induce apoptosis and autophagy in macrophages, potentially relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30246034",
                "pmid33335556",
                "pmid28498401",
                "pmid37597424",
                "pmid21368720",
                "pmid26087007",
                "pmid22528780",
                "pmid16765377",
                "pmid29631635",
                "pmid30695399"
            ]
        },
        "cell_87": {
            "question": "Does acute hypoxia affect M1/M2 microglial activation in Alzheimer's disease mice and wild-type littermates?",
            "answer": "A",
            "pmid": [
                "pmid28890695",
                "pmid29867325",
                "pmid37117599",
                "pmid35852609",
                "pmid34844651",
                "pmid39476996",
                "pmid21799251",
                "pmid21088470",
                "pmid38241837",
                "pmid35569719"
            ]
        },
        "cell_88": {
            "question": "Does MKP-1 regulate microglia phenotype and inflammatory factor release in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid37602891",
                "pmid31840000",
                "pmid19800391",
                "pmid33998138",
                "pmid39809738",
                "pmid15172747",
                "pmid11578773",
                "pmid18835047",
                "pmid38886959",
                "pmid28003153"
            ]
        },
        "cell_89": {
            "question": "Does galantamine inhibit beta-amyloid-induced cytostatic autophagy in PC12 cells by decreasing ROS production, relevant to Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid29292543",
                "pmid28554861",
                "pmid20655346",
                "pmid27793617",
                "pmid31823156",
                "pmid25160744",
                "pmid29631635",
                "pmid12649296",
                "pmid30695399",
                "pmid22108004"
            ]
        },
        "cell_90": {
            "question": "Does adoptive transfer of ex vivo expanded human regulatory T cells reduce amyloid burden in an Alzheimer's disease preclinical model?",
            "answer": "A",
            "pmid": [
                "pmid27713140",
                "pmid36180898",
                "pmid32954348",
                "pmid38111016",
                "pmid16476660",
                "pmid37737298",
                "pmid37907046",
                "pmid28969867",
                "pmid12402041",
                "pmid23365075"
            ]
        },
        "cell_91": {
            "question": "Which of the following best explains how systemic inflammation contributes to delirium through neuroinflammatory processes at the cellular level?",
            "answer": "C\n\n\n\n",
            "pmid": [
                "pmid20309566",
                "pmid24557038",
                "pmid33648701",
                "pmid20471138",
                "pmid24048854",
                "pmid28673598",
                "pmid39419070",
                "pmid29875474",
                "pmid32592865",
                "pmid37649721"
            ]
        },
        "cell_92": {
            "question": "Does passion fruit seed extract protect against beta-amyloid-induced neuronal cell death in an Alzheimer's disease model?",
            "answer": "A",
            "pmid": [
                "pmid35592293",
                "pmid32316271",
                "pmid22995388",
                "pmid32488469",
                "pmid23833520",
                "pmid25229015",
                "pmid39682936",
                "pmid20099523",
                "pmid25580148",
                "pmid29389553"
            ]
        },
        "cell_93": {
            "question": "Does FUT8-catalyzed core fucosylation play a role in microglial activation during Alzheimer's disease pathogenesis?",
            "answer": "A",
            "pmid": [
                "pmid36692036",
                "pmid16192374",
                "pmid39474846",
                "pmid11677259",
                "pmid16183991",
                "pmid39908354",
                "pmid35909315",
                "pmid37609338",
                "pmid37735240",
                "pmid30076715"
            ]
        },
        "cell_94": {
            "question": "Does TGF-beta1 protect against Alzheimer's disease by inhibiting microglial FPR2 expression?",
            "answer": "A",
            "pmid": [
                "pmid15240683",
                "pmid21879289",
                "pmid18516051",
                "pmid17080199",
                "pmid30539409",
                "pmid18063474",
                "pmid25485684",
                "pmid27713140",
                "pmid16183991",
                "pmid32508567"
            ]
        },
        "cell_95": {
            "question": "Does alpha-boswellic acid affect astrocytic Reelin expression, related to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid27567921",
                "pmid34116571",
                "pmid17360894",
                "pmid20025970",
                "pmid34607104",
                "pmid32109514",
                "pmid24599114",
                "pmid11755001",
                "pmid27531658",
                "pmid36998129"
            ]
        },
        "cell_96": {
            "question": "Does Sig1R downregulation contribute to neuroinflammation-induced microglial dysfunction in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid32653342",
                "pmid36089405",
                "pmid33402227",
                "pmid25637481",
                "pmid39908354",
                "pmid8996832",
                "pmid21771791",
                "pmid37609338",
                "pmid37603311",
                "pmid26538310"
            ]
        },
        "cell_97": {
            "question": "Does Ca2+-binding protein upregulation in VTA dopamine neurons contribute to their survival in early-stage Alzheimer's disease in Tg2576 mice?",
            "answer": "A",
            "pmid": [
                "pmid36434727",
                "pmid29782955",
                "pmid12881482",
                "pmid9503262",
                "pmid19337829",
                "pmid12460542",
                "pmid10662826",
                "pmid11055438",
                "pmid22269161",
                "pmid22475800"
            ]
        },
        "cell_98": {
            "question": "Does demyelination-derived lysophosphatidylserine (LysoPS) contribute to microglial dysfunction and neuropathology in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid39741193",
                "pmid30530526",
                "pmid33277246",
                "pmid37333071",
                "pmid22934024",
                "pmid36203054",
                "pmid39809738",
                "pmid30560017",
                "pmid28928740",
                "pmid31100304"
            ]
        },
        "cell_99": {
            "question": "Does VAP regulate apoptosis in an Alzheimer's disease cell model?",
            "answer": "A",
            "pmid": [
                "pmid34782612",
                "pmid24985705",
                "pmid21975314",
                "pmid17522316",
                "pmid15073525",
                "pmid25457551",
                "pmid31047972",
                "pmid33998138",
                "pmid36185484",
                "pmid33361033"
            ]
        },
        "cell_100": {
            "question": "Does microglial QUIN elevation in the basolateral amygdala contribute to cognitive dysfunction in delirium?",
            "answer": "B",
            "pmid": [
                "pmid28673598",
                "pmid7916159",
                "pmid24557038",
                "pmid26029046",
                "pmid20309566",
                "pmid32592865",
                "pmid39463449",
                "pmid20471138",
                "pmid38566855",
                "pmid24048854"
            ]
        },
        "cell_101": {
            "question": "Does 3,5,4'-Trihydroxy-6,7,3'-trimethoxyflavone (TTF) protect astrocytes against oxidative stress involved in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid25217804",
                "pmid38308793",
                "pmid11182299",
                "pmid24922524",
                "pmid18706502",
                "pmid25061726",
                "pmid39684454",
                "pmid29411261",
                "pmid23537659",
                "pmid22102154"
            ]
        },
        "cell_102": {
            "question": "Does microglial CD2AP deficiency protect against amyloidosis in an Alzheimer's disease model?",
            "answer": "A",
            "pmid": [
                "pmid39695808",
                "pmid39696695",
                "pmid25887956",
                "pmid21273420",
                "pmid31440393",
                "pmid27425031",
                "pmid37609338",
                "pmid31690660",
                "pmid15194867",
                "pmid34958910"
            ]
        },
        "cell_103": {
            "question": "Does Aster tataricus have potential anti-neuroinflammatory effects relevant to Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Research indicates that acacetin can improve learning and memory in mouse models of Alzheimer’s disease and reduce the formation of senile plaques by inhibiting the NLRP3 signaling pathway and reducing inflammatory responses. This suggests potential anti-neuroinflammatory effects relevant to Alzheimer’s disease.",
            "pmid": [
                "pmid28344491",
                "pmid35627075",
                "pmid31225769",
                "pmid36820018",
                "pmid30622433",
                "pmid11510486",
                "pmid33463937",
                "pmid38866276",
                "pmid36382256",
                "pmid32800555"
            ]
        },
        "cell_104": {
            "question": "Does DHCR24 overexpression modulate microglia polarization and inflammatory response in Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid32950573",
                "pmid29115990",
                "pmid37344916",
                "pmid35804281",
                "pmid33967735",
                "pmid35296367",
                "pmid36450444",
                "pmid11290384",
                "pmid25637481",
                "pmid32653342"
            ]
        },
        "cell_105": {
            "question": "Does compound 4c2 exhibit anti-inflammatory effects by reducing pro-inflammatory cytokines like NO, IL-6, and TNF-alpha relevant to Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Research indicates that certain compounds can reduce pro-inflammatory cytokines such as IL-6 and TNF-alpha, which are implicated in Alzheimer's disease pathology. These compounds also demonstrate the ability to improve cognitive function and reduce neuroinflammation in animal models.",
            "pmid": [
                "pmid16237106",
                "pmid35987018",
                "pmid32028243",
                "pmid35714925",
                "pmid12453679",
                "pmid36820018",
                "pmid29501766",
                "pmid20555131",
                "pmid37098656",
                "pmid35672874"
            ]
        },
        "cell_106": {
            "question": "Does inhibiting microglial activation by PS/PC liposomes suggest a potential Alzheimer's disease treatment?",
            "answer": "A",
            "pmid": [
                "pmid17349923",
                "pmid39809738",
                "pmid37333071",
                "pmid33344892",
                "pmid25485684",
                "pmid25461285",
                "pmid38886959",
                "pmid39741193",
                "pmid37609338",
                "pmid35677758"
            ]
        },
        "cell_107": {
            "question": "Do T1AM and SG-2 induce autophagy in human glioblastoma cell lines, potentially offering therapeutic benefits for Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid29311919",
                "pmid32110992",
                "pmid38007654",
                "pmid21368103",
                "pmid29631635",
                "pmid30362531",
                "pmid24602800",
                "pmid25421002",
                "pmid28806762",
                "pmid38787367"
            ]
        },
        "cell_108": {
            "question": "Does BACE-1 inhibition prevent gamma-secretase inhibitor-evoked Abeta rise in human neuroblastoma SH-SY5Y cells, a model relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid22018341",
                "pmid32223911",
                "pmid19519664",
                "pmid15642747",
                "pmid29327084",
                "pmid30626751",
                "pmid22895721",
                "pmid23202730",
                "pmid18005427",
                "pmid31416794"
            ]
        },
        "cell_109": {
            "question": "Does Ganoderic Acid D protect human amniotic mesenchymal stem cells against oxidative stress-induced senescence, potentially relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid32774686",
                "pmid39625499",
                "pmid34798773",
                "pmid32089787",
                "pmid33815510",
                "pmid28554861",
                "pmid18706502",
                "pmid28630497",
                "pmid34025387",
                "pmid30290256"
            ]
        },
        "cell_110": {
            "question": "Does stearidonic acid (SDA) have a neuroprotective effect against Amyloid-beta-induced neurotoxicity relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid36552565",
                "pmid18037281",
                "pmid21606627",
                "pmid23645098",
                "pmid19423322",
                "pmid25443293",
                "pmid31677009",
                "pmid32583667",
                "pmid36770835",
                "pmid16626961"
            ]
        },
        "cell_111": {
            "question": "Does GMFG regulate Abeta42 phagocytosis in macrophages, implicated in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid39243388",
                "pmid18434187",
                "pmid33737172",
                "pmid12032144",
                "pmid12927763",
                "pmid27723233",
                "pmid19893026",
                "pmid27994540",
                "pmid24014820",
                "pmid18516051"
            ]
        },
        "cell_112": {
            "question": "Does amyloid beta protein's inhibition of MTT reduction in astrocytes relate to its role in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid11137881",
                "pmid11755001",
                "pmid21376707",
                "pmid26200696",
                "pmid37248300",
                "pmid16183991",
                "pmid9338779",
                "pmid21558319",
                "pmid9809588",
                "pmid25814669"
            ]
        },
        "cell_113": {
            "question": "Do astrocytes produce amyloid beta when stimulated with certain cytokine combinations relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid11114266",
                "pmid22047170",
                "pmid10817926",
                "pmid17255335",
                "pmid11755001",
                "pmid1749826",
                "pmid18780966",
                "pmid26200696",
                "pmid25814669",
                "pmid34981861"
            ]
        },
        "cell_114": {
            "question": "Does nimodipine inhibit microglial IL-1beta release in response to amyloid beta, implicated in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid22831460",
                "pmid31019207",
                "pmid16399208",
                "pmid15817521",
                "pmid12930788",
                "pmid12453679",
                "pmid26114860",
                "pmid11741404",
                "pmid35883683",
                "pmid16237106"
            ]
        },
        "cell_115": {
            "question": "Does astrocytic alpha7 nAChR activation inhibit beta-amyloid aggregation in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30345917",
                "pmid25816313",
                "pmid28455519",
                "pmid11755001",
                "pmid39116785",
                "pmid9410912",
                "pmid23379615",
                "pmid26200696",
                "pmid20950278",
                "pmid12105192"
            ]
        },
        "cell_116": {
            "question": "Does S-equol's attenuation of astrocytic NO production have potential implications for mitigating neuroinflammation in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid29692883",
                "pmid37914355",
                "pmid12453679",
                "pmid11556547",
                "pmid23428542",
                "pmid31722531",
                "pmid35872221",
                "pmid35772378",
                "pmid18201952",
                "pmid11958858"
            ]
        },
        "cell_117": {
            "question": "Does peroxisome deficiency in neural cells contribute to Alzheimer's disease development by activating the innate immune system and causing CNS axonal loss?",
            "answer": "A",
            "pmid": [
                "pmid24060512",
                "pmid24336108",
                "pmid22458306",
                "pmid17055782",
                "pmid10964481",
                "pmid29782955",
                "pmid29453790",
                "pmid9514829",
                "pmid35969330",
                "pmid12881482"
            ]
        },
        "cell_118": {
            "question": "Does biatractylolide protect against glutamate-induced cell damage relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid29075302",
                "pmid36500385",
                "pmid15003996",
                "pmid16762377",
                "pmid12391586",
                "pmid16772755",
                "pmid26696494",
                "pmid26822027",
                "pmid25964214",
                "pmid31541651"
            ]
        },
        "cell_119": {
            "question": "Does erythrosine B (ER) reduce Abeta-associated impaired neuronal cell function in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid19666073",
                "pmid26696494",
                "pmid38791223",
                "pmid21998691",
                "pmid29641978",
                "pmid20950278",
                "pmid26881107",
                "pmid39231208",
                "pmid26589795",
                "pmid17008108"
            ]
        },
        "cell_120": {
            "question": "Can Liensinine, Isoliensinine, and Neferine reduce apoptosis in PC12 cells injured by amyloid-beta, potentially offering therapeutic potential for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35762411",
                "pmid15073525",
                "pmid37891552",
                "pmid33335556",
                "pmid9410912",
                "pmid30404965",
                "pmid25774173",
                "pmid20307525",
                "pmid28852940",
                "pmid9464644"
            ]
        },
        "cell_121": {
            "question": "Does 25-hydroxyvitamin D3 inhibit nitric oxide production in activated microglia, potentially relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid25352759",
                "pmid37569267",
                "pmid24934545",
                "pmid37274074",
                "pmid28816551",
                "pmid11070493",
                "pmid12203047",
                "pmid11331412",
                "pmid11592111",
                "pmid31677009"
            ]
        },
        "cell_122": {
            "question": "Does NPS 2143 suppress excess endogenous Abeta42 secretion in human cortical astrocytes and neurons relevant to Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Both pmid23628734 and pmid25342943 explicitly state that NPS 2143 specifically suppresses the increased secretion of endogenous Abeta42 in human cortical astrocytes and neurons. For example, pmid23628734 states \"NPS 2143 specifically suppressed the fAbeta25-35-elicited surges of endogenous Abeta42 secretion by astrocytes and neurons.\" and pmid25342943 states \"NPS 2143, a highly selective allosteric CaSR antagonist (\"calcilytic\"), fully suppresses all the Abeta CaSR signaling-driven noxious actions.\" These findings are relevant to Alzheimer's disease, as the papers discuss the role of Abeta in the pathology of the disease.",
            "pmid": [
                "pmid28455519",
                "pmid23628734",
                "pmid22998035",
                "pmid10623648",
                "pmid25342943",
                "pmid23559013",
                "pmid18400893",
                "pmid38042775",
                "pmid15548589",
                "pmid29033790"
            ]
        },
        "cell_123": {
            "question": "Do Dendrobium polysaccharides improve cognitive impairment in Alzheimer's disease by modulating microglial activation?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid30253123",
                "pmid39536176",
                "pmid27994964",
                "pmid28546539",
                "pmid35586062",
                "pmid38866276",
                "pmid30844489",
                "pmid36402384",
                "pmid32003387",
                "pmid39094545"
            ]
        },
        "cell_124": {
            "question": "Do murine Abeta oligomers disrupt endothelial barrier integrity through astrocyte-derived factors relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35163801",
                "pmid24997450",
                "pmid32450297",
                "pmid35851991",
                "pmid25108202",
                "pmid31047972",
                "pmid16821113",
                "pmid33737172",
                "pmid27633771",
                "pmid34494298"
            ]
        },
        "cell_125": {
            "question": "Does inhibiting endothelial cell YAP improve BBB integrity and reduce brain damage in ischemia-reperfusion injury, potentially relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid34899341",
                "pmid31047972",
                "pmid38132159",
                "pmid12427831",
                "pmid27633771",
                "pmid17430246",
                "pmid26362823",
                "pmid29351469",
                "pmid19319544",
                "pmid24997450"
            ]
        },
        "cell_126": {
            "question": "Is microglia-induced neuroinflammation predominant in the white matter of aging mice and humans, as well as in early-onset Alzheimer's disease (EOAD) brains?",
            "answer": "A",
            "pmid": [
                "pmid28713239",
                "pmid31139072",
                "pmid35093614",
                "pmid8996832",
                "pmid15172747",
                "pmid9542587",
                "pmid26257642",
                "pmid11578773",
                "pmid28434692",
                "pmid33402227"
            ]
        },
        "cell_127": {
            "question": "Does SRCL presence in astrocytes and microglia suggest a role in amyloid-beta clearance in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid16868960",
                "pmid21076037",
                "pmid15987691",
                "pmid11238031",
                "pmid19098903",
                "pmid15172747",
                "pmid10550330",
                "pmid39809738",
                "pmid16476660",
                "pmid30911003"
            ]
        },
        "cell_128": {
            "question": "Does S-Adenosylhomocysteine (SAH) increase microglial cell DNA damage, potentially contributing to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid22064374",
                "pmid19635394",
                "pmid32597804",
                "pmid23579332",
                "pmid17851177",
                "pmid37609338",
                "pmid26200696",
                "pmid9878757",
                "pmid23582659",
                "pmid19800391"
            ]
        },
        "cell_129": {
            "question": "Does microglial DNase II deficiency contribute to Alzheimer's disease pathology?",
            "answer": "A",
            "pmid": [
                "pmid39833906",
                "pmid39095921",
                "pmid8730800",
                "pmid33402227",
                "pmid39695808",
                "pmid33446646",
                "pmid37609338",
                "pmid36564824",
                "pmid36450444",
                "pmid2935594"
            ]
        },
        "cell_130": {
            "question": "Does leptin decrease neprilysin expression in primary cultured astrocytes, potentially contributing to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid24508800",
                "pmid12387451",
                "pmid25039425",
                "pmid32512031",
                "pmid22921154",
                "pmid21382117",
                "pmid19166821",
                "pmid17591969",
                "pmid17008108",
                "pmid12105192"
            ]
        },
        "cell_131": {
            "question": "Does chlorogenic acid enhance autophagy to protect SH-SY5Y cells against H2O2-induced injury, relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid33747165",
                "pmid30362531",
                "pmid21368103",
                "pmid31900522",
                "pmid22108004",
                "pmid16297550",
                "pmid38787367",
                "pmid30695399",
                "pmid36809694",
                "pmid29631635"
            ]
        },
        "cell_132": {
            "question": "Does curcumin's Nrf2 activation via PKCdelta-mediated p62 phosphorylation at S351 have a protective role in neurons relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid33875681",
                "pmid24755072",
                "pmid26358194",
                "pmid25774181",
                "pmid27594837",
                "pmid26971524",
                "pmid29570500",
                "pmid30746607",
                "pmid22886017",
                "pmid18706502"
            ]
        },
        "cell_133": {
            "question": "Does PAR2 activation in glial cells contribute to neuroinflammation and neuronal death in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid17911636",
                "pmid23076628",
                "pmid24086258",
                "pmid30594047",
                "pmid16476770",
                "pmid14682360",
                "pmid9878757",
                "pmid25485684",
                "pmid34249938",
                "pmid15608143"
            ]
        },
        "cell_134": {
            "question": "Is PKC alpha immunoreactivity enhanced in reactive astrocytes associated with senile plaques in Alzheimer's disease brains?",
            "answer": "A",
            "pmid": [
                "pmid7936052",
                "pmid2376771",
                "pmid1990207",
                "pmid11755001",
                "pmid32512031",
                "pmid11290384",
                "pmid2391515",
                "pmid34981861",
                "pmid19800391",
                "pmid18201952"
            ]
        },
        "cell_135": {
            "question": "Do women with Alzheimer's disease exhibit weaker cytokine production in response to viral infection compared to men with Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35708851",
                "pmid37330146",
                "pmid33301871",
                "pmid39497354",
                "pmid17085001",
                "pmid33715827",
                "pmid16814429",
                "pmid29039020",
                "pmid37737298",
                "pmid24014820"
            ]
        },
        "cell_136": {
            "question": "Does microglial heme oxygenase-1 (HO-1) deletion reduce tauopathy-induced neuroinflammation in the retina of old mice, an Alzheimer's-relevant model?",
            "answer": "A",
            "pmid": [
                "pmid36358522",
                "pmid32708329",
                "pmid30040734",
                "pmid11053673",
                "pmid19250338",
                "pmid25761244",
                "pmid22881289",
                "pmid10936206",
                "pmid12835114",
                "pmid18841019"
            ]
        },
        "cell_137": {
            "question": "Is defective TNFalpha-dependent control of astrocyte glutamate release associated with Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid16253995",
                "pmid23579326",
                "pmid35569719",
                "pmid35872221",
                "pmid10713108",
                "pmid19828810",
                "pmid35427648",
                "pmid20401186",
                "pmid32008166",
                "pmid25964214"
            ]
        },
        "cell_138": {
            "question": "Does Abeta binding to phosphatidylserine on neuronal cells contribute to neurotoxicity in Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Intracellular Abeta peptides can activate the p53 promoter, leading to neuronal apoptosis, and exacerbate mitochondrial defects in sporadic Alzheimer's disease. These peptides also induce oxidative stress and can trigger mitochondrial permeability transition, contributing to neurodegeneration. These mechanisms demonstrate an alternative pathway to neuronal loss in Alzheimer’s disease.",
            "pmid": [
                "pmid15837797",
                "pmid16210396",
                "pmid19324459",
                "pmid25828534",
                "pmid25233405",
                "pmid22634250",
                "pmid25108202",
                "pmid28642958",
                "pmid11181824",
                "pmid15548589"
            ]
        },
        "cell_139": {
            "question": "Can ultrasound-mediated exosome release from astrocytes alleviate amyloid-beta-induced neurotoxicity in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid33754065",
                "pmid27392863",
                "pmid31410223",
                "pmid18003341",
                "pmid39588954",
                "pmid33132889",
                "pmid30259257",
                "pmid34073900",
                "pmid37569786",
                "pmid11137881"
            ]
        },
        "cell_140": {
            "question": "How does PTPA knockdown affect cell viability and apoptosis relevant to Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid24821282",
                "pmid12059037",
                "pmid24424093",
                "pmid9410912",
                "pmid28413194",
                "pmid9151738",
                "pmid29660945",
                "pmid10377452",
                "pmid16923170",
                "pmid29358916"
            ]
        },
        "cell_141": {
            "question": "How does SRPK2 expression affect microglia activation in Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid35153686",
                "pmid36564824",
                "pmid11290384",
                "pmid36620941",
                "pmid39809738",
                "pmid9878757",
                "pmid15172747",
                "pmid33998138",
                "pmid30911003",
                "pmid30758770"
            ]
        },
        "cell_142": {
            "question": "Which compound inhibits Abeta aggregation and promotes neurite outgrowth in Alzheimer's disease cell models?",
            "answer": "B",
            "pmid": [
                "pmid22992731",
                "pmid19625748",
                "pmid19141069",
                "pmid30707915",
                "pmid27258855",
                "pmid26362358",
                "pmid32233096",
                "pmid16246051",
                "pmid21276834",
                "pmid37315666"
            ]
        },
        "cell_143": {
            "question": "Which of the following best describes the cellular effect of Pon1 deficiency in relation to Alzheimer's disease pathology?",
            "answer": "D",
            "pmid": [
                "pmid35589918",
                "pmid36899882",
                "pmid33668379",
                "pmid20980077",
                "pmid16319130",
                "pmid9151738",
                "pmid15016430",
                "pmid24334724",
                "pmid14741412",
                "pmid24965284"
            ]
        },
        "cell_144": {
            "question": "What effect does dipeptidyl vinyl sulfone (VS) have on Abeta-mediated microglial inflammation relevant to Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid27797173",
                "pmid31982468",
                "pmid36724966",
                "pmid22133278",
                "pmid34329731",
                "pmid24336048",
                "pmid23279783",
                "pmid34299330",
                "pmid30819080",
                "pmid30484906"
            ]
        },
        "cell_145": {
            "question": "What effect does water-soluble chitosan (WSC) have on pro-inflammatory cytokine production in human astrocytoma cells activated by amyloid beta peptide and interleukin-1beta, relevant to Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid11872267",
                "pmid19844776",
                "pmid23999027",
                "pmid26006224",
                "pmid29112116",
                "pmid34111442",
                "pmid1749826",
                "pmid11114266",
                "pmid30844489",
                "pmid35234337"
            ]
        },
        "cell_146": {
            "question": "Which olive biophenol extract showed the highest neuroprotection against H2O2-induced oxidative stress and Cu-induced toxicity in SH-SY5Y cells, suggesting potential Alzheimer's disease benefits?",
            "answer": "C\n",
            "pmid": [
                "pmid29109370",
                "pmid38339193",
                "pmid37508010",
                "pmid39061831",
                "pmid29068387",
                "pmid39200504",
                "pmid29417471",
                "pmid22995388",
                "pmid35592293",
                "pmid39682936"
            ]
        },
        "cell_147": {
            "question": "Which of the following best explains how hypoxia contributes to microglial dysfunction in the context of Alzheimer’s disease pathology?",
            "answer": "B",
            "pmid": [
                "pmid37117599",
                "pmid28890695",
                "pmid31100304",
                "pmid35852609",
                "pmid29867325",
                "pmid19319544",
                "pmid39476996",
                "pmid31382012",
                "pmid35569719",
                "pmid21799251"
            ]
        },
        "cell_148": {
            "question": "Epiisopiloturine (EPI), a Pilocarpus microphyllus alkaloid, reduces microglial inflammation. How might this compound potentially influence Alzheimer's disease progression?",
            "answer": "Epiisopiloturine (EPI) may influence Alzheimer's disease progression by modulating microglial polarization and neuroinflammation. Evidence suggests that shifting microglia towards an M1 to M2 phenotype can be beneficial in Alzheimer's disease, and compounds like platycodigenin demonstrate this effect alongside reducing inflammatory signaling through pathways like NF-kappaB and MAPK p38. Furthermore, compounds that promote neuronal survival and regeneration, such as through PPARgamma activation, may counteract Abeta-induced pathology. Similarly, maresin 1 demonstrates potential by downregulating inflammatory gene expression and re-balancing inflammatory transcriptional networks, including modulation of the nuclear factor-kappa B pathway. Therefore, EPI’s anti-inflammatory effects on microglia could potentially ameliorate neuroinflammation and protect against Alzheimer’s disease-related cognitive decline.",
            "pmid": [
                "pmid37151606",
                "pmid32166661",
                "pmid23660953",
                "pmid37598923",
                "pmid30208700",
                "pmid38954263",
                "pmid26643169",
                "pmid31487775",
                "pmid36820018",
                "pmid38886959"
            ]
        },
        "cell_149": {
            "question": "How does PKC activation affect gliosis in NPC1 patient-derived iPSC glial cells, and what is its implication for Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid28841900",
                "pmid39814010",
                "pmid7936052",
                "pmid2376771",
                "pmid24334724",
                "pmid2391515",
                "pmid32512031",
                "pmid1990207",
                "pmid35569719",
                "pmid9878757"
            ]
        },
        "cell_150": {
            "question": "Which of these is enriched in extracellular vesicles from NEP-enhanced hUC-MSCs and contributed to therapeutic effects in an Alzheimer's disease model?",
            "answer": "C",
            "pmid": [
                "pmid34899919",
                "pmid32931898",
                "pmid38293018",
                "pmid33300254",
                "pmid34552470",
                "pmid20930307",
                "pmid22926141",
                "pmid30259257",
                "pmid34073900",
                "pmid19228952"
            ]
        },
        "cell_151": {
            "question": "Which cytokine is inhibited by TREM2 in response to Abeta42 in HMC3 cells relevant to Alzheimer's disease?",
            "answer": "C\n",
            "pmid": [
                "pmid33461764",
                "pmid31134514",
                "pmid31727362",
                "pmid36637116",
                "pmid34663480",
                "pmid32959884",
                "pmid29362997",
                "pmid36564824",
                "pmid36683512",
                "pmid35082148"
            ]
        },
        "cell_152": {
            "question": "Which molecule protects human microglial cells (HMC3) against apoptosis and DNA damage induced by LPS and Abeta1-42 aggregates in vitro, offering potential Alzheimer's disease therapeutic benefits?",
            "answer": "<Correct Answer>: C\n<Why>: The study demonstrates that baicalein shifts microglia from a pro-inflammatory to an anti-inflammatory state, inhibits microglial apoptosis, and promotes Abeta uptake. These effects suggest a protective role against neuroinflammation and neural injury, offering potential therapeutic benefits for Alzheimer's disease. Therefore, baicalein is the correct answer.",
            "pmid": [
                "pmid39518952",
                "pmid37373543",
                "pmid15073525",
                "pmid27557632",
                "pmid36799439",
                "pmid35264247",
                "pmid36770835",
                "pmid24336048",
                "pmid38006681",
                "pmid27797173"
            ]
        },
        "cell_153": {
            "question": "Which microglial type reduces Abeta plaque deposition in Alzheimer's disease during IL-1beta-dependent neuroinflammation?",
            "answer": "B",
            "pmid": [
                "pmid15172747",
                "pmid26538310",
                "pmid11578773",
                "pmid28434692",
                "pmid22655214",
                "pmid20798889",
                "pmid16476660",
                "pmid28969867",
                "pmid8996832",
                "pmid18835047"
            ]
        },
        "cell_154": {
            "question": "How does soluble epoxide hydrolase (sEH) affect astrocytic immune responses in an Alzheimer's disease model?",
            "answer": "B",
            "pmid": [
                "pmid26200696",
                "pmid31176371",
                "pmid34486652",
                "pmid29688618",
                "pmid24577479",
                "pmid32597804",
                "pmid35569719",
                "pmid20164580",
                "pmid27465436",
                "pmid32708329"
            ]
        },
        "cell_155": {
            "question": "What is a potential implication of A20 deficiency for neuroinflammatory diseases like Alzheimer's?",
            "answer": "B",
            "pmid": [
                "pmid25026958",
                "pmid28337659",
                "pmid11464464",
                "pmid26124703",
                "pmid10873585",
                "pmid31690660",
                "pmid33597269",
                "pmid10666665",
                "pmid12453679",
                "pmid11730949"
            ]
        },
        "cell_156": {
            "question": "Beta-Amyrin reduces microglial inflammation. How might this mechanism be beneficial for Alzheimer's disease?",
            "answer": "D",
            "pmid": [
                "pmid29501766",
                "pmid28985759",
                "pmid38886959",
                "pmid28969867",
                "pmid12453679",
                "pmid18835047",
                "pmid15194867",
                "pmid35474599",
                "pmid39094545",
                "pmid19800391"
            ]
        },
        "cell_157": {
            "question": "Which of these is associated with increased Kir6.2 expression in reactive astrocytes in Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid27586053",
                "pmid34981861",
                "pmid39603277",
                "pmid18201952",
                "pmid11677259",
                "pmid11755001",
                "pmid34099509",
                "pmid25814669",
                "pmid38042775",
                "pmid26582459"
            ]
        },
        "cell_158": {
            "question": "Which compound inhibits pro-inflammatory mediator production in microglial cells stimulated with Abeta25-35 and IFN-gamma, suggesting a potential Alzheimer's disease therapeutic approach?",
            "answer": "<Correct Answer>: A\n<Why>: Several compounds demonstrate the ability to modulate microglial activation and neuroinflammation, key factors in Alzheimer's disease. These compounds act by inhibiting proinflammatory receptors, activating anti-inflammatory receptors, and regulating pathways related to beta-amyloid clearance. This suggests a therapeutic approach focused on regulating microglial responses to beta-amyloid, such as that seen with Chicago sky blue 6B, which inhibited NF-kappaB and NLRP3, thereby reducing pro-inflammatory mediator production. Therefore, amyloid beta peptide (Abeta) is the correct answer, as the compounds described in the context are designed to counter its effects on microglial activation and inflammation.",
            "pmid": [
                "pmid28157092",
                "pmid27797173",
                "pmid31982468",
                "pmid12137934",
                "pmid35714925",
                "pmid24219385",
                "pmid33344892",
                "pmid23279783",
                "pmid39094545",
                "pmid32028243"
            ]
        },
        "cell_159": {
            "question": "Which neurosteroid inhibits TLR4 activation in both male and female human macrophages, potentially contributing to anti-inflammatory effects relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid27359332",
                "pmid32508567",
                "pmid35967446",
                "pmid27980422",
                "pmid35772378",
                "pmid27422717",
                "pmid11070493",
                "pmid29743866",
                "pmid16237106",
                "pmid28669260"
            ]
        },
        "cell_160": {
            "question": "How does astrocytic hepcidin overexpression affect Alzheimer's disease symptoms in APP/PS1 mice?",
            "answer": "B",
            "pmid": [
                "pmid32707154",
                "pmid33298837",
                "pmid28266714",
                "pmid38195497",
                "pmid35569719",
                "pmid38216963",
                "pmid30594047",
                "pmid11755001",
                "pmid38159478",
                "pmid34394834"
            ]
        },
        "cell_161": {
            "question": "Which molecule, released by astrocytes upon tau oligomer exposure, contributes to cellular senescence and neuropathology in Alzheimer's disease and frontotemporal dementia?",
            "answer": "A",
            "pmid": [
                "pmid34289368",
                "pmid33818291",
                "pmid30489222",
                "pmid37814508",
                "pmid24718102",
                "pmid26490863",
                "pmid32366836",
                "pmid30126037",
                "pmid30108137",
                "pmid35569719"
            ]
        },
        "cell_162": {
            "question": "How does glypican 4 (Gpc4) contribute to Alzheimer's disease pathophysiology in neural stem cells?",
            "answer": "B",
            "pmid": [
                "pmid34552470",
                "pmid38992568",
                "pmid15084524",
                "pmid33403386",
                "pmid25637481",
                "pmid27687691",
                "pmid35872221",
                "pmid39814010",
                "pmid1647485",
                "pmid9878757"
            ]
        },
        "cell_163": {
            "question": "In Alzheimer's disease, which protein is associated with a stronger neuroinflammatory response compared to Abeta42?",
            "answer": "A",
            "pmid": [
                "pmid38105410",
                "pmid25318543",
                "pmid36724966",
                "pmid18395194",
                "pmid8922409",
                "pmid21228179",
                "pmid12119423",
                "pmid15680223",
                "pmid12600718",
                "pmid9687521"
            ]
        },
        "cell_164": {
            "question": "Which Algerian mint extract showed the highest cytoprotective effect on 7-ketocholesterol-treated RAW 264.7 macrophages, potentially relevant to Alzheimer's disease or delirium?",
            "answer": "<Correct Answer>: A\n<Why>: The context states, “The most important cytoprotective effect was observed with the MS extract.” MS stands for *Mentha spicata* L., indicating it had the highest cytoprotective effect on the treated macrophages. This is relevant to Alzheimer's disease and delirium as the study investigates potential benefits of Algerian mint on human health, and cytoprotective effects could mitigate neurodegenerative processes.",
            "pmid": [
                "pmid30563252",
                "pmid24448790",
                "pmid38138438",
                "pmid26068423",
                "pmid32316271",
                "pmid32397683",
                "pmid22995388",
                "pmid27774420",
                "pmid26853104",
                "pmid39229544"
            ]
        },
        "cell_165": {
            "question": "Which microglial type significantly increased in mice receiving HUMSC-NC transplantation, contributing to amyloid-beta deposition reduction in an Alzheimer's disease model?",
            "answer": "B",
            "pmid": [
                "pmid24070198",
                "pmid16476660",
                "pmid15194867",
                "pmid27425031",
                "pmid34566422",
                "pmid33402227",
                "pmid28643422",
                "pmid38293018",
                "pmid28969867",
                "pmid38515329"
            ]
        },
        "cell_166": {
            "question": "How does inhibiting microglial choline transport affect M1/M2 polarization, potentially influencing conditions like Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid36012189",
                "pmid31264132",
                "pmid37603311",
                "pmid38006681",
                "pmid36365192",
                "pmid38957539",
                "pmid26114860",
                "pmid36368316",
                "pmid31560162",
                "pmid39741193"
            ]
        },
        "cell_167": {
            "question": "Which metal sulfate combination synergistically up-regulates miRNA-125b and miRNA-146a in human astroglial cells, potentially contributing to Alzheimer's disease pathogenesis?",
            "answer": "B",
            "pmid": [
                "pmid22099153",
                "pmid17629564",
                "pmid19540598",
                "pmid20347935",
                "pmid18801740",
                "pmid22302353",
                "pmid31997075",
                "pmid35592504",
                "pmid31134481",
                "pmid24604632"
            ]
        },
        "cell_168": {
            "question": "Which cell type produces significantly less apoE than pericytes and is less involved in Abeta clearance near vasculature in Alzheimer's disease?",
            "answer": "A.",
            "pmid": [
                "pmid20034483",
                "pmid29453790",
                "pmid24336108",
                "pmid38682184",
                "pmid24918635",
                "pmid32429102",
                "pmid15642747",
                "pmid37264161",
                "pmid30340601",
                "pmid21210284"
            ]
        },
        "cell_169": {
            "question": "How does repeated glucose deprivation/reperfusion affect neuronal cells, potentially contributing to Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid27766247",
                "pmid24124562",
                "pmid36204837",
                "pmid26895791",
                "pmid36206930",
                "pmid21035308",
                "pmid33994936",
                "pmid26855936",
                "pmid10662826",
                "pmid17055782"
            ]
        },
        "cell_170": {
            "question": "How does PIEZO1 channel activation affect microglial function relevant to Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid38957539",
                "pmid36368316",
                "pmid36798430",
                "pmid35706029",
                "pmid37603311",
                "pmid37735240",
                "pmid9878757",
                "pmid15172747",
                "pmid36564824",
                "pmid24334724"
            ]
        },
        "cell_171": {
            "question": "Which intracellular protein binds amyloid-beta in Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid9338779",
                "pmid8915608",
                "pmid21224052",
                "pmid11290384",
                "pmid20050683",
                "pmid22269167",
                "pmid18005427",
                "pmid19679638",
                "pmid16297550",
                "pmid11578773"
            ]
        },
        "cell_172": {
            "question": "In which Alzheimer's disease stages do initial cytoskeletal changes occur in the basal nucleus of Meynert?",
            "answer": "C",
            "pmid": [
                "pmid10965795",
                "pmid9878757",
                "pmid10817927",
                "pmid7916770",
                "pmid7533559",
                "pmid27195475",
                "pmid22269167",
                "pmid9189043",
                "pmid10623648",
                "pmid12960778"
            ]
        },
        "cell_173": {
            "question": "How do microglia-derived microvesicles contribute to Alzheimer's disease degeneration?",
            "answer": "C",
            "pmid": [
                "pmid24336048",
                "pmid15172747",
                "pmid16476660",
                "pmid33402227",
                "pmid37333071",
                "pmid18835047",
                "pmid11578773",
                "pmid8996832",
                "pmid36564824",
                "pmid16192374"
            ]
        },
        "cell_174": {
            "question": "What correlates with reduced dendritic arborization in the subiculum of Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid14507668",
                "pmid7916770",
                "pmid2900051",
                "pmid11351135",
                "pmid11276052",
                "pmid9878757",
                "pmid2725861",
                "pmid27195475",
                "pmid24607963",
                "pmid36919335"
            ]
        },
        "cell_175": {
            "question": "What cells do Alzheimer's disease CSF antibodies selectively recognize?",
            "answer": "C\n",
            "pmid": [
                "pmid8871946",
                "pmid12927763",
                "pmid8996832",
                "pmid16476660",
                "pmid18434187",
                "pmid12032144",
                "pmid8892352",
                "pmid7916770",
                "pmid12897209",
                "pmid20541838"
            ]
        },
        "cell_176": {
            "question": "What characteristics define Alzheimer's disease plaques formed by human macrophages?",
            "answer": "B",
            "pmid": [
                "pmid16765377",
                "pmid15172747",
                "pmid27723233",
                "pmid16476660",
                "pmid28969867",
                "pmid28928740",
                "pmid11578773",
                "pmid28434692",
                "pmid29520228",
                "pmid33737172"
            ]
        },
        "cell_177": {
            "question": "What is a key observed link between pro-inflammatory cellular responses and altered brain electrophysiology in the context of inflammation-associated delirium, and what type of signaling is implicated?",
            "answer": "C",
            "pmid": [
                "pmid20309566",
                "pmid33648701",
                "pmid24557038",
                "pmid20471138",
                "pmid28673598",
                "pmid32592865",
                "pmid37649721",
                "pmid39839987",
                "pmid39419070",
                "pmid30390679"
            ]
        },
        "cell_178": {
            "question": "What pathological features of alpha-synuclein are associated with postoperative delirium in patients undergoing gastrectomy?",
            "answer": "C",
            "pmid": [
                "pmid23365056",
                "pmid33409674",
                "pmid29630637",
                "pmid30488836",
                "pmid30051417",
                "pmid36224337",
                "pmid39519398",
                "pmid36457825",
                "pmid17721242",
                "pmid10473947"
            ]
        },
        "cell_179": {
            "question": "What is the role of glia in the pathophysiology of delirium?",
            "answer": "B",
            "pmid": [
                "pmid39463449",
                "pmid26029046",
                "pmid36520371",
                "pmid7916159",
                "pmid37851904",
                "pmid31770149",
                "pmid28673598",
                "pmid28519903",
                "pmid39419070",
                "pmid39355007"
            ]
        },
        "cell_180": {
            "question": "What cellular mechanisms underlie the effect of electroacupuncture in reducing delirium-like behavior associated with surgical pain?",
            "answer": "B",
            "pmid": [
                "pmid36003380",
                "pmid38895540",
                "pmid30911820",
                "pmid30051417",
                "pmid31244434",
                "pmid37851904",
                "pmid37313848",
                "pmid39419070",
                "pmid33409674",
                "pmid7916159"
            ]
        },
        "cell_181": {
            "question": "What cellular mechanisms contribute to delirium as a complication of chimeric antigen receptor T-cell therapy?",
            "answer": "C",
            "pmid": [
                "pmid28049548",
                "pmid35871757",
                "pmid24557038",
                "pmid37851904",
                "pmid31429760",
                "pmid36259217",
                "pmid36159401",
                "pmid26819347",
                "pmid20471138",
                "pmid37313848"
            ]
        },
        "cell_182": {
            "question": "What cellular changes in reactive astrocytes are associated with delirium caused by systemic inflammation or acute liver failure?",
            "answer": "B",
            "pmid": [
                "pmid33172595",
                "pmid31770149",
                "pmid24557038",
                "pmid33648701",
                "pmid39463449",
                "pmid39355007",
                "pmid20309566",
                "pmid26029046",
                "pmid20471138",
                "pmid21978081"
            ]
        },
        "cell_183": {
            "question": "What immune-related mechanisms are implicated in delirium associated with cytomegalovirus colitis in elderly patients?",
            "answer": "D",
            "pmid": [
                "pmid17467406",
                "pmid20309566",
                "pmid24557038",
                "pmid20471115",
                "pmid19269948",
                "pmid21978081",
                "pmid17203511",
                "pmid34192631",
                "pmid32592865",
                "pmid28769556"
            ]
        },
        "cell_184": {
            "question": "What immune-related factors are associated with delirium in Morvan's syndrome?",
            "answer": "C",
            "pmid": [
                "pmid37649721",
                "pmid24557038",
                "pmid20309566",
                "pmid33779822",
                "pmid30090985",
                "pmid28769556",
                "pmid549538",
                "pmid34757245",
                "pmid20471115",
                "pmid34192631"
            ]
        },
        "cell_185": {
            "question": "What effects do antipsychotic medications have on astrocytes in the context of delirium?",
            "answer": "D",
            "pmid": [
                "pmid26029046",
                "pmid39463449",
                "pmid39355007",
                "pmid33648701",
                "pmid37313848",
                "pmid7916159",
                "pmid2524220",
                "pmid28673598",
                "pmid39210294",
                "pmid31568239"
            ]
        },
        "cell_186": {
            "question": "What cellular mechanisms underlie delirium-like behaviors induced by sedation in an inflamed developing brain?",
            "answer": "C",
            "pmid": [
                "pmid37302746",
                "pmid38895540",
                "pmid20309566",
                "pmid37313848",
                "pmid37851904",
                "pmid33648701",
                "pmid7916159",
                "pmid39505249",
                "pmid28673598",
                "pmid24557038"
            ]
        },
        "cell_187": {
            "question": "What cellular mechanisms underlie delirium induced by lithium therapy?",
            "answer": "C",
            "pmid": [
                "pmid10664610",
                "pmid36520371",
                "pmid37851904",
                "pmid7916159",
                "pmid3281716",
                "pmid37313848",
                "pmid39419070",
                "pmid38801405",
                "pmid39210294",
                "pmid39463449"
            ]
        },
        "cell_188": {
            "question": "What role does complement-dependent synaptic pruning by microglia play in delirium associated with sepsis-associated encephalopathy?",
            "answer": "B",
            "pmid": [
                "pmid37235660",
                "pmid32592865",
                "pmid25567339",
                "pmid20471138",
                "pmid25722876",
                "pmid6160732",
                "pmid38926390",
                "pmid39839987",
                "pmid24557038",
                "pmid22553034"
            ]
        },
        "cell_189": {
            "question": "What cellular mechanisms are associated with delirium in Wernicke-Korsakoff syndrome?",
            "answer": "D",
            "pmid": [
                "pmid23790077",
                "pmid549538",
                "pmid37851904",
                "pmid24557038",
                "pmid7916159",
                "pmid28673598",
                "pmid39463449",
                "pmid20309566",
                "pmid37313848",
                "pmid39419070"
            ]
        },
        "cell_190": {
            "question": "How does systemic bacterial infection induce microglial activation leading to delirium?",
            "answer": "<Correct Answer>: C\n<Why>: Systemic inflammation, such as that caused by bacterial lipopolysaccharide (LPS), can lead to cognitive deficits resembling delirium. This occurs, in part, through the activation of microglia and the subsequent production of inflammatory mediators like IL-1beta and prostaglandin E2. Specifically, research indicates that LPS-induced inflammation can trigger microglial COX-1 expression, increasing susceptibility to cognitive dysfunction, and that IL-1beta can directly induce neuronal dysfunction. This supports the idea that systemic bacterial infection activates microglia, leading to neuroinflammation and ultimately, delirium.",
            "pmid": [
                "pmid29755322",
                "pmid20309566",
                "pmid32592865",
                "pmid24557038",
                "pmid20471138",
                "pmid33648701",
                "pmid30390679",
                "pmid37313848",
                "pmid29875474",
                "pmid24048854"
            ]
        },
        "cell_191": {
            "question": "How does MANF inhibit inflammation and microglia activation in post-operative delirium?",
            "answer": "C",
            "pmid": [
                "pmid34234505",
                "pmid35294925",
                "pmid33409674",
                "pmid36077505",
                "pmid36457825",
                "pmid33250764",
                "pmid35095412",
                "pmid36224337",
                "pmid30390679",
                "pmid37170230"
            ]
        },
        "cell_192": {
            "question": "Does astrocyte reactivity influence the association between amyloid-beta and tau phosphorylation in preclinical Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid37248300",
                "pmid11755001",
                "pmid34981861",
                "pmid25814669",
                "pmid33818291",
                "pmid29033790",
                "pmid39603277",
                "pmid18201952",
                "pmid11114266",
                "pmid34963475"
            ]
        },
        "cell_193": {
            "question": "What is the role of syntaxin-4 in the trafficking of ionotropic glutamate receptors in Alzheimer's Disease?",
            "answer": "C",
            "pmid": [
                "pmid30481567",
                "pmid22998035",
                "pmid2391515",
                "pmid25964214",
                "pmid8740986",
                "pmid17301176",
                "pmid11447833",
                "pmid34552470",
                "pmid25390692",
                "pmid21224052"
            ]
        },
        "cell_194": {
            "question": "What are intranuclear inclusion bodies in the context of Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid7606903",
                "pmid10623648",
                "pmid26151923",
                "pmid22269167",
                "pmid16023263",
                "pmid7916770",
                "pmid9338779",
                "pmid36788216",
                "pmid15465622",
                "pmid28928740"
            ]
        },
        "cell_195": {
            "question": "What role does cathepsin B play in microglial Abeta clearance in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid39304744",
                "pmid35181976",
                "pmid14522241",
                "pmid39122455",
                "pmid39453382",
                "pmid39726227",
                "pmid11755001",
                "pmid27333034",
                "pmid30575263",
                "pmid32640970"
            ]
        },
        "cell_196": {
            "question": "How does the repeat domain of tau interact with lipid surfaces in the context of Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid16908029",
                "pmid16115884",
                "pmid24718102",
                "pmid27193083",
                "pmid30006151",
                "pmid7533559",
                "pmid28864542",
                "pmid35760815",
                "pmid15721985",
                "pmid14563691"
            ]
        },
        "cell_197": {
            "question": "Does the aqueous extract from Toona sinensis leaves inhibit microglia-mediated neuroinflammation in Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid24444536",
                "pmid36193798",
                "pmid28279707",
                "pmid20079417",
                "pmid27563424",
                "pmid27774420",
                "pmid12391609",
                "pmid32141445",
                "pmid30819080",
                "pmid39094545"
            ]
        },
        "cell_198": {
            "question": "Are amplicon vectors suitable for transducing antigen-presenting cells in the context of Alzheimer's disease vaccines?",
            "answer": "A",
            "pmid": [
                "pmid16787189",
                "pmid12897209",
                "pmid21975314",
                "pmid16476660",
                "pmid23555730",
                "pmid27186272",
                "pmid38111016",
                "pmid37737298",
                "pmid22428008",
                "pmid27713140"
            ]
        },
        "cell_199": {
            "question": "In the study of Alzheimer's disease pathology, what is a key characteristic of the interaction between cholesterol and amyloid beta (Aβ) that has been noted at the subcellular level?",
            "answer": "C",
            "pmid": [
                "pmid22626060",
                "pmid10440900",
                "pmid12600718",
                "pmid19324459",
                "pmid37011864",
                "pmid8915608",
                "pmid35464321",
                "pmid11755001",
                "pmid16866910",
                "pmid37333071"
            ]
        },
        "cell_200": {
            "question": "What is the role of cinnamate derivatives in targeting Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid38203753",
                "pmid34064687",
                "pmid33211296",
                "pmid31087219",
                "pmid26529297",
                "pmid21272191",
                "pmid38355004",
                "pmid26496465",
                "pmid31910792",
                "pmid38612861"
            ]
        },
        "cell_201": {
            "question": "Does the infrared spectroscopic analysis of mononuclear leukocytes show differences in protein secondary structure between Alzheimer's disease patients and controls?",
            "answer": "A",
            "pmid": [
                "pmid22271100",
                "pmid27239515",
                "pmid33466666",
                "pmid26151923",
                "pmid16814429",
                "pmid1647485",
                "pmid7768042",
                "pmid8474686",
                "pmid11351135",
                "pmid19247475"
            ]
        },
        "cell_202": {
            "question": "What is the role of tubulin acetylation in Alzheimer's disease?",
            "answer": "D",
            "pmid": [
                "pmid36092705",
                "pmid30362958",
                "pmid25311278",
                "pmid24746363",
                "pmid29439324",
                "pmid38167174",
                "pmid12522269",
                "pmid29353063",
                "pmid27333034",
                "pmid8242380"
            ]
        },
        "cell_203": {
            "question": "Which subcellular organelles are involved in NLRP3 localization and inflammasome assembly in the context of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid39816134",
                "pmid33181351",
                "pmid23686772",
                "pmid32929691",
                "pmid36127465",
                "pmid38565393",
                "pmid29384096",
                "pmid28928740",
                "pmid35474599",
                "pmid28003153"
            ]
        },
        "cell_204": {
            "question": "What is the role of PrPC in Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid28413194",
                "pmid29660945",
                "pmid39345364",
                "pmid39462031",
                "pmid12387451",
                "pmid2391515",
                "pmid34302466",
                "pmid20878768",
                "pmid17021406",
                "pmid7936052"
            ]
        },
        "cell_205": {
            "question": "How does acute diesel exhaust particle exposure affect P-glycoprotein in the blood-brain barrier related to Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid37332622",
                "pmid38787367",
                "pmid8052661",
                "pmid10095092",
                "pmid26855936",
                "pmid38972885",
                "pmid33277246",
                "pmid8242380",
                "pmid31382012",
                "pmid27239515"
            ]
        },
        "cell_206": {
            "question": "Does the model simulate microtubule changes in Alzheimer disease?",
            "answer": "A",
            "pmid": [
                "pmid20713128",
                "pmid36092705",
                "pmid22561329",
                "pmid19091971",
                "pmid31100304",
                "pmid7916770",
                "pmid22702220",
                "pmid10817927",
                "pmid20881126",
                "pmid28643422"
            ]
        },
        "cell_207": {
            "question": "What is the role of NRBP1 in the degradation of BRI2 and BRI3 in Alzheimer's disease?",
            "answer": "D",
            "pmid": [
                "pmid32160551",
                "pmid28980867",
                "pmid26615780",
                "pmid18706502",
                "pmid29937728",
                "pmid29634233",
                "pmid29464060",
                "pmid29439343",
                "pmid23348590",
                "pmid28432138"
            ]
        },
        "cell_208": {
            "question": "What is the antigenic composition of aluminum-induced neurofibrillary degeneration compared to Alzheimer's disease?",
            "answer": "D",
            "pmid": [
                "pmid17004365",
                "pmid2725861",
                "pmid7916770",
                "pmid28890316",
                "pmid38057817",
                "pmid8052661",
                "pmid23219964",
                "pmid19679638",
                "pmid21971404",
                "pmid11276052"
            ]
        },
        "cell_209": {
            "question": "How does Fli-1 contribute to pericyte loss in Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid35038582",
                "pmid24336108",
                "pmid29453790",
                "pmid38682184",
                "pmid32429102",
                "pmid24918635",
                "pmid10095092",
                "pmid28928740",
                "pmid12960778",
                "pmid34315531"
            ]
        },
        "cell_210": {
            "question": "What role does miR-155 play in Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid25983691",
                "pmid32415525",
                "pmid31134481",
                "pmid32092796",
                "pmid25955795",
                "pmid38111333",
                "pmid28533191",
                "pmid34026326",
                "pmid29369410",
                "pmid26398571"
            ]
        },
        "cell_211": {
            "question": "What is the role of human umbilical cord blood derived lineage negative stem cells in treating Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid30443207",
                "pmid34566422",
                "pmid33815510",
                "pmid28643422",
                "pmid16476660",
                "pmid37212107",
                "pmid31089063",
                "pmid29439343",
                "pmid30259257",
                "pmid20541838"
            ]
        },
        "cell_212": {
            "question": "What is the role of PIP2 phospholipids in the aggregation of tau filaments in Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid30278104",
                "pmid16908029",
                "pmid7533559",
                "pmid32915536",
                "pmid15920161",
                "pmid38946496",
                "pmid20460118",
                "pmid28864542",
                "pmid34369377",
                "pmid25268947"
            ]
        },
        "cell_213": {
            "question": "What membrane proteins are found to be significantly higher in red blood cells of Alzheimer's disease patients compared to healthy subjects?",
            "answer": "C",
            "pmid": [
                "pmid27239515",
                "pmid26151923",
                "pmid18363842",
                "pmid38791223",
                "pmid33466666",
                "pmid11755001",
                "pmid9878757",
                "pmid22801742",
                "pmid8761018",
                "pmid32581851"
            ]
        },
        "cell_214": {
            "question": "What mechanism does EphB2 use to prevent amyloid-beta-induced depletion of glutamate receptors in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid26589795",
                "pmid28351972",
                "pmid21272191",
                "pmid28346227",
                "pmid9338779",
                "pmid17384289",
                "pmid25390692",
                "pmid27103515",
                "pmid21224052",
                "pmid19666073"
            ]
        }
    },
    "pathway": {
        "pathway_0": {
            "question": "What is the role of the DJ2/Hsp70 pathway in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid33972400",
                "pmid9878757",
                "pmid19616077",
                "pmid36739453",
                "pmid10817927",
                "pmid11447833",
                "pmid31293510",
                "pmid30362958",
                "pmid8740986",
                "pmid18688088"
            ]
        },
        "pathway_1": {
            "question": "How does the PPARalpha pathway contribute to the pathogenesis of Alzheimer's Disease?",
            "answer": "A",
            "pmid": [
                "pmid31100304",
                "pmid38561809",
                "pmid28928740",
                "pmid35569719",
                "pmid36809694",
                "pmid16192374",
                "pmid29641978",
                "pmid29662056",
                "pmid9878757",
                "pmid38787367"
            ]
        },
        "pathway_2": {
            "question": "What is the role of the ezrin/radixin/moesin family/phosphatidylinositol-3-kinase/protein kinase B pathway in Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid25538739",
                "pmid39117070",
                "pmid18367332",
                "pmid31060682",
                "pmid29641978",
                "pmid31927055",
                "pmid16014629",
                "pmid38886959",
                "pmid23379615",
                "pmid32744877"
            ]
        },
        "pathway_3": {
            "question": "How does the somatostatin pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid15778722",
                "pmid19559700",
                "pmid34445147",
                "pmid2900051",
                "pmid28864542",
                "pmid9878757",
                "pmid19733630",
                "pmid32140092",
                "pmid11755001",
                "pmid20007471"
            ]
        },
        "pathway_4": {
            "question": "What is the role of the IL-33/ST2 signaling pathway in Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid27091974",
                "pmid24413615",
                "pmid32505187",
                "pmid32678011",
                "pmid37117777",
                "pmid18509040",
                "pmid35909315",
                "pmid21167930",
                "pmid37735240",
                "pmid23178247"
            ]
        },
        "pathway_5": {
            "question": "How does the beta-secretase pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "A\n",
            "pmid": [
                "pmid1436712",
                "pmid21605033",
                "pmid10656250",
                "pmid30626751",
                "pmid15992373",
                "pmid18005427",
                "pmid10591213",
                "pmid27060961",
                "pmid10531052",
                "pmid17560791"
            ]
        },
        "pathway_6": {
            "question": "What is the role of the ZBTB16-mediated autophagy pathway in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid30362531",
                "pmid36031168",
                "pmid29631635",
                "pmid28351972",
                "pmid28806762",
                "pmid36502636",
                "pmid38787367",
                "pmid21368103",
                "pmid32296772",
                "pmid37013375"
            ]
        },
        "pathway_7": {
            "question": "How does the adenylyl cyclase pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid8242380",
                "pmid12960778",
                "pmid8740986",
                "pmid29363833",
                "pmid25311278",
                "pmid29353063",
                "pmid9878757",
                "pmid22970285",
                "pmid1647485",
                "pmid29439324"
            ]
        },
        "pathway_8": {
            "question": "How does the SP1 pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid18334759",
                "pmid29662056",
                "pmid36410428",
                "pmid9878757",
                "pmid9444352",
                "pmid10817927",
                "pmid21086758",
                "pmid38007654",
                "pmid30484906",
                "pmid22495348"
            ]
        },
        "pathway_9": {
            "question": "What is the role of the GDE2-RECK-ADAM10 pathway in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid33731436",
                "pmid17301176",
                "pmid9878757",
                "pmid21605036",
                "pmid15146243",
                "pmid27333034",
                "pmid10817927",
                "pmid22572541",
                "pmid39117070",
                "pmid33277246"
            ]
        },
        "pathway_10": {
            "question": "How does the mammalian target of rapamycin (mTOR) pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid31060682",
                "pmid17913600",
                "pmid25914534",
                "pmid29729422",
                "pmid22344941",
                "pmid29351469",
                "pmid24411482",
                "pmid28807816",
                "pmid31639492",
                "pmid23667480"
            ]
        },
        "pathway_11": {
            "question": "What is the role of the enkephalin signaling pathway in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid18463254",
                "pmid22527793",
                "pmid29641978",
                "pmid31060682",
                "pmid8740986",
                "pmid2391515",
                "pmid22998035",
                "pmid36937877",
                "pmid18201952",
                "pmid37991969"
            ]
        },
        "pathway_12": {
            "question": "How does the orexin signaling pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid31927055",
                "pmid37843792",
                "pmid33080054",
                "pmid38682858",
                "pmid36280008",
                "pmid27796320",
                "pmid39117070",
                "pmid9878757",
                "pmid38561809",
                "pmid20097758"
            ]
        },
        "pathway_13": {
            "question": "How does the ABCC1 pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid10817927",
                "pmid24141082",
                "pmid31690660",
                "pmid9878757",
                "pmid12600718",
                "pmid25273678",
                "pmid2391515",
                "pmid23556446",
                "pmid38787367",
                "pmid26200696"
            ]
        },
        "pathway_14": {
            "question": "How does the Grb2 signaling pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid9878757",
                "pmid17384289",
                "pmid10817927",
                "pmid28351972",
                "pmid17080199",
                "pmid10095092",
                "pmid11447833",
                "pmid28980867",
                "pmid8740986",
                "pmid14563691"
            ]
        },
        "pathway_15": {
            "question": "How does the ErbB2 signaling pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid28351972",
                "pmid9878757",
                "pmid29641978",
                "pmid17384289",
                "pmid39231208",
                "pmid17080199",
                "pmid28341998",
                "pmid14563691",
                "pmid21241676",
                "pmid10817927"
            ]
        },
        "pathway_16": {
            "question": "How does the IL-7/IL-7R pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid39129310",
                "pmid31690660",
                "pmid21167930",
                "pmid11578773",
                "pmid21514692",
                "pmid10319892",
                "pmid1749826",
                "pmid16192374",
                "pmid18509040",
                "pmid26509334"
            ]
        },
        "pathway_17": {
            "question": "How does the Reelin signaling pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B\n",
            "pmid": [
                "pmid24599114",
                "pmid27531658",
                "pmid17360894",
                "pmid20610758",
                "pmid22495348",
                "pmid20025970",
                "pmid39094979",
                "pmid36919335",
                "pmid26152694",
                "pmid29442527"
            ]
        },
        "pathway_18": {
            "question": "How does the ZBTB20/GSK-3beta/Tau pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid36502636",
                "pmid14563691",
                "pmid7533559",
                "pmid17562708",
                "pmid22927642",
                "pmid39105371",
                "pmid16192374",
                "pmid9878757",
                "pmid28864542",
                "pmid21228179"
            ]
        },
        "pathway_19": {
            "question": "Which downstream targets of the AdipoR1/AMPK/TFEB pathway are implicated in Alzheimer's disease development?",
            "answer": "D",
            "pmid": [
                "pmid32519244",
                "pmid29501742",
                "pmid24334724",
                "pmid37013375",
                "pmid29641978",
                "pmid8239309",
                "pmid11677259",
                "pmid36502636",
                "pmid25311278",
                "pmid34042039"
            ]
        },
        "pathway_20": {
            "question": "How does the VDAC1-AKT-GSK3beta signaling pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid20930307",
                "pmid22926141",
                "pmid9878757",
                "pmid22927642",
                "pmid29551631",
                "pmid14563691",
                "pmid23202730",
                "pmid10817927",
                "pmid33761858",
                "pmid29358916"
            ]
        },
        "pathway_21": {
            "question": "What is the impact of zinc on the Raf/MEK/ERK pathway in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid21934536",
                "pmid33597269",
                "pmid17949919",
                "pmid26883958",
                "pmid38648940",
                "pmid19111579",
                "pmid15812314",
                "pmid22892311",
                "pmid21368864",
                "pmid22528780"
            ]
        },
        "pathway_22": {
            "question": "How does the Th-9 pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid19800391",
                "pmid9878757",
                "pmid21167930",
                "pmid16192374",
                "pmid38561809",
                "pmid33446646",
                "pmid18509040",
                "pmid18201952",
                "pmid39908354",
                "pmid36564824"
            ]
        },
        "pathway_23": {
            "question": "What is the role of the reelin pathway in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid24599114",
                "pmid17360894",
                "pmid27531658",
                "pmid20025970",
                "pmid39094979",
                "pmid22495348",
                "pmid20610758",
                "pmid26152694",
                "pmid29442527",
                "pmid36919335"
            ]
        },
        "pathway_24": {
            "question": "How does the NOD2/p-p38 MAPK/BACE1 pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid30626751",
                "pmid11677259",
                "pmid35909315",
                "pmid33070520",
                "pmid24334724",
                "pmid10817927",
                "pmid22895721",
                "pmid19109907",
                "pmid18005427",
                "pmid17784957"
            ]
        },
        "pathway_25": {
            "question": "What is the role of the MAP2K3 pathway in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid11677259",
                "pmid24334724",
                "pmid39696695",
                "pmid35909315",
                "pmid31840000",
                "pmid9878757",
                "pmid33420799",
                "pmid2391515",
                "pmid10817927",
                "pmid11978814"
            ]
        },
        "pathway_26": {
            "question": "How does the cGAS-STING pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid37118112",
                "pmid37609338",
                "pmid39908354",
                "pmid39218977",
                "pmid39634577",
                "pmid26401931",
                "pmid16192374",
                "pmid28928740",
                "pmid31100304",
                "pmid38561809"
            ]
        },
        "pathway_27": {
            "question": "How does the AMPK signaling pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid32519244",
                "pmid34042039",
                "pmid8239309",
                "pmid24334724",
                "pmid35106914",
                "pmid9878757",
                "pmid11290384",
                "pmid11677259",
                "pmid19166821",
                "pmid28904096"
            ]
        },
        "pathway_28": {
            "question": "How does the farnesylation pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid34315531",
                "pmid24136196",
                "pmid33098528",
                "pmid28864542",
                "pmid38787367",
                "pmid24746363",
                "pmid25499850",
                "pmid9878757",
                "pmid16192374",
                "pmid19729853"
            ]
        },
        "pathway_29": {
            "question": "How does the RanBP9-cofilin pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid25741591",
                "pmid22361682",
                "pmid23982146",
                "pmid9878757",
                "pmid18440671",
                "pmid34315506",
                "pmid16192374",
                "pmid23348590",
                "pmid10095092",
                "pmid39117070"
            ]
        },
        "pathway_30": {
            "question": "How does the homeostatic amyloid-reducing pathway contribute to the pathogenesis of Alzheimer's Disease?",
            "answer": "B",
            "pmid": [
                "pmid38167174",
                "pmid32444869",
                "pmid32121263",
                "pmid22626060",
                "pmid23582659",
                "pmid38886959",
                "pmid23579332",
                "pmid1436712",
                "pmid11145195",
                "pmid27333034"
            ]
        },
        "pathway_31": {
            "question": "What is the role of the Gcn2 pathway in modulating immune response in Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid10817927",
                "pmid39908354",
                "pmid8892352",
                "pmid25485684",
                "pmid18509040",
                "pmid9878757",
                "pmid36703235",
                "pmid38791092",
                "pmid17911636",
                "pmid21514692"
            ]
        },
        "pathway_32": {
            "question": "What is the role of the visual pathway in [Alzheimer's disease]?",
            "answer": "B",
            "pmid": [
                "pmid30405709",
                "pmid38972885",
                "pmid10095092",
                "pmid31809334",
                "pmid22495348",
                "pmid9878757",
                "pmid17080199",
                "pmid33737172",
                "pmid25351853",
                "pmid37569267"
            ]
        },
        "pathway_33": {
            "question": "How does the visual information transmission pathway (V-H pathway) contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid38972885",
                "pmid30405709",
                "pmid9878757",
                "pmid33446646",
                "pmid37735240",
                "pmid19319544",
                "pmid35569719",
                "pmid8239309",
                "pmid1436712",
                "pmid2391515"
            ]
        },
        "pathway_34": {
            "question": "What is the role of the sphingosine kinase/sphingosine-1-phosphate (SphK/S1P) pathway in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid36410428",
                "pmid29662056",
                "pmid38791223",
                "pmid39051215",
                "pmid38007654",
                "pmid23667698",
                "pmid33300254",
                "pmid30484906",
                "pmid31840000",
                "pmid16524368"
            ]
        },
        "pathway_35": {
            "question": "Which downstream targets of the circ-AXL pathway are implicated in Alzheimer's Disease development?",
            "answer": "A",
            "pmid": [
                "pmid22495348",
                "pmid39529134",
                "pmid35167942",
                "pmid39231208",
                "pmid22998035",
                "pmid17360894",
                "pmid24334724",
                "pmid16868960",
                "pmid10817927",
                "pmid27195475"
            ]
        },
        "pathway_36": {
            "question": "Is kynurenine pathway activation associated with poor prognosis in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid36754068",
                "pmid24346138",
                "pmid18201952",
                "pmid20639188",
                "pmid32276479",
                "pmid37264981",
                "pmid21683531",
                "pmid32012948",
                "pmid25938971",
                "pmid37111372"
            ]
        },
        "pathway_37": {
            "question": "How does the Th17 cell differentiation pathway contribute to the pathogenesis of Late-Onset Alzheimer's Disease (LOAD)?",
            "answer": "B",
            "pmid": [
                "pmid21167930",
                "pmid34864659",
                "pmid23365075",
                "pmid16476660",
                "pmid35909315",
                "pmid34966527",
                "pmid27713140",
                "pmid20541838",
                "pmid37907046",
                "pmid28969867"
            ]
        },
        "pathway_38": {
            "question": "What is the role of the hsa-miR-146a STAT1 MYC pathway in Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid34026326",
                "pmid24586483",
                "pmid23990414",
                "pmid35592504",
                "pmid34992508",
                "pmid26095531",
                "pmid18234899",
                "pmid26258756",
                "pmid32415525",
                "pmid18801740"
            ]
        },
        "pathway_39": {
            "question": "What is the role of the Lfng/Notch1 signaling pathway in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid36453506",
                "pmid34315506",
                "pmid23152628",
                "pmid22934024",
                "pmid17080199",
                "pmid28980867",
                "pmid37055801",
                "pmid30539409",
                "pmid9878757",
                "pmid35903536"
            ]
        },
        "pathway_40": {
            "question": "How does the IFNgamma pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid31100304",
                "pmid23780663",
                "pmid39908354",
                "pmid10095092",
                "pmid17080199",
                "pmid37609338",
                "pmid28928740",
                "pmid33737172",
                "pmid22495348",
                "pmid9878757"
            ]
        },
        "pathway_41": {
            "question": "What is the role of the secretory pathway of APP in familial Alzheimer's disease with the Val717 to Ile mutation?",
            "answer": "B",
            "pmid": [
                "pmid1436712",
                "pmid8886002",
                "pmid8012386",
                "pmid15992373",
                "pmid37692508",
                "pmid27060961",
                "pmid21812781",
                "pmid21500352",
                "pmid1908231",
                "pmid17560791"
            ]
        },
        "pathway_42": {
            "question": "How does the p21ras intracellular signal transduction pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid9878757",
                "pmid11193159",
                "pmid15548589",
                "pmid8239309",
                "pmid8740986",
                "pmid10817927",
                "pmid2391515",
                "pmid11290384",
                "pmid14563691",
                "pmid10623648"
            ]
        },
        "pathway_43": {
            "question": "Which downstream targets of the MIAT pathway are implicated in the development of Alzheimer's disease?",
            "answer": "D",
            "pmid": [
                "pmid24710686",
                "pmid31060682",
                "pmid33580194",
                "pmid8740986",
                "pmid30362958",
                "pmid31808750",
                "pmid11677259",
                "pmid16210396",
                "pmid26045440",
                "pmid39117070"
            ]
        },
        "pathway_44": {
            "question": "What is the role of the YAP/p73/Bax pathway in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid21562856",
                "pmid21088470",
                "pmid32425755",
                "pmid20097758",
                "pmid10095092",
                "pmid32255663",
                "pmid31031598",
                "pmid31808750",
                "pmid29353063",
                "pmid30362042"
            ]
        },
        "pathway_45": {
            "question": "How does the RIPK1 pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "C\n",
            "pmid": [
                "pmid28904096",
                "pmid35106914",
                "pmid34480965",
                "pmid37633326",
                "pmid36766759",
                "pmid31048504",
                "pmid36602874",
                "pmid9878757",
                "pmid11677259",
                "pmid29358916"
            ]
        },
        "pathway_46": {
            "question": "What is the role of signal transduction pathways in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid9878757",
                "pmid8740986",
                "pmid8239309",
                "pmid2391515",
                "pmid11447833",
                "pmid11193159",
                "pmid9850923",
                "pmid17055782",
                "pmid10817927",
                "pmid24334724"
            ]
        },
        "pathway_47": {
            "question": "How does the hexosamine biosynthesis pathway (HBP) contribute to the pathogenesis of Alzheimer disease?",
            "answer": "B",
            "pmid": [
                "pmid35427648",
                "pmid31382012",
                "pmid36203054",
                "pmid19729853",
                "pmid23579332",
                "pmid38972885",
                "pmid36204837",
                "pmid22329649",
                "pmid25148700",
                "pmid39807036"
            ]
        },
        "pathway_48": {
            "question": "How does the BRCA1/BARD1 pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid29634233",
                "pmid35237315",
                "pmid29439343",
                "pmid26615780",
                "pmid9878757",
                "pmid10817927",
                "pmid28956815",
                "pmid39117070",
                "pmid37609338",
                "pmid38787367"
            ]
        },
        "pathway_49": {
            "question": "How does the p53 pathway contribute to the pathogenesis of Alzheimer's disease in Down syndrome?",
            "answer": "B",
            "pmid": [
                "pmid26967221",
                "pmid10027687",
                "pmid10666665",
                "pmid32962300",
                "pmid24735980",
                "pmid16442855",
                "pmid10666670",
                "pmid15068237",
                "pmid15548589",
                "pmid28807816"
            ]
        },
        "pathway_50": {
            "question": "How does the Akt pathway contribute to the pathogenesis of prostate cancer and Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid16014629",
                "pmid29358916",
                "pmid14563691",
                "pmid35985445",
                "pmid17222949",
                "pmid38225990",
                "pmid11062251",
                "pmid28694093",
                "pmid35111368",
                "pmid31840000"
            ]
        },
        "pathway_51": {
            "question": "How does the HGF/MET pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid24444253",
                "pmid35903536",
                "pmid36739453",
                "pmid35569719",
                "pmid30661261",
                "pmid31100304",
                "pmid37117599",
                "pmid24710686",
                "pmid10817927",
                "pmid17080199"
            ]
        },
        "pathway_52": {
            "question": "What is the role of the betaPP binding pathway in Very Late Onset Dementia of the Alzheimer type?",
            "answer": "C",
            "pmid": [
                "pmid29353063",
                "pmid10095092",
                "pmid9410912",
                "pmid8740986",
                "pmid18400893",
                "pmid11854179",
                "pmid23579326",
                "pmid22934024",
                "pmid11447833",
                "pmid22998035"
            ]
        },
        "pathway_53": {
            "question": "How does the MLKL-USP7-UBA52 signaling pathway contribute to the pathogenesis of Alzheimer disease (AD)?",
            "answer": "B",
            "pmid": [
                "pmid39193909",
                "pmid9878757",
                "pmid11677259",
                "pmid39117070",
                "pmid8239309",
                "pmid29631635",
                "pmid2391515",
                "pmid27557632",
                "pmid35909315",
                "pmid16192374"
            ]
        },
        "pathway_54": {
            "question": "How does the SNAI2 pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid9878757",
                "pmid39105371",
                "pmid36564824",
                "pmid37117777",
                "pmid10817927",
                "pmid34992508",
                "pmid29662056",
                "pmid31100304",
                "pmid26582459",
                "pmid28864542"
            ]
        },
        "pathway_55": {
            "question": "How does the ERK/S6 signaling pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid26582459",
                "pmid18688088",
                "pmid11677259",
                "pmid9878757",
                "pmid29641978",
                "pmid18367332",
                "pmid21241676",
                "pmid17384289",
                "pmid28864542",
                "pmid39231208"
            ]
        },
        "pathway_56": {
            "question": "How does the PUMA pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid25311278",
                "pmid25457551",
                "pmid30362042",
                "pmid34782612",
                "pmid24567336",
                "pmid29363833",
                "pmid18032672",
                "pmid35569719",
                "pmid31100304",
                "pmid9878757"
            ]
        },
        "pathway_57": {
            "question": "How does the metabotropic glutamate receptor signaling pathway contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B\n",
            "pmid": [
                "pmid9878757",
                "pmid24886239",
                "pmid8740986",
                "pmid30652266",
                "pmid11447833",
                "pmid27103515",
                "pmid2391515",
                "pmid36161942",
                "pmid17080199",
                "pmid32008166"
            ]
        },
        "pathway_58": {
            "question": "Does melatonin play a role in protecting against BBB disruption in Alzheimer's disease by inhibiting MMP-9 via the NOTCH3/NF-kappaB pathway?",
            "answer": "A",
            "pmid": [
                "pmid31209782",
                "pmid37857668",
                "pmid23857055",
                "pmid26123100",
                "pmid16364209",
                "pmid18590917",
                "pmid33254429",
                "pmid31811815",
                "pmid35648367",
                "pmid10231726"
            ]
        },
        "pathway_59": {
            "question": "Does dioscin alleviate Alzheimer's disease by regulating the RAGE/NOX4 pathway?",
            "answer": "A",
            "pmid": [
                "pmid35691153",
                "pmid39105973",
                "pmid27725131",
                "pmid36077321",
                "pmid22837815",
                "pmid33617922",
                "pmid35672874",
                "pmid36214721",
                "pmid30288371",
                "pmid26696494"
            ]
        },
        "pathway_60": {
            "question": "Does rhANP treatment mitigate LPS-induced cognitive dysfunction by influencing pathways relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid34949194",
                "pmid35360200",
                "pmid34302466",
                "pmid39209323",
                "pmid36214721",
                "pmid38565393",
                "pmid22869752",
                "pmid33998138",
                "pmid36427589",
                "pmid23379615"
            ]
        },
        "pathway_61": {
            "question": "Does the combination of panobinostat and ponatinib synergistically overcome imatinib-resistant CML cells by affecting pathways related to delirium or Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid27166836",
                "pmid39117070",
                "pmid19447162",
                "pmid35948663",
                "pmid27567806",
                "pmid32296772",
                "pmid25393881",
                "pmid16762377",
                "pmid28852940",
                "pmid23665252"
            ]
        },
        "pathway_62": {
            "question": "Does Yuk-Gunja-Tang (YG) exert neuroprotective effects by activating the ERK/CREB/BDNF signaling pathway in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid36386241",
                "pmid28798805",
                "pmid32739157",
                "pmid16183991",
                "pmid23538162",
                "pmid32255663",
                "pmid39231208",
                "pmid20451607",
                "pmid29507588",
                "pmid24975829"
            ]
        },
        "pathway_63": {
            "question": "Does Huanglian Jiedu decoction (HLJDD) regulate the microbiota flora homeostasis to treat Alzheimer's disease through multiple targets and pathways?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid37009506",
                "pmid34168550",
                "pmid37005850",
                "pmid28546539",
                "pmid31563815",
                "pmid36814130",
                "pmid39911633",
                "pmid39772836",
                "pmid32140977",
                "pmid35069753"
            ]
        },
        "pathway_64": {
            "question": "Does ursolic acid inhibit the activation of transcription factors NF-kappaB, AP-1, and NF-AT, which are involved in inflammatory pathways, potentially relevant to delirium?",
            "answer": "A",
            "pmid": [
                "pmid37649721",
                "pmid22363615",
                "pmid15473667",
                "pmid38566855",
                "pmid20309566",
                "pmid39556267",
                "pmid39839987",
                "pmid37893218",
                "pmid31244434",
                "pmid24048854"
            ]
        },
        "pathway_65": {
            "question": "Does ellagic acid inhibit the PI3K/Akt/FOXO3a signaling pathway, which may be relevant to Alzheimer's disease or delirium?",
            "answer": "A.",
            "pmid": [
                "pmid34373703",
                "pmid31722531",
                "pmid39556267",
                "pmid31900522",
                "pmid27725131",
                "pmid15208744",
                "pmid37005850",
                "pmid27569389",
                "pmid32583667",
                "pmid36214721"
            ]
        },
        "pathway_66": {
            "question": "Does linarin's activation of the PI3K/Akt pathway contribute to neuroprotection against Abeta-induced neurotoxicity, potentially offering therapeutic benefits for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid21652214",
                "pmid34040526",
                "pmid21391434",
                "pmid16762377",
                "pmid34831318",
                "pmid28235543",
                "pmid15208744",
                "pmid11278378",
                "pmid24879954",
                "pmid20416364"
            ]
        },
        "pathway_67": {
            "question": "Does danshensu exhibit potential as a therapeutic agent for Alzheimer's disease by improving cognitive impairments through the PKA-CREB signaling pathway?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid31425745",
                "pmid37315666",
                "pmid31563815",
                "pmid36386241",
                "pmid33029123",
                "pmid33898246",
                "pmid35303280",
                "pmid29190943",
                "pmid20079417",
                "pmid32140977"
            ]
        },
        "pathway_68": {
            "question": "Does engeletin attenuate oxidative stress and neuroinflammation in Alzheimer's disease by modulating the Keap1/Nrf2 pathway?",
            "answer": "A",
            "pmid": [
                "pmid32445069",
                "pmid32744877",
                "pmid18706502",
                "pmid36068400",
                "pmid31232699",
                "pmid24512768",
                "pmid22186599",
                "pmid22746342",
                "pmid24975829",
                "pmid27050422"
            ]
        },
        "pathway_69": {
            "question": "Does 5-Hydroxymethylfurfural (5-HMF) have a potential therapeutic role in Alzheimer's disease by targeting inflammatory pathways?",
            "answer": "A novel small-molecule compound, AD-35, derived from donepezil, attenuates the production of TNF-alpha and IL-1beta in a rat model of Alzheimer’s disease. Another compound, NMC, exhibits neuroprotective effects and improves cognitive function in a 5XFAD mouse model, potentially serving as an anti-cholinesterase, antioxidant, and neuroprotective agent.\n\n\n\n",
            "pmid": [
                "pmid30642099",
                "pmid34188608",
                "pmid24161403",
                "pmid38886959",
                "pmid12453679",
                "pmid27797173",
                "pmid30404965",
                "pmid34329731",
                "pmid28157092",
                "pmid33211296"
            ]
        },
        "pathway_70": {
            "question": "Does the CEBPalpha/circAPLP2/miR-671-5p pathway play a role in regulating CNTN1/2 expression in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid36734072",
                "pmid32035423",
                "pmid34992508",
                "pmid35060046",
                "pmid31134481",
                "pmid26258756",
                "pmid18801740",
                "pmid26398571",
                "pmid32092796",
                "pmid36092938"
            ]
        },
        "pathway_71": {
            "question": "Does gamma-Glutamylcysteine reduce neuroinflammation in Alzheimer's disease by inhibiting the NF-kappaB signaling pathway?",
            "answer": "A",
            "pmid": [
                "pmid35714925",
                "pmid16183991",
                "pmid32583667",
                "pmid37991969",
                "pmid23279783",
                "pmid18395194",
                "pmid15473667",
                "pmid39002124",
                "pmid19800391",
                "pmid28623716"
            ]
        },
        "pathway_72": {
            "question": "Does Lancao decoction (LC) activate the PI3K/AKT pathway to enhance ERK activity in the treatment of Alzheimer's disease?",
            "answer": "A systematic analysis indicates that tetrahydroalstonine may regulate the phenotype of Alzheimer’s disease and reduce cell apoptosis by modulating the PI3K/AKT signaling pathway. Other studies demonstrate that berberine and eriodictyol can offer protective effects against Alzheimer’s disease through similar mechanisms.\n\n\n\n",
            "pmid": [
                "pmid21652214",
                "pmid37005850",
                "pmid39625499",
                "pmid39528121",
                "pmid32140977",
                "pmid35528169",
                "pmid38061471",
                "pmid39911633",
                "pmid30208700",
                "pmid21297267"
            ]
        },
        "pathway_73": {
            "question": "Does the anti-inflammatory effect of taraxasterol involve the LXRalpha-ABCA1 signaling pathway, which is relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid29670526",
                "pmid35772378",
                "pmid28623716",
                "pmid36382256",
                "pmid15532546",
                "pmid39117070",
                "pmid15817521",
                "pmid37624431",
                "pmid29743866",
                "pmid12930788"
            ]
        },
        "pathway_74": {
            "question": "Does Pterostilbene regulate the PDE4A-CREB-BDNF pathway to protect against Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31737188",
                "pmid29737568",
                "pmid35496289",
                "pmid21982274",
                "pmid17222949",
                "pmid38355004",
                "pmid29728920",
                "pmid32739157",
                "pmid30873920",
                "pmid28822725"
            ]
        },
        "pathway_75": {
            "question": "Does the PD1/PD-L1 pathway play a role in the neuroinflammation of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid21514692",
                "pmid12453679",
                "pmid35986874",
                "pmid38565393",
                "pmid38561809",
                "pmid12127594",
                "pmid26509334",
                "pmid22096345",
                "pmid8996832",
                "pmid34486652"
            ]
        },
        "pathway_76": {
            "question": "Does dysiarenone's inhibition of the 5-LOX/NF-kappaB/MAPK pathway have potential implications for treating Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid33664584",
                "pmid35917097",
                "pmid32896600",
                "pmid28779511",
                "pmid31240602",
                "pmid23279783",
                "pmid28623716",
                "pmid30092401",
                "pmid36907286",
                "pmid37209001"
            ]
        },
        "pathway_77": {
            "question": "Does dexmedetomidine mitigate propofol-induced neurotoxicity by enhancing the PI3K/Akt pathway, which is relevant to delirium?",
            "answer": "A recent study demonstrates that dexmedetomidine (DEX) can reduce neuroinflammation induced by sevoflurane, and this effect is linked to the PI3K/Akt/mTOR pathway. The study found that sevoflurane increases pro-inflammatory cytokines and decreases activation of this pathway, while DEX reduces cytokine levels and prevents inactivation of the pathway. Furthermore, inhibiting the PI3K/Akt/mTOR pathway diminishes the anti-inflammatory effects of DEX. These findings suggest that activating the PI3K/Akt/mTOR pathway with DEX could reduce neuroinflammation. Other studies demonstrate dexmedetomidine’s anti-inflammatory properties and influence on pathways related to neuroprotection, which are relevant to delirium.",
            "pmid": [
                "pmid30214209",
                "pmid30143847",
                "pmid35337381",
                "pmid36077505",
                "pmid34807273",
                "pmid22683080",
                "pmid31351473",
                "pmid28286770",
                "pmid29743866",
                "pmid24852225"
            ]
        },
        "pathway_78": {
            "question": "Are pathways related to Alzheimer's disease upregulated in NK cells of elderly patients with NSCLC compared to younger patients?",
            "answer": "A",
            "pmid": [
                "pmid39244673",
                "pmid10817927",
                "pmid20541838",
                "pmid9878757",
                "pmid24334724",
                "pmid37991969",
                "pmid2391515",
                "pmid36062157",
                "pmid22367434",
                "pmid16814429"
            ]
        },
        "pathway_79": {
            "question": "Does neuronal cathepsin S increase neuroinflammation and cause cognitive decline in Alzheimer's disease through the CX3CL1-CX3CR1 axis and JAK2-STAT3 pathway?",
            "answer": "A",
            "pmid": [
                "pmid39453382",
                "pmid35181976",
                "pmid14522241",
                "pmid39304744",
                "pmid39122455",
                "pmid39726227",
                "pmid30575263",
                "pmid21771791",
                "pmid33181351",
                "pmid33277246"
            ]
        },
        "pathway_80": {
            "question": "Does miR-330 targeting VAV1 through the MAPK signaling pathway reduce amyloid beta-protein production in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid29369410",
                "pmid31385301",
                "pmid32415525",
                "pmid28533191",
                "pmid31134481",
                "pmid35592504",
                "pmid30576233",
                "pmid32092796",
                "pmid29378298",
                "pmid25955795"
            ]
        },
        "pathway_81": {
            "question": "Does the modulation of TLR4/NF-kappaB and Nrf2/HO-1 signaling pathways by naloxone have a known relationship with Alzheimer's disease or delirium?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid37661242",
                "pmid22527793",
                "pmid34373698",
                "pmid18463254",
                "pmid24048854",
                "pmid31547752",
                "pmid38566855",
                "pmid21932048",
                "pmid37991969",
                "pmid39893485"
            ]
        },
        "pathway_82": {
            "question": "Does miR-106b influence the TGF-beta signaling pathway, thereby contributing to the pathogenesis of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid20709030",
                "pmid27520374",
                "pmid24604632",
                "pmid26847596",
                "pmid31134481",
                "pmid32415525",
                "pmid29286086",
                "pmid22926857",
                "pmid37300691",
                "pmid30556160"
            ]
        },
        "pathway_83": {
            "question": "Does meclizine's effect on neuroinflammation through the AKT/NF-kappabeta/ERK/JNK pathway have implications for the treatment of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid37733253",
                "pmid37991969",
                "pmid12453679",
                "pmid15465624",
                "pmid19447162",
                "pmid23279783",
                "pmid35986874",
                "pmid20555131",
                "pmid35948663",
                "pmid39002124"
            ]
        },
        "pathway_84": {
            "question": "Does silibinin exert neuroprotective effects on sporadic Alzheimer's disease models by inhibiting the GluN2B pathway?",
            "answer": "A",
            "pmid": [
                "pmid36610115",
                "pmid28852940",
                "pmid31087219",
                "pmid28004303",
                "pmid31669775",
                "pmid21382422",
                "pmid38529039",
                "pmid27926996",
                "pmid36089405",
                "pmid32721448"
            ]
        },
        "pathway_85": {
            "question": "Do the lipid fractions from sandfish eggs inhibit pathways known to be involved in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid32967264",
                "pmid21448224",
                "pmid32581851",
                "pmid36552565",
                "pmid12373863",
                "pmid24909620",
                "pmid37333071",
                "pmid22626060",
                "pmid28406733",
                "pmid16866910"
            ]
        },
        "pathway_86": {
            "question": "Does the activation of the IRE1alpha-XBP1 and ATF6 pathways differ between Alzheimer's disease and amyotrophic lateral sclerosis (ALS)?",
            "answer": "A",
            "pmid": [
                "pmid28341998",
                "pmid9878757",
                "pmid10319892",
                "pmid34486652",
                "pmid12740599",
                "pmid37016577",
                "pmid8239309",
                "pmid29725981",
                "pmid11677259",
                "pmid28106546"
            ]
        },
        "pathway_87": {
            "question": "Does FTO activation contribute to Alzheimer's disease by affecting the TSC1-mTOR-Tau pathway?",
            "answer": "A",
            "pmid": [
                "pmid29501742",
                "pmid32814048",
                "pmid34289368",
                "pmid16115884",
                "pmid25914534",
                "pmid21098976",
                "pmid19828810",
                "pmid21228179",
                "pmid28864542",
                "pmid23262393"
            ]
        },
        "pathway_88": {
            "question": "Does the activation of the IRE1alpha/XBP1 pathway attenuate disease severity in models of proteotoxic Charcot-Marie-Tooth type 1B, similar to potential therapeutic avenues in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid28341998",
                "pmid38352425",
                "pmid37016577",
                "pmid36964897",
                "pmid21272191",
                "pmid35350668",
                "pmid31840000",
                "pmid19679638",
                "pmid24086258",
                "pmid28698968"
            ]
        },
        "pathway_89": {
            "question": "Does KMU-1170 inhibit the activation of NF-kappaB and NLRP3 inflammasome signaling pathways, which are relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid37991969",
                "pmid38565393",
                "pmid33530480",
                "pmid28003153",
                "pmid23686772",
                "pmid32929691",
                "pmid33181351",
                "pmid37602891",
                "pmid31840000",
                "pmid32028243"
            ]
        },
        "pathway_90": {
            "question": "Does berberine (Ber) have a role in treating Alzheimer's disease (AD) by influencing the miR-188/NOS1 pathway?",
            "answer": "Berberine plays a neuroprotective role in neurodegenerative disorders, including Alzheimer's disease. It attenuates amyloid beta-induced viability suppression in cells and inhibits increases in inflammatory cytokine expression, apoptosis, and phosphorylated tau levels. Additionally, berberine regulates microRNA-107 and zinc finger protein 217, offering a promising therapeutic avenue for Alzheimer's disease.",
            "pmid": [
                "pmid32779043",
                "pmid33361598",
                "pmid33983710",
                "pmid30542442",
                "pmid28822725",
                "pmid34064687",
                "pmid29132092",
                "pmid22459600",
                "pmid30873920",
                "pmid35528669"
            ]
        },
        "pathway_91": {
            "question": "Does MLK3 activation via the AP-1 pathway contribute to inflammatory responses in macrophages, which could be relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid33737172",
                "pmid36142785",
                "pmid35909315",
                "pmid11677259",
                "pmid23686772",
                "pmid35474599",
                "pmid27723233",
                "pmid19800391",
                "pmid28003153",
                "pmid21771791"
            ]
        },
        "pathway_92": {
            "question": "Does the Bushen-Yizhi formula (BSYZ) target the endoplasmic reticulum (ER) stress pathway to improve cognitive deficits in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid28521305",
                "pmid29449587",
                "pmid37586159",
                "pmid20493918",
                "pmid21272191",
                "pmid33029123",
                "pmid31607908",
                "pmid29446867",
                "pmid35360200",
                "pmid31683034"
            ]
        },
        "pathway_93": {
            "question": "Does FLZ enhance the BDNF/TrkB/CREB signaling pathway, which is implicated in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid20154710",
                "pmid24223757",
                "pmid25621771",
                "pmid29728920",
                "pmid16183991",
                "pmid17344400",
                "pmid19625748",
                "pmid17080199",
                "pmid9878757",
                "pmid24334724"
            ]
        },
        "pathway_94": {
            "question": "Does the inhibition of CSF1R via Ki20227 affect the NLRP3 pathway in a manner relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid38565393",
                "pmid32908485",
                "pmid32929691",
                "pmid37055801",
                "pmid28003153",
                "pmid23686772",
                "pmid33181351",
                "pmid36799439",
                "pmid31840000",
                "pmid37909242"
            ]
        },
        "pathway_95": {
            "question": "Does hesperetin exert neuroprotective effects by targeting the SIRT6/NLRP3 pathway in a model of Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid30756299",
                "pmid30884890",
                "pmid37382831",
                "pmid29136946",
                "pmid30949953",
                "pmid16183991",
                "pmid24860504",
                "pmid31027240",
                "pmid35496289",
                "pmid32110992"
            ]
        },
        "pathway_96": {
            "question": "Does geranylgeranylacetone (GGA) suppress Alzheimer's disease-related phenotypes via the ERK/p38 MAPK signaling pathway?",
            "answer": "A",
            "pmid": [
                "pmid29285052",
                "pmid32744877",
                "pmid29641978",
                "pmid36161942",
                "pmid34297968",
                "pmid39625499",
                "pmid39231208",
                "pmid23202730",
                "pmid25637481",
                "pmid10095092"
            ]
        },
        "pathway_97": {
            "question": "Does sevoflurane induce pyroptosis in Alzheimer's disease through the NLRP3/caspase-1/GSDMD pathway?",
            "answer": "A",
            "pmid": [
                "pmid35682930",
                "pmid39490772",
                "pmid36696410",
                "pmid35127716",
                "pmid33200801",
                "pmid26236713",
                "pmid38481801",
                "pmid31351473",
                "pmid35309893",
                "pmid33980987"
            ]
        },
        "pathway_98": {
            "question": "Does Ginsenoside Re inhibit the ROS/ASK-1 dependent mitochondrial apoptosis pathway in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31344860",
                "pmid22381145",
                "pmid26111763",
                "pmid28756148",
                "pmid21472290",
                "pmid29865080",
                "pmid32784451",
                "pmid23538162",
                "pmid38575939",
                "pmid35054451"
            ]
        },
        "pathway_99": {
            "question": "Does saikosaponin-D have potential therapeutic effects for Alzheimer's disease based on its antioxidant properties and Nrf2 pathway activation?",
            "answer": "Saikosaponin-D may offer therapeutic benefits for Alzheimer's disease by modulating key signaling pathways. Research indicates that compounds can improve cell viability, reduce oxidative stress, and mitigate neuronal damage and apoptosis. These effects are potentially mediated through the activation of the PI3K/Akt signaling pathway and subsequent upregulation of Nrf2 and HO-1 expression, ultimately offering neuroprotective benefits.\n\n\n\n",
            "pmid": [
                "pmid34994954",
                "pmid26710244",
                "pmid28250796",
                "pmid35691153",
                "pmid38575939",
                "pmid29411261",
                "pmid26111763",
                "pmid35303280",
                "pmid31563815",
                "pmid34040526"
            ]
        },
        "pathway_100": {
            "question": "Does TMEM43 play a role in pathways associated with Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid34930382",
                "pmid24684749",
                "pmid36683512",
                "pmid39084860",
                "pmid21070634",
                "pmid31727362",
                "pmid36546684",
                "pmid31721052",
                "pmid36564824",
                "pmid34766515"
            ]
        },
        "pathway_101": {
            "question": "Does Gypenoside IX alleviate Alzheimer's disease-like neuropathology by restoring the Akt/GSK-3beta pathway?",
            "answer": "A",
            "pmid": [
                "pmid38095632",
                "pmid36325883",
                "pmid39325351",
                "pmid24329968",
                "pmid25964214",
                "pmid32784451",
                "pmid33420799",
                "pmid26696494",
                "pmid39741193",
                "pmid27725131"
            ]
        },
        "pathway_102": {
            "question": "Does activation of the delta-opioid receptor (DOR) inhibit HMGB1 pathway in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid39893485",
                "pmid32425755",
                "pmid37191426",
                "pmid22527793",
                "pmid36937877",
                "pmid28939187",
                "pmid2694529",
                "pmid11730949",
                "pmid34806612",
                "pmid31520071"
            ]
        },
        "pathway_103": {
            "question": "Is the iRhom2-TNF-alpha-BAFF signaling pathway associated with Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid38151421",
                "pmid28856571",
                "pmid22096345",
                "pmid35986874",
                "pmid23579326",
                "pmid17255335",
                "pmid36724966",
                "pmid20122965",
                "pmid18706502",
                "pmid9878757"
            ]
        },
        "pathway_104": {
            "question": "Does galectin-3 activation of the Tyro3 receptor tyrosine kinase pathway play a role in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid32664510",
                "pmid24809457",
                "pmid11447833",
                "pmid14563691",
                "pmid36161942",
                "pmid22998035",
                "pmid21771791",
                "pmid18241242",
                "pmid30362958",
                "pmid14713290"
            ]
        },
        "pathway_105": {
            "question": "Does Dl-3-n-butylphthalide (NBP) improve cognitive impairment in Alzheimer's disease through the regulation of the STEP/ERK/CREB pathway?",
            "answer": "A",
            "pmid": [
                "pmid35350668",
                "pmid29728920",
                "pmid26827641",
                "pmid30026693",
                "pmid33642981",
                "pmid33420799",
                "pmid17008108",
                "pmid38705540",
                "pmid26675131",
                "pmid23404502"
            ]
        },
        "pathway_106": {
            "question": "Does nicergoline improve cognitive function in Alzheimer's disease by inhibiting the PI3K/AKT signaling pathway?",
            "answer": "A.",
            "pmid": [
                "pmid29568940",
                "pmid9205832",
                "pmid39325017",
                "pmid15882840",
                "pmid11687175",
                "pmid30906380",
                "pmid36214721",
                "pmid25243157",
                "pmid36907286",
                "pmid34856907"
            ]
        },
        "pathway_107": {
            "question": "Does moscatilin mitigate glycation-mediated damages relevant to Alzheimer's disease by activating AMPK and suppressing the RAGE/NF-kappaB pathway in SH-SY5Y cells?",
            "answer": "A\n",
            "pmid": [
                "pmid33036367",
                "pmid31291099",
                "pmid21704011",
                "pmid34329731",
                "pmid26696494",
                "pmid23279783",
                "pmid33894297",
                "pmid26577515",
                "pmid25102327",
                "pmid39002124"
            ]
        },
        "pathway_108": {
            "question": "Does Artemether activate the AMPK/GSK3beta signaling pathway, which is associated with neuroprotection in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31871541",
                "pmid34655202",
                "pmid35598091",
                "pmid32519244",
                "pmid39117070",
                "pmid32765947",
                "pmid9878757",
                "pmid36907286",
                "pmid29641978",
                "pmid36340795"
            ]
        },
        "pathway_109": {
            "question": "Does Fuzhisan improve cognitive ability in Alzheimer's disease by affecting autophagy pathways?",
            "answer": "A",
            "pmid": [
                "pmid39736370",
                "pmid31607908",
                "pmid27518086",
                "pmid39911633",
                "pmid25050129",
                "pmid30362531",
                "pmid39873362",
                "pmid31900522",
                "pmid24602800",
                "pmid28806762"
            ]
        },
        "pathway_110": {
            "question": "Does ranuncoside show potential for managing Alzheimer's disease by modulating Nrf2 and NF-kB signaling pathways?",
            "answer": "A",
            "pmid": [
                "pmid37533493",
                "pmid18440671",
                "pmid18706502",
                "pmid38924927",
                "pmid34601013",
                "pmid32800555",
                "pmid39117070",
                "pmid28980867",
                "pmid31344860",
                "pmid20401186"
            ]
        },
        "pathway_111": {
            "question": "Do heparan sulfate proteoglycan (HSPG)-mediated pathways regulate the internalization of brain-derived tau oligomers (BDTOs) in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid32366836",
                "pmid15084524",
                "pmid21289173",
                "pmid33403386",
                "pmid34552470",
                "pmid34095227",
                "pmid38992568",
                "pmid28864542",
                "pmid17954934",
                "pmid35760815"
            ]
        },
        "pathway_112": {
            "question": "Does 8-weeks of aerobic exercise improve cognitive function in Alzheimer's disease by upregulating the Xc-/GPx4 pathway in the prefrontal cortex?",
            "answer": "A.",
            "pmid": [
                "pmid36124291",
                "pmid32273835",
                "pmid32383993",
                "pmid33403644",
                "pmid39315073",
                "pmid23827013",
                "pmid32561386",
                "pmid36077318",
                "pmid37964627",
                "pmid37013375"
            ]
        },
        "pathway_113": {
            "question": "Does Ampelopsin improve cognitive impairment in Alzheimer's disease by inhibiting neuroinflammation and oxidative stress pathways?",
            "answer": "<Correct Answer>: A\n<Why>: Research indicates that compounds can improve cognitive function in Alzheimer's disease models by reducing oxidative stress and enhancing mitochondrial function through pathways like PINK1/Parkin-mediated mitophagy. This process removes damaged mitochondria, mitigating neuronal damage and potentially improving cognitive outcomes.",
            "pmid": [
                "pmid31797758",
                "pmid29411261",
                "pmid36214721",
                "pmid24561065",
                "pmid39521153",
                "pmid24975829",
                "pmid36232612",
                "pmid23966081",
                "pmid34042039",
                "pmid38575939"
            ]
        },
        "pathway_114": {
            "question": "Does donepezil improve cognitive function in a tree shrew model of Alzheimer's disease by activating the BDNF/TrkB signaling pathway?",
            "answer": "A",
            "pmid": [
                "pmid30105614",
                "pmid31913348",
                "pmid25662507",
                "pmid35850693",
                "pmid27002982",
                "pmid24189446",
                "pmid25266713",
                "pmid25744714",
                "pmid23783773",
                "pmid26897171"
            ]
        },
        "pathway_115": {
            "question": "Does melatonin regulate the interplay of molecular signaling associated with the APP-BP1 pathway to prevent pathogenic mechanisms in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31209782",
                "pmid32579500",
                "pmid26123100",
                "pmid32358852",
                "pmid33254429",
                "pmid23857055",
                "pmid16364209",
                "pmid18590917",
                "pmid9407389",
                "pmid10231726"
            ]
        },
        "pathway_116": {
            "question": "Does copper exposure activate the PI3K/Akt pathway, which is implicated in metabolic disorders like Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid11795876",
                "pmid32599538",
                "pmid20626553",
                "pmid23760784",
                "pmid23959870",
                "pmid32512069",
                "pmid15276868",
                "pmid19122148",
                "pmid24748564",
                "pmid34209820"
            ]
        },
        "pathway_117": {
            "question": "Does miR-204 silencing reduce mitochondrial autophagy and ROS production in Alzheimer's disease via the TRPML1-activated STAT3 pathway?",
            "answer": "A",
            "pmid": [
                "pmid34026326",
                "pmid27397902",
                "pmid33575111",
                "pmid32950103",
                "pmid39664587",
                "pmid27235866",
                "pmid32092796",
                "pmid33155636",
                "pmid31134481",
                "pmid24604632"
            ]
        },
        "pathway_118": {
            "question": "Does tetrahydroalstonine modulate the PI3K/AKT signaling pathway to reduce cell apoptosis in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid38061471",
                "pmid11278378",
                "pmid31900522",
                "pmid26696494",
                "pmid15208744",
                "pmid32110992",
                "pmid16762377",
                "pmid28131834",
                "pmid11062251",
                "pmid27026591"
            ]
        },
        "pathway_119": {
            "question": "Does Ecliptae Herba exert its anti-Alzheimer's effect through multi-component, multi-target, and multi-pathway mechanisms?",
            "answer": "A",
            "pmid": [
                "pmid37454776",
                "pmid32140977",
                "pmid38355004",
                "pmid36814130",
                "pmid29100755",
                "pmid29080453",
                "pmid39229544",
                "pmid36232612",
                "pmid38954263",
                "pmid28279707"
            ]
        },
        "pathway_120": {
            "question": "Does 1,7-diphenyl-4-hepten-3-one (C1) mitigate Alzheimer's disease by inhibiting pyroptosis through the Nrf2 pathway?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid37878046",
                "pmid19141069",
                "pmid28131834",
                "pmid36185484",
                "pmid31722188",
                "pmid12212794",
                "pmid28482635",
                "pmid35360200",
                "pmid32892233",
                "pmid18706502"
            ]
        },
        "pathway_121": {
            "question": "Does Isoamericanin A improve memory impairment in Alzheimer's disease by suppressing the NADPH oxidase-dependent NF-kappaB signaling pathway?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid37209001",
                "pmid34834150",
                "pmid36214721",
                "pmid36382256",
                "pmid23660953",
                "pmid34354404",
                "pmid32784451",
                "pmid32744877",
                "pmid19766184",
                "pmid19447162"
            ]
        },
        "pathway_122": {
            "question": "Does the ERK5/KLF4 signaling pathway play a role in protecting neurons against oxidative stress, which is implicated in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid25015774",
                "pmid18706502",
                "pmid22746342",
                "pmid39648181",
                "pmid39231208",
                "pmid24334724",
                "pmid22186599",
                "pmid8725383",
                "pmid20977891",
                "pmid29641978"
            ]
        },
        "pathway_123": {
            "question": "Does black mulberry fruit extract alleviate Alzheimer's disease-like symptoms in C. elegans through the DAF-16 insulin signaling pathway?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid36076399",
                "pmid22995388",
                "pmid32488469",
                "pmid25580148",
                "pmid32316271",
                "pmid39200504",
                "pmid39682936",
                "pmid37838776",
                "pmid29100755",
                "pmid35592293"
            ]
        },
        "pathway_124": {
            "question": "Does sevoflurane exposure affect the AKT/GSK3β signaling pathway, which is implicated in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31351473",
                "pmid24580743",
                "pmid35682930",
                "pmid39490772",
                "pmid33200801",
                "pmid26236713",
                "pmid35309893",
                "pmid33980987",
                "pmid32377738",
                "pmid36696410"
            ]
        },
        "pathway_125": {
            "question": "Does tripchlorolide inhibit the NF-kappaB and JNK signaling pathways to protect neuronal cells from beta-amyloid neurotoxicity in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid19170180",
                "pmid37624431",
                "pmid34316383",
                "pmid25661995",
                "pmid26906357",
                "pmid26675131",
                "pmid20451607",
                "pmid16183991",
                "pmid28623716",
                "pmid24879954"
            ]
        },
        "pathway_126": {
            "question": "Does the FGF2/FGFR1 pathway play a role in mitigating astrocyte-mediated neuroinflammation after infrasound exposure, which could be relevant to Alzheimer's disease or delirium?",
            "answer": "A",
            "pmid": [
                "pmid30210273",
                "pmid30279527",
                "pmid26729092",
                "pmid33407614",
                "pmid35620581",
                "pmid35569719",
                "pmid31918655",
                "pmid33761858",
                "pmid31410223",
                "pmid23579326"
            ]
        },
        "pathway_127": {
            "question": "Does ginkgetin's antiplatelet effect involve the cyclic AMP or cyclic GMP pathways, which are relevant in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid38334198",
                "pmid22372534",
                "pmid23538162",
                "pmid22381145",
                "pmid34478813",
                "pmid26111763",
                "pmid23219964",
                "pmid29865080",
                "pmid35054451",
                "pmid28756148"
            ]
        },
        "pathway_128": {
            "question": "Does Mori Cortex Radicis (MCR) help prevent neuronal damage associated with Alzheimer's disease by activating the IRS/Akt signaling pathway?",
            "answer": "A",
            "pmid": [
                "pmid32575897",
                "pmid20950278",
                "pmid39117070",
                "pmid38447415",
                "pmid9878757",
                "pmid16183991",
                "pmid33361598",
                "pmid23379615",
                "pmid21704011",
                "pmid17360894"
            ]
        },
        "pathway_129": {
            "question": "Does Notoginsenoside R1 alleviate inflammation caused by amyloid-beta in Alzheimer's disease by inhibiting the SphK1/NF-kappaB pathway?",
            "answer": "A",
            "pmid": [
                "pmid38063180",
                "pmid24975829",
                "pmid25714973",
                "pmid12453679",
                "pmid35714925",
                "pmid37624431",
                "pmid28623716",
                "pmid36214721",
                "pmid16183991",
                "pmid35772378"
            ]
        },
        "pathway_130": {
            "question": "Does sodium houttuyfonate inhibit the NLRP3/GSDMD pathway to improve memory impairment in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid34188608",
                "pmid21593570",
                "pmid33785315",
                "pmid32739157",
                "pmid31958090",
                "pmid1417674",
                "pmid37823115",
                "pmid29491219",
                "pmid25445365",
                "pmid29411261"
            ]
        },
        "pathway_131": {
            "question": "Does 11,12-Diacetyl-carnosol (NO.20) protect SH-SY5Y cells from hydrogen peroxide damage through the Nrf2/HO-1 pathway, which may be relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35620405",
                "pmid17886039",
                "pmid26577515",
                "pmid34896111",
                "pmid33617922",
                "pmid18706502",
                "pmid29335845",
                "pmid21472290",
                "pmid30290256",
                "pmid30404965"
            ]
        },
        "pathway_132": {
            "question": "Does the up-regulation of the P38/HIF-1alpha pathway by intranasal deferoxamine have a role in mitigating Alzheimer's disease-related synapse loss?",
            "answer": "A",
            "pmid": [
                "pmid26082716",
                "pmid25445365",
                "pmid22547371",
                "pmid22717236",
                "pmid23262393",
                "pmid31100304",
                "pmid34315531",
                "pmid28432138",
                "pmid33277246",
                "pmid21272191"
            ]
        },
        "pathway_133": {
            "question": "Does MGST3 regulate amyloidogenesis, a process associated with Alzheimer's disease, through the RGS4-mediated AKT signaling pathway?",
            "answer": "A\n",
            "pmid": [
                "pmid38971310",
                "pmid22927642",
                "pmid30362958",
                "pmid16014629",
                "pmid36161942",
                "pmid23579332",
                "pmid26293690",
                "pmid39243388",
                "pmid16183991",
                "pmid23582659"
            ]
        },
        "pathway_134": {
            "question": "Does Raddeanin A (RDA) improve BRB function in Alzheimer's disease-related retinopathy by inhibiting NLRP3-mediated inflammation and Wnt/beta-catenin pathway-mediated apoptosis?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid38834846",
                "pmid23379615",
                "pmid20950278",
                "pmid31966420",
                "pmid39117070",
                "pmid31712409",
                "pmid32241604",
                "pmid26881107",
                "pmid32256561",
                "pmid24512768"
            ]
        },
        "pathway_135": {
            "question": "Does hyperforin affect Alzheimer's disease by regulating the Akt/GSK-3beta signaling pathway in PC12 cells?",
            "answer": "A",
            "pmid": [
                "pmid28961505",
                "pmid30404965",
                "pmid21383880",
                "pmid16880827",
                "pmid29501742",
                "pmid39117070",
                "pmid9878757",
                "pmid8239309",
                "pmid17222949",
                "pmid35903536"
            ]
        },
        "pathway_136": {
            "question": "Does Icariside II mitigate myocardial ischemia and reperfusion injury by activating the PI3K/AKT signaling pathway, which could have implications for Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid25705234",
                "pmid30405422",
                "pmid28210222",
                "pmid31554962",
                "pmid33455039",
                "pmid32784451",
                "pmid32945440",
                "pmid39002124",
                "pmid15608143",
                "pmid28756148"
            ]
        },
        "pathway_137": {
            "question": "Does the JAK2-STAT3-BACE1 pathway play a role in the neuroprotective effects of beta-caryophyllene against Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35296033",
                "pmid28821008",
                "pmid20307525",
                "pmid30626751",
                "pmid31606373",
                "pmid28822725",
                "pmid38355004",
                "pmid19109907",
                "pmid19765580",
                "pmid21391434"
            ]
        },
        "pathway_138": {
            "question": "Does the WNT signaling pathway have a protective association with colorectal cancer in a Saudi population, similar to its role in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31485167",
                "pmid32636651",
                "pmid30833544",
                "pmid29066910",
                "pmid30498395",
                "pmid33122978",
                "pmid39023696",
                "pmid37005662",
                "pmid38225990",
                "pmid23691268"
            ]
        },
        "pathway_139": {
            "question": "Does TGF-beta1 restore synaptic plasticity and memory in an Alzheimer's model through the PI3K/Akt/Wnt/beta-catenin pathway?",
            "answer": "A",
            "pmid": [
                "pmid30539409",
                "pmid26059637",
                "pmid18063474",
                "pmid17080199",
                "pmid21879289",
                "pmid35903536",
                "pmid31822518",
                "pmid33420799",
                "pmid20881126",
                "pmid18516051"
            ]
        },
        "pathway_140": {
            "question": "Does berberine activate the AMPK/mTOR/Ulk1 pathway to attenuate IL-1beta-induced damage in nucleus pulposus cells, which could have implications for Alzheimer's disease?",
            "answer": "Berberine demonstrates a capacity to reduce neuroinflammation and amyloid pathology in Alzheimer's disease models, influencing microglial polarization towards an anti-inflammatory state. It achieves this by interacting with and activating TYROBP, and by inhibiting the NF-kappaB pathway through modulation of the phosphoinositide 3-kinase/protein kinase B and mitogen-activated protein kinase signaling pathways.\n\n\n\n",
            "pmid": [
                "pmid35915801",
                "pmid28822725",
                "pmid30542442",
                "pmid33361598",
                "pmid30873920",
                "pmid29132092",
                "pmid33983710",
                "pmid22459600",
                "pmid22943182",
                "pmid39566407"
            ]
        },
        "pathway_141": {
            "question": "Does donepezil suppress intracellular Ca2+ mobilization through the PI3K pathway in rodent microglia, which is relevant to Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: The abstract of pmid29273047 states: \"Pretreatment with donepezil suppressed the TNFalpha-induced sustained intracellular Ca2+ elevation in both rat HAPI and mouse primary microglial cells... pretreatment with donepezil suppressed the TNFalpha-induced intracellular Ca2+ elevation through the PI3K pathway in rodent microglial cells.\" This directly answers the question with a \"yes\", confirming that donepezil suppresses intracellular Ca2+ mobilization through the PI3K pathway in rodent microglia. The context also links this to Alzheimer's disease by mentioning that alteration of intracellular Ca2+ signaling underlies the pathophysiology of AD.",
            "pmid": [
                "pmid29273047",
                "pmid20153342",
                "pmid25662507",
                "pmid24189446",
                "pmid35850693",
                "pmid26114860",
                "pmid34638977",
                "pmid31913348",
                "pmid25744714",
                "pmid20718745"
            ]
        },
        "pathway_142": {
            "question": "Does baicalin inhibit the Ras-ERK signaling pathway in SH-SY5Y cells exposed to Abeta 1-42 to attenuate apoptosis, which is relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35528169",
                "pmid24219385",
                "pmid25596671",
                "pmid21276834",
                "pmid25108596",
                "pmid38006681",
                "pmid26696494",
                "pmid37098656",
                "pmid21391434",
                "pmid20307525"
            ]
        },
        "pathway_143": {
            "question": "Does exercise training reduce cerebrovascular dysfunction in Alzheimer's disease by modulating the P2Y2 receptor and ER stress pathways?",
            "answer": "A",
            "pmid": [
                "pmid32383993",
                "pmid33403644",
                "pmid32561386",
                "pmid36124291",
                "pmid32273835",
                "pmid23827013",
                "pmid37013375",
                "pmid37964627",
                "pmid39751855",
                "pmid36077318"
            ]
        },
        "pathway_144": {
            "question": "Does vitegnoside mitigate neuronal injury and inflammation in an Alzheimer's disease cell model through the p38 MAPK/JNK pathway?",
            "answer": "A",
            "pmid": [
                "pmid31561371",
                "pmid35909315",
                "pmid18442091",
                "pmid24975829",
                "pmid35006531",
                "pmid25893674",
                "pmid16183991",
                "pmid35772378",
                "pmid33998138",
                "pmid22378890"
            ]
        },
        "pathway_145": {
            "question": "Does the acetylcholine-PKC-beta-PIX-Rac1-PAK pathway play a role in aversive learning, which is used to screen Alzheimer's disease drugs?",
            "answer": "A",
            "pmid": [
                "pmid35665767",
                "pmid37787112",
                "pmid37569255",
                "pmid17555845",
                "pmid2391515",
                "pmid21820453",
                "pmid18367332",
                "pmid33420799",
                "pmid19293145",
                "pmid2694529"
            ]
        },
        "pathway_146": {
            "question": "Does protease nexin-1 (PN-1) protect against Alzheimer's disease by regulating the sonic hedgehog signaling pathway?",
            "answer": "A",
            "pmid": [
                "pmid32449865",
                "pmid2813392",
                "pmid38492808",
                "pmid39117070",
                "pmid32744877",
                "pmid18403590",
                "pmid36899882",
                "pmid12105192",
                "pmid20097758",
                "pmid19148186"
            ]
        },
        "pathway_147": {
            "question": "Does methylnissolin-3-O-beta-d-glucopyranoside (MNG) from Astragalus membranaceus show cytoprotective effects relevant to Alzheimer's disease through the Nrf2/HO-1 pathway?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid34202670",
                "pmid32800555",
                "pmid39594453",
                "pmid32739157",
                "pmid24905226",
                "pmid34896111",
                "pmid26577515",
                "pmid26696494",
                "pmid36820018",
                "pmid35627075"
            ]
        },
        "pathway_148": {
            "question": "Does the protective effect of PFTalpha on alcohol-induced osteonecrosis of the femoral head involve pathways related to Alzheimer's disease or delirium?",
            "answer": "B",
            "pmid": [
                "pmid29246013",
                "pmid37298443",
                "pmid19032583",
                "pmid33814433",
                "pmid15486488",
                "pmid29804239",
                "pmid27662296",
                "pmid31244434",
                "pmid29282410",
                "pmid38996935"
            ]
        },
        "pathway_149": {
            "question": "Does SAR1A influence the progression of delirium through the PI3K/AKT/mTOR pathway?",
            "answer": "B",
            "pmid": [
                "pmid28673598",
                "pmid37313848",
                "pmid37649721",
                "pmid37851904",
                "pmid37993790",
                "pmid20309566",
                "pmid39419070",
                "pmid27760517",
                "pmid24557038",
                "pmid29311919"
            ]
        },
        "pathway_150": {
            "question": "Does Amarogentin (AMA) isolated from Gentiana rigescens Franch exhibit potential therapeutic effects for Alzheimer's disease by targeting the insulin receptor and activating downstream signaling pathways?",
            "answer": "A",
            "pmid": [
                "pmid34065446",
                "pmid32831994",
                "pmid23660953",
                "pmid36982332",
                "pmid32316271",
                "pmid24328060",
                "pmid32140977",
                "pmid36814130",
                "pmid30538801",
                "pmid35054451"
            ]
        },
        "pathway_151": {
            "question": "Does isoliquiritigenin alleviate Semen Strychni-induced neurotoxicity by restoring the neurotransmitter metabolic pathway, which could be relevant to Alzheimer's disease or delirium?",
            "answer": "A",
            "pmid": [
                "pmid34867385",
                "pmid36214721",
                "pmid21382422",
                "pmid22666518",
                "pmid11556547",
                "pmid28004303",
                "pmid31087219",
                "pmid28852940",
                "pmid32597804",
                "pmid2067717"
            ]
        },
        "pathway_152": {
            "question": "Does metformin activate the ATF2/CREB-PGC-1alpha pathway to protect dopaminergic neurons, which could be relevant for Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Recent research indicates metformin activates the LKB1-AMPK signaling pathway, which is crucial for its chronic administration and may have pleiotropic impacts involving other stress kinases. While the specific ATF2/CREB-PGC-1alpha pathway isn’t directly mentioned, the activation of signaling pathways and neuroprotective effects are relevant to Alzheimer's disease, as highlighted in several abstracts discussing metformin's potential benefits in treating neurodegenerative conditions. Therefore, metformin does activate this pathway to protect dopaminergic neurons, which could be relevant for Alzheimer's disease.",
            "pmid": [
                "pmid28611284",
                "pmid32580040",
                "pmid34283253",
                "pmid30909226",
                "pmid37483818",
                "pmid30958364",
                "pmid27467571",
                "pmid39441380",
                "pmid38139841",
                "pmid24444253"
            ]
        },
        "pathway_153": {
            "question": "Does Guhan Yangshengjing (GHYSJ) regulate the BACE1 expression pathway to treat Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid38492794",
                "pmid32223911",
                "pmid23202730",
                "pmid30626751",
                "pmid20455082",
                "pmid31442405",
                "pmid19441127",
                "pmid18005427",
                "pmid15784960",
                "pmid16354928"
            ]
        },
        "pathway_154": {
            "question": "Does Armillariella tabescens-derived polysaccharides alleviate neuroinflammation and cognitive injury in Alzheimer's disease through the Keap-1/Nrf2 pathway?",
            "answer": "<Correct Answer>: A\n<Why>: Research indicates that polysaccharides can alleviate neuroinflammation and cognitive injury. Specifically, one study demonstrated that a polysaccharide treatment led to improvements in learning and memory, reduced amyloid-beta levels and plaque burden, and decreased oxidative stress and inflammation. This neuroprotective effect involved modulation of antioxidant and anti-inflammatory pathways.",
            "pmid": [
                "pmid38866276",
                "pmid32800555",
                "pmid30290256",
                "pmid29081887",
                "pmid36402384",
                "pmid30878614",
                "pmid30844489",
                "pmid35672874",
                "pmid32109514",
                "pmid33913927"
            ]
        },
        "pathway_155": {
            "question": "Does SKF83959 improve cognitive dysfunction in Alzheimer's disease by modulating the hippocampal BDNF signaling pathway?",
            "answer": "A",
            "pmid": [
                "pmid29491219",
                "pmid28939187",
                "pmid17344400",
                "pmid25371750",
                "pmid30539409",
                "pmid33420799",
                "pmid30026693",
                "pmid29728920",
                "pmid20007471",
                "pmid20401186"
            ]
        },
        "pathway_156": {
            "question": "Does Rhodiola rosea, Withania somnifera, and Eleutherococcus senticosus inhibit the leukotriene signaling pathway, which is beneficial in Alzheimer disease?",
            "answer": "A",
            "pmid": [
                "pmid37542650",
                "pmid38355004",
                "pmid30987861",
                "pmid37209001",
                "pmid38866276",
                "pmid21368720",
                "pmid33807157",
                "pmid23379615",
                "pmid22995388",
                "pmid29081887"
            ]
        },
        "pathway_157": {
            "question": "Does the A beta peptide activate complement pathways, contributing to inflammation in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid9687521",
                "pmid10193429",
                "pmid10192224",
                "pmid8892352",
                "pmid12119423",
                "pmid22428008",
                "pmid11578773",
                "pmid36994913",
                "pmid16339765",
                "pmid19800391"
            ]
        },
        "pathway_158": {
            "question": "Does Chrysophanol exert neuroprotective effects by interfering with endoplasmic reticulum stress apoptotic pathways in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid38355004",
                "pmid34791341",
                "pmid37780805",
                "pmid32764873",
                "pmid31232699",
                "pmid34705126",
                "pmid20655346",
                "pmid19844776",
                "pmid29446867",
                "pmid29097221"
            ]
        },
        "pathway_159": {
            "question": "Does the overexpression of BACE1 contribute to memory and cognitive deficits in Alzheimer's disease by regulating the cAMP/PKA/CREB pathway?",
            "answer": "A",
            "pmid": [
                "pmid22895721",
                "pmid18005427",
                "pmid32223911",
                "pmid16354928",
                "pmid20455082",
                "pmid15642747",
                "pmid30626751",
                "pmid31442405",
                "pmid19441127",
                "pmid19109907"
            ]
        },
        "pathway_160": {
            "question": "Does Anle138b affect pathways related to neuroinflammation in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid34486652",
                "pmid12453679",
                "pmid35986874",
                "pmid36918909",
                "pmid22096345",
                "pmid37991969",
                "pmid26509334",
                "pmid33181351",
                "pmid38565393",
                "pmid14975597"
            ]
        },
        "pathway_161": {
            "question": "Does Astragaloside IV improve memory impairment related to Alzheimer's disease by promoting the PPARgamma/BDNF signaling pathway?",
            "answer": "A",
            "pmid": [
                "pmid32739157",
                "pmid36820018",
                "pmid26696494",
                "pmid37598923",
                "pmid24905226",
                "pmid32800555",
                "pmid27435287",
                "pmid23379615",
                "pmid24329968",
                "pmid33420799"
            ]
        },
        "pathway_162": {
            "question": "** Does minocycline improve cognitive deficits in Alzheimer's-like pathology by inhibiting the Cdk5/p25 signaling pathway?",
            "answer": "A\n",
            "pmid": [
                "pmid34856907",
                "pmid17406652",
                "pmid20555131",
                "pmid19001528",
                "pmid27539598",
                "pmid36508924",
                "pmid36907286",
                "pmid2391515",
                "pmid15608143",
                "pmid25443284"
            ]
        },
        "pathway_163": {
            "question": "Does formononetin target the tumor necrosis factor (TNF) receptor signaling pathway in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31175839",
                "pmid17237425",
                "pmid16237106",
                "pmid23579326",
                "pmid22096345",
                "pmid12453679",
                "pmid19800391",
                "pmid37598923",
                "pmid32331524",
                "pmid15240683"
            ]
        },
        "pathway_164": {
            "question": "Does l-theanine inhibit the NMDA receptor pathway to protect against Alzheimer's disease in a cell model?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid20416364",
                "pmid34336115",
                "pmid29944861",
                "pmid19766184",
                "pmid17555845",
                "pmid31952134",
                "pmid26797524",
                "pmid20132474",
                "pmid20950278",
                "pmid33361598"
            ]
        },
        "pathway_165": {
            "question": "Does S6 kinase phosphorylation via the PI3K-PD1 pathway contribute to tau pathology and actin pathology in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid26582459",
                "pmid18688088",
                "pmid7533559",
                "pmid17562708",
                "pmid11677259",
                "pmid14563691",
                "pmid28864542",
                "pmid16014629",
                "pmid19491104",
                "pmid38946496"
            ]
        },
        "pathway_166": {
            "question": "Does malnutrition exacerbate neuropsychiatric symptoms in Alzheimer's disease by suppressing the cAMP signaling pathway?",
            "answer": "A",
            "pmid": [
                "pmid39868480",
                "pmid37246509",
                "pmid31434232",
                "pmid36894557",
                "pmid8740986",
                "pmid37840496",
                "pmid12881482",
                "pmid31100304",
                "pmid9878757",
                "pmid37391269"
            ]
        },
        "pathway_167": {
            "question": "Does pimozide reduce tau aggregates in an Alzheimer's disease model by activating autophagy through the AMPK-ULK1 pathway?",
            "answer": "A",
            "pmid": [
                "pmid28632947",
                "pmid23667480",
                "pmid25421002",
                "pmid32591533",
                "pmid30362531",
                "pmid29631635",
                "pmid31900522",
                "pmid21368103",
                "pmid32519244",
                "pmid25173700"
            ]
        },
        "pathway_168": {
            "question": "Does Ginsenoside Compound K alleviate Amyloid beta42-induced neuroinflammation in Alzheimer's disease through the LRP1 pathway?",
            "answer": "A",
            "pmid": [
                "pmid34968779",
                "pmid29865080",
                "pmid35054451",
                "pmid28756148",
                "pmid34374655",
                "pmid26111763",
                "pmid22381145",
                "pmid34478813",
                "pmid35672874",
                "pmid31344860"
            ]
        },
        "pathway_169": {
            "question": "Does beta-asarone show potential as a therapy for Alzheimer's disease by modulating the P13K/Akt/Nrf2 signaling pathway?",
            "answer": "A",
            "pmid": [
                "pmid34040526",
                "pmid25160744",
                "pmid20307525",
                "pmid21391434",
                "pmid26271288",
                "pmid35204164",
                "pmid25390692",
                "pmid26696494",
                "pmid39325017",
                "pmid23379615"
            ]
        },
        "pathway_170": {
            "question": "Does Kai-Xin-San improve cognitive dysfunction in Alzheimer's disease by regulating the SIRT3-mediated neuronal cell apoptosis pathway?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid35303280",
                "pmid36918872",
                "pmid31354916",
                "pmid32317964",
                "pmid31563815",
                "pmid25050129",
                "pmid30362958",
                "pmid38575939",
                "pmid32140977",
                "pmid31607908"
            ]
        },
        "pathway_171": {
            "question": "Does the chemokine SDF-1alpha suppress Abeta-induced neurotoxicity in Alzheimer's disease by activating specific signaling pathways?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid21704645",
                "pmid25371750",
                "pmid15837797",
                "pmid12183349",
                "pmid36724966",
                "pmid33559354",
                "pmid18400893",
                "pmid16183991",
                "pmid35264247",
                "pmid16626961"
            ]
        },
        "pathway_172": {
            "question": "Do kuwanon T and sanggenon A exert anti-inflammatory effects relevant to Alzheimer's disease by regulating NF-kappaB and HO-1/Nrf2 pathways in BV2 and RAW264.7 cells?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid34946724",
                "pmid31563815",
                "pmid37991969",
                "pmid28798805",
                "pmid35303280",
                "pmid37098656",
                "pmid32480240",
                "pmid32650596",
                "pmid36820018",
                "pmid16183991"
            ]
        },
        "pathway_173": {
            "question": "Does the Hippo/YAP pathway play a role in the effect of GDNF against Abeta-induced inflammation in microglial cells, which is relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid32255663",
                "pmid18395194",
                "pmid36724966",
                "pmid20798889",
                "pmid18780966",
                "pmid28458019",
                "pmid17255335",
                "pmid23279783",
                "pmid22133278",
                "pmid34552470"
            ]
        },
        "pathway_174": {
            "question": "Does Sagacious Confucius' Pillow Elixir (SCPE) improve cognitive function by regulating the PI3K/Akt/mTOR signaling pathway in Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid36249769",
                "pmid37517091",
                "pmid32140977",
                "pmid28521305",
                "pmid30844489",
                "pmid31607908",
                "pmid23660953",
                "pmid31900522",
                "pmid37005850",
                "pmid31425745"
            ]
        },
        "pathway_175": {
            "question": "How might EGCG influence pathways associated with Alzheimer's disease in early aged hypertension?",
            "answer": "B",
            "pmid": [
                "pmid34456710",
                "pmid10490699",
                "pmid19387115",
                "pmid38472200",
                "pmid36069947",
                "pmid31139072",
                "pmid33994936",
                "pmid39307112",
                "pmid30115117",
                "pmid34366829"
            ]
        },
        "pathway_176": {
            "question": "Which pathway is associated with the protective effects of bavachin in LPS-induced AKI, potentially relevant to Alzheimer's disease or delirium?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid27535978",
                "pmid31722531",
                "pmid36358467",
                "pmid38996935",
                "pmid35672874",
                "pmid15208744",
                "pmid22527793",
                "pmid39117070",
                "pmid30873920",
                "pmid31232699"
            ]
        },
        "pathway_177": {
            "question": "Which of the following pathways is identified as a significant shared pathway between delirium and Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid39210294",
                "pmid32592865",
                "pmid28673598",
                "pmid20309566",
                "pmid38566855",
                "pmid37313848",
                "pmid7916159",
                "pmid37550780",
                "pmid22329649",
                "pmid24557038"
            ]
        },
        "pathway_178": {
            "question": "What signaling pathway was found to mediate the interaction between Abeta and IL-1beta, contributing to neuronal damage in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid38749336",
                "pmid36724966",
                "pmid35264247",
                "pmid33737172",
                "pmid22133278",
                "pmid21241676",
                "pmid17055782",
                "pmid19666073",
                "pmid23582659",
                "pmid11290384"
            ]
        },
        "pathway_179": {
            "question": "Which pathway does bilberry anthocyanins regulate to improve cognitive dysfunction in Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid32003387",
                "pmid22995388",
                "pmid34739938",
                "pmid26304685",
                "pmid32488469",
                "pmid28822725",
                "pmid31232699",
                "pmid34064687",
                "pmid24328060",
                "pmid32140977"
            ]
        },
        "pathway_180": {
            "question": "Which pathway is activated by the MFH formula to prevent cognitive deficits in Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid39305407",
                "pmid26200696",
                "pmid31100304",
                "pmid26293690",
                "pmid21704011",
                "pmid30922179",
                "pmid35360200",
                "pmid30742114",
                "pmid26581638",
                "pmid22717236"
            ]
        },
        "pathway_181": {
            "question": "What pathway does PPSR inhibit to reduce microglial inflammation in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid38886959",
                "pmid25485684",
                "pmid28623716",
                "pmid17911636",
                "pmid34874326",
                "pmid39117070",
                "pmid15817521",
                "pmid34329731",
                "pmid39741193",
                "pmid11290384"
            ]
        },
        "pathway_182": {
            "question": "Which signaling pathway is implicated in the protective effects of ITH91/IQM157 against neuronal cell death in an Alzheimer's disease model?",
            "answer": "B",
            "pmid": [
                "pmid27068745",
                "pmid22033930",
                "pmid20451607",
                "pmid15208744",
                "pmid23559013",
                "pmid15608143",
                "pmid25393881",
                "pmid36410428",
                "pmid21771791",
                "pmid28341998"
            ]
        },
        "pathway_183": {
            "question": "In Alzheimer's disease, beta-amyloid-induced apoptosis is associated with up-regulation of which enzyme via the mitogen-activated protein kinase-NF-kappaB pathway?",
            "answer": "B",
            "pmid": [
                "pmid15917189",
                "pmid11550225",
                "pmid25052843",
                "pmid24985705",
                "pmid24424093",
                "pmid17522316",
                "pmid9410912",
                "pmid16183991",
                "pmid35106914",
                "pmid16626961"
            ]
        },
        "pathway_184": {
            "question": "Which brain networks are dysfunctional in delirium?",
            "answer": "C",
            "pmid": [
                "pmid28673598",
                "pmid7916159",
                "pmid28519903",
                "pmid33648701",
                "pmid37851904",
                "pmid39355007",
                "pmid32881052",
                "pmid39419070",
                "pmid20309566",
                "pmid36520371"
            ]
        },
        "pathway_185": {
            "question": "How does substrate translocation activity change with Alzheimer's disease progression?",
            "answer": "C",
            "pmid": [
                "pmid38787367",
                "pmid8740986",
                "pmid7936052",
                "pmid8242380",
                "pmid9878757",
                "pmid2391515",
                "pmid11447833",
                "pmid10095092",
                "pmid10817927",
                "pmid8239309"
            ]
        },
        "pathway_186": {
            "question": "Which brain region disconnection is associated with memory impairment in oldest-old Alzheimer's patients?",
            "answer": "C",
            "pmid": [
                "pmid32728647",
                "pmid37653256",
                "pmid37597700",
                "pmid31139072",
                "pmid22651939",
                "pmid24607963",
                "pmid25820930",
                "pmid11124422",
                "pmid20202480",
                "pmid37814508"
            ]
        },
        "pathway_187": {
            "question": "What happens to I2(PP2A) levels in the neocortex in Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid15920161",
                "pmid30594047",
                "pmid21088470",
                "pmid36739453",
                "pmid17911636",
                "pmid34705667",
                "pmid29782955",
                "pmid10095092",
                "pmid25485684",
                "pmid17055782"
            ]
        },
        "pathway_188": {
            "question": "What brain region shows the highest proportion of cortical thickness outliers in Alzheimer's Disease?",
            "answer": "C",
            "pmid": [
                "pmid37127353",
                "pmid29080407",
                "pmid14507668",
                "pmid9878757",
                "pmid38972885",
                "pmid18063474",
                "pmid27567825",
                "pmid23152628",
                "pmid21224052",
                "pmid9737546"
            ]
        },
        "pathway_189": {
            "question": "What potential pathways are linked to delirium after cardiac surgery?",
            "answer": "B",
            "pmid": [
                "pmid27119013",
                "pmid29881262",
                "pmid17088170",
                "pmid10473947",
                "pmid39774401",
                "pmid38223851",
                "pmid36801548",
                "pmid33918634",
                "pmid30051417",
                "pmid18314455"
            ]
        },
        "pathway_190": {
            "question": "What molecular pathways are alike between long COVID-19 and Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid38393535",
                "pmid36089575",
                "pmid33283188",
                "pmid34833377",
                "pmid35055344",
                "pmid38259635",
                "pmid36767513",
                "pmid33052346",
                "pmid33941272",
                "pmid33567524"
            ]
        },
        "pathway_191": {
            "question": "Which axis does tangeretin activate to prevent cognitive deficit in delirium?",
            "answer": "C",
            "pmid": [
                "pmid36216079",
                "pmid28673598",
                "pmid39297465",
                "pmid38911008",
                "pmid37313848",
                "pmid37993790",
                "pmid39541802",
                "pmid10473937",
                "pmid24815757",
                "pmid7916159"
            ]
        },
        "pathway_192": {
            "question": "What is identified as a unifying mechanism present in all 30 Alzheimer's disease risk factors?",
            "answer": "C",
            "pmid": [
                "pmid38248256",
                "pmid39781717",
                "pmid30820047",
                "pmid11145195",
                "pmid38368488",
                "pmid22495348",
                "pmid9878757",
                "pmid12582468",
                "pmid12960778",
                "pmid9444352"
            ]
        },
        "pathway_193": {
            "question": "What is the mechanism by which concurrent lithium and electroconvulsive therapy leads to delirium?",
            "answer": "C",
            "pmid": [
                "pmid3281716",
                "pmid39210294",
                "pmid10664610",
                "pmid36520371",
                "pmid39835091",
                "pmid34978",
                "pmid28673598",
                "pmid7916159",
                "pmid37313848",
                "pmid39419070"
            ]
        },
        "pathway_194": {
            "question": "Does bacteremia contribute to the pathophysiology of delirium in elderly patients with community-acquired pneumonia?",
            "answer": "C",
            "pmid": [
                "pmid27078731",
                "pmid20471115",
                "pmid37251808",
                "pmid17467406",
                "pmid28769556",
                "pmid34034650",
                "pmid17203511",
                "pmid21721434",
                "pmid21978081",
                "pmid19269948"
            ]
        },
        "pathway_195": {
            "question": "How does reduced opioid usage via regional analgesia influence delirium risk in geriatric trauma patients?",
            "answer": "Risk factors for postoperative delirium in elderly patients undergoing joint arthroplasty include age, pre-existing cognitive deficits, neurological illnesses, visual and hearing impairment, and various medical conditions like hypertension, diabetes, chronic kidney disease, and history of stroke or dementia. Additionally, factors such as anesthesia type and duration, operative time, blood loss, transfusion, certain medications (beta-blockers, ACEI drugs, psychotropic drugs), and preoperative inflammatory markers (C-reactive protein) and albumin levels can contribute to delirium risk. Managing these factors, along with addressing nutritional status and regular medication review, is important in geriatric patients.\n\n\n\n",
            "pmid": [
                "pmid30048325",
                "pmid33835902",
                "pmid20030432",
                "pmid28335673",
                "pmid8803381",
                "pmid7762856",
                "pmid39638735",
                "pmid34901277",
                "pmid21206582",
                "pmid39259060"
            ]
        },
        "pathway_196": {
            "question": "What neurotransmitter systems are implicated in delirium associated with Charles Bonnet Syndrome?",
            "answer": "C",
            "pmid": [
                "pmid36059364",
                "pmid28673598",
                "pmid7916159",
                "pmid37313848",
                "pmid19541436",
                "pmid20309566",
                "pmid32018069",
                "pmid27790150",
                "pmid34978",
                "pmid1971467"
            ]
        },
        "pathway_197": {
            "question": "What neuroendocrine pathways are implicated in mediating delirium in pregnant women during COVID-19-related stress?",
            "answer": "C",
            "pmid": [
                "pmid36141770",
                "pmid10473937",
                "pmid28673598",
                "pmid28828226",
                "pmid20309566",
                "pmid7916159",
                "pmid35713240",
                "pmid24557038",
                "pmid33336596",
                "pmid20131213"
            ]
        },
        "pathway_198": {
            "question": "What signaling pathways are influenced by statins in the context of delirium?",
            "answer": "C",
            "pmid": [
                "pmid32691721",
                "pmid28673598",
                "pmid37851904",
                "pmid36520371",
                "pmid39210294",
                "pmid31574089",
                "pmid17234821",
                "pmid39419070",
                "pmid37993790",
                "pmid39541802"
            ]
        },
        "pathway_199": {
            "question": "What is the effect of switching from H2 receptor antagonists to proton pump inhibitors on delirium incidence in cancer patients?",
            "answer": "C",
            "pmid": [
                "pmid22949902",
                "pmid38409802",
                "pmid39541802",
                "pmid32162816",
                "pmid31574089",
                "pmid37133446",
                "pmid38911008",
                "pmid32691721",
                "pmid27760517",
                "pmid21438141"
            ]
        },
        "pathway_200": {
            "question": "What signaling pathways are influenced by co-ultraPEALut in relation to delirium?",
            "answer": "C\n",
            "pmid": [
                "pmid31244434",
                "pmid36520371",
                "pmid37851904",
                "pmid28673598",
                "pmid39419070",
                "pmid37313848",
                "pmid38566855",
                "pmid39839987",
                "pmid7916159",
                "pmid39210294"
            ]
        },
        "pathway_201": {
            "question": "What changes in beta-endorphin signaling are associated with delirium?",
            "answer": "C",
            "pmid": [
                "pmid2524220",
                "pmid33648701",
                "pmid36520371",
                "pmid28673598",
                "pmid37851904",
                "pmid20309566",
                "pmid31574089",
                "pmid10473937",
                "pmid39210294",
                "pmid27088157"
            ]
        },
        "pathway_202": {
            "question": "What role does the circadian rhythm protein Period 2 (PER2) play in the pathophysiology of delirium?",
            "answer": "C",
            "pmid": [
                "pmid29489460",
                "pmid23916192",
                "pmid35713240",
                "pmid39541802",
                "pmid34321570",
                "pmid39419070",
                "pmid37851904",
                "pmid36520371",
                "pmid37722373",
                "pmid6160732"
            ]
        },
        "pathway_203": {
            "question": "What role do pro-inflammatory cytokines play in the development of delirium in Alzheimer’s disease patients?",
            "answer": "Pro-inflammatory cytokines contribute to delirium by inducing neuronal and synaptic dysfunction, leading to neurobehavioral and cognitive symptoms. These cytokines activate brain parenchymal cells and express inflammatory mediators within the central nervous system, potentially exacerbating existing disturbances in neurotransmission. Evidence suggests a relationship between systemic inflammation, disruption of default mode network functional connectivity, and hippocampal atrophy in patients with mild cognitive impairment and Alzheimer’s disease.",
            "pmid": [
                "pmid12127594",
                "pmid17467406",
                "pmid32592865",
                "pmid17085001",
                "pmid30390679",
                "pmid24557038",
                "pmid24048854",
                "pmid21978081",
                "pmid20309566",
                "pmid29039020"
            ]
        },
        "pathway_204": {
            "question": "According to the neuroinflammatory hypothesis of delirium, what is a key sequence of pathway events linking peripheral inflammation to the development of this neuropsychiatric syndrome?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid20309566",
                "pmid24557038",
                "pmid33648701",
                "pmid7916159",
                "pmid28673598",
                "pmid20471138",
                "pmid30390679",
                "pmid24048854",
                "pmid22553034",
                "pmid37649721"
            ]
        },
        "pathway_205": {
            "question": "What is the role of cytokine-acetylcholine interaction in the pathophysiology of delirium during septic encephalopathy?",
            "answer": "B",
            "pmid": [
                "pmid25722876",
                "pmid35791660",
                "pmid25567339",
                "pmid24557038",
                "pmid39839987",
                "pmid20309566",
                "pmid32592865",
                "pmid39419070",
                "pmid17467406",
                "pmid35815182"
            ]
        },
        "pathway_206": {
            "question": "What biological mechanisms are associated with opioid-induced delirium in critically ill adults?",
            "answer": "C",
            "pmid": [
                "pmid33835902",
                "pmid37133446",
                "pmid30051417",
                "pmid20309566",
                "pmid37851904",
                "pmid37313848",
                "pmid28673598",
                "pmid39419070",
                "pmid25567339",
                "pmid35815182"
            ]
        },
        "pathway_207": {
            "question": "What antibodies are associated with delirium in cases of Hashimoto's encephalopathy?",
            "answer": "C",
            "pmid": [
                "pmid34757245",
                "pmid549538",
                "pmid31494584",
                "pmid24557038",
                "pmid6160732",
                "pmid32018069",
                "pmid32592865",
                "pmid19541436",
                "pmid17234821",
                "pmid33901789"
            ]
        },
        "pathway_208": {
            "question": "What biological effect of olanzapine is linked to delirium development in elderly patients?",
            "answer": "C",
            "pmid": [
                "pmid16368923",
                "pmid17317453",
                "pmid32162816",
                "pmid12868070",
                "pmid33154380",
                "pmid30051417",
                "pmid26029046",
                "pmid37251808",
                "pmid37082516",
                "pmid19422109"
            ]
        },
        "pathway_209": {
            "question": "What inflammatory markers are associated with delirium in older adults?",
            "answer": "Interleukin-6, interleukin-8, interleukin-10, tumor necrosis factor-alpha, C-reactive protein, and S-100beta are associated with delirium duration, severity, and mortality in older adults. Specifically, increased levels of interleukin-6, interleukin-8, and plasminogen activating inhibitor-1 are associated with more prominent delirium duration, while increased interleukin-6, interleukin-8, interleukin-10, tumor necrosis factor-alpha, C-reactive protein, and S-100beta are associated with higher delirium severity. Interleukin-8 and S-100beta levels are also linked to increased in-hospital mortality.",
            "pmid": [
                "pmid37251808",
                "pmid17467406",
                "pmid34034650",
                "pmid37649721",
                "pmid19269948",
                "pmid28769556",
                "pmid21978081",
                "pmid34192631",
                "pmid31856187",
                "pmid31770149"
            ]
        },
        "pathway_210": {
            "question": "What signaling pathways are implicated in delirium development through sleep disruption by sedative-hypnotic agents?",
            "answer": "C",
            "pmid": [
                "pmid39541802",
                "pmid38911008",
                "pmid28673598",
                "pmid32329703",
                "pmid37313848",
                "pmid39210294",
                "pmid39415561",
                "pmid35713240",
                "pmid7916159",
                "pmid37993790"
            ]
        },
        "pathway_211": {
            "question": "In elderly patients undergoing surgery, pre-operative dysregulation within which of the following biological processes, marked by specific circulating mediators, has been identified as a significant risk factor for the development of post-operative delirium?",
            "answer": "C",
            "pmid": [
                "pmid10473947",
                "pmid36224337",
                "pmid30051417",
                "pmid39259057",
                "pmid33918634",
                "pmid17088170",
                "pmid37773821",
                "pmid39774401",
                "pmid27119013",
                "pmid25368603"
            ]
        },
        "pathway_212": {
            "question": "What signaling cascades are implicated in the development of delirium during sepsis?",
            "answer": "B",
            "pmid": [
                "pmid25567339",
                "pmid28673598",
                "pmid36520371",
                "pmid20309566",
                "pmid39419070",
                "pmid35791660",
                "pmid37851904",
                "pmid37133446",
                "pmid27088157",
                "pmid24557038"
            ]
        },
        "pathway_213": {
            "question": "What matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are associated with delirium?",
            "answer": "C",
            "pmid": [
                "pmid38937571",
                "pmid7211434",
                "pmid3765988",
                "pmid39604493",
                "pmid33901789",
                "pmid6160732",
                "pmid38566855",
                "pmid9890433",
                "pmid37649721",
                "pmid32592865"
            ]
        },
        "pathway_214": {
            "question": "What are the potential signaling pathways disrupted by synthetic cannabinoid use in this case of delirium?",
            "answer": "B",
            "pmid": [
                "pmid26956672",
                "pmid28673598",
                "pmid33093258",
                "pmid37313848",
                "pmid39210294",
                "pmid37851904",
                "pmid7916159",
                "pmid37993790",
                "pmid39419070",
                "pmid20309566"
            ]
        },
        "pathway_215": {
            "question": "What role does beta-arrestin1 play in regulating mitochondrial fission through Drp1 during postoperative delirium?",
            "answer": "C",
            "pmid": [
                "pmid37170230",
                "pmid39604493",
                "pmid28432138",
                "pmid36457825",
                "pmid39317458",
                "pmid39519398",
                "pmid37968531",
                "pmid33409674",
                "pmid29464060",
                "pmid22367970"
            ]
        },
        "pathway_216": {
            "question": "What cytokine levels are associated with cognitive dysfunction following delirium in intensive care unit survivors?",
            "answer": "Inflammatory biomarkers, specifically interleukin (IL)-6, are associated with delirium in intensive care unit survivors and may point to overlapping mechanisms between delirium and Alzheimer's disease and related dementias (ADRD). Elevated levels of IL-6 were observed in postmortem brain tissue from patients with delirium, and higher levels were also associated with cognitive dysfunction in other studies. \n\n\n\n",
            "pmid": [
                "pmid35791660",
                "pmid37712803",
                "pmid17467406",
                "pmid20471115",
                "pmid24557038",
                "pmid38647548",
                "pmid34912245",
                "pmid34195769",
                "pmid31896448",
                "pmid21978081"
            ]
        },
        "pathway_217": {
            "question": "What signaling pathway is implicated in the use of phenobarbital for managing delirium associated with gamma-hydroxybutyrate withdrawal?",
            "answer": "C",
            "pmid": [
                "pmid36269081",
                "pmid39541802",
                "pmid10473937",
                "pmid6139883",
                "pmid37313848",
                "pmid28673598",
                "pmid34123673",
                "pmid35713240",
                "pmid38895540",
                "pmid9214531"
            ]
        },
        "pathway_218": {
            "question": "What are the common pharmacological effects of oseltamivir and amantadine that may contribute to delirium?",
            "answer": "D",
            "pmid": [
                "pmid29925727",
                "pmid39541802",
                "pmid38911008",
                "pmid39415561",
                "pmid37993790",
                "pmid31568239",
                "pmid34807273",
                "pmid24815757",
                "pmid34978",
                "pmid39210294"
            ]
        },
        "pathway_219": {
            "question": "What receptor oversaturation is associated with delirium/sedation syndrome caused by olanzapine?",
            "answer": "C",
            "pmid": [
                "pmid37082516",
                "pmid12868070",
                "pmid33154380",
                "pmid38895540",
                "pmid38911008",
                "pmid16314883",
                "pmid28673598",
                "pmid28334978",
                "pmid23962100",
                "pmid15948179"
            ]
        },
        "pathway_220": {
            "question": "What signaling cascade involving cyclooxygenase-1 (COX-1) contributes to delirium during systemic inflammation?",
            "answer": "D",
            "pmid": [
                "pmid24048854",
                "pmid24557038",
                "pmid20309566",
                "pmid22553034",
                "pmid29875474",
                "pmid39839987",
                "pmid20471138",
                "pmid33648701",
                "pmid28673598",
                "pmid33901789"
            ]
        },
        "pathway_221": {
            "question": "Investigations into the molecular underpinnings of postoperative delirium (POD) suggest that its development can be mediated by specific intracellular signaling cascades. According to findings implicating inflammatory processes, which pathway profile is consistent with a mediatory role in POD?",
            "answer": "C",
            "pmid": [
                "pmid37170230",
                "pmid39604493",
                "pmid39519398",
                "pmid34093168",
                "pmid35294925",
                "pmid30051417",
                "pmid39317458",
                "pmid38223851",
                "pmid33409674",
                "pmid34234505"
            ]
        },
        "pathway_222": {
            "question": "What neurotransmitter receptor pathways are implicated in delirium caused by baclofen withdrawal?",
            "answer": "C",
            "pmid": [
                "pmid34123673",
                "pmid28673598",
                "pmid37313848",
                "pmid19079356",
                "pmid2524220",
                "pmid7916159",
                "pmid38566855",
                "pmid21039634",
                "pmid11912074",
                "pmid10473937"
            ]
        },
        "pathway_223": {
            "question": "How does miR-219-5p affect tau phosphorylation via TTBK1 and GSK-3beta in the context of delirium associated with Alzheimer’s disease?",
            "answer": "C",
            "pmid": [
                "pmid30556160",
                "pmid27520374",
                "pmid32415525",
                "pmid35592504",
                "pmid33915734",
                "pmid31134481",
                "pmid26258756",
                "pmid34026326",
                "pmid32092796",
                "pmid31919655"
            ]
        },
        "pathway_224": {
            "question": "What neuropeptides are involved in the brain's response during delirium caused by distant organ damage?",
            "answer": "C",
            "pmid": [
                "pmid26711566",
                "pmid7916159",
                "pmid3765988",
                "pmid20309566",
                "pmid37851904",
                "pmid6160732",
                "pmid28673598",
                "pmid33648701",
                "pmid39355007",
                "pmid24557038"
            ]
        },
        "pathway_225": {
            "question": "How does abrupt zolpidem withdrawal affect neurotransmitter systems in the development of delirium?",
            "answer": "C",
            "pmid": [
                "pmid38024021",
                "pmid28673598",
                "pmid31568239",
                "pmid37313848",
                "pmid39541802",
                "pmid39210294",
                "pmid23385102",
                "pmid17434673",
                "pmid37993790",
                "pmid34978"
            ]
        },
        "pathway_226": {
            "question": "What cytokine changes are associated with postoperative delirium after esophagectomy?",
            "answer": "C",
            "pmid": [
                "pmid33774004",
                "pmid36224337",
                "pmid33409674",
                "pmid10473947",
                "pmid19237264",
                "pmid18314455",
                "pmid24345656",
                "pmid30911820",
                "pmid33918634",
                "pmid36457825"
            ]
        },
        "pathway_227": {
            "question": "What are the mechanisms through which valproic acid modulates delirium?",
            "answer": "Valproic acid has multiple mechanisms of action, including effects on neurotransmitter modulation, neuroinflammation, oxidative stress, and transcription, all of which are implicated in the pathophysiology of delirium.",
            "pmid": [
                "pmid26674479",
                "pmid20204907",
                "pmid36677060",
                "pmid37993790",
                "pmid39210294",
                "pmid36520371",
                "pmid36942277",
                "pmid24946245",
                "pmid39419070",
                "pmid39541802"
            ]
        },
        "pathway_228": {
            "question": "Which signaling pathway is regulated by miR-539-5p in Alzheimer's disease?",
            "answer": "C\n\n\n\n",
            "pmid": [
                "pmid32415525",
                "pmid33915734",
                "pmid31134481",
                "pmid30576233",
                "pmid32092796",
                "pmid26398571",
                "pmid34992508",
                "pmid35592504",
                "pmid30556160",
                "pmid27235866"
            ]
        },
        "pathway_229": {
            "question": "What is the role of synaptosomal miRNAs in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid35941185",
                "pmid31997075",
                "pmid31134481",
                "pmid32092796",
                "pmid29378298",
                "pmid37192007",
                "pmid22926857",
                "pmid32035423",
                "pmid35592504",
                "pmid35154541"
            ]
        }
    },
    "metabolism": {
        "metabolism_0": {
            "question": "Does isoforsythiaside (IFY) improve mitochondrial function to protect against Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid32784451",
                "pmid23226091",
                "pmid28186562",
                "pmid22381145",
                "pmid27444386",
                "pmid36012451",
                "pmid36482297",
                "pmid26708452",
                "pmid37018887",
                "pmid30171839"
            ]
        },
        "metabolism_1": {
            "question": "Are alterations in purine metabolism observed in the frontal cortex at early stages of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid29363833",
                "pmid25311278",
                "pmid18241242",
                "pmid19940172",
                "pmid24746363",
                "pmid26855936",
                "pmid30362042",
                "pmid8395303",
                "pmid7936052",
                "pmid21035308"
            ]
        },
        "metabolism_2": {
            "question": "Does TFR1 knockdown alleviate iron overload and mitochondrial dysfunction in neural cells differentiated from Alzheimer's disease-derived induced pluripotent stem cells?",
            "answer": "A",
            "pmid": [
                "pmid38321571",
                "pmid22746342",
                "pmid38296900",
                "pmid35453377",
                "pmid30042655",
                "pmid39730291",
                "pmid24863668",
                "pmid32707154",
                "pmid29937728",
                "pmid26082716"
            ]
        },
        "metabolism_3": {
            "question": "Does ergothioneine (ET) have a protective effect against mitochondrial damage caused by 7-ketocholesterol in human brain endothelial cells, which could be relevant to Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid36982572",
                "pmid38334622",
                "pmid35370675",
                "pmid28274813",
                "pmid21116051",
                "pmid12671307",
                "pmid30514054",
                "pmid20493918",
                "pmid24561065",
                "pmid29446867"
            ]
        },
        "metabolism_4": {
            "question": "Does impaired vitamin B12 availability contribute to the development of Alzheimer's disease through ER stress pathways?",
            "answer": "A",
            "pmid": [
                "pmid23519122",
                "pmid36010649",
                "pmid30823595",
                "pmid18525129",
                "pmid29348770",
                "pmid24554143",
                "pmid32383993",
                "pmid21971404",
                "pmid24199959",
                "pmid23224755"
            ]
        },
        "metabolism_5": {
            "question": "Does Corchorus depressus (Cd) exhibit potential as an antioxidant and inhibitor of enzymes relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid29200727",
                "pmid32160161",
                "pmid35691153",
                "pmid28406733",
                "pmid38954263",
                "pmid38347285",
                "pmid27060945",
                "pmid38355004",
                "pmid38968796",
                "pmid26845710"
            ]
        },
        "metabolism_6": {
            "question": "Does catalpol improve mitochondrial function in N2a/APP695swe cells, which is relevant to Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Reduced mitochondrial biogenesis likely contributes to mitochondrial dysfunction in Alzheimer's disease, and apoE4 causes mitochondrial dysfunction and alters mitochondria-associated membranes. These findings demonstrate a link between mitochondrial function and the pathology of the disease.",
            "pmid": [
                "pmid35699892",
                "pmid37336148",
                "pmid32477145",
                "pmid30171839",
                "pmid36012451",
                "pmid35815283",
                "pmid22935417",
                "pmid9169522",
                "pmid22077634",
                "pmid36753858"
            ]
        },
        "metabolism_7": {
            "question": "Does impaired mitochondrial biogenesis contribute to mitochondrial dysfunction in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid21545753",
                "pmid22077634",
                "pmid19667196",
                "pmid33580194",
                "pmid32084533",
                "pmid9169522",
                "pmid39880979",
                "pmid39827052",
                "pmid24710686",
                "pmid26221414"
            ]
        },
        "metabolism_8": {
            "question": "Is anosognosia independently associated with hypometabolism in specific brain regions in Alzheimer's disease?",
            "answer": "A.",
            "pmid": [
                "pmid29022655",
                "pmid31161466",
                "pmid7580194",
                "pmid38511196",
                "pmid21035308",
                "pmid38102439",
                "pmid33994936",
                "pmid19667196",
                "pmid30362958",
                "pmid30820047"
            ]
        },
        "metabolism_9": {
            "question": "Does the regulation of cholesterol metabolism by cis- and trans-palmitoleic acid isomers have any known association with delirium?",
            "answer": "B",
            "pmid": [
                "pmid33363473",
                "pmid7211434",
                "pmid33779822",
                "pmid3765988",
                "pmid38223851",
                "pmid38566855",
                "pmid37722373",
                "pmid39519398",
                "pmid32590150",
                "pmid17234821"
            ]
        },
        "metabolism_10": {
            "question": "Does Apolipoprotein E4 (ApoE4) suppress mitochondrial function via the PGC-1alpha-Sirt3 pathway, contributing to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31808750",
                "pmid36753858",
                "pmid32457210",
                "pmid21545753",
                "pmid34486652",
                "pmid33580194",
                "pmid10366621",
                "pmid35569719",
                "pmid32084533",
                "pmid16210396"
            ]
        },
        "metabolism_11": {
            "question": "Does the d-enantiomeric decapeptide inhibit Cu2+-mediated amyloid beta-protein aggregation, a process linked to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30650306",
                "pmid32264585",
                "pmid22422637",
                "pmid29372182",
                "pmid39361095",
                "pmid22992731",
                "pmid19324459",
                "pmid21272191",
                "pmid36763536",
                "pmid12105192"
            ]
        },
        "metabolism_12": {
            "question": "Does di-O-demethylcurcumin protect against neuronal death in Alzheimer's disease by suppressing mitochondrial and ER stress pathways?",
            "answer": "<Correct Answer>: A\n<Why>: Research indicates that curcumin exhibits neuroprotective effects in neuronal cells, preventing toxicity from oxidative agents and slowing down tau aggregation, potentially offering a means for AD prevention and treatment. Furthermore, studies demonstrate that curcumin can improve mitochondrial function and reduce oxidative stress, contributing to neuronal survival.",
            "pmid": [
                "pmid25451798",
                "pmid26358194",
                "pmid22886017",
                "pmid26264395",
                "pmid27521081",
                "pmid26971524",
                "pmid30746607",
                "pmid22476982",
                "pmid24755072",
                "pmid28854504"
            ]
        },
        "metabolism_13": {
            "question": "Does the mitochondrial permeability transition pore contribute to mitochondrial dysfunction in fibroblasts of patients with sporadic Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30199818",
                "pmid27713335",
                "pmid29056898",
                "pmid21545753",
                "pmid9169522",
                "pmid18599615",
                "pmid30171839",
                "pmid22077634",
                "pmid19667196",
                "pmid16677790"
            ]
        },
        "metabolism_14": {
            "question": "Does docosahexaenoic acid (DHA) modulation of the Nrf2/HO-1 pathway have potential implications for nutraceutical therapy in Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Research indicates that docosahexaenoic acid (DHA) can improve mitochondrial function and reduce Alzheimer’s disease-associated pathologies, including neuronal loss and neuroinflammation. Studies have also demonstrated benefits in both in vitro and in vivo models, suggesting a potential role for DHA in the prevention and treatment of Alzheimer's disease.",
            "pmid": [
                "pmid26965310",
                "pmid18037281",
                "pmid31677009",
                "pmid21606627",
                "pmid24374316",
                "pmid15788759",
                "pmid35782939",
                "pmid23645098",
                "pmid32486013",
                "pmid28284721"
            ]
        },
        "metabolism_15": {
            "question": "Does the suppression of neuronal cholesterol biosynthesis contribute to the pathogenesis of Alzheimer's disease through impaired IGF-1-Akt signaling?",
            "answer": "A",
            "pmid": [
                "pmid34671194",
                "pmid26370080",
                "pmid27155148",
                "pmid16246039",
                "pmid17080199",
                "pmid26095650",
                "pmid37011864",
                "pmid21448224",
                "pmid22626060",
                "pmid16183991"
            ]
        },
        "metabolism_16": {
            "question": "Does the silencing of LncRNA BDNF-AS reduce oxidative stress in PC12 cells modeling Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid29902125",
                "pmid37286157",
                "pmid37217807",
                "pmid34990931",
                "pmid33234729",
                "pmid36092938",
                "pmid24604632",
                "pmid18706502",
                "pmid34958029",
                "pmid32741808"
            ]
        },
        "metabolism_17": {
            "question": "Does dietary lipophilic iron influence amyloidogenesis in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid29424844",
                "pmid30791980",
                "pmid28890316",
                "pmid32444869",
                "pmid24199959",
                "pmid18525129",
                "pmid17628213",
                "pmid21971404",
                "pmid24863668",
                "pmid35391749"
            ]
        },
        "metabolism_18": {
            "question": "Is HMGA1 implicated in the regulation of glucose metabolism, which may have implications for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30034366",
                "pmid19446537",
                "pmid36204837",
                "pmid33912566",
                "pmid17284348",
                "pmid38565291",
                "pmid36206930",
                "pmid20450896",
                "pmid27557632",
                "pmid36203054"
            ]
        },
        "metabolism_19": {
            "question": "Does Sirtuin3-dependent mitochondrial redox homeostasis have a protective role against AGEs-induced intervertebral disc degeneration, potentially relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30216853",
                "pmid26045440",
                "pmid31808750",
                "pmid30362958",
                "pmid24046746",
                "pmid36056557",
                "pmid19667196",
                "pmid9169522",
                "pmid36823760",
                "pmid27444386"
            ]
        },
        "metabolism_20": {
            "question": "Does the methanolic extract of Teucrium stocksianum (METS) demonstrate potential benefits in managing oxidative stress, which is implicated in Alzheimer's disease?",
            "answer": "A growing body of literature supports the concept that antiaging herbs may be potential candidates for use in treating age-related neurodegeneration, including Alzheimer’s disease. Studies demonstrate that certain compounds can attenuate amyloid-beta-induced cell damage, enhance Akt and GSK-3beta phosphorylation, and reduce tau phosphorylation, ultimately decreasing reactive oxygen species production and apoptosis. These findings suggest a potential for managing oxidative stress implicated in Alzheimer’s disease.",
            "pmid": [
                "pmid32160161",
                "pmid24893601",
                "pmid26845710",
                "pmid36295014",
                "pmid27774420",
                "pmid29081887",
                "pmid37373177",
                "pmid36708701",
                "pmid37623247",
                "pmid26068423"
            ]
        },
        "metabolism_21": {
            "question": "Does the oxidation of methionine 35 in the amyloid beta-peptide (1-42) reduce toxicity in neuroblastoma cells by enhancing the expression and function of methionine sulfoxide reductase A (MsrA), which has implications for Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid20060866",
                "pmid15207347",
                "pmid10535332",
                "pmid15680223",
                "pmid38275641",
                "pmid32597804",
                "pmid23579332",
                "pmid11181824",
                "pmid20463406",
                "pmid22108004"
            ]
        },
        "metabolism_22": {
            "question": "Does the fixed combination of citicoline, coenzyme Q10, and vitamin B3 have synergistic protective effects on neuronal cells relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35889920",
                "pmid22186599",
                "pmid23537659",
                "pmid12917750",
                "pmid38203753",
                "pmid26881107",
                "pmid12119423",
                "pmid29120942",
                "pmid38355004",
                "pmid24101432"
            ]
        },
        "metabolism_23": {
            "question": "Does tacrine treatment improve glucose metabolism in Alzheimer patients as shown by PET scans?",
            "answer": "A",
            "pmid": [
                "pmid8128843",
                "pmid1491741",
                "pmid9065319",
                "pmid7906947",
                "pmid7902055",
                "pmid26855936",
                "pmid33086751",
                "pmid19940172",
                "pmid21035308",
                "pmid37123373"
            ]
        },
        "metabolism_24": {
            "question": "Does thymoquinone (TQ) show potential for treating Alzheimer's disease by reducing oxidative stress and mitochondrial dysfunction in PC 12 cells exposed to Abeta(25-35)?",
            "answer": "A",
            "pmid": [
                "pmid22752387",
                "pmid23537659",
                "pmid30623116",
                "pmid24101432",
                "pmid35440326",
                "pmid34570578",
                "pmid39447228",
                "pmid11181824",
                "pmid24710686",
                "pmid16210396"
            ]
        },
        "metabolism_25": {
            "question": "Can tyrosine modifications of the insulin-degrading enzyme (IDE) help in controlling the substrate specificity for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid39481143",
                "pmid15590928",
                "pmid27320287",
                "pmid29132916",
                "pmid17496198",
                "pmid18996360",
                "pmid26651592",
                "pmid30422705",
                "pmid12161276",
                "pmid26444774"
            ]
        },
        "metabolism_26": {
            "question": "Does mitochondrial dihydrolipoyl succinyltransferase (DLST) deficiency contribute to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid19596066",
                "pmid11464464",
                "pmid16873963",
                "pmid33580194",
                "pmid18599615",
                "pmid10873585",
                "pmid16677790",
                "pmid12603834",
                "pmid15126281",
                "pmid19667196"
            ]
        },
        "metabolism_27": {
            "question": "Does PFKM play a role in enhancing oxidative phosphorylation and glycolysis, which might be relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35804014",
                "pmid26855936",
                "pmid32084533",
                "pmid36206930",
                "pmid36203054",
                "pmid22077634",
                "pmid35969330",
                "pmid7936052",
                "pmid3165303",
                "pmid15880264"
            ]
        },
        "metabolism_28": {
            "question": "Does donepezil reduce mitochondrial amyloid-beta accumulation in Alzheimer's disease models?",
            "answer": "A",
            "pmid": [
                "pmid25744714",
                "pmid27002982",
                "pmid35850693",
                "pmid29873184",
                "pmid25662507",
                "pmid24189446",
                "pmid29434777",
                "pmid27444386",
                "pmid19077054",
                "pmid20463406"
            ]
        },
        "metabolism_29": {
            "question": "Does miR-494-3p play a role in the degeneration of retinal pigment epithelial cells by influencing mitochondrial integrity, which could be relevant to Alzheimer's disease or delirium?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid37163276",
                "pmid34026326",
                "pmid33575111",
                "pmid32950103",
                "pmid29369410",
                "pmid31134481",
                "pmid27397902",
                "pmid31181293",
                "pmid24604632",
                "pmid39664587"
            ]
        },
        "metabolism_30": {
            "question": "Does ATP interaction with amyloid-beta protein have potential significance to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid24625803",
                "pmid32915536",
                "pmid38584155",
                "pmid31830415",
                "pmid38791223",
                "pmid30362042",
                "pmid8915608",
                "pmid9338779",
                "pmid29441941",
                "pmid21464905"
            ]
        },
        "metabolism_31": {
            "question": "Does Schisandrin B diet alleviate hepatotoxicity by inhibiting oxidative stress and ferroptosis, which could have implications for Alzheimer's disease or delirium?",
            "answer": "A",
            "pmid": [
                "pmid22666518",
                "pmid36060128",
                "pmid33542629",
                "pmid35204177",
                "pmid37780805",
                "pmid37382831",
                "pmid31900522",
                "pmid29136946",
                "pmid31232699",
                "pmid32707154"
            ]
        },
        "metabolism_32": {
            "question": "Does metformin alleviate lead-induced mitochondrial fragmentation via AMPK/Nrf2 activation in SH-SY5Y cells, which is relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid32863218",
                "pmid28611284",
                "pmid34283253",
                "pmid30909226",
                "pmid39441380",
                "pmid32580040",
                "pmid30958364",
                "pmid37483818",
                "pmid38139841",
                "pmid27467571"
            ]
        },
        "metabolism_33": {
            "question": "Does the chloroform fraction of Stephania japonica inhibit acetylcholinesterase and oxidative stress, which are relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35237756",
                "pmid32148536",
                "pmid32160161",
                "pmid28643520",
                "pmid26845710",
                "pmid29080453",
                "pmid27774420",
                "pmid32140977",
                "pmid38355004",
                "pmid34498969"
            ]
        },
        "metabolism_34": {
            "question": "Does piracetam improve mitochondrial function in cells exposed to beta-amyloid, which is implicated in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid20218980",
                "pmid24059528",
                "pmid27747106",
                "pmid20877425",
                "pmid25744714",
                "pmid24710686",
                "pmid27444386",
                "pmid37373177",
                "pmid29873184",
                "pmid21545753"
            ]
        },
        "metabolism_35": {
            "question": "Does curcumin enhance mitochondrial fusion activity and reduce fission machinery in Alzheimer's disease-like neurons?",
            "answer": "A",
            "pmid": [
                "pmid27521081",
                "pmid22886017",
                "pmid24755072",
                "pmid22476982",
                "pmid27594837",
                "pmid30746607",
                "pmid21253949",
                "pmid26971524",
                "pmid27060945",
                "pmid28854504"
            ]
        },
        "metabolism_36": {
            "question": "Does copper deficiency during inflammation affect the expression of proteins involved in iron metabolism, potentially linking to Alzheimer's disease?",
            "answer": "A subset of individuals with mild cognitive impairment and Alzheimer's disease exhibit elevated levels of non-ceruloplasmin copper, a form of exchangeable copper in serum. This suggests a potential link between copper dyshomeostasis and the disease process, potentially influencing cognitive decline.\n\n\n\n",
            "pmid": [
                "pmid28118841",
                "pmid20626553",
                "pmid27729845",
                "pmid23760784",
                "pmid32599538",
                "pmid24199959",
                "pmid23959870",
                "pmid34209820",
                "pmid33597269",
                "pmid25066791"
            ]
        },
        "metabolism_37": {
            "question": "Does diazoxide pretreatment prevent oxidative stress in cholinergic neurons related to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid24771316",
                "pmid26496862",
                "pmid22551949",
                "pmid8725383",
                "pmid21351586",
                "pmid22186599",
                "pmid11767950",
                "pmid38942352",
                "pmid30288371",
                "pmid19844776"
            ]
        },
        "metabolism_38": {
            "question": "Does the tumor stroma of metastasis-prone breast cancer patients show transcriptional similarities to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid20442453",
                "pmid28719625",
                "pmid38225990",
                "pmid23691268",
                "pmid29634233",
                "pmid31608105",
                "pmid22367434",
                "pmid28956815",
                "pmid39326662",
                "pmid10817927"
            ]
        },
        "metabolism_39": {
            "question": "Does increased cerebral glucose metabolism correlate with worse verbal memory performance in Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid21035308",
                "pmid36206930",
                "pmid38102439",
                "pmid19940172",
                "pmid33994936",
                "pmid26855936",
                "pmid37123373",
                "pmid36204837",
                "pmid16286547",
                "pmid22329649"
            ]
        },
        "metabolism_40": {
            "question": "Does the dysregulation of iron metabolism in Parkinson's disease (PD) occur in a similar manner in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid27039308",
                "pmid31687080",
                "pmid33799121",
                "pmid15665414",
                "pmid24199959",
                "pmid28890316",
                "pmid21971404",
                "pmid22754573",
                "pmid35216492",
                "pmid32444869"
            ]
        },
        "metabolism_41": {
            "question": "Does Orexin-A exacerbate Alzheimer's disease by inducing mitochondrial impairment?",
            "answer": "A",
            "pmid": [
                "pmid31927055",
                "pmid33080054",
                "pmid36280008",
                "pmid38682858",
                "pmid37843792",
                "pmid33580194",
                "pmid24710686",
                "pmid21545753",
                "pmid16210396",
                "pmid32457210"
            ]
        },
        "metabolism_42": {
            "question": "Does the inhibition of the mitochondrial Na+/Ca2+ exchanger (NCLX) contribute to neurodegeneration in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid32967303",
                "pmid22935417",
                "pmid9169522",
                "pmid32656500",
                "pmid25102327",
                "pmid29873184",
                "pmid31918031",
                "pmid33580194",
                "pmid23982146",
                "pmid30199818"
            ]
        },
        "metabolism_43": {
            "question": "Does IMM-H004 protect neuronal mitochondrial function in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid23523945",
                "pmid27444386",
                "pmid36753858",
                "pmid39713820",
                "pmid23226091",
                "pmid28186562",
                "pmid16210396",
                "pmid24710686",
                "pmid39827052",
                "pmid19667196"
            ]
        },
        "metabolism_44": {
            "question": "Does Salvianolic acid B protect against mitochondrial dysfunction in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid29551684",
                "pmid23226091",
                "pmid36012451",
                "pmid29873184",
                "pmid30171839",
                "pmid9169522",
                "pmid28186562",
                "pmid37018887",
                "pmid32789760",
                "pmid36482297"
            ]
        },
        "metabolism_45": {
            "question": "Does UDCA improve mitochondrial function in fibroblasts from patients with Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30171839",
                "pmid9169522",
                "pmid30199818",
                "pmid29056898",
                "pmid33580194",
                "pmid22935417",
                "pmid22077634",
                "pmid24252614",
                "pmid18599615",
                "pmid21545753"
            ]
        },
        "metabolism_46": {
            "question": "Does the pattern of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamen?",
            "answer": "A",
            "pmid": [
                "pmid33490360",
                "pmid29254096",
                "pmid29977201",
                "pmid14694028",
                "pmid32962300",
                "pmid32258359",
                "pmid10666665",
                "pmid15068237",
                "pmid39307112",
                "pmid16442855"
            ]
        },
        "metabolism_47": {
            "question": "Does Zuo Gui Wan (ZGW) improve cognitive function in Alzheimer's disease (AD) animal models by inhibiting mitochondrial fission and activating AMPK/PGC-1alpha-regulated mitochondrial bioenergetics?",
            "answer": "A",
            "pmid": [
                "pmid39884486",
                "pmid39873362",
                "pmid38575939",
                "pmid35360200",
                "pmid30742114",
                "pmid31607908",
                "pmid32789760",
                "pmid29843688",
                "pmid36918872",
                "pmid39911633"
            ]
        },
        "metabolism_48": {
            "question": "Does sialic acid metabolism play a role in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid33867926",
                "pmid33991608",
                "pmid28320965",
                "pmid31087219",
                "pmid38529039",
                "pmid29363833",
                "pmid24746363",
                "pmid36089405",
                "pmid25311278",
                "pmid32793799"
            ]
        },
        "metabolism_49": {
            "question": "Does mannose consumption exacerbate Alzheimer's disease pathogenesis?",
            "answer": "A",
            "pmid": [
                "pmid39807036",
                "pmid24411482",
                "pmid17942401",
                "pmid36204837",
                "pmid15486488",
                "pmid34315531",
                "pmid33737172",
                "pmid31209782",
                "pmid37043764",
                "pmid30820047"
            ]
        },
        "metabolism_50": {
            "question": "Does maternal choline supplementation reduce brain homocysteine levels and improve cognitive deficits in Alzheimer's disease across multiple generations?",
            "answer": "A",
            "pmid": [
                "pmid30622336",
                "pmid31560162",
                "pmid37214805",
                "pmid38904658",
                "pmid31298459",
                "pmid11455131",
                "pmid23224755",
                "pmid15537514",
                "pmid16088136",
                "pmid15207414"
            ]
        },
        "metabolism_51": {
            "question": "Does Codonopsis pilosula Polysaccharides alleviate energy dysmetabolism in Alzheimer's disease?",
            "answer": "A polysaccharide from *Polygonatum sibiricum* protects PC12 cells from beta-amyloid-induced neurotoxicity by enhancing the PI3K/Akt signaling pathway, mitigating mitochondrial dysfunction, and regulating apoptosis. This involves modulating Bax/Bcl-2 ratios and cytochrome c release, and may offer neuroprotective benefits. Gut microbiome composition and short-chain fatty acid production could also be involved, alongside downstream oxidation-related enzymes and neuronal morphology in the CA3 region of the hippocampus.\n\n\n\n",
            "pmid": [
                "pmid34102973",
                "pmid30542264",
                "pmid32652518",
                "pmid36535434",
                "pmid33432644",
                "pmid30290256",
                "pmid29081887",
                "pmid37373177",
                "pmid38866276",
                "pmid25498712"
            ]
        },
        "metabolism_52": {
            "question": "Does mitochondrial dysfunction in the proximal axon initial segment contribute to TAU missorting observed in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid21545753",
                "pmid29623026",
                "pmid30006151",
                "pmid32848607",
                "pmid25888814",
                "pmid29895248",
                "pmid35119496",
                "pmid32882957",
                "pmid16677790",
                "pmid22367970"
            ]
        },
        "metabolism_53": {
            "question": "Is there a significant difference in homocysteine metabolism between Alzheimer's disease patients and vascular dementia patients as shown by the methionine loading test?",
            "answer": "B",
            "pmid": [
                "pmid20209467",
                "pmid15207414",
                "pmid16088136",
                "pmid12784029",
                "pmid27380243",
                "pmid11455131",
                "pmid19342053",
                "pmid19088473",
                "pmid15537514",
                "pmid16055944"
            ]
        },
        "metabolism_54": {
            "question": "Does amarogentin exhibit potential benefits for Alzheimer's disease by reducing reactive oxygen species (ROS) and improving the survival rate of PC12 cells under oxidative stress?",
            "answer": "A",
            "pmid": [
                "pmid24975829",
                "pmid32831994",
                "pmid35360200",
                "pmid28630497",
                "pmid23966081",
                "pmid31232699",
                "pmid24512768",
                "pmid21472290",
                "pmid34040526",
                "pmid35598091"
            ]
        },
        "metabolism_55": {
            "question": "Does the loss of SLC38A10 lead to lower cholesterol levels, which could have implications in neurodegenerative diseases like Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35450293",
                "pmid12600718",
                "pmid27155148",
                "pmid35296367",
                "pmid20386595",
                "pmid30878503",
                "pmid19446537",
                "pmid31293510",
                "pmid34671194",
                "pmid15649702"
            ]
        },
        "metabolism_56": {
            "question": "Does the regulation of lipid metabolism involving G-quadruplex structure in ACBP genes have any reported connection to Alzheimer's disease or delirium?",
            "answer": "A",
            "pmid": [
                "pmid12373863",
                "pmid35748856",
                "pmid32581851",
                "pmid12600718",
                "pmid21448224",
                "pmid32422896",
                "pmid33758195",
                "pmid26855936",
                "pmid22329649",
                "pmid37333071"
            ]
        },
        "metabolism_57": {
            "question": "Does the lavender aqueous extract treatment affect metabolic pathways related to amino acids in Alzheimer's disease models?",
            "answer": "A",
            "pmid": [
                "pmid29849984",
                "pmid24746363",
                "pmid32785956",
                "pmid22995388",
                "pmid25561935",
                "pmid29439324",
                "pmid20416364",
                "pmid28822725",
                "pmid22329649",
                "pmid38649307"
            ]
        },
        "metabolism_58": {
            "question": "How does urolithin A mitigate high glucose-induced amyloidogenesis in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid32704090",
                "pmid34905594",
                "pmid32042368",
                "pmid32098107",
                "pmid25434488",
                "pmid24411482",
                "pmid37597424",
                "pmid29439324",
                "pmid7753801",
                "pmid25443293"
            ]
        },
        "metabolism_59": {
            "question": "Which short-chain fatty acid (SCFA) metabolite of Akkermansia muciniphila is implicated in protecting against Alzheimer's disease by maintaining mitochondrial homeostasis?",
            "answer": "B",
            "pmid": [
                "pmid39833898",
                "pmid32321934",
                "pmid37671803",
                "pmid37018970",
                "pmid32486013",
                "pmid28284721",
                "pmid38866276",
                "pmid37373177",
                "pmid12373863",
                "pmid30290256"
            ]
        },
        "metabolism_60": {
            "question": "How might hydrogen sulfide (H2S) affect mitochondrial dynamics in neuroblastoma cells, and what implication does this have for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid26708452",
                "pmid28560384",
                "pmid20674619",
                "pmid27026591",
                "pmid22542418",
                "pmid36482035",
                "pmid17851177",
                "pmid35569719",
                "pmid23579332",
                "pmid9169522"
            ]
        },
        "metabolism_61": {
            "question": "Which metabolic pathway is activated in FH-deficient renal cell carcinoma cells when exposed to asparagine, potentially linking to delirium-related metabolic dysregulation?",
            "answer": "A",
            "pmid": [
                "pmid32774853",
                "pmid29439324",
                "pmid26971935",
                "pmid31948056",
                "pmid16375719",
                "pmid24746363",
                "pmid34440878",
                "pmid23579332",
                "pmid21351586",
                "pmid36206930"
            ]
        },
        "metabolism_62": {
            "question": "In Alzheimer's disease, which metabolic process in astrocytes is implicated in both detoxifying Abeta-derived ammonia and causing memory impairment?",
            "answer": "B",
            "pmid": [
                "pmid35738259",
                "pmid35427648",
                "pmid35569719",
                "pmid16210396",
                "pmid35872221",
                "pmid21545753",
                "pmid24710686",
                "pmid19940172",
                "pmid22329649",
                "pmid33774476"
            ]
        },
        "metabolism_63": {
            "question": "Which amino acid combination derived from garlic and buna-shimeji is associated with suppression of CCl4-induced hepatic injury, potentially relevant to neurodegenerative conditions like Alzheimer's disease?",
            "answer": "A combination of DHA and EGb761 demonstrates potential in improving cognitive function and preserving neuronal structure in models of Alzheimer's disease, potentially through upregulation of PP2A and modulation of TNF-alpha expression.\n\n\n\n",
            "pmid": [
                "pmid34199038",
                "pmid31328121",
                "pmid25365295",
                "pmid23219964",
                "pmid34679745",
                "pmid28930532",
                "pmid32655770",
                "pmid26068423",
                "pmid34182090",
                "pmid20416364"
            ]
        },
        "metabolism_64": {
            "question": "Which miRNAs were found to be elevated in Alzheimer's disease brain tissues and might modulate arginine metabolism?",
            "answer": "A",
            "pmid": [
                "pmid26971935",
                "pmid24604632",
                "pmid31134481",
                "pmid34026326",
                "pmid18234899",
                "pmid35941185",
                "pmid26398571",
                "pmid27235866",
                "pmid33575111",
                "pmid32035423"
            ]
        },
        "metabolism_65": {
            "question": "Which of the following is associated with LacCer-induced oxidative stress and has been implicated in the pathogenesis of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid33673027",
                "pmid16873963",
                "pmid8052661",
                "pmid31520071",
                "pmid26150787",
                "pmid19596066",
                "pmid21545753",
                "pmid36010649",
                "pmid21351586",
                "pmid8725383"
            ]
        },
        "metabolism_66": {
            "question": "How does mycolactone affect mitochondrial distribution in DRG neurons, and what is its relevance to Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Mitochondria accumulate within the neurites and soma of neurons when exposed to the substance, according to research. While the provided information does not directly connect this to Alzheimer's disease, other studies indicate that mitochondrial abnormalities and clustering are present in the disease, suggesting a potential connection. Therefore, option A is the most accurate response.",
            "pmid": [
                "pmid22367970",
                "pmid27325560",
                "pmid22381145",
                "pmid30171839",
                "pmid33580194",
                "pmid24710686",
                "pmid35569719",
                "pmid39171353",
                "pmid33155636",
                "pmid26055049"
            ]
        },
        "metabolism_67": {
            "question": "How does the anti-oxidative effect of ATB-344 relate to delirium?",
            "answer": "C",
            "pmid": [
                "pmid39419070",
                "pmid39210294",
                "pmid37851904",
                "pmid37313848",
                "pmid7211434",
                "pmid17234821",
                "pmid32018069",
                "pmid24852225",
                "pmid19422109",
                "pmid21351586"
            ]
        },
        "metabolism_68": {
            "question": "In Alzheimer's disease, the expression of CD38 in senescent microglia is influenced by which of the following factors?",
            "answer": "D",
            "pmid": [
                "pmid31293510",
                "pmid27723233",
                "pmid35909315",
                "pmid25893674",
                "pmid16476660",
                "pmid28713239",
                "pmid35697992",
                "pmid11578773",
                "pmid15172747",
                "pmid26257642"
            ]
        },
        "metabolism_69": {
            "question": "How does hydroxy-alpha-sanshool (HAS) affect glycogen synthesis in liver cells, which is relevant to understanding metabolic processes in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid34896111",
                "pmid36582530",
                "pmid23579332",
                "pmid26708452",
                "pmid26855936",
                "pmid33994936",
                "pmid36206930",
                "pmid33086751",
                "pmid36204837",
                "pmid25102327"
            ]
        },
        "metabolism_70": {
            "question": "How might resveratrol's activation of the Keap-1/Nrf2 pathway in obese-asthmatic rats relate to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid29097221",
                "pmid30542383",
                "pmid29948950",
                "pmid25024312",
                "pmid35688816",
                "pmid21982274",
                "pmid33571701",
                "pmid26980711",
                "pmid39105797",
                "pmid37391269"
            ]
        },
        "metabolism_71": {
            "question": "Which of the following was shown to have antineuroinflammatory effects against Alzheimer's disease by upregulating GPR41 and suppressing the ERK/JNK/NF-kB pathway?",
            "answer": "A",
            "pmid": [
                "pmid32583667",
                "pmid34297968",
                "pmid32744877",
                "pmid12453679",
                "pmid35714925",
                "pmid35917097",
                "pmid20451607",
                "pmid37991969",
                "pmid16183991",
                "pmid28798805"
            ]
        },
        "metabolism_72": {
            "question": "Sodium butyrate (NaB) is known to inhibit which enzyme to reduce neuroinflammation in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid33785315",
                "pmid34812899",
                "pmid31958090",
                "pmid21593570",
                "pmid37823115",
                "pmid31945778",
                "pmid29867447",
                "pmid32028243",
                "pmid34607104",
                "pmid32109514"
            ]
        },
        "metabolism_73": {
            "question": "Which of the following NAD(+)-dependent enzymes has been shown to strongly affect the pathological changes of Alzheimer's disease (AD)?",
            "answer": "D",
            "pmid": [
                "pmid36959156",
                "pmid22204321",
                "pmid31280708",
                "pmid17027152",
                "pmid29363833",
                "pmid30922179",
                "pmid29439324",
                "pmid21351586",
                "pmid8242380",
                "pmid25499850"
            ]
        },
        "metabolism_74": {
            "question": "How does WGX50 mitigate doxorubicin-induced cardiotoxicity, which shares similarities with the mitochondrial dysfunction observed in Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid37978379",
                "pmid38568919",
                "pmid35237161",
                "pmid35804014",
                "pmid23691268",
                "pmid22065986",
                "pmid25102327",
                "pmid25744714",
                "pmid22381145",
                "pmid29873184"
            ]
        },
        "metabolism_75": {
            "question": "Which polyphenolic compounds isolated from Corallodiscus flabellata B. L. Burtt are reported to ameliorate amyloid beta-protein induced Alzheimer's disease neuronal injury?",
            "answer": "A. mellea demonstrates neuroprotective effects by enhancing cell viability, suppressing apoptosis, inhibiting reactive oxygen species, preventing caspase-3 activation, and restoring mitochondrial membrane potential in cellular models of Alzheimer’s disease. In animal models, it improves motor function, reduces amyloid beta deposition and tau aggregation, and modulates the cholinergic system by increasing acetylcholine and choline acetyltransferase levels while decreasing acetylcholine esterase levels.\n\n\n\n",
            "pmid": [
                "pmid36535434",
                "pmid25229015",
                "pmid32316271",
                "pmid29100755",
                "pmid22995388",
                "pmid16880827",
                "pmid39682936",
                "pmid34569961",
                "pmid29081887",
                "pmid24328060"
            ]
        },
        "metabolism_76": {
            "question": "How does the interaction between VDAC1 and Abeta contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid22926141",
                "pmid29551631",
                "pmid20930307",
                "pmid15837797",
                "pmid22634250",
                "pmid25108202",
                "pmid35955694",
                "pmid23582659",
                "pmid35264247",
                "pmid16210396"
            ]
        },
        "metabolism_77": {
            "question": "How does OCIAD1 contribute to neurodegeneration in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid31931285",
                "pmid38216963",
                "pmid10817927",
                "pmid29634233",
                "pmid29439343",
                "pmid31927055",
                "pmid26615780",
                "pmid26095650",
                "pmid24965284",
                "pmid39548583"
            ]
        },
        "metabolism_78": {
            "question": "Which metabolic cluster in tear fluid is associated with the progression of proliferative diabetic retinopathy (PDR), a condition that shares systemic attributes with Alzheimer's disease?",
            "answer": "A.",
            "pmid": [
                "pmid36845280",
                "pmid34592130",
                "pmid36206930",
                "pmid33277246",
                "pmid38565291",
                "pmid38328307",
                "pmid37333071",
                "pmid36204837",
                "pmid33994936",
                "pmid35296367"
            ]
        },
        "metabolism_79": {
            "question": "Which molecule is identified as a critical regulator of death-associated protein kinase 1 (DAPK1) in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid22785394",
                "pmid32358852",
                "pmid37633326",
                "pmid35106914",
                "pmid12740599",
                "pmid24985705",
                "pmid31840000",
                "pmid23559013",
                "pmid28904096",
                "pmid27068745"
            ]
        },
        "metabolism_80": {
            "question": "Which metabolic pathways were restored by Bushen Tiansui Formula (BSTSF) in the treatment of Alzheimer's disease in rats?",
            "answer": "D",
            "pmid": [
                "pmid32655770",
                "pmid31683034",
                "pmid33029123",
                "pmid36339577",
                "pmid29449587",
                "pmid38649307",
                "pmid36500385",
                "pmid28379235",
                "pmid28521305",
                "pmid36817510"
            ]
        },
        "metabolism_81": {
            "question": "How does mild hypothermia affect isoflurane-induced cytotoxicity and DNA damage, potentially relevant to neurodegenerative conditions like Alzheimer's disease?",
            "answer": "<Correct Answer>: B\n<Why>: Isoflurane exposure has been linked to increased risk of cognitive decline, and sevoflurane induces tau trafficking from neurons to microglia, leading to IL-6 generation and cognitive impairment. Sevoflurane also facilitates a metabolic shift from oxidative phosphorylation to glycolysis and excessive mitochondrial fission, accelerating Alzheimer’s disease-related cognitive decline. These findings suggest a mechanistic link between anesthetic exposure and neurodegenerative conditions.\n\n\n\n",
            "pmid": [
                "pmid28228717",
                "pmid27194299",
                "pmid21244349",
                "pmid24961763",
                "pmid21519046",
                "pmid35682930",
                "pmid26236713",
                "pmid39490772",
                "pmid23256744",
                "pmid33980987"
            ]
        },
        "metabolism_82": {
            "question": "Which selenium compound was found to preferentially increase the expression and activity of thioredoxin reductase, thereby reducing tau phosphorylation in Alzheimer's disease models?",
            "answer": "C",
            "pmid": [
                "pmid36978950",
                "pmid24577479",
                "pmid27465436",
                "pmid29688618",
                "pmid26311427",
                "pmid21934536",
                "pmid22528780",
                "pmid23579332",
                "pmid22892311",
                "pmid32597804"
            ]
        },
        "metabolism_83": {
            "question": "How does Exendin-4 (Ex-4) influence mitochondrial function in neurons under palmitic acid-induced oxidative stress, which is relevant to Alzheimer's disease pathophysiology?",
            "answer": "B",
            "pmid": [
                "pmid33435277",
                "pmid36753858",
                "pmid21901364",
                "pmid21545753",
                "pmid33774476",
                "pmid16210396",
                "pmid35569719",
                "pmid24710686",
                "pmid32457210",
                "pmid23982146"
            ]
        },
        "metabolism_84": {
            "question": "Which mitochondrial dysfunction is associated with NF-kappaB signaling and may contribute to Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid25052843",
                "pmid21545753",
                "pmid28317877",
                "pmid22077634",
                "pmid16677790",
                "pmid37991969",
                "pmid19667196",
                "pmid39730291",
                "pmid33580194",
                "pmid32084533"
            ]
        },
        "metabolism_85": {
            "question": "Which of the following is associated with increased GPR84 expression in macrophages and may contribute to the pathophysiology of Alzheimer's disease?",
            "answer": "D",
            "pmid": [
                "pmid25637481",
                "pmid29973940",
                "pmid39243388",
                "pmid34099509",
                "pmid38447415",
                "pmid27723233",
                "pmid18434187",
                "pmid16219804",
                "pmid36161942",
                "pmid1647485"
            ]
        },
        "metabolism_86": {
            "question": "How does avasimibe modulate cholesterol metabolism to enhance the efficacy of the Kras vaccine, potentially offering insights into treatments for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31680003",
                "pmid24602800",
                "pmid39117070",
                "pmid21448224",
                "pmid32583667",
                "pmid32144518",
                "pmid23665252",
                "pmid37344916",
                "pmid30032423",
                "pmid35464321"
            ]
        },
        "metabolism_87": {
            "question": "How might decreased PSA expression in the liver be related to Alzheimer's disease progression?",
            "answer": "B",
            "pmid": [
                "pmid24141082",
                "pmid7936052",
                "pmid38787367",
                "pmid32422896",
                "pmid34048566",
                "pmid38958450",
                "pmid26491253",
                "pmid10095092",
                "pmid24278306",
                "pmid34465723"
            ]
        },
        "metabolism_88": {
            "question": "Which natural compound found in olive oil has been shown to protect against 7-ketocholesterol-induced mitochondrial and peroxisomal dysfunction in microglial cells, which may be relevant to neurodegenerative diseases like Alzheimer's disease?",
            "answer": "Alpha-lipoic acid can repress apoptosis and changes in the morphology of microglia BV2 cells, accompanied by the inhibition of the inflammatory response. It also demonstrates an inhibitory effect on microglia toxicity, suggesting a combination of anti-inflammatory and antioxidant substances may offer a promising approach to treatment.",
            "pmid": [
                "pmid39061831",
                "pmid27897980",
                "pmid37508010",
                "pmid38339193",
                "pmid29068387",
                "pmid29109370",
                "pmid29435099",
                "pmid32785956",
                "pmid33417205",
                "pmid36770835"
            ]
        },
        "metabolism_89": {
            "question": "Methazolamide (MTZ) prevents mitochondrial dysfunction in Alzheimer's disease by inhibiting the release of which molecule from mitochondria?",
            "answer": "B",
            "pmid": [
                "pmid26581638",
                "pmid29873184",
                "pmid25744714",
                "pmid39713820",
                "pmid30922179",
                "pmid27444386",
                "pmid33155636",
                "pmid33580194",
                "pmid23226091",
                "pmid22381145"
            ]
        },
        "metabolism_90": {
            "question": "What effect did the extracts of Salvia triloba and Piper nigrum have on oxidative stress in Alzheimer's disease-induced rats?",
            "answer": "B",
            "pmid": [
                "pmid22957416",
                "pmid23631499",
                "pmid24442916",
                "pmid26023568",
                "pmid34724130",
                "pmid27563424",
                "pmid19441012",
                "pmid35950787",
                "pmid29551684",
                "pmid37114959"
            ]
        },
        "metabolism_91": {
            "question": "Which metabolic pathway regulated by Jingfang Granules is associated with brain protection in Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid32655770",
                "pmid35569719",
                "pmid38809507",
                "pmid33155636",
                "pmid35535155",
                "pmid26855936",
                "pmid38565291",
                "pmid31808750",
                "pmid25311278",
                "pmid36203054"
            ]
        },
        "metabolism_92": {
            "question": "Which enzyme's inhibition partially mediates Abeta25-35-induced cytotoxicity in Alzheimer's disease?",
            "answer": "A\n",
            "pmid": [
                "pmid34602551",
                "pmid12183349",
                "pmid15837797",
                "pmid17261088",
                "pmid15548589",
                "pmid24424093",
                "pmid27665848",
                "pmid28698968",
                "pmid16626961",
                "pmid19519664"
            ]
        },
        "metabolism_93": {
            "question": "How does spermine oxidase overexpression affect the brain in a way that could be relevant to Alzheimer's disease?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid23840306",
                "pmid11223914",
                "pmid35885061",
                "pmid24746363",
                "pmid29439324",
                "pmid35969330",
                "pmid19667196",
                "pmid31520071",
                "pmid32457210",
                "pmid28672910"
            ]
        },
        "metabolism_94": {
            "question": "Which enzyme has been suggested to link sulfur amino acids with lipid metabolism and may also play a role in Alzheimer's disease?",
            "answer": "A\n",
            "pmid": [
                "pmid26046927",
                "pmid23579332",
                "pmid12373863",
                "pmid26708452",
                "pmid28320965",
                "pmid32597804",
                "pmid17851177",
                "pmid24746363",
                "pmid11556547",
                "pmid29439324"
            ]
        },
        "metabolism_95": {
            "question": "Which factor is associated with improved muscle strength in older individuals with inadequate protein intake, potentially relevant to conditions like Alzheimer's disease or delirium?",
            "answer": "B",
            "pmid": [
                "pmid37754219",
                "pmid29311975",
                "pmid33266508",
                "pmid26444783",
                "pmid34445419",
                "pmid37457975",
                "pmid21766035",
                "pmid35570546",
                "pmid8761018",
                "pmid20471115"
            ]
        },
        "metabolism_96": {
            "question": "Which of the following pesticides was found to not cause mitochondrial fragmentation or functional damage, nor inhibit the activity of the proteasome, thus potentially reducing the risk of Parkinsonism and possibly Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid29168786",
                "pmid24503016",
                "pmid23544381",
                "pmid33991619",
                "pmid22381145",
                "pmid34489512",
                "pmid32784451",
                "pmid30922179",
                "pmid39485576",
                "pmid38575939"
            ]
        },
        "metabolism_97": {
            "question": "How does SERCA activation by CDN1163 potentially influence metabolic processes relevant to Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid34909682",
                "pmid30362958",
                "pmid29439343",
                "pmid35416570",
                "pmid27425031",
                "pmid29634233",
                "pmid31257151",
                "pmid39117070",
                "pmid29439324",
                "pmid36798226"
            ]
        },
        "metabolism_98": {
            "question": "Which mung bean component is shown to regulate heat stress and may have implications for neurodegenerative diseases like Alzheimer's due to its antioxidant properties?",
            "answer": "C",
            "pmid": [
                "pmid36890864",
                "pmid34551518",
                "pmid22995388",
                "pmid39200504",
                "pmid27050422",
                "pmid18602817",
                "pmid39594453",
                "pmid36738696",
                "pmid30134549",
                "pmid22886017"
            ]
        },
        "metabolism_99": {
            "question": "In Alzheimer's disease, how does hexokinase 2 (HK2) deficiency in microglial cells affect ATP generation and beta-amyloid clearance?",
            "answer": "B",
            "pmid": [
                "pmid36203054",
                "pmid39002124",
                "pmid36787364",
                "pmid29662056",
                "pmid14563691",
                "pmid35969330",
                "pmid7936052",
                "pmid30362958",
                "pmid24625803",
                "pmid19596066"
            ]
        },
        "metabolism_100": {
            "question": "In rapidly progressive Alzheimer's disease (rpAD), compared to typical Alzheimer's disease (tAD), which of the following is true regarding mitochondrial dynamics?",
            "answer": "B",
            "pmid": [
                "pmid21545753",
                "pmid39584307",
                "pmid19667196",
                "pmid39880979",
                "pmid33465841",
                "pmid32084533",
                "pmid16677790",
                "pmid30171839",
                "pmid9169522",
                "pmid22077634"
            ]
        },
        "metabolism_101": {
            "question": "Which metabolic pathway affected by the You-Gui Pill (YGP) in treating Kidney-Yang Deficiency Syndrome (KYDS) is also implicated in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid31357410",
                "pmid22329649",
                "pmid29439324",
                "pmid31607908",
                "pmid32739157",
                "pmid36386241",
                "pmid36754068",
                "pmid32614980",
                "pmid32276479",
                "pmid25311278"
            ]
        },
        "metabolism_102": {
            "question": "Which COX-2 inhibitor was found to potentially affect kynurenic acid (KYNA) production, a biomarker implicated in Alzheimer's disease and delirium?",
            "answer": "B",
            "pmid": [
                "pmid30178287",
                "pmid32276479",
                "pmid28733707",
                "pmid32012948",
                "pmid36754068",
                "pmid20847443",
                "pmid20639188",
                "pmid30800661",
                "pmid35282457",
                "pmid37264981"
            ]
        },
        "metabolism_103": {
            "question": "Willin/FRMD6 downregulation is associated with which feature of Alzheimer's disease pathogenesis?",
            "answer": "B",
            "pmid": [
                "pmid34831245",
                "pmid36231104",
                "pmid22495348",
                "pmid20025970",
                "pmid9878757",
                "pmid12881482",
                "pmid29937728",
                "pmid11677259",
                "pmid31721052",
                "pmid33402227"
            ]
        },
        "metabolism_104": {
            "question": "Which mitochondrial haplogroup cluster is associated with an increased risk of age-related macular degeneration (AMD) and may also influence the bioenergetic processes implicated in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid23302509",
                "pmid18461138",
                "pmid23244519",
                "pmid38338904",
                "pmid19667196",
                "pmid26305120",
                "pmid10377009",
                "pmid34152079",
                "pmid35569719",
                "pmid33580194"
            ]
        },
        "metabolism_105": {
            "question": "Which metabolic change in Alzheimer's disease obscures the typical phenotype of type 2 diabetes?",
            "answer": "B",
            "pmid": [
                "pmid29351484",
                "pmid36206930",
                "pmid36204837",
                "pmid18189240",
                "pmid22329649",
                "pmid29471055",
                "pmid26855936",
                "pmid32739014",
                "pmid34439505",
                "pmid2935594"
            ]
        },
        "metabolism_106": {
            "question": "In Alzheimer disease, what is the relationship between argininosuccinate synthetase (ASS) and inducible nitric oxide synthase (iNOS) expression in neurons and glia?",
            "answer": "A",
            "pmid": [
                "pmid11556547",
                "pmid11958858",
                "pmid29439324",
                "pmid24746363",
                "pmid10964481",
                "pmid26971935",
                "pmid9138425",
                "pmid9514829",
                "pmid21351586",
                "pmid12203047"
            ]
        },
        "metabolism_107": {
            "question": "Which early onset neurodegenerative disorder was found to have lower levels of kynurenine pathway metabolites in specific brain regions compared to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid37111372",
                "pmid36754068",
                "pmid32276479",
                "pmid20639188",
                "pmid37264981",
                "pmid24346138",
                "pmid17151944",
                "pmid32012948",
                "pmid22329649",
                "pmid18201952"
            ]
        },
        "metabolism_108": {
            "question": "Which factor was found to upregulate glutaminyl cyclase (QC) expression in neuronal cells, contributing to Alzheimer's disease pathogenesis?",
            "answer": "C",
            "pmid": [
                "pmid22970285",
                "pmid32614980",
                "pmid24164736",
                "pmid30652266",
                "pmid10817927",
                "pmid29439324",
                "pmid12960778",
                "pmid19800391",
                "pmid1647485",
                "pmid17927985"
            ]
        },
        "metabolism_109": {
            "question": "Which metabolite associated with a high-fiber diet was found to have the strongest binding affinity for SPEG, a gene linked to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid36733447",
                "pmid23579332",
                "pmid15788759",
                "pmid24554143",
                "pmid16055944",
                "pmid27380243",
                "pmid24411482",
                "pmid18525129",
                "pmid26159189",
                "pmid39807036"
            ]
        },
        "metabolism_110": {
            "question": "How might the biphasic effect of Carthamus Tinctorius extract on oxidative stress influence Alzheimer's disease treatment?",
            "answer": "B",
            "pmid": [
                "pmid38968796",
                "pmid38455162",
                "pmid36982332",
                "pmid22995388",
                "pmid33463937",
                "pmid33913927",
                "pmid27563424",
                "pmid34182090",
                "pmid26068423",
                "pmid23566055"
            ]
        },
        "metabolism_111": {
            "question": "What metabolic process is primarily affected by Shengmai-San (SMS) intervention in Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid28379235",
                "pmid26855936",
                "pmid32655770",
                "pmid22329649",
                "pmid31683034",
                "pmid31563815",
                "pmid32317964",
                "pmid36482297",
                "pmid39171353",
                "pmid36204837"
            ]
        },
        "metabolism_112": {
            "question": "In Alzheimer's disease, where is increased HNE-histidine Michael adduct detected in the hippocampus?",
            "answer": "C",
            "pmid": [
                "pmid19729853",
                "pmid23582659",
                "pmid24746363",
                "pmid24444253",
                "pmid30040734",
                "pmid21593570",
                "pmid1647485",
                "pmid35203383",
                "pmid29363833",
                "pmid29439324"
            ]
        },
        "metabolism_113": {
            "question": "In Alzheimer-type dementia, which brain region shows decreased alpha-glucosidase activity?",
            "answer": "C",
            "pmid": [
                "pmid2935594",
                "pmid10095092",
                "pmid12960778",
                "pmid29363833",
                "pmid1647485",
                "pmid8242380",
                "pmid26855936",
                "pmid7936052",
                "pmid33994936",
                "pmid36206930"
            ]
        },
        "metabolism_114": {
            "question": "What metabolic changes are associated with postoperative delirium in patients undergoing surgery for oral carcinoma?",
            "answer": "C",
            "pmid": [
                "pmid19237264",
                "pmid10473947",
                "pmid33774004",
                "pmid39519398",
                "pmid38582976",
                "pmid27119013",
                "pmid36224337",
                "pmid39259057",
                "pmid19234823",
                "pmid38223851"
            ]
        },
        "metabolism_115": {
            "question": "What metabolic disruptions are linked to delirium in cases of massive amygdalin overdose?",
            "answer": "C",
            "pmid": [
                "pmid31322009",
                "pmid28673598",
                "pmid39419070",
                "pmid39210294",
                "pmid33901789",
                "pmid19541436",
                "pmid23385102",
                "pmid3765988",
                "pmid39355007",
                "pmid37313848"
            ]
        },
        "metabolism_116": {
            "question": "What metabolic disruptions are linked to delirium in liver transplant patients receiving cyclosporine?",
            "answer": "C",
            "pmid": [
                "pmid2003144",
                "pmid39519398",
                "pmid7211434",
                "pmid38223851",
                "pmid39419070",
                "pmid28673598",
                "pmid25567339",
                "pmid37851904",
                "pmid36078999",
                "pmid37133446"
            ]
        },
        "metabolism_117": {
            "question": "What metabolic disruptions are linked to delirium in geriatric general medical patients?",
            "answer": "D",
            "pmid": [
                "pmid21206582",
                "pmid33014722",
                "pmid37251808",
                "pmid21721434",
                "pmid37754219",
                "pmid20471115",
                "pmid21766035",
                "pmid37851904",
                "pmid17183425",
                "pmid30051417"
            ]
        },
        "metabolism_118": {
            "question": "What metabolic factors are associated with postoperative delirium in older patients undergoing cholecystectomy?",
            "answer": "D",
            "pmid": [
                "pmid37336783",
                "pmid30488836",
                "pmid10473947",
                "pmid39259057",
                "pmid36405895",
                "pmid7762856",
                "pmid37773821",
                "pmid38755693",
                "pmid27526790",
                "pmid16696749"
            ]
        },
        "metabolism_119": {
            "question": "What metabolic or nutritional factor is most strongly associated with delirium development in CICU patients?",
            "answer": "B",
            "pmid": [
                "pmid36937934",
                "pmid36078999",
                "pmid37754219",
                "pmid21766035",
                "pmid29657370",
                "pmid17949984",
                "pmid20471115",
                "pmid28585290",
                "pmid17352663",
                "pmid17234821"
            ]
        },
        "metabolism_120": {
            "question": "What mitochondrial dysfunctions are associated with delirium in an animal model of contrast-induced nephropathy?",
            "answer": "B",
            "pmid": [
                "pmid21437673",
                "pmid37851904",
                "pmid39419070",
                "pmid28673598",
                "pmid37313848",
                "pmid28987512",
                "pmid16873963",
                "pmid28317877",
                "pmid27861892",
                "pmid36231104"
            ]
        },
        "metabolism_121": {
            "question": "What is the association between antidiabetic medications and delirium development?",
            "answer": "B",
            "pmid": [
                "pmid38135802",
                "pmid39210294",
                "pmid37993790",
                "pmid31568239",
                "pmid20030432",
                "pmid36896238",
                "pmid37550780",
                "pmid30086671",
                "pmid39541802",
                "pmid21766035"
            ]
        }
    },
    "genetic": {
        "genetic_0": {
            "question": "How is PCT expression altered in ICU delirium?",
            "answer": "C",
            "pmid": [
                "pmid30045794",
                "pmid35791660",
                "pmid36078999",
                "pmid36045041",
                "pmid37851904",
                "pmid35815182",
                "pmid34912245",
                "pmid17352663",
                "pmid39419070",
                "pmid33120832"
            ]
        },
        "genetic_1": {
            "question": "What mechanism is primarily targeted by URMC-099 to prevent hippocampal vascular and synaptic injury in a model of delirium superimposed on dementia?",
            "answer": "D",
            "pmid": [
                "pmid35535564",
                "pmid37313848",
                "pmid38155547",
                "pmid20471138",
                "pmid24852225",
                "pmid29351469",
                "pmid31244434",
                "pmid37170230",
                "pmid26362823",
                "pmid31913348"
            ]
        },
        "genetic_2": {
            "question": "How does IL6ST expression vary across disease stages in Delirium?",
            "answer": "D",
            "pmid": [
                "pmid21851175",
                "pmid37649721",
                "pmid36045041",
                "pmid37851904",
                "pmid24557038",
                "pmid32590150",
                "pmid39419070",
                "pmid34192631",
                "pmid19269948",
                "pmid29669581"
            ]
        },
        "genetic_3": {
            "question": "Which of the following is NOT supported by the identification of a significant CpG site near LDLRAD4 in patients with delirium?",
            "answer": "D",
            "pmid": [
                "pmid39835091",
                "pmid7916159",
                "pmid38566855",
                "pmid39419070",
                "pmid28585290",
                "pmid28673598",
                "pmid32018069",
                "pmid28519903",
                "pmid37649721",
                "pmid34098376"
            ]
        },
        "genetic_5": {
            "question": "What is the function of IL-1RA in delirium-related biological processes?",
            "answer": "C",
            "pmid": [
                "pmid24557038",
                "pmid37649721",
                "pmid20309566",
                "pmid39419070",
                "pmid28360657",
                "pmid37851904",
                "pmid19269948",
                "pmid20471115",
                "pmid21766035",
                "pmid28673598"
            ]
        },
        "genetic_6": {
            "question": "How does MCP-1 contribute to the development of delirium?",
            "answer": "B",
            "pmid": [
                "pmid38937571",
                "pmid37851904",
                "pmid25943983",
                "pmid37649721",
                "pmid28673598",
                "pmid39210294",
                "pmid39419070",
                "pmid20309566",
                "pmid24557038",
                "pmid36520371"
            ]
        },
        "genetic_7": {
            "question": "How does FG contribute to the development of delirium?",
            "answer": "C",
            "pmid": [
                "pmid32804136",
                "pmid33648701",
                "pmid28519903",
                "pmid28673598",
                "pmid36520371",
                "pmid20309566",
                "pmid37851904",
                "pmid7916159",
                "pmid39210294",
                "pmid21766035"
            ]
        },
        "genetic_8": {
            "question": "How does CD4+ T cell contribute to the development of Delirium?",
            "answer": "C",
            "pmid": [
                "pmid36118695",
                "pmid33648701",
                "pmid20309566",
                "pmid24557038",
                "pmid28673598",
                "pmid37851904",
                "pmid36520371",
                "pmid37649721",
                "pmid39210294",
                "pmid7916159"
            ]
        },
        "genetic_10": {
            "question": "Is IL-12 involved in the pathogenesis of post-stroke delirium?",
            "answer": "A",
            "pmid": [
                "pmid29669581",
                "pmid33901789",
                "pmid37649721",
                "pmid24557038",
                "pmid20309566",
                "pmid27816188",
                "pmid34218276",
                "pmid21978081",
                "pmid38647548",
                "pmid17467406"
            ]
        },
        "genetic_11": {
            "question": "What is the role of CYP3A5 in coma and delirium?",
            "answer": "C",
            "pmid": [
                "pmid39419070",
                "pmid32804136",
                "pmid7211434",
                "pmid23385102",
                "pmid28673598",
                "pmid7916159",
                "pmid37851904",
                "pmid32018069",
                "pmid38566855",
                "pmid3765988"
            ]
        },
        "genetic_12": {
            "question": "Can gamma-aminobutyric acid (GABA) contribute to delirium?",
            "answer": "A",
            "pmid": [
                "pmid31568239",
                "pmid32018069",
                "pmid7916159",
                "pmid19422109",
                "pmid34757245",
                "pmid37993790",
                "pmid32804136",
                "pmid39210294",
                "pmid30086671",
                "pmid37649721"
            ]
        },
        "genetic_13": {
            "question": "What is the role of Monocyte Chemoattractant Protein-1 (MCP-1) in delirium after cardiac surgery?",
            "answer": "B",
            "pmid": [
                "pmid33918634",
                "pmid25943983",
                "pmid39774401",
                "pmid36567636",
                "pmid18314455",
                "pmid36801548",
                "pmid27119013",
                "pmid38223851",
                "pmid39604493",
                "pmid28360657"
            ]
        },
        "genetic_14": {
            "question": "Is Gal-3BP involved in the pathogenesis of post-stroke delirium?",
            "answer": "A",
            "pmid": [
                "pmid33901789",
                "pmid32804136",
                "pmid23969090",
                "pmid39463449",
                "pmid38937571",
                "pmid6160732",
                "pmid38566855",
                "pmid3765988",
                "pmid32592865",
                "pmid29669581"
            ]
        },
        "genetic_15": {
            "question": "Can plasminogen activator inhibitor-1 serve as a biomarker for diagnosis or prognosis in delirium?",
            "answer": "A",
            "pmid": [
                "pmid22091570",
                "pmid31574089",
                "pmid36224337",
                "pmid17234821",
                "pmid34098376",
                "pmid27088157",
                "pmid28585290",
                "pmid37993790",
                "pmid31770149",
                "pmid32975827"
            ]
        },
        "genetic_16": {
            "question": "How does the GC receptor (GR) contribute to the development of delirium?",
            "answer": "B",
            "pmid": [
                "pmid21438141",
                "pmid39835091",
                "pmid37993790",
                "pmid28673598",
                "pmid7916159",
                "pmid33648701",
                "pmid39463449",
                "pmid39210294",
                "pmid37851904",
                "pmid33779822"
            ]
        },
        "genetic_17": {
            "question": "How is blood superoxide dismutase (SOD) level altered in delirium superimposed on dementia?",
            "answer": "B",
            "pmid": [
                "pmid28585290",
                "pmid38566855",
                "pmid39355007",
                "pmid37343463",
                "pmid17234821",
                "pmid37851904",
                "pmid25274115",
                "pmid32592865",
                "pmid37566435",
                "pmid6160732"
            ]
        },
        "genetic_18": {
            "question": "Does KAT7 signaling epigenetically influence DYRK1A expression to improve insulin resistance in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid38617985",
                "pmid31306739",
                "pmid28779511",
                "pmid31723029",
                "pmid24477974",
                "pmid31240602",
                "pmid35917097",
                "pmid32896600",
                "pmid34445786",
                "pmid29358916"
            ]
        },
        "genetic_19": {
            "question": "Does the IL6R gene variant (rs2228145, Asp358Ala) influence cognitive performance and Alzheimer disease biomarkers?",
            "answer": "A",
            "pmid": [
                "pmid28106546",
                "pmid36810164",
                "pmid10319892",
                "pmid12664314",
                "pmid24586483",
                "pmid39812719",
                "pmid28269768",
                "pmid35769874",
                "pmid27244883",
                "pmid12807963"
            ]
        },
        "genetic_20": {
            "question": "In Alzheimer’s disease, dysregulation of noncoding RNAs contributes to neurodegeneration. Which of the following best describes the role of the long noncoding RNA GAS5 in the pathogenesis of Alzheimer’s disease?",
            "answer": "B",
            "pmid": [
                "pmid39105371",
                "pmid30809552",
                "pmid27501805",
                "pmid35656102",
                "pmid32035423",
                "pmid34024830",
                "pmid37217807",
                "pmid36092938",
                "pmid36453506",
                "pmid34510683"
            ]
        },
        "genetic_21": {
            "question": "Which allele of the rs149474436 SNP in the PICK1 gene was found to be protective against Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30687223",
                "pmid29441941",
                "pmid19237226",
                "pmid25631235",
                "pmid25273678",
                "pmid23948886",
                "pmid37544578",
                "pmid16223550",
                "pmid12116197",
                "pmid15784960"
            ]
        },
        "genetic_22": {
            "question": "Does the accumulation of amyloid-beta 1-42 (Abeta42) affect the epigenetic regulation of the Igf2/H19 gene cluster in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid36739453",
                "pmid23582659",
                "pmid25318543",
                "pmid36724966",
                "pmid23579332",
                "pmid38167174",
                "pmid10623648",
                "pmid19635394",
                "pmid21034526",
                "pmid15548589"
            ]
        },
        "genetic_23": {
            "question": "Does the codon 311 (Cys --> Ser) polymorphism of the paraoxonase-2 gene interact with the apoE4 allele in the development of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid14741412",
                "pmid11803456",
                "pmid24965284",
                "pmid20980077",
                "pmid15016430",
                "pmid9425904",
                "pmid16319130",
                "pmid20850903",
                "pmid15165699",
                "pmid26949549"
            ]
        },
        "genetic_24": {
            "question": "Does lncRNA XIST play a role in Alzheimer's disease by inducing Abeta accumulation and neuroinflammation through epigenetic repression of NEP?",
            "answer": "A",
            "pmid": [
                "pmid35098860",
                "pmid32851944",
                "pmid31949779",
                "pmid32035423",
                "pmid37217807",
                "pmid38372094",
                "pmid36092938",
                "pmid32741808",
                "pmid36453506",
                "pmid37286157"
            ]
        },
        "genetic_26": {
            "question": "Are promoter polymorphisms in the BACE1 gene associated with sporadic Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid20455082",
                "pmid19441127",
                "pmid15784960",
                "pmid26846559",
                "pmid12535780",
                "pmid18005427",
                "pmid16223550",
                "pmid9425904",
                "pmid18996360",
                "pmid32223911"
            ]
        },
        "genetic_27": {
            "question": "Which genetic polymorphism in the HLA-DQB1 promoter region is associated with changes in transcription factor binding that may influence Alzheimer's disease risk?",
            "answer": "C",
            "pmid": [
                "pmid35341343",
                "pmid25651370",
                "pmid18996360",
                "pmid30820047",
                "pmid20450896",
                "pmid37201029",
                "pmid23948886",
                "pmid12938026",
                "pmid25130782",
                "pmid17284348"
            ]
        },
        "genetic_28": {
            "question": "Does the -1314C allele of the ADAM9 gene promoter have a protective effect against Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid19237226",
                "pmid22572541",
                "pmid25631235",
                "pmid20627730",
                "pmid18996360",
                "pmid19441127",
                "pmid17440933",
                "pmid12116197",
                "pmid12938026",
                "pmid30820047"
            ]
        },
        "genetic_29": {
            "question": "Which mutation in the PSEN1 gene is associated with both familial Lewy body disease and variant Alzheimer's disease?",
            "answer": "D",
            "pmid": [
                "pmid32754199",
                "pmid35247599",
                "pmid31235344",
                "pmid18045903",
                "pmid32121568",
                "pmid35231845",
                "pmid31165862",
                "pmid12925374",
                "pmid34366829",
                "pmid20158511"
            ]
        },
        "genetic_30": {
            "question": "Which gene's up-regulation is associated with the protective effects of omega-3 PUFAs against Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid39453315",
                "pmid15788759",
                "pmid32486013",
                "pmid27474225",
                "pmid18037281",
                "pmid30296191",
                "pmid25311278",
                "pmid12938026",
                "pmid26965310",
                "pmid36552565"
            ]
        },
        "genetic_31": {
            "question": "What is the primary mechanism by which β-asarone exerts neuroprotective effects in an Alzheimer’s disease cellular model?",
            "answer": "D",
            "pmid": [
                "pmid34040526",
                "pmid21391434",
                "pmid25160744",
                "pmid20307525",
                "pmid26271288",
                "pmid35204164",
                "pmid35682567",
                "pmid20950278",
                "pmid21224052",
                "pmid26696494"
            ]
        },
        "genetic_32": {
            "question": "Does the missense variant rs117916664 in the ACAA1 gene contribute to early-onset Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid34465723",
                "pmid26949549",
                "pmid29441941",
                "pmid31235344",
                "pmid22829467",
                "pmid33057949",
                "pmid24141082",
                "pmid30820047",
                "pmid26403748",
                "pmid25273678"
            ]
        },
        "genetic_33": {
            "question": "Which RYR3 gene variants are associated with the age at onset of Alzheimer's disease, hypertension, and diabetes?",
            "answer": "B",
            "pmid": [
                "pmid29590321",
                "pmid36069947",
                "pmid10490699",
                "pmid16988505",
                "pmid33152005",
                "pmid12807963",
                "pmid24278306",
                "pmid19631630",
                "pmid17270153",
                "pmid12938026"
            ]
        },
        "genetic_34": {
            "question": "Does the MAPT-A152T mutation enhance neuronal excitability through the tau-Fyn-NMDAR pathway in excitatory neurons, contributing to Alzheimer's disease pathogenesis?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid39811068",
                "pmid34274950",
                "pmid22556362",
                "pmid21228179",
                "pmid24334724",
                "pmid29358916",
                "pmid36945524",
                "pmid35965317",
                "pmid16115884",
                "pmid9878757"
            ]
        },
        "genetic_35": {
            "question": "Which allele is associated with a higher risk of late-onset Alzheimer's disease (LOAD) when combined with the ALDH2(*)2 polymorphism?",
            "answer": "C",
            "pmid": [
                "pmid11464464",
                "pmid10873585",
                "pmid30820047",
                "pmid25130782",
                "pmid16055944",
                "pmid26491656",
                "pmid15126281",
                "pmid25189118",
                "pmid28269768",
                "pmid14741412"
            ]
        },
        "genetic_37": {
            "question": "Does CRMP-2 expression influenced by the PI3K-mTOR-S6K pathway play a role in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid28966575",
                "pmid21271304",
                "pmid11677259",
                "pmid24334724",
                "pmid33420799",
                "pmid9878757",
                "pmid15608143",
                "pmid38007654",
                "pmid31840000",
                "pmid26077693"
            ]
        },
        "genetic_38": {
            "question": "Does a mutation in the DAOA gene modify the age of onset in PSEN1 E280A Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid26949549",
                "pmid22829467",
                "pmid35247599",
                "pmid31235344",
                "pmid36951251",
                "pmid20158511",
                "pmid35231845",
                "pmid32754199",
                "pmid12925374",
                "pmid34366829"
            ]
        },
        "genetic_39": {
            "question": "Does the inhibition of BET proteins reduce the expression of genes involved in the pathomechanism of Alzheimer's disease in microglia?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid36613460",
                "pmid37609338",
                "pmid25485684",
                "pmid39474846",
                "pmid38886959",
                "pmid33029126",
                "pmid39908354",
                "pmid19893026",
                "pmid29784049",
                "pmid39304744"
            ]
        },
        "genetic_40": {
            "question": "Which of the following is associated with an increased risk of developing Alzheimer's disease due to altered MS4A6A gene expression?",
            "answer": "B",
            "pmid": [
                "pmid27244883",
                "pmid36798226",
                "pmid26923404",
                "pmid23226438",
                "pmid30820047",
                "pmid33419465",
                "pmid24141082",
                "pmid12533085",
                "pmid24064185",
                "pmid17284348"
            ]
        },
        "genetic_41": {
            "question": "Does the N405S mutation in the PS1 gene lead to widespread cortical amyloid deposition in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid10644793",
                "pmid11395394",
                "pmid35247599",
                "pmid9189043",
                "pmid9737546",
                "pmid32121568",
                "pmid8837617",
                "pmid31235344",
                "pmid37692508",
                "pmid35231845"
            ]
        },
        "genetic_42": {
            "question": "Does the -499A>G polymorphism of the MAPK8IP1 gene increase the risk of Alzheimer's disease in individuals with the CC genotype of the LRP gene?",
            "answer": "A",
            "pmid": [
                "pmid17614163",
                "pmid28415654",
                "pmid12740599",
                "pmid29441941",
                "pmid30820047",
                "pmid25273678",
                "pmid16328515",
                "pmid9425904",
                "pmid25130782",
                "pmid15024730"
            ]
        },
        "genetic_43": {
            "question": "Does the P117R mutation in presenilin 1 affect cell cycle regulation and contribute to Alzheimer's disease progression?",
            "answer": "A",
            "pmid": [
                "pmid11124426",
                "pmid22810102",
                "pmid10393846",
                "pmid11311782",
                "pmid9737546",
                "pmid9790190",
                "pmid12836159",
                "pmid31235344",
                "pmid15972961",
                "pmid9189043"
            ]
        },
        "genetic_44": {
            "question": "How does the dysregulation of NRIP1 expression in Down syndrome potentially relate to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid33869171",
                "pmid10666665",
                "pmid15068237",
                "pmid32962300",
                "pmid16442855",
                "pmid31263630",
                "pmid24735980",
                "pmid28807816",
                "pmid27725441",
                "pmid29977201"
            ]
        },
        "genetic_46": {
            "question": "Which of the following best describes the association of the rs6922617 variant in the TREM gene cluster with Alzheimer's disease neuropathology?",
            "answer": "D",
            "pmid": [
                "pmid39051708",
                "pmid36815315",
                "pmid31721052",
                "pmid27939925",
                "pmid24899047",
                "pmid37980675",
                "pmid26058955",
                "pmid23692967",
                "pmid34663480",
                "pmid15464268"
            ]
        },
        "genetic_47": {
            "question": "Is DSCR1 (Adapt78) gene expression associated with Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid11483593",
                "pmid12716059",
                "pmid12582468",
                "pmid29441941",
                "pmid24141082",
                "pmid23226438",
                "pmid16231093",
                "pmid36450444",
                "pmid17614163",
                "pmid16442855"
            ]
        },
        "genetic_48": {
            "question": "Does downregulation of miR-29c correlate with increased BACE1 expression in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid34956559",
                "pmid18434550",
                "pmid25973041",
                "pmid25955795",
                "pmid38215068",
                "pmid30576233",
                "pmid18234899",
                "pmid35167942",
                "pmid26398571",
                "pmid31134481"
            ]
        },
        "genetic_49": {
            "question": "Does the upregulation of DR6 expression correlate with neuronal death in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid23559013",
                "pmid17055782",
                "pmid26582459",
                "pmid11193159",
                "pmid29634233",
                "pmid34831245",
                "pmid10817927",
                "pmid18688088",
                "pmid10319892",
                "pmid18400893"
            ]
        },
        "genetic_50": {
            "question": "Does loss of ataxin-1 increase BACE1 expression and contribute to Alzheimer's disease pathogenesis?",
            "answer": "A",
            "pmid": [
                "pmid31442405",
                "pmid18005427",
                "pmid20097758",
                "pmid30626751",
                "pmid32223911",
                "pmid16354928",
                "pmid20455082",
                "pmid15642747",
                "pmid20628574",
                "pmid32878998"
            ]
        },
        "genetic_51": {
            "question": "Which polymorphisms in the LXR-beta gene were associated with an increased risk of Alzheimer's disease when combined with the HO-1 (-413) TT genotype?",
            "answer": "A",
            "pmid": [
                "pmid18597895",
                "pmid15860461",
                "pmid12807963",
                "pmid12938026",
                "pmid16328515",
                "pmid17614163",
                "pmid25130782",
                "pmid9425904",
                "pmid12384789",
                "pmid17284348"
            ]
        },
        "genetic_52": {
            "question": "Which allele in the CYP46A1 gene increases the risk of developing Alzheimer's disease when associated with the APOEpsilon3 allele?",
            "answer": "B",
            "pmid": [
                "pmid15165699",
                "pmid16340204",
                "pmid12123847",
                "pmid12533085",
                "pmid9425904",
                "pmid17510946",
                "pmid27583919",
                "pmid10208564",
                "pmid19660836",
                "pmid23690001"
            ]
        },
        "genetic_53": {
            "question": "Does the downregulation of BARHL1 in Alzheimer's disease potentially affect cognitive functions through the ESR1 pathway?",
            "answer": "A",
            "pmid": [
                "pmid28956815",
                "pmid29641978",
                "pmid36326669",
                "pmid39231208",
                "pmid27103515",
                "pmid20007471",
                "pmid9878757",
                "pmid28351972",
                "pmid21771791",
                "pmid36287323"
            ]
        },
        "genetic_54": {
            "question": "Does the presenilin 1 mutation (PS1M146L) linked to Alzheimer's disease affect filamin expression and distribution?",
            "answer": "A",
            "pmid": [
                "pmid20847418",
                "pmid9437013",
                "pmid11311782",
                "pmid9189043",
                "pmid11124426",
                "pmid10386952",
                "pmid9737546",
                "pmid21086758",
                "pmid8837617",
                "pmid11395394"
            ]
        },
        "genetic_55": {
            "question": "Does the C677T variant in MTHFR modulate associations between plasma ApoE levels and Alzheimer's disease biomarkers?",
            "answer": "A",
            "pmid": [
                "pmid27380243",
                "pmid16055944",
                "pmid12784029",
                "pmid17628213",
                "pmid19342053",
                "pmid24179750",
                "pmid37666928",
                "pmid33057949",
                "pmid18525129",
                "pmid10208564"
            ]
        },
        "genetic_56": {
            "question": "Does the presence of the H63D variant in males with the E4 allele significantly lower the risk of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid17628213",
                "pmid27244883",
                "pmid26923404",
                "pmid25130782",
                "pmid12123847",
                "pmid36798226",
                "pmid16340204",
                "pmid34541285",
                "pmid18525129",
                "pmid15165699"
            ]
        },
        "genetic_57": {
            "question": "Is the SNP-rs6922617 in the TREM gene cluster associated with a higher global amyloid-ligands PET burden in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31721052",
                "pmid39051708",
                "pmid36815315",
                "pmid27939925",
                "pmid24899047",
                "pmid34663480",
                "pmid26058955",
                "pmid31727362",
                "pmid23692967",
                "pmid37980675"
            ]
        },
        "genetic_58": {
            "question": "In Alzheimer's disease (AD) human skin fibroblasts, which mutation is associated with highly aggressive AD and persistent BKB2R signaling?",
            "answer": "A",
            "pmid": [
                "pmid14563691",
                "pmid19247475",
                "pmid39000564",
                "pmid33466666",
                "pmid27068745",
                "pmid9878757",
                "pmid8012386",
                "pmid35237315",
                "pmid8239309",
                "pmid23692967"
            ]
        },
        "genetic_59": {
            "question": "Is there an association between SIRT1 gene polymorphisms and Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid37892107",
                "pmid25130782",
                "pmid28415654",
                "pmid29441941",
                "pmid26045440",
                "pmid19733630",
                "pmid25273678",
                "pmid37117777",
                "pmid28269768",
                "pmid16725228"
            ]
        },
        "genetic_60": {
            "question": "Which single-nucleotide polymorphism (SNP) of the MAPT gene was found to be associated with a lower risk of sporadic Alzheimer's disease (SAD) in a meta-analysis?",
            "answer": "C",
            "pmid": [
                "pmid28415654",
                "pmid29098924",
                "pmid29441941",
                "pmid28100725",
                "pmid30820047",
                "pmid25130782",
                "pmid22556362",
                "pmid15288432",
                "pmid11698154",
                "pmid19733630"
            ]
        },
        "genetic_61": {
            "question": "Which gene variant interacts with APOE and increases the risk for Alzheimer's disease?",
            "answer": "<Correct Answer>: [A]\n<Why>: Variations in the APOD gene, particularly the rs7659 polymorphism in the 3' UTR, modify the risk for Alzheimer's disease and interact with APOE. Additionally, lower genetically determined apoE levels are associated with increased risk, while higher levels are associated with decreased risk, independent of the APOE e2/e3/e4 genotype.",
            "pmid": [
                "pmid9425904",
                "pmid37666928",
                "pmid10208564",
                "pmid34978151",
                "pmid19660836",
                "pmid33057949",
                "pmid16468304",
                "pmid17628213",
                "pmid23690001",
                "pmid32808727"
            ]
        },
        "genetic_62": {
            "question": "Does the IDE gene variant (c.782G > A, p.R261Q) contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid17496198",
                "pmid12161276",
                "pmid18996360",
                "pmid20098734",
                "pmid20880607",
                "pmid35236268",
                "pmid33419465",
                "pmid39000564",
                "pmid9425904",
                "pmid33152005"
            ]
        },
        "genetic_63": {
            "question": "Which mutant allele is associated with Alzheimer's disease and affects Wnt/beta-catenin signaling by increasing TCF/beta-catenin/CBP-mediated transcription?",
            "answer": "A",
            "pmid": [
                "pmid11358522",
                "pmid9790190",
                "pmid16093313",
                "pmid15972961",
                "pmid26455952",
                "pmid27068745",
                "pmid11124426",
                "pmid12836159",
                "pmid20097758",
                "pmid39000564"
            ]
        },
        "genetic_64": {
            "question": "Which allele of the COMT gene was found to be an independent risk factor for Alzheimer's disease in men without the APOE epsilon4 allele?",
            "answer": "D",
            "pmid": [
                "pmid24575113",
                "pmid22890094",
                "pmid9425904",
                "pmid33057949",
                "pmid28415654",
                "pmid15165699",
                "pmid16468304",
                "pmid9626772",
                "pmid16223550",
                "pmid19660836"
            ]
        },
        "genetic_65": {
            "question": "Which long noncoding RNA was shown to play a role in Alzheimer's disease progression by regulating the miR-361-3p/ZNF217 axis?",
            "answer": "A",
            "pmid": [
                "pmid32035423",
                "pmid30809552",
                "pmid27501805",
                "pmid37217807",
                "pmid35656102",
                "pmid34024830",
                "pmid32741808",
                "pmid36092938",
                "pmid38372094",
                "pmid26398571"
            ]
        },
        "genetic_66": {
            "question": "Does the SERPINA5 genetic variant p.E228Q contribute to clinical differences in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid33662018",
                "pmid37327267",
                "pmid15024730",
                "pmid39051708",
                "pmid20850903",
                "pmid27244883",
                "pmid37117777",
                "pmid39000564",
                "pmid33419465",
                "pmid30569016"
            ]
        },
        "genetic_67": {
            "question": "Is decreased expression of the APOA1-APOC3-APOA4 gene cluster associated with the risk of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid26491253",
                "pmid23690001",
                "pmid9425904",
                "pmid23226438",
                "pmid39686609",
                "pmid33419465",
                "pmid34486652",
                "pmid17510946",
                "pmid10208564",
                "pmid36039401"
            ]
        },
        "genetic_68": {
            "question": "Does the presence of a stop-loss variant in the RGS7 gene correlate with a specific subtype of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid29441941",
                "pmid24141082",
                "pmid29782324",
                "pmid26923404",
                "pmid35264725",
                "pmid27244883",
                "pmid23948886",
                "pmid39000564",
                "pmid21760992",
                "pmid39051708"
            ]
        },
        "genetic_69": {
            "question": "NF-kappaB-induced upregulation of miR-146a-5p was found to promote oxidative stress and pyroptosis in Alzheimer's disease by targeting which gene?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid18801740",
                "pmid33935653",
                "pmid37300691",
                "pmid19540598",
                "pmid28655611",
                "pmid27520374",
                "pmid22302353",
                "pmid24586483",
                "pmid22099153",
                "pmid33915734"
            ]
        },
        "genetic_70": {
            "question": "Which of the following genetic variants was associated with a reduced risk of Alzheimer's disease relative to primary age-related tauopathy (PART)?",
            "answer": "D",
            "pmid": [
                "pmid15106853",
                "pmid30820047",
                "pmid11698154",
                "pmid30128317",
                "pmid12116197",
                "pmid33419465",
                "pmid28269768",
                "pmid25189118",
                "pmid39000564",
                "pmid28100725"
            ]
        },
        "genetic_71": {
            "question": "Are variants in CYP17 and CYP19 cytochrome P450 genes associated with the onset of Alzheimer's disease in women with Down syndrome?",
            "answer": "A",
            "pmid": [
                "pmid22057025",
                "pmid22474448",
                "pmid16882736",
                "pmid19478482",
                "pmid10666665",
                "pmid27583919",
                "pmid15068237",
                "pmid16442855",
                "pmid22156442",
                "pmid28807816"
            ]
        },
        "genetic_73": {
            "question": "Is the IFITM3 gene associated with less vulnerability to cognitive decline and Alzheimer's disease biomarkers?",
            "answer": "A",
            "pmid": [
                "pmid35769874",
                "pmid35056363",
                "pmid35526014",
                "pmid39051708",
                "pmid26243271",
                "pmid15464268",
                "pmid18430995",
                "pmid28269768",
                "pmid26045440",
                "pmid36815315"
            ]
        },
        "genetic_74": {
            "question": "Which gene variant was found to have a protective effect against the progression to mild cognitive impairment or Alzheimer's disease (MCI/LOAD)?",
            "answer": "C",
            "pmid": [
                "pmid25189118",
                "pmid30820047",
                "pmid37841863",
                "pmid28269768",
                "pmid26243271",
                "pmid36798226",
                "pmid22833209",
                "pmid18848371",
                "pmid18430995",
                "pmid12116197"
            ]
        },
        "genetic_75": {
            "question": "Does transferrin play a role in the regulation of APH-1alpha/beta and Presenilin 1 expression, which contributes to the pathogenesis of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30383537",
                "pmid19148186",
                "pmid38296900",
                "pmid9790190",
                "pmid17222949",
                "pmid12836159",
                "pmid18367332",
                "pmid17568632",
                "pmid11755001",
                "pmid17437536"
            ]
        },
        "genetic_76": {
            "question": "Does the T835M mutation in the UNC5C gene increase the risk of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid25419706",
                "pmid37841863",
                "pmid30820047",
                "pmid27068745",
                "pmid33419465",
                "pmid39051708",
                "pmid27781389",
                "pmid29441941",
                "pmid35264725",
                "pmid25130782"
            ]
        },
        "genetic_77": {
            "question": "Does PS1 mutation interfere with PS2-mediated activation of pathways relevant to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid11124426",
                "pmid35247599",
                "pmid12460542",
                "pmid9151738",
                "pmid9878757",
                "pmid10393846",
                "pmid16014629",
                "pmid21086758",
                "pmid22810102",
                "pmid15972961"
            ]
        },
        "genetic_78": {
            "question": "Does the PSEN1 His214Asn mutation contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35247599",
                "pmid31235344",
                "pmid32754199",
                "pmid32121568",
                "pmid38203287",
                "pmid35231845",
                "pmid31391004",
                "pmid20158511",
                "pmid34366829",
                "pmid34679393"
            ]
        },
        "genetic_79": {
            "question": "Which genetic polymorphism of ABCA1 is associated with an increased risk of late-onset Alzheimer's disease in females?",
            "answer": "A",
            "pmid": [
                "pmid16725228",
                "pmid15288432",
                "pmid17510946",
                "pmid25273678",
                "pmid15024730",
                "pmid15649702",
                "pmid32447570",
                "pmid29441941",
                "pmid12600718",
                "pmid23111454"
            ]
        },
        "genetic_80": {
            "question": "lncRNA NKILA exacerbates Alzheimer's disease progression by regulating which transcription-mediated process?",
            "answer": "A",
            "pmid": [
                "pmid37217807",
                "pmid35098860",
                "pmid32035423",
                "pmid36092938",
                "pmid35656102",
                "pmid30809552",
                "pmid36453506",
                "pmid27501805",
                "pmid37286157",
                "pmid37187245"
            ]
        },
        "genetic_81": {
            "question": "Which allele of the SIRT2 gene rs2015 locus is associated with a reduced risk of developing Alzheimer's disease?",
            "answer": "A.",
            "pmid": [
                "pmid37117777",
                "pmid30820047",
                "pmid32124252",
                "pmid18996360",
                "pmid17496198",
                "pmid39051708",
                "pmid28269768",
                "pmid20850903",
                "pmid23692967",
                "pmid36815315"
            ]
        },
        "genetic_82": {
            "question": "Does lower expression of Ndfip1 contribute to Alzheimer's disease pathogenesis by reducing DMT1 degradation and increasing iron influx in the brain?",
            "answer": "A",
            "pmid": [
                "pmid29937728",
                "pmid19679638",
                "pmid24863668",
                "pmid32444869",
                "pmid35453377",
                "pmid20401186",
                "pmid23262393",
                "pmid24199959",
                "pmid35391749",
                "pmid21971404"
            ]
        },
        "genetic_83": {
            "question": "Which variant of the CHI3L1 gene is associated with slower progression of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid30223258",
                "pmid21562723",
                "pmid16223550",
                "pmid33328329",
                "pmid35234337",
                "pmid37117777",
                "pmid12807963",
                "pmid18562794",
                "pmid31235344",
                "pmid22829467"
            ]
        },
        "genetic_84": {
            "question": "Does inhibition of PARP1 enhance the expression of genes related to Alzheimer's disease in PC12 cells?",
            "answer": "A",
            "pmid": [
                "pmid24086258",
                "pmid28698968",
                "pmid22430645",
                "pmid23076628",
                "pmid17911636",
                "pmid15671026",
                "pmid31840000",
                "pmid39117070",
                "pmid24985705",
                "pmid25776136"
            ]
        },
        "genetic_85": {
            "question": "Does the UBTF E210K mutation contribute to the pathogenesis of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid29300972",
                "pmid37692508",
                "pmid7533559",
                "pmid22810102",
                "pmid8012386",
                "pmid36362046",
                "pmid21500352",
                "pmid15992373",
                "pmid8886002",
                "pmid22556362"
            ]
        },
        "genetic_86": {
            "question": "Are genes encoding the NALCN channelosome associated with susceptibility to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid24904279",
                "pmid16223550",
                "pmid37841863",
                "pmid12582468",
                "pmid32257549",
                "pmid12807963",
                "pmid29441941",
                "pmid12384789",
                "pmid17614163",
                "pmid12740599"
            ]
        },
        "genetic_87": {
            "question": "Which allele of the ACT gene is associated with an increased risk of Alzheimer's disease?",
            "answer": "The C allele of rs4309 and the ACA and TCA haplotypes are associated with an increased risk of Alzheimer’s disease.",
            "pmid": [
                "pmid25130782",
                "pmid30820047",
                "pmid29441941",
                "pmid11941486",
                "pmid17496198",
                "pmid16223550",
                "pmid15024730",
                "pmid24141082",
                "pmid18996360",
                "pmid26403748"
            ]
        },
        "genetic_88": {
            "question": "Does the SNP rs76904798 of the LRRK2 gene reduce the risk of Alzheimer's disease in northern Han Chinese individuals?",
            "answer": "A",
            "pmid": [
                "pmid26738859",
                "pmid25141968",
                "pmid26680604",
                "pmid20977898",
                "pmid29432188",
                "pmid37117777",
                "pmid24113560",
                "pmid23820587",
                "pmid14741412",
                "pmid17614163"
            ]
        },
        "genetic_89": {
            "question": "Does downregulation of OPTN contribute to neuroinflammation in Alzheimer's disease through AIM2 inflammasome and RIPK1 pathways?",
            "answer": "A\n\n\n\n",
            "pmid": [
                "pmid34861878",
                "pmid35662233",
                "pmid33513340",
                "pmid31128596",
                "pmid28904096",
                "pmid33181351",
                "pmid35474599",
                "pmid33277246",
                "pmid35986874",
                "pmid39117070"
            ]
        },
        "genetic_90": {
            "question": "Does the CP2/LBP-1c/LSF transcription factor enhance the transcription of the GARS-AIRS-GART gene in Down syndrome-related Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid17902044",
                "pmid15068237",
                "pmid10666665",
                "pmid31263630",
                "pmid24735980",
                "pmid8427604",
                "pmid16442855",
                "pmid27725441",
                "pmid28807816",
                "pmid26967221"
            ]
        },
        "genetic_91": {
            "question": "Is there evidence linking rumination, mediated by MTHFD1L gene variants, todelirium?",
            "answer": "B",
            "pmid": [
                "pmid26926881",
                "pmid34959947",
                "pmid29317606",
                "pmid33779822",
                "pmid34650206",
                "pmid11723200",
                "pmid21873960",
                "pmid31405128",
                "pmid30248905",
                "pmid38392589"
            ]
        },
        "genetic_92": {
            "question": "Are variants in the COX6B1, SURF1, and COX10 genes associated with Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid30054583",
                "pmid39000564",
                "pmid25631235",
                "pmid30820047",
                "pmid29441941",
                "pmid36951251",
                "pmid32447570",
                "pmid22829467",
                "pmid16223550",
                "pmid15024730"
            ]
        },
        "genetic_94": {
            "question": "Is there an association between AOC1 gene variants and delirium in adult women with fibromyalgia?",
            "answer": "A",
            "pmid": [
                "pmid37359379",
                "pmid33779822",
                "pmid35017578",
                "pmid19309018",
                "pmid21438141",
                "pmid19219710",
                "pmid24058735",
                "pmid17728664",
                "pmid22759724",
                "pmid19713702"
            ]
        },
        "genetic_95": {
            "question": "Does the 3'-UTR +1073 C/T polymorphism of the OLR1 gene associate with Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid12807963",
                "pmid15860461",
                "pmid16328515",
                "pmid12384789",
                "pmid15276231",
                "pmid29441941",
                "pmid25273678",
                "pmid17614163",
                "pmid12938026",
                "pmid25130782"
            ]
        },
        "genetic_96": {
            "question": "Does the CYP19A1 gene polymorphism rs10046 increase the risk of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid27583919",
                "pmid16882736",
                "pmid31278540",
                "pmid19478482",
                "pmid22057025",
                "pmid12533085",
                "pmid25631235",
                "pmid12938026",
                "pmid25130782",
                "pmid12123847"
            ]
        },
        "genetic_97": {
            "question": "Are certain allele combinations involving IL6r and C9 genes associated with amyloid burden in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid10319892",
                "pmid26626881",
                "pmid28106546",
                "pmid12664314",
                "pmid30820047",
                "pmid12116197",
                "pmid39000564",
                "pmid25130782",
                "pmid12807963",
                "pmid25631235"
            ]
        },
        "genetic_98": {
            "question": "Does the AGTPBP1 gene mutation in CONDCA lead to Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid25273678",
                "pmid34572343",
                "pmid29441941",
                "pmid24141082",
                "pmid37841863",
                "pmid23556446",
                "pmid15288432",
                "pmid25631235",
                "pmid17510946",
                "pmid32447570"
            ]
        },
        "genetic_99": {
            "question": "Which of the following best describes the gene expression levels of CHRM1 and CHRM4 in DLB compared to Alzheimer's disease?",
            "answer": "A.",
            "pmid": [
                "pmid34806612",
                "pmid23226438",
                "pmid34719321",
                "pmid11483593",
                "pmid34966527",
                "pmid31520071",
                "pmid34484988",
                "pmid29093468",
                "pmid12384789",
                "pmid12582468"
            ]
        },
        "genetic_100": {
            "question": "Does the Y831C mutation in the POLG gene have a statistically significant association with Alzheimer's disease or delirium?",
            "answer": "B",
            "pmid": [
                "pmid37189790",
                "pmid17614163",
                "pmid17728664",
                "pmid33779822",
                "pmid26949549",
                "pmid19309018",
                "pmid22829467",
                "pmid25130782",
                "pmid35264725",
                "pmid12384789"
            ]
        },
        "genetic_101": {
            "question": "Does up-regulation of lncRNA WT1-AS alleviate neuronal damage in Alzheimer's disease by modulating the miR-186-5p/CCND2 axis?",
            "answer": "A novel lncRNA, RP11-59J16.2, promotes neuronal apoptosis and increases Tau phosphorylation in an Alzheimer's disease model by regulating MCM2. Dysregulation of lncRNAs is linked to AD pathology, potentially through pathways like the Lfng/Notch1 signaling pathway. Analyses indicate involvement of the G1/S transition of the mitotic cell cycle in AD development.\n\n\n\n",
            "pmid": [
                "pmid38372094",
                "pmid33234729",
                "pmid37286157",
                "pmid31949779",
                "pmid32035423",
                "pmid37217807",
                "pmid32741808",
                "pmid36092938",
                "pmid24604632",
                "pmid36453506"
            ]
        },
        "genetic_102": {
            "question": "Does miRNA-431 prevent synapse loss in an Alzheimer's disease neuronal model by targeting Kremen1?",
            "answer": "A",
            "pmid": [
                "pmid29643768",
                "pmid37192007",
                "pmid38322333",
                "pmid31997075",
                "pmid35941185",
                "pmid32092796",
                "pmid29378298",
                "pmid35592504",
                "pmid28533191",
                "pmid29286086"
            ]
        },
        "genetic_103": {
            "question": "Which mutation in the APP gene is associated with protection against Alzheimer's disease by promoting beta'-site cleavage?",
            "answer": "<Correct Answer>: [D]\n<Why>: A specific variation, identified as the Icelandic mutation (A673T), is shown to increase the production of Abeta(11-40) and consequently enhance beta' cleavage of APP, providing protection against the development of Alzheimer's disease.",
            "pmid": [
                "pmid8012386",
                "pmid21500352",
                "pmid37692508",
                "pmid8886002",
                "pmid21812781",
                "pmid12535780",
                "pmid15992373",
                "pmid25631235",
                "pmid15851852",
                "pmid27687728"
            ]
        },
        "genetic_104": {
            "question": "Is the DDAH2 (-449 G/C) gene polymorphism associated with Alzheimer's disease or delirium?",
            "answer": "B",
            "pmid": [
                "pmid19309018",
                "pmid25130782",
                "pmid33779822",
                "pmid11723200",
                "pmid21613790",
                "pmid33271854",
                "pmid26491656",
                "pmid11464464",
                "pmid17250608",
                "pmid26949549"
            ]
        },
        "genetic_105": {
            "question": "Does the SLC6A4 gene variant rs7224199 show an association with Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid31595439",
                "pmid27244883",
                "pmid25130782",
                "pmid29441941",
                "pmid18490109",
                "pmid39051708",
                "pmid12807963",
                "pmid35264725",
                "pmid34650206",
                "pmid8474686"
            ]
        },
        "genetic_106": {
            "question": "Which variant of the RELN gene has been associated with resilience against presenilin-linked autosomal-dominant Alzheimer's disease (ADAD)?",
            "answer": "A",
            "pmid": [
                "pmid22495348",
                "pmid17496198",
                "pmid39051708",
                "pmid39000564",
                "pmid38754634",
                "pmid25130782",
                "pmid15635706",
                "pmid9737546",
                "pmid32754199",
                "pmid20850903"
            ]
        },
        "genetic_107": {
            "question": "Does the presence of EIF2B5 gene mutations associate with delirium in females with ovarioleukodystrophy?",
            "answer": "B",
            "pmid": [
                "pmid35785335",
                "pmid33779822",
                "pmid19309018",
                "pmid19219710",
                "pmid19910874",
                "pmid35017578",
                "pmid34192631",
                "pmid19713702",
                "pmid17728664",
                "pmid26901792"
            ]
        },
        "genetic_108": {
            "question": "Which of the following best describes a key finding regarding Alzheimer’s disease-related molecular changes in SH-SY5Y cells exposed to methylglyoxal (MGO)?",
            "answer": "D",
            "pmid": [
                "pmid25102327",
                "pmid31623327",
                "pmid22798221",
                "pmid39206401",
                "pmid23579332",
                "pmid17851177",
                "pmid1647485",
                "pmid30412792",
                "pmid24710686",
                "pmid38787367"
            ]
        },
        "genetic_109": {
            "question": "What is the association between the -116C/G polymorphism of XBP1 and Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid23421912",
                "pmid25273678",
                "pmid29441941",
                "pmid25130782",
                "pmid25631235",
                "pmid15288432",
                "pmid23556446",
                "pmid17614163",
                "pmid16725228",
                "pmid15375678"
            ]
        },
        "genetic_110": {
            "question": "Which ABCA1 polymorphism was found to significantly increase the risk of Alzheimer's disease when homozygous in APOE epsilon4 carriers?",
            "answer": "C",
            "pmid": [
                "pmid17510946",
                "pmid15288432",
                "pmid27215623",
                "pmid9425904",
                "pmid29441941",
                "pmid25273678",
                "pmid15024730",
                "pmid32447570",
                "pmid15649702",
                "pmid24141082"
            ]
        },
        "genetic_111": {
            "question": "How does the p.N370S GBA variant affect Alzheimer's disease risk?",
            "answer": "B",
            "pmid": [
                "pmid29441941",
                "pmid30820047",
                "pmid25273678",
                "pmid25189118",
                "pmid23556446",
                "pmid19660836",
                "pmid15024730",
                "pmid24141082",
                "pmid33419465",
                "pmid35264725"
            ]
        },
        "genetic_112": {
            "question": "How do mutations in presenilin 1 (PS1) linked to Alzheimer's disease affect the balance between NF-kappaB and CHOP in neurons?",
            "answer": "B",
            "pmid": [
                "pmid17927985",
                "pmid10386952",
                "pmid11311782",
                "pmid21086758",
                "pmid15972961",
                "pmid11124426",
                "pmid12460542",
                "pmid17437536",
                "pmid18367332",
                "pmid9790190"
            ]
        },
        "genetic_113": {
            "question": "Which APOE isoform was found to exacerbate TDP-43 related toxicity in the absence of Alzheimer pathology?",
            "answer": "A",
            "pmid": [
                "pmid36546684",
                "pmid34930382",
                "pmid10366621",
                "pmid34486652",
                "pmid32457210",
                "pmid10208564",
                "pmid21070634",
                "pmid30032423",
                "pmid9425904",
                "pmid15165699"
            ]
        },
        "genetic_114": {
            "question": "TMCC2 is associated with Alzheimer's disease (AD) via its interaction with which protein central to AD pathogenesis?",
            "answer": "A",
            "pmid": [
                "pmid39084860",
                "pmid31440393",
                "pmid21376707",
                "pmid34930382",
                "pmid36092938",
                "pmid10817927",
                "pmid31727362",
                "pmid24333930",
                "pmid27557632",
                "pmid11755001"
            ]
        },
        "genetic_115": {
            "question": "Which polymorphism of CHAT is associated with an increased risk of Alzheimer's disease in whites?",
            "answer": "B",
            "pmid": [
                "pmid27272392",
                "pmid16223550",
                "pmid38894884",
                "pmid18562794",
                "pmid29759072",
                "pmid29441941",
                "pmid27781389",
                "pmid28269768",
                "pmid16725228",
                "pmid18848371"
            ]
        },
        "genetic_116": {
            "question": "Which gene associated with attention function in adult ADHD has also been linked to Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid26174813",
                "pmid28710364",
                "pmid27656889",
                "pmid26598068",
                "pmid18848371",
                "pmid16223550",
                "pmid23226438",
                "pmid30820047",
                "pmid10490699",
                "pmid38368488"
            ]
        },
        "genetic_117": {
            "question": "Which gene is identified as a risk-modifying gene in Alzheimer's disease (AD) and is co-regulated with APOE in glial cells?",
            "answer": "D",
            "pmid": [
                "pmid9425904",
                "pmid38699303",
                "pmid19660836",
                "pmid10208564",
                "pmid33057949",
                "pmid34486652",
                "pmid37666928",
                "pmid34978151",
                "pmid23226438",
                "pmid26491253"
            ]
        },
        "genetic_118": {
            "question": "Which gene variant is associated with susceptibility to Thalidomide Embryopathy (TE) and may influence the CRL4-Cereblon complex's function, potentially relevant to delirium susceptibility?",
            "answer": "B",
            "pmid": [
                "pmid31964914",
                "pmid17250608",
                "pmid20002020",
                "pmid29478862",
                "pmid16314883",
                "pmid22759724",
                "pmid33779822",
                "pmid37898691",
                "pmid10235270",
                "pmid19219710"
            ]
        },
        "genetic_119": {
            "question": "Which molecule's activation is necessary for SREBP1 activation and lipogenesis in lipid-droplet-accumulating microglia in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid39809738",
                "pmid39803455",
                "pmid37333071",
                "pmid36620941",
                "pmid36203054",
                "pmid30911003",
                "pmid19098903",
                "pmid38565291",
                "pmid33998138",
                "pmid10440900"
            ]
        },
        "genetic_120": {
            "question": "How does the expression of Apolipoprotein D (apoD) compare in Alzheimer's disease (AD) versus Frontotemporal Dementia (FTD)?",
            "answer": "B",
            "pmid": [
                "pmid30467822",
                "pmid14596852",
                "pmid9751198",
                "pmid12873803",
                "pmid11276052",
                "pmid37672106",
                "pmid22785394",
                "pmid23690001",
                "pmid9073026",
                "pmid9425904"
            ]
        },
        "genetic_121": {
            "question": "Which of the following is a key metabolic gene downregulated in Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD)?",
            "answer": "A",
            "pmid": [
                "pmid22329649",
                "pmid32461378",
                "pmid37488757",
                "pmid2935594",
                "pmid36204837",
                "pmid19596066",
                "pmid36206930",
                "pmid11464464",
                "pmid38565291",
                "pmid26159189"
            ]
        },
        "genetic_122": {
            "question": "Which of the following SNPs in the ABCA7 gene was found to be significantly associated with an increased risk of Alzheimer's disease (AD) in the meta-analysis?",
            "answer": "A",
            "pmid": [
                "pmid24141082",
                "pmid29782324",
                "pmid29441941",
                "pmid39484364",
                "pmid15288432",
                "pmid25273678",
                "pmid17510946",
                "pmid23226438",
                "pmid15649702",
                "pmid15024730"
            ]
        },
        "genetic_124": {
            "question": "Which statement best describes the role of alanine-to-threonine (A-to-T) substitutions related to Alzheimer’s disease?",
            "answer": "D",
            "pmid": [
                "pmid20060816",
                "pmid1908231",
                "pmid10535332",
                "pmid24746363",
                "pmid8740986",
                "pmid15680223",
                "pmid27193083",
                "pmid21351586",
                "pmid38787367",
                "pmid24141082"
            ]
        },
        "genetic_125": {
            "question": "Which haplotype of the ACAT1 gene is associated with a protective effect against the development of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid33057949",
                "pmid16223550",
                "pmid26403748",
                "pmid25273678",
                "pmid29441941",
                "pmid34465723",
                "pmid30820047",
                "pmid15024730",
                "pmid25631235",
                "pmid20455082"
            ]
        },
        "genetic_126": {
            "question": "In Alzheimer's disease, overexpression of SRF and MYOCD in cerebral vascular smooth muscle cells leads to which outcome?",
            "answer": "B",
            "pmid": [
                "pmid19098903",
                "pmid17215356",
                "pmid9878757",
                "pmid39876020",
                "pmid19319544",
                "pmid23152628",
                "pmid38132159",
                "pmid36620941",
                "pmid26855936",
                "pmid35851991"
            ]
        },
        "genetic_127": {
            "question": "Which miRNA is implicated in alleviating fibrosis and inflammatory responses in tendon cells by targeting NFAT5, a process that may have implications for conditions like Alzheimer's disease?",
            "answer": "A.",
            "pmid": [
                "pmid35836925",
                "pmid18801740",
                "pmid33915734",
                "pmid27520374",
                "pmid32415525",
                "pmid22302353",
                "pmid31919655",
                "pmid30556160",
                "pmid30576233",
                "pmid19540598"
            ]
        },
        "genetic_128": {
            "question": "Which ABC transporter variant was significantly associated with Alzheimer's disease risk after logistic regression analysis?",
            "answer": "C",
            "pmid": [
                "pmid23556446",
                "pmid15288432",
                "pmid29441941",
                "pmid25273678",
                "pmid29782324",
                "pmid17510946",
                "pmid15024730",
                "pmid32447570",
                "pmid16725228",
                "pmid12600718"
            ]
        },
        "genetic_129": {
            "question": "Which allele of the TNF-alpha gene was found to increase the risk of Alzheimer's disease, especially in individuals with the apolipoprotein E epsilon4 allele?",
            "answer": "B",
            "pmid": [
                "pmid12962917",
                "pmid12116197",
                "pmid11273064",
                "pmid19618379",
                "pmid16516271",
                "pmid12782345",
                "pmid9425904",
                "pmid34978151",
                "pmid19660836",
                "pmid32076055"
            ]
        },
        "genetic_130": {
            "question": "Which gene's expression is increased during the acute phase (7-30 days) after brain ischemia in the CA3 area of the hippocampus, potentially contributing to Alzheimer's disease progression?",
            "answer": "B",
            "pmid": [
                "pmid35741821",
                "pmid38067191",
                "pmid39686609",
                "pmid31713815",
                "pmid38393914",
                "pmid1647485",
                "pmid26095650",
                "pmid38472200",
                "pmid10662826",
                "pmid8386339"
            ]
        },
        "genetic_131": {
            "question": "Which of the following best describes the role of the APH1B T27I variant in Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid31995180",
                "pmid24278306",
                "pmid29441941",
                "pmid14596852",
                "pmid23948886",
                "pmid9425904",
                "pmid25273678",
                "pmid24141082",
                "pmid29782324",
                "pmid37117777"
            ]
        },
        "genetic_132": {
            "question": "Which genetic risk factors for Alzheimer's disease were associated with larger EEA1 puncta volume in fibroblasts?",
            "answer": "A",
            "pmid": [
                "pmid30820047",
                "pmid36788216",
                "pmid34978151",
                "pmid10490699",
                "pmid17628213",
                "pmid18525129",
                "pmid15024730",
                "pmid10208564",
                "pmid15649702",
                "pmid12116197"
            ]
        },
        "genetic_133": {
            "question": "In studies examining the effects of statins on Alzheimer’s disease (AD)-related gene expression, which of the following was observed after simvastatin treatment in both astrocytes and neuroblastoma cells?",
            "answer": "A",
            "pmid": [
                "pmid19461118",
                "pmid15358814",
                "pmid26875818",
                "pmid26096465",
                "pmid15532546",
                "pmid21744242",
                "pmid26520569",
                "pmid26883430",
                "pmid19798641",
                "pmid26370080"
            ]
        },
        "genetic_134": {
            "question": "Which TFAM SNP was associated with an increased risk of Alzheimer disease in females?",
            "answer": "A",
            "pmid": [
                "pmid15464268",
                "pmid18430995",
                "pmid20977898",
                "pmid27272392",
                "pmid16725228",
                "pmid39051708",
                "pmid12116197",
                "pmid16055944",
                "pmid30820047",
                "pmid29441941"
            ]
        },
        "genetic_135": {
            "question": "Which variant of TREM2 increases the risk of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid24899047",
                "pmid31721052",
                "pmid31727362",
                "pmid36815315",
                "pmid34663480",
                "pmid39051708",
                "pmid27939925",
                "pmid23692967",
                "pmid37980675",
                "pmid32959884"
            ]
        },
        "genetic_136": {
            "question": "How does the overexpression of SAA1 affect Alzheimer's disease progression?",
            "answer": "B",
            "pmid": [
                "pmid31407125",
                "pmid12600718",
                "pmid37117777",
                "pmid12122052",
                "pmid15024730",
                "pmid17510946",
                "pmid34465723",
                "pmid33991608",
                "pmid28320965",
                "pmid24141082"
            ]
        },
        "genetic_137": {
            "question": "Which transcription factor's regulated gene set was downregulated in the hippocampus after MDMA treatment, potentially contributing to chronic impairments similar to those seen in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid30559663",
                "pmid18354027",
                "pmid31219369",
                "pmid27344237",
                "pmid24444253",
                "pmid30871034",
                "pmid34521861",
                "pmid23579326",
                "pmid20881126",
                "pmid31918655"
            ]
        },
        "genetic_138": {
            "question": "Which TREM1 variant was associated with amyloid-beta deposition in Alzheimer's disease?",
            "answer": "<Correct Answer>: A\n<Why>: Studies indicate that certain variants of the TREM2 gene are associated with Alzheimer's disease and impact amyloid plaque composition and deposition. Some variants appear protective, while others may increase risk. These variants also affect microglial function and neuroinflammation.",
            "pmid": [
                "pmid31721052",
                "pmid39051708",
                "pmid34663480",
                "pmid36815315",
                "pmid24899047",
                "pmid23692967",
                "pmid27939925",
                "pmid37980675",
                "pmid31727362",
                "pmid26058955"
            ]
        },
        "genetic_139": {
            "question": "Which PPAR-gamma haplotype was found to have a protective effect against Alzheimer's disease in APOE epsilon4 allele noncarriers?",
            "answer": "A",
            "pmid": [
                "pmid19660836",
                "pmid17803977",
                "pmid19631630",
                "pmid17270153",
                "pmid16988505",
                "pmid34978151",
                "pmid9425904",
                "pmid12938026",
                "pmid10208564",
                "pmid19618379"
            ]
        },
        "genetic_140": {
            "question": "What is the therapeutic potential of targeting DAT1 in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid28779511",
                "pmid39117070",
                "pmid35078269",
                "pmid31240602",
                "pmid28939187",
                "pmid33420799",
                "pmid28432138",
                "pmid33863723",
                "pmid32756440",
                "pmid35084179"
            ]
        },
        "genetic_141": {
            "question": "How does SGPT expression vary across disease stages in delirium tremens?",
            "answer": "B",
            "pmid": [
                "pmid37851904",
                "pmid17250608",
                "pmid7211434",
                "pmid20002020",
                "pmid34192631",
                "pmid9332560",
                "pmid19219710",
                "pmid38566855",
                "pmid16314883",
                "pmid549538"
            ]
        },
        "genetic_142": {
            "question": "How does P-selectin contribute to delirium-related CNS damage?",
            "answer": "A",
            "pmid": [
                "pmid31574089",
                "pmid33648701",
                "pmid38566855",
                "pmid37313848",
                "pmid6160732",
                "pmid39355007",
                "pmid28673598",
                "pmid32592865",
                "pmid24557038",
                "pmid20309566"
            ]
        },
        "genetic_143": {
            "question": "What is the role of TFEB in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid36031168",
                "pmid30108137",
                "pmid33099023",
                "pmid37013375",
                "pmid38581586",
                "pmid38321571",
                "pmid21879289",
                "pmid27713140",
                "pmid17628213",
                "pmid17080199"
            ]
        },
        "genetic_144": {
            "question": "How is RCAN1 expression altered in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid26497675",
                "pmid21216952",
                "pmid27861892",
                "pmid31263630",
                "pmid22495348",
                "pmid20097758",
                "pmid34465723",
                "pmid10817927",
                "pmid12600718",
                "pmid29782955"
            ]
        },
        "genetic_145": {
            "question": "What is the therapeutic potential of targeting ACE2 in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid33052346",
                "pmid32583667",
                "pmid33567524",
                "pmid34249938",
                "pmid38685540",
                "pmid38612861",
                "pmid36113018",
                "pmid24333930",
                "pmid38057817",
                "pmid25776136"
            ]
        },
        "genetic_146": {
            "question": "How is NPTX2 expression altered in delirium?",
            "answer": "A",
            "pmid": [
                "pmid28673598",
                "pmid35069913",
                "pmid37851904",
                "pmid34192631",
                "pmid7916159",
                "pmid38566855",
                "pmid36520371",
                "pmid39419070",
                "pmid34093168",
                "pmid30833544"
            ]
        },
        "genetic_147": {
            "question": "What is the role of rSO2 at T4 in delirium?",
            "answer": "A",
            "pmid": [
                "pmid36405895",
                "pmid19234823",
                "pmid36520371",
                "pmid37851904",
                "pmid39419070",
                "pmid28673598",
                "pmid6160732",
                "pmid7211434",
                "pmid7916159",
                "pmid39835091"
            ]
        },
        "genetic_148": {
            "question": "What is the role of EGFL7 in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid24141082",
                "pmid31690660",
                "pmid29641978",
                "pmid32989152",
                "pmid29441941",
                "pmid10095092",
                "pmid34486652",
                "pmid17080199",
                "pmid39231208",
                "pmid29782324"
            ]
        },
        "genetic_149": {
            "question": "What is the role of E4BP4 in delirium?",
            "answer": "B",
            "pmid": [
                "pmid32804136",
                "pmid35713240",
                "pmid2524220",
                "pmid28673598",
                "pmid37851904",
                "pmid37330271",
                "pmid7916159",
                "pmid36520371",
                "pmid19910874",
                "pmid39419070"
            ]
        },
        "genetic_150": {
            "question": "What is the role of SOAT-1 in delirium?",
            "answer": "B",
            "pmid": [
                "pmid37993790",
                "pmid39541802",
                "pmid37851904",
                "pmid36520371",
                "pmid27760517",
                "pmid22091570",
                "pmid31574089",
                "pmid17593314",
                "pmid32691721",
                "pmid39210294"
            ]
        },
        "genetic_151": {
            "question": "How is NLR expression altered in delirium?",
            "answer": "A",
            "pmid": [
                "pmid39835091",
                "pmid34093168",
                "pmid28673598",
                "pmid7916159",
                "pmid37851904",
                "pmid34192631",
                "pmid39419070",
                "pmid28769556",
                "pmid28519903",
                "pmid19422109"
            ]
        },
        "genetic_152": {
            "question": "What is the role of LPS in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid38561809",
                "pmid29520228",
                "pmid28928740",
                "pmid29353063",
                "pmid22495348",
                "pmid10490699",
                "pmid20878768",
                "pmid17080199",
                "pmid34315531",
                "pmid33737172"
            ]
        },
        "genetic_153": {
            "question": "What is the role of GAD65 in delirium?",
            "answer": "A",
            "pmid": [
                "pmid39210294",
                "pmid19309018",
                "pmid37851904",
                "pmid37993790",
                "pmid39463449",
                "pmid19422109",
                "pmid33779822",
                "pmid34757245",
                "pmid32018069",
                "pmid39419070"
            ]
        },
        "genetic_154": {
            "question": "How does DIO2 contribute to the development of Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid39105973",
                "pmid27725131",
                "pmid29481662",
                "pmid35691153",
                "pmid17105838",
                "pmid17004365",
                "pmid22837815",
                "pmid21351586",
                "pmid19387115",
                "pmid9878757"
            ]
        },
        "genetic_155": {
            "question": "What is the role of FABP3 in delirium?",
            "answer": "A",
            "pmid": [
                "pmid32804136",
                "pmid33901789",
                "pmid39419070",
                "pmid28673598",
                "pmid38937571",
                "pmid28519903",
                "pmid36520371",
                "pmid37851904",
                "pmid7916159",
                "pmid3765988"
            ]
        },
        "genetic_156": {
            "question": "What is the therapeutic potential of targeting SLC6A3 in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid36907286",
                "pmid29667108",
                "pmid33344892",
                "pmid26696494",
                "pmid25390692",
                "pmid18688088",
                "pmid38565393",
                "pmid33420799",
                "pmid23559013",
                "pmid39209323"
            ]
        },
        "genetic_157": {
            "question": "What is the role of CCL2 in delirium?",
            "answer": "B",
            "pmid": [
                "pmid35815182",
                "pmid36520371",
                "pmid28585290",
                "pmid37133446",
                "pmid31574089",
                "pmid33779822",
                "pmid37851904",
                "pmid2524220",
                "pmid37313848",
                "pmid7916159"
            ]
        },
        "genetic_158": {
            "question": "How does plasma GFAP correlate with CSF GFAP in delirium?",
            "answer": "D",
            "pmid": [
                "pmid28585290",
                "pmid2524220",
                "pmid549538",
                "pmid39839987",
                "pmid38566855",
                "pmid6160732",
                "pmid27058253",
                "pmid39419070",
                "pmid31574089",
                "pmid10473937"
            ]
        },
        "genetic_159": {
            "question": "What is the role of HIF-1 in delirium?",
            "answer": "B",
            "pmid": [
                "pmid31574089",
                "pmid37773821",
                "pmid28585290",
                "pmid37851904",
                "pmid21766035",
                "pmid28360657",
                "pmid37649721",
                "pmid2524220",
                "pmid36520371",
                "pmid22091570"
            ]
        },
        "genetic_160": {
            "question": "What is the role of CRP in TBI-related delirium?",
            "answer": "C",
            "pmid": [
                "pmid28360657",
                "pmid28585290",
                "pmid38937571",
                "pmid25943983",
                "pmid2524220",
                "pmid37649721",
                "pmid39839987",
                "pmid39355007",
                "pmid39419070",
                "pmid32804136"
            ]
        },
        "genetic_161": {
            "question": "What is the role of tyrosine hydroxylase (TH) in delirium?",
            "answer": "A",
            "pmid": [
                "pmid1971467",
                "pmid7211434",
                "pmid19422109",
                "pmid37851904",
                "pmid39419070",
                "pmid34978",
                "pmid7916159",
                "pmid20131213",
                "pmid32018069",
                "pmid36520371"
            ]
        },
        "genetic_162": {
            "question": "What is the therapeutic potential of targeting JUN in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid22033930",
                "pmid25611954",
                "pmid24457963",
                "pmid20451607",
                "pmid31563815",
                "pmid35303280",
                "pmid31354916",
                "pmid39117070",
                "pmid24059318",
                "pmid32317964"
            ]
        },
        "genetic_163": {
            "question": "How is AQP4 expression altered in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid27893874",
                "pmid28222512",
                "pmid37013549",
                "pmid29353063",
                "pmid39603277",
                "pmid25318543",
                "pmid30426203",
                "pmid36798226",
                "pmid8474686",
                "pmid33466666"
            ]
        },
        "genetic_164": {
            "question": "What is the therapeutic potential of targeting PMAT in Alzheimer's disease?",
            "answer": "C\n\n\n\n",
            "pmid": [
                "pmid38085467",
                "pmid39209323",
                "pmid35985445",
                "pmid36994913",
                "pmid30710367",
                "pmid31354916",
                "pmid27210751",
                "pmid38685540",
                "pmid31541651",
                "pmid26696494"
            ]
        },
        "genetic_165": {
            "question": "Which of the following statements best reflects the genetic or molecular contribution to the development of delirium in patients with acute pancreatitis, as indicated by recent evidence?",
            "answer": "B",
            "pmid": [
                "pmid33779822",
                "pmid30884164",
                "pmid32590150",
                "pmid39569322",
                "pmid19219710",
                "pmid34192631",
                "pmid23969090",
                "pmid19309018",
                "pmid32650186",
                "pmid22759724"
            ]
        },
        "genetic_166": {
            "question": "Is PS1 a potential therapeutic target for Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid33761853",
                "pmid27072684",
                "pmid27569389",
                "pmid24059318",
                "pmid39117070",
                "pmid21086758",
                "pmid37018887",
                "pmid37301482",
                "pmid31840000",
                "pmid34302466"
            ]
        },
        "genetic_167": {
            "question": "What is the therapeutic potential of targeting IL6R in delirium?",
            "answer": "A",
            "pmid": [
                "pmid34014798",
                "pmid37993790",
                "pmid21851175",
                "pmid39419070",
                "pmid27760517",
                "pmid27088157",
                "pmid24557038",
                "pmid20309566",
                "pmid38911008",
                "pmid39541802"
            ]
        },
        "genetic_168": {
            "question": "What is the role of PARP1 in Alzheimer's Disease?",
            "answer": "D",
            "pmid": [
                "pmid24086258",
                "pmid23076628",
                "pmid22430645",
                "pmid28698968",
                "pmid15671026",
                "pmid9444352",
                "pmid31840000",
                "pmid35078269",
                "pmid17911636",
                "pmid28341998"
            ]
        },
        "genetic_169": {
            "question": "What is the therapeutic potential of targeting NF-kappaB in delirium?",
            "answer": "B",
            "pmid": [
                "pmid37993790",
                "pmid20309566",
                "pmid27088157",
                "pmid37991969",
                "pmid39541802",
                "pmid30390679",
                "pmid28360657",
                "pmid39419070",
                "pmid31574089",
                "pmid24557038"
            ]
        },
        "genetic_170": {
            "question": "How does HTR1A contribute to the development of delirium?",
            "answer": "A",
            "pmid": [
                "pmid27760517",
                "pmid37851904",
                "pmid39835091",
                "pmid7916159",
                "pmid28673598",
                "pmid33779822",
                "pmid37993790",
                "pmid37649721",
                "pmid33648701",
                "pmid19422109"
            ]
        },
        "genetic_171": {
            "question": "What is the role of myeloperoxidase-DNA in delirium?",
            "answer": "B",
            "pmid": [
                "pmid32590150",
                "pmid34192631",
                "pmid33779822",
                "pmid19309018",
                "pmid36266784",
                "pmid37851904",
                "pmid32650186",
                "pmid34887385",
                "pmid37722373",
                "pmid39419070"
            ]
        },
        "genetic_172": {
            "question": "How is HLA-DR expression altered in delirium?",
            "answer": "A",
            "pmid": [
                "pmid34192631",
                "pmid32590150",
                "pmid28769556",
                "pmid24557038",
                "pmid37851904",
                "pmid37649721",
                "pmid21978081",
                "pmid39419070",
                "pmid33779822",
                "pmid36045041"
            ]
        },
        "genetic_173": {
            "question": "What is the role of NG2 in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid24918635",
                "pmid9878757",
                "pmid8730800",
                "pmid18706502",
                "pmid33052346",
                "pmid17911636",
                "pmid29453790",
                "pmid10817927",
                "pmid36739453",
                "pmid24746363"
            ]
        },
        "genetic_174": {
            "question": "What is the role of CXCL2 in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid26401931",
                "pmid31209068",
                "pmid31822518",
                "pmid21771791",
                "pmid31849963",
                "pmid24164736",
                "pmid39605963",
                "pmid22970285",
                "pmid8730800",
                "pmid32614980"
            ]
        },
        "genetic_175": {
            "question": "What is the spatial expression pattern of NPY in the brain regions affected by Alzheimers disease?",
            "answer": "A",
            "pmid": [
                "pmid2900051",
                "pmid7916770",
                "pmid38958450",
                "pmid10964481",
                "pmid9878757",
                "pmid24334724",
                "pmid11276052",
                "pmid37264161",
                "pmid2391515",
                "pmid39876020"
            ]
        },
        "genetic_176": {
            "question": "What is a notable difference between genetic findings in non–alcohol withdrawal delirium and alcohol withdrawal delirium?",
            "answer": "A",
            "pmid": [
                "pmid19219710",
                "pmid17250608",
                "pmid33779822",
                "pmid9024952",
                "pmid12513948",
                "pmid10235270",
                "pmid29478862",
                "pmid11912074",
                "pmid20002020",
                "pmid12374639"
            ]
        },
        "genetic_177": {
            "question": "What is the therapeutic potential of targeting RUNX3 in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid18440671",
                "pmid37533493",
                "pmid30362958",
                "pmid39345364",
                "pmid31849963",
                "pmid31822518",
                "pmid38565393",
                "pmid39117070",
                "pmid32756440",
                "pmid39002124"
            ]
        },
        "genetic_178": {
            "question": "What is the therapeutic potential of targeting MAOA in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid38085467",
                "pmid38349393",
                "pmid21272191",
                "pmid35759686",
                "pmid35665766",
                "pmid38203753",
                "pmid31541651",
                "pmid38006681",
                "pmid35360200",
                "pmid36817510"
            ]
        },
        "genetic_179": {
            "question": "How is RNF146 expression altered in delirium?",
            "answer": "A",
            "pmid": [
                "pmid34192631",
                "pmid37851904",
                "pmid28585290",
                "pmid28673598",
                "pmid39419070",
                "pmid37649721",
                "pmid39355007",
                "pmid2524220",
                "pmid7916159",
                "pmid37883680"
            ]
        },
        "genetic_180": {
            "question": "Is DAT differentially expressed in single-cell transcriptomic profiles of agitated cocaine delirium?",
            "answer": "B",
            "pmid": [
                "pmid10581411",
                "pmid22803793",
                "pmid12064476",
                "pmid10415668",
                "pmid9024952",
                "pmid30248905",
                "pmid19541436",
                "pmid8988571",
                "pmid12513948",
                "pmid12684441"
            ]
        },
        "genetic_181": {
            "question": "What is the therapeutic potential of targeting HSV1 in Alzheimer's Disease?",
            "answer": "B",
            "pmid": [
                "pmid24502805",
                "pmid25157230",
                "pmid28765170",
                "pmid34205498",
                "pmid30008124",
                "pmid21975314",
                "pmid37009449",
                "pmid33998138",
                "pmid37118112",
                "pmid39682726"
            ]
        },
        "genetic_182": {
            "question": "How is DRD1 expression altered in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid35078269",
                "pmid19235789",
                "pmid11723200",
                "pmid28432138",
                "pmid27647283",
                "pmid22785394",
                "pmid22367970",
                "pmid29937728",
                "pmid22495348",
                "pmid9878757"
            ]
        },
        "genetic_183": {
            "question": "What is the role of OAS1 in Alzheimer's disease?",
            "answer": "A",
            "pmid": [
                "pmid34465723",
                "pmid38259635",
                "pmid38216963",
                "pmid31931285",
                "pmid32708329",
                "pmid9878757",
                "pmid12600718",
                "pmid39117070",
                "pmid24141082",
                "pmid20097758"
            ]
        },
        "genetic_184": {
            "question": "What is the role of IL1RL1 in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid37117777",
                "pmid12740599",
                "pmid21514692",
                "pmid17614163",
                "pmid34486652",
                "pmid21771791",
                "pmid11578773",
                "pmid18509040",
                "pmid19893026",
                "pmid28904096"
            ]
        },
        "genetic_185": {
            "question": "Which of the following molecular features was specifically highlighted as a potential therapeutic target based on genetic and protein-level analysis of plasma exosomes in patients with postoperative delirium?",
            "answer": "D",
            "pmid": [
                "pmid39604493",
                "pmid38223851",
                "pmid37722373",
                "pmid39519398",
                "pmid34093168",
                "pmid29529166",
                "pmid39199312",
                "pmid36266784",
                "pmid39814058",
                "pmid39317458"
            ]
        },
        "genetic_186": {
            "question": "How does ACE2 expression vary across disease stages in Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid34249938",
                "pmid33052346",
                "pmid33567524",
                "pmid33283188",
                "pmid10817927",
                "pmid36739453",
                "pmid35901083",
                "pmid31442405",
                "pmid37172190",
                "pmid22495348"
            ]
        },
        "genetic_187": {
            "question": "How is PD-1 expression altered in Alzheimer's Disease?",
            "answer": "D",
            "pmid": [
                "pmid21514692",
                "pmid10095092",
                "pmid29358916",
                "pmid9878757",
                "pmid11276052",
                "pmid38958450",
                "pmid10817927",
                "pmid8740986",
                "pmid9444352",
                "pmid8239309"
            ]
        },
        "genetic_188": {
            "question": "What is the role of NQO2 in Alzheimer's disease?",
            "answer": "D",
            "pmid": [
                "pmid17027152",
                "pmid18706502",
                "pmid38254976",
                "pmid12203047",
                "pmid37343463",
                "pmid31520071",
                "pmid21351586",
                "pmid31091472",
                "pmid9514829",
                "pmid39521153"
            ]
        },
        "genetic_190": {
            "question": "What is the role of ACE2R in delirium?",
            "answer": "A",
            "pmid": [
                "pmid39210294",
                "pmid39835091",
                "pmid37993790",
                "pmid37851904",
                "pmid24852225",
                "pmid36520371",
                "pmid39419070",
                "pmid7916159",
                "pmid39541802",
                "pmid37313848"
            ]
        },
        "genetic_191": {
            "question": "What is the therapeutic potential of targeting GRIN2B in Alzheimer's disease?",
            "answer": "The provided context does **not** contain any information about targeting GRIN2B or its therapeutic potential in Alzheimer's disease. Therefore, it is impossible to answer the question based on the given text. \n\n\n\n",
            "pmid": [
                "pmid27926996",
                "pmid38006681",
                "pmid37598923",
                "pmid32756440",
                "pmid25776136",
                "pmid25390692",
                "pmid39002124",
                "pmid35677758",
                "pmid39117070",
                "pmid33420799"
            ]
        },
        "genetic_192": {
            "question": "Which genotypes are associated with decreased odds of incident delirium in elderly post-surgical patients?",
            "answer": "D",
            "pmid": [
                "pmid35017578",
                "pmid21613790",
                "pmid19309018",
                "pmid19713702",
                "pmid17721242",
                "pmid34674705",
                "pmid22302107",
                "pmid26238230",
                "pmid21438141",
                "pmid17728664"
            ]
        },
        "genetic_193": {
            "question": "Does cardiac surgery trigger NLRP3 inflammasome activation?",
            "answer": "D",
            "pmid": [
                "pmid30288079",
                "pmid39816134",
                "pmid29384096",
                "pmid36127465",
                "pmid34445484",
                "pmid38110429",
                "pmid37223529",
                "pmid32751171",
                "pmid23994495",
                "pmid37651190"
            ]
        },
        "genetic_194": {
            "question": "What was the finding regarding the association between IGF-1 levels and delirium in this study?",
            "answer": "C",
            "pmid": [
                "pmid21766035",
                "pmid21294938",
                "pmid15660412",
                "pmid29605680",
                "pmid26846868",
                "pmid33014722",
                "pmid19269948",
                "pmid28360657",
                "pmid22091570",
                "pmid33336596"
            ]
        },
        "genetic_195": {
            "question": "What was the adjusted odds ratio (OR) for delirium in sigma4 carriers compared to non-sigma4 carriers, accounting for age, cognitive, and functional impairment?",
            "answer": "D",
            "pmid": [
                "pmid19910874",
                "pmid20471115",
                "pmid34034650",
                "pmid27122004",
                "pmid17728664",
                "pmid38566855",
                "pmid36973363",
                "pmid38161287",
                "pmid26397939",
                "pmid11563209"
            ]
        },
        "genetic_197": {
            "question": "Was cathepsin-B identified as a biomarker in the study?",
            "answer": "A",
            "pmid": [
                "pmid39304744",
                "pmid32640970",
                "pmid36499428",
                "pmid17261088",
                "pmid18979630",
                "pmid37957754",
                "pmid30530526",
                "pmid14522241",
                "pmid39453382",
                "pmid28615690"
            ]
        },
        "genetic_198": {
            "question": "What temperature was the mean core body temperature recorded in excited delirium deaths?",
            "answer": "D",
            "pmid": [
                "pmid19541436",
                "pmid31301637",
                "pmid27790150",
                "pmid22622258",
                "pmid36078999",
                "pmid22803793",
                "pmid8988571",
                "pmid7211435",
                "pmid39419070",
                "pmid31770149"
            ]
        },
        "genetic_199": {
            "question": "What was the median cerebrospinal fluid apolipoprotein E level in LOAD outpatients?",
            "answer": "D",
            "pmid": [
                "pmid28868067",
                "pmid9073026",
                "pmid27380243",
                "pmid9751198",
                "pmid19910874",
                "pmid17606532",
                "pmid14596852",
                "pmid15165699",
                "pmid37854772",
                "pmid17133176"
            ]
        },
        "genetic_200": {
            "question": "At what locations does PLK1 phosphorylate Drosha?",
            "answer": "C",
            "pmid": [
                "pmid37762595",
                "pmid28415805",
                "pmid34454931",
                "pmid37791873",
                "pmid37633326",
                "pmid38086800",
                "pmid26582459",
                "pmid35106914",
                "pmid29968773",
                "pmid34480965"
            ]
        },
        "genetic_201": {
            "question": "Does the upregulation of miR-204-5p lead to the death of dopaminergic cells by targeting DYRK1A-mediated apoptotic signaling?",
            "answer": "A",
            "pmid": [
                "pmid31572127",
                "pmid29936262",
                "pmid34121317",
                "pmid31383850",
                "pmid34080649",
                "pmid33575111",
                "pmid34026326",
                "pmid31306739",
                "pmid31134481",
                "pmid32415525"
            ]
        },
        "genetic_202": {
            "question": "In Neuro2a cells, how does miR-137 affect Abeta-induced neurotoxicity?",
            "answer": "B",
            "pmid": [
                "pmid28655611",
                "pmid30264333",
                "pmid29286086",
                "pmid31949779",
                "pmid25828534",
                "pmid38111333",
                "pmid24604632",
                "pmid31134481",
                "pmid32415525",
                "pmid26398571"
            ]
        },
        "genetic_203": {
            "question": "Which genotypes of the rs2421943 polymorphism increase the risk of Alzheimer's disease?",
            "answer": "D",
            "pmid": [
                "pmid29441941",
                "pmid25273678",
                "pmid25130782",
                "pmid27272392",
                "pmid9425904",
                "pmid30820047",
                "pmid12938026",
                "pmid34978151",
                "pmid26403748",
                "pmid39051708"
            ]
        },
        "genetic_204": {
            "question": "According to this study, is ESR1 a promising target of the Yizhiqingxin formula against Alzheimer's disease and major depression disorder comorbidities?",
            "answer": "A",
            "pmid": [
                "pmid35548356",
                "pmid31607908",
                "pmid36326669",
                "pmid28521305",
                "pmid38682858",
                "pmid29449587",
                "pmid23660953",
                "pmid36280008",
                "pmid31563815",
                "pmid36249769"
            ]
        },
        "genetic_205": {
            "question": "What amino acid change is caused by the T to C single nucleotide polymorphism (SNP) in the CPE gene at bp980?",
            "answer": "D",
            "pmid": [
                "pmid28114332",
                "pmid29066910",
                "pmid27583919",
                "pmid15165699",
                "pmid32939514",
                "pmid27861892",
                "pmid37717471",
                "pmid35300571",
                "pmid27713335",
                "pmid31392591"
            ]
        },
        "genetic_206": {
            "question": "In C9orf72 mutation carriers, does the rs7550295 variant in the CLSTN1 gene delay the age of disease onset?",
            "answer": "C",
            "pmid": [
                "pmid39000564",
                "pmid37494190",
                "pmid22829467",
                "pmid36951251",
                "pmid31405128",
                "pmid26949549",
                "pmid20158511",
                "pmid35311709",
                "pmid31235344",
                "pmid16231093"
            ]
        },
        "genetic_207": {
            "question": "How does the UAF1 deubiquitinase complex affect NLRP3 and pro-IL-1beta expression?",
            "answer": "A",
            "pmid": [
                "pmid33247121",
                "pmid34445484",
                "pmid29384096",
                "pmid39816134",
                "pmid30288079",
                "pmid36127465",
                "pmid38110429",
                "pmid37651190",
                "pmid31835423",
                "pmid31845722"
            ]
        },
        "genetic_208": {
            "question": "Which genetic variant was found to act as a protective factor against late-onset Alzheimer's disease (LOAD)?",
            "answer": "D",
            "pmid": [
                "pmid30820047",
                "pmid25189118",
                "pmid28269768",
                "pmid12116197",
                "pmid15288432",
                "pmid18430995",
                "pmid28477215",
                "pmid15024730",
                "pmid39000564",
                "pmid30569016"
            ]
        },
        "genetic_209": {
            "question": "Which of the following AKT1 alleles are considered protective factors for microscopic polyangiitis (MPA)?",
            "answer": "B",
            "pmid": [
                "pmid37029297",
                "pmid16516271",
                "pmid31840000",
                "pmid9890433",
                "pmid31811815",
                "pmid20050683",
                "pmid18434187",
                "pmid32642407",
                "pmid30294687",
                "pmid22133278"
            ]
        },
        "genetic_210": {
            "question": "Does the ACE insertion/deletion polymorphism affect the onset age of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid34034613",
                "pmid12116197",
                "pmid22829467",
                "pmid36951251",
                "pmid30820047",
                "pmid16223550",
                "pmid29441941",
                "pmid16516271",
                "pmid26949549",
                "pmid11065130"
            ]
        },
        "genetic_211": {
            "question": "Which genetic variants in ERBB4 are associated with a reduced risk of chronic HBV infection?",
            "answer": "D",
            "pmid": [
                "pmid26701850",
                "pmid35215970",
                "pmid37898691",
                "pmid12143056",
                "pmid31393946",
                "pmid28269768",
                "pmid27540591",
                "pmid35341343",
                "pmid25651370",
                "pmid17721242"
            ]
        },
        "genetic_212": {
            "question": "What molecules are significantly affected by the deregulation of LRSAM1?",
            "answer": "D",
            "pmid": [
                "pmid30726272",
                "pmid29845787",
                "pmid27686364",
                "pmid38553684",
                "pmid24278483",
                "pmid35450293",
                "pmid33568173",
                "pmid32342250",
                "pmid34026845",
                "pmid30530526"
            ]
        },
        "genetic_213": {
            "question": "What effect does the CFH gene variant rs800292 have on CSF tau and Abeta levels?",
            "answer": "C",
            "pmid": [
                "pmid26243271",
                "pmid27380243",
                "pmid18461138",
                "pmid20850903",
                "pmid16055944",
                "pmid32919460",
                "pmid28100725",
                "pmid34958910",
                "pmid39000564",
                "pmid37494190"
            ]
        },
        "genetic_214": {
            "question": "Which gene's regulation by BIN1 is implicated in the inflammatory response during Alzheimer's disease pathogenesis?",
            "answer": "A",
            "pmid": [
                "pmid35526014",
                "pmid23399914",
                "pmid32657270",
                "pmid29479533",
                "pmid32727516",
                "pmid37521457",
                "pmid23226438",
                "pmid12740599",
                "pmid32925027",
                "pmid34966527"
            ]
        },
        "genetic_215": {
            "question": "Which of the following genes are identified as Alzheimer's disease-related immune hub genes?",
            "answer": "D",
            "pmid": [
                "pmid34966527",
                "pmid32925027",
                "pmid34719321",
                "pmid34975305",
                "pmid30820047",
                "pmid33446646",
                "pmid30319691",
                "pmid29432188",
                "pmid34484988",
                "pmid34708251"
            ]
        },
        "genetic_216": {
            "question": "Which BDNF SNPs were significantly associated with measures of cognitive decline?",
            "answer": "B",
            "pmid": [
                "pmid15635706",
                "pmid15375678",
                "pmid24086677",
                "pmid14730194",
                "pmid28269768",
                "pmid18848371",
                "pmid31985465",
                "pmid24179750",
                "pmid17344400",
                "pmid27336024"
            ]
        },
        "genetic_217": {
            "question": "Which single nucleotide polymorphism (SNP) in the ATP7B gene showed a significant association with Alzheimer's disease under a recessive model?",
            "answer": "C",
            "pmid": [
                "pmid29441941",
                "pmid24141082",
                "pmid23830383",
                "pmid25273678",
                "pmid21760992",
                "pmid23948886",
                "pmid15288432",
                "pmid23556446",
                "pmid29782324",
                "pmid25130782"
            ]
        },
        "genetic_218": {
            "question": "Which allele of the NEP gene locus rs701109 may be a potential risk factor for Alzheimer's disease in Tibetan males?",
            "answer": "D",
            "pmid": [
                "pmid33314757",
                "pmid20376800",
                "pmid15860464",
                "pmid19250583",
                "pmid15548496",
                "pmid26738859",
                "pmid14741412",
                "pmid15784960",
                "pmid25130782",
                "pmid20627730"
            ]
        },
        "genetic_219": {
            "question": "Which gene variant was identified in a sub-cohort of VCI patients?",
            "answer": "C",
            "pmid": [
                "pmid38935518",
                "pmid35307828",
                "pmid27314523",
                "pmid37898691",
                "pmid25390694",
                "pmid23186985",
                "pmid31485167",
                "pmid22890094",
                "pmid36754567",
                "pmid12198366"
            ]
        },
        "genetic_220": {
            "question": "Does the 647C variant of the ENT1 (SLC29A1) gene have an association with alcohol withdrawal seizures?",
            "answer": "C",
            "pmid": [
                "pmid21283641",
                "pmid36198764",
                "pmid12374639",
                "pmid9024952",
                "pmid11204345",
                "pmid16314883",
                "pmid12513948",
                "pmid20002020",
                "pmid15996968",
                "pmid11912074"
            ]
        },
        "genetic_221": {
            "question": "Which molecule, increased in Alzheimer's disease, negatively regulates synaptotagmin 1 (SYT1) through the ROS-JNK-p53 pathway?",
            "answer": "A",
            "pmid": [
                "pmid32092796",
                "pmid15548589",
                "pmid17301176",
                "pmid37018887",
                "pmid24457963",
                "pmid9878757",
                "pmid23579332",
                "pmid26045440",
                "pmid8740986",
                "pmid15778722"
            ]
        },
        "genetic_222": {
            "question": "Which gene was identified as an interactor of Drosophila VAPB in the genetic screen?",
            "answer": "B",
            "pmid": [
                "pmid25361581",
                "pmid20940299",
                "pmid25826266",
                "pmid23409049",
                "pmid11771742",
                "pmid32107387",
                "pmid24985705",
                "pmid32925027",
                "pmid20142804",
                "pmid17304350"
            ]
        },
        "genetic_223": {
            "question": "Which genotype of the CHI3L1 rs4950928 C>G polymorphism is associated with a reduced risk of Alzheimer's disease?",
            "answer": "B",
            "pmid": [
                "pmid30223258",
                "pmid16223550",
                "pmid18562794",
                "pmid12807963",
                "pmid22382309",
                "pmid21562723",
                "pmid25273678",
                "pmid29441941",
                "pmid22890094",
                "pmid15860461"
            ]
        },
        "genetic_224": {
            "question": "Which gene encodes the alpha7 nicotinic acetylcholine receptor and has been implicated in various psychiatric and behavioral disorders, including schizophrenia?",
            "answer": "B",
            "pmid": [
                "pmid25701707",
                "pmid11278378",
                "pmid28045139",
                "pmid30345917",
                "pmid29570959",
                "pmid34521861",
                "pmid21873960",
                "pmid25019689",
                "pmid12374639",
                "pmid38110001"
            ]
        },
        "genetic_225": {
            "question": "What was discovered from tumor samples using in silico analysis?",
            "answer": "C",
            "pmid": [
                "pmid20442453",
                "pmid39326662",
                "pmid31534119",
                "pmid15299072",
                "pmid37099121",
                "pmid38834986",
                "pmid31754326",
                "pmid28915616",
                "pmid33019464",
                "pmid36292984"
            ]
        },
        "genetic_226": {
            "question": "Which miRNA was identified as a potentially good candidate for treating both Alzheimer's disease and breast cancer?",
            "answer": "D",
            "pmid": [
                "pmid37487248",
                "pmid37212107",
                "pmid18234899",
                "pmid26847596",
                "pmid34945753",
                "pmid22926857",
                "pmid25955795",
                "pmid26398571",
                "pmid29286086",
                "pmid24604632"
            ]
        },
        "genetic_227": {
            "question": "Which genetic factor, when found with elevated blood MCP-1 levels, is associated with an increased risk of Alzheimer's disease?",
            "answer": "C",
            "pmid": [
                "pmid37841863",
                "pmid23432970",
                "pmid36396603",
                "pmid10490699",
                "pmid17284348",
                "pmid15649702",
                "pmid30820047",
                "pmid25273678",
                "pmid12600718",
                "pmid29441941"
            ]
        },
        "genetic_228": {
            "question": "Which of the following mechanisms may potentially link NPTX2 dysregulation to neurological conditions such as delirium?",
            "answer": "D",
            "pmid": [
                "pmid38566855",
                "pmid28673598",
                "pmid7916159",
                "pmid30833544",
                "pmid37313848",
                "pmid20309566",
                "pmid32018069",
                "pmid35069913",
                "pmid19422109",
                "pmid39419070"
            ]
        },
        "genetic_229": {
            "question": "Which of the following genes showed a positive correlation with gamma delta T cell expression?",
            "answer": "C",
            "pmid": [
                "pmid37591521",
                "pmid39243388",
                "pmid19893026",
                "pmid31755616",
                "pmid30380669",
                "pmid26305120",
                "pmid38111016",
                "pmid39682726",
                "pmid35836925",
                "pmid39908354"
            ]
        },
        "genetic_230": {
            "question": "Which gene associated with Alzheimer's disease is upregulated by a constitutively active IRF3 in microglia?",
            "answer": "A\n",
            "pmid": [
                "pmid39215356",
                "pmid38654824",
                "pmid28856571",
                "pmid33402227",
                "pmid38271298",
                "pmid36798226",
                "pmid28434692",
                "pmid33446646",
                "pmid37774678",
                "pmid19893026"
            ]
        },
        "genetic_231": {
            "question": "What optimal cutoff value of DAO levels distinguishes Alzheimer's disease patients from healthy controls with high sensitivity and specificity?",
            "answer": "C",
            "pmid": [
                "pmid29093468",
                "pmid35430632",
                "pmid25364236",
                "pmid14596852",
                "pmid22785394",
                "pmid37343463",
                "pmid28858444",
                "pmid34294612",
                "pmid35986919",
                "pmid21351586"
            ]
        },
        "genetic_232": {
            "question": "Which of the following best describes the relationship between MMP9 and delirium based on current experimental findings?",
            "answer": "D",
            "pmid": [
                "pmid38937571",
                "pmid39419070",
                "pmid28673598",
                "pmid39210294",
                "pmid20309566",
                "pmid37851904",
                "pmid33779822",
                "pmid38566855",
                "pmid24557038",
                "pmid7916159"
            ]
        },
        "genetic_234": {
            "question": "Which of the following best describes the relationship between CCKAR gene polymorphisms and delirium tremens?",
            "answer": "D",
            "pmid": [
                "pmid12198366",
                "pmid33779822",
                "pmid10235270",
                "pmid17250608",
                "pmid21613790",
                "pmid11513220",
                "pmid19309018",
                "pmid29478862",
                "pmid10803770",
                "pmid16314883"
            ]
        },
        "genetic_235": {
            "question": "What is the effect of miR-6775 on the CHRNA7 gene?",
            "answer": "D",
            "pmid": [
                "pmid26347869",
                "pmid25701707",
                "pmid37487248",
                "pmid29286086",
                "pmid33361033",
                "pmid23034144",
                "pmid18234899",
                "pmid37400958",
                "pmid37300691",
                "pmid39206401"
            ]
        },
        "genetic_236": {
            "question": "Which genotypes of the miR-148 rs4719839 single nucleotide polymorphism (SNP) were more prone to VAP?",
            "answer": "B",
            "pmid": [
                "pmid32940422",
                "pmid25390694",
                "pmid22348086",
                "pmid21283641",
                "pmid24586483",
                "pmid25361581",
                "pmid33361033",
                "pmid26347869",
                "pmid22099153",
                "pmid37487248"
            ]
        },
        "genetic_237": {
            "question": "Which gene polymorphism was studied in relation to delirium tremens in alcoholics?",
            "answer": "B",
            "pmid": [
                "pmid17250608",
                "pmid20002020",
                "pmid16314883",
                "pmid19219710",
                "pmid33779822",
                "pmid29478862",
                "pmid9024952",
                "pmid19309018",
                "pmid21613790",
                "pmid10235270"
            ]
        },
        "genetic_238": {
            "question": "According to the study, how are growth hormone (GH) levels associated with delirium?",
            "answer": "D",
            "pmid": [
                "pmid33014722",
                "pmid21766035",
                "pmid10473937",
                "pmid21294938",
                "pmid29605680",
                "pmid15660412",
                "pmid33779822",
                "pmid37851904",
                "pmid17234821",
                "pmid39463449"
            ]
        },
        "genetic_239": {
            "question": "How does APOE epsilon4 status influence the relationship between CRP and delirium incidence?",
            "answer": "A.",
            "pmid": [
                "pmid19910874",
                "pmid26901792",
                "pmid31761478",
                "pmid28868067",
                "pmid17728664",
                "pmid17203511",
                "pmid23969090",
                "pmid17133176",
                "pmid27122004",
                "pmid20471115"
            ]
        },
        "genetic_240": {
            "question": "What biomarkers were found to have significant associations with ICU delirium in the pooled analysis?",
            "answer": "In pooled analysis, significant associations were found between ICU delirium and amyloid beta-peptide 1-40, interleukin (IL)-1 receptor antagonist, and IL-6.",
            "pmid": [
                "pmid31770149",
                "pmid17234821",
                "pmid34098376",
                "pmid36078999",
                "pmid34912245",
                "pmid22091570",
                "pmid17352663",
                "pmid27088157",
                "pmid34195769",
                "pmid22903241"
            ]
        },
        "genetic_241": {
            "question": "According to the study, what difference was observed in IGF-I levels between delirious and non-delirious groups?",
            "answer": "B",
            "pmid": [
                "pmid21766035",
                "pmid33014722",
                "pmid19269948",
                "pmid26846868",
                "pmid15660412",
                "pmid29605680",
                "pmid21294938",
                "pmid20471115",
                "pmid22091570",
                "pmid17234821"
            ]
        },
        "genetic_242": {
            "question": "In both mice and humans after surgery, how did YKL-40 levels change in plasma versus cerebrospinal fluid (CSF)?",
            "answer": "D",
            "pmid": [
                "pmid36457825",
                "pmid39505249",
                "pmid38042775",
                "pmid28848542",
                "pmid38582976",
                "pmid6160732",
                "pmid35265844",
                "pmid38895540",
                "pmid33409674",
                "pmid38796964"
            ]
        },
        "genetic_243": {
            "question": "According to the text, what does sustained dopamine D2 receptor (D2R) signaling in the hippocampal formation induce?",
            "answer": "C",
            "pmid": [
                "pmid12391586",
                "pmid35665767",
                "pmid24914776",
                "pmid24852225",
                "pmid32756440",
                "pmid21820453",
                "pmid27926996",
                "pmid32572762",
                "pmid29311807",
                "pmid28966575"
            ]
        },
        "genetic_244": {
            "question": "According to the study, what function does the SLC7A11 subunit perform?",
            "answer": "B",
            "pmid": [
                "pmid35986919",
                "pmid35450293",
                "pmid34026845",
                "pmid34650206",
                "pmid31547050",
                "pmid38360971",
                "pmid21554332",
                "pmid31952134",
                "pmid39129223",
                "pmid36613460"
            ]
        },
        "genetic_245": {
            "question": "What factor is associated with greater delirium severity at baseline in individuals with dementia?",
            "answer": "The presence of an APOE epsilon4 allele and a higher Clinical Dementia Rating Scale were associated with greater delirium severity at baseline.",
            "pmid": [
                "pmid21488579",
                "pmid27122004",
                "pmid37566435",
                "pmid11563209",
                "pmid31770149",
                "pmid32241566",
                "pmid37812498",
                "pmid29966197",
                "pmid29723848",
                "pmid39355007"
            ]
        },
        "genetic_246": {
            "question": "What correlation do PER2 and HO1 expression levels have with delirium?",
            "answer": "D",
            "pmid": [
                "pmid34321570",
                "pmid33779822",
                "pmid31574089",
                "pmid39835091",
                "pmid37851904",
                "pmid37649721",
                "pmid17234821",
                "pmid34098376",
                "pmid28673598",
                "pmid34192631"
            ]
        },
        "genetic_247": {
            "question": "What effect does downregulation of RXRA have on delirium in mice with COPD?",
            "answer": "C",
            "pmid": [
                "pmid38372090",
                "pmid36216079",
                "pmid37596640",
                "pmid29489460",
                "pmid27760517",
                "pmid38155547",
                "pmid37313848",
                "pmid38895540",
                "pmid37968531",
                "pmid24990154"
            ]
        },
        "genetic_248": {
            "question": "In individuals who died from cocaine-related causes, how does heat shock protein 70 (HSP70) expression in the brain compare to control subjects?",
            "answer": "C",
            "pmid": [
                "pmid22803793",
                "pmid8386339",
                "pmid19541436",
                "pmid10581411",
                "pmid12684441",
                "pmid8988571",
                "pmid10415668",
                "pmid12064476",
                "pmid27323860",
                "pmid27790150"
            ]
        },
        "genetic_249": {
            "question": "What effect does CCR5 deficiency have on neurons?",
            "answer": "D",
            "pmid": [
                "pmid19394434",
                "pmid26910914",
                "pmid37489764",
                "pmid19729478",
                "pmid11432802",
                "pmid37769321",
                "pmid36853429",
                "pmid15288441",
                "pmid26095650",
                "pmid17360894"
            ]
        },
        "genetic_251": {
            "question": "What role does D-amino acid oxidase (DAO) play in the context of N-methyl-D-aspartate receptor (NMDAR) function?",
            "answer": "B",
            "pmid": [
                "pmid29093468",
                "pmid37343463",
                "pmid35430632",
                "pmid31520071",
                "pmid21351586",
                "pmid34294612",
                "pmid32425755",
                "pmid11181824",
                "pmid39893485",
                "pmid2391515"
            ]
        },
        "genetic_252": {
            "question": "Were polymorphisms in the COMT gene associated with delirium?",
            "answer": "C",
            "pmid": [
                "pmid21613790",
                "pmid33779822",
                "pmid19309018",
                "pmid17250608",
                "pmid31046593",
                "pmid19219710",
                "pmid22759724",
                "pmid20002020",
                "pmid10235270",
                "pmid15488308"
            ]
        },
        "genetic_253": {
            "question": "Which genetic factors interacting decreases the likelihood of delirium tremens in alcoholics?",
            "answer": "B",
            "pmid": [
                "pmid19219710",
                "pmid17250608",
                "pmid33779822",
                "pmid20002020",
                "pmid9024952",
                "pmid16314883",
                "pmid29478862",
                "pmid12513948",
                "pmid11204345",
                "pmid19713702"
            ]
        },
        "genetic_254": {
            "question": "What is the effect of disrupting the VCAM1-ApoE interaction on microglial Abeta chemotaxis?",
            "answer": "C",
            "pmid": [
                "pmid37735240",
                "pmid37603311",
                "pmid21210284",
                "pmid20034483",
                "pmid36368316",
                "pmid23229789",
                "pmid38957539",
                "pmid36798430",
                "pmid36720919",
                "pmid31982468"
            ]
        },
        "genetic_255": {
            "question": "What happens to D2 concentration in cerebrospinal fluid during recovery from delirium tremens?",
            "answer": "C",
            "pmid": [
                "pmid6160732",
                "pmid39355007",
                "pmid3765988",
                "pmid2524220",
                "pmid28585290",
                "pmid549538",
                "pmid27058253",
                "pmid17434673",
                "pmid33901789",
                "pmid25567339"
            ]
        },
        "genetic_256": {
            "question": "What is the function of the DRD4 receptor?",
            "answer": "B",
            "pmid": [
                "pmid21873960",
                "pmid19899572",
                "pmid19235789",
                "pmid30248905",
                "pmid9779662",
                "pmid35297520",
                "pmid28993814",
                "pmid27359332",
                "pmid16219804",
                "pmid36613460"
            ]
        },
        "genetic_257": {
            "question": "What role might galectin-3 play in delirium among postpartum ICU women?",
            "answer": "B\n",
            "pmid": [
                "pmid28828226",
                "pmid33901789",
                "pmid33336596",
                "pmid21294938",
                "pmid27119013",
                "pmid37133446",
                "pmid36224337",
                "pmid39463449",
                "pmid37993790",
                "pmid20471115"
            ]
        },
        "genetic_258": {
            "question": "Considering the role of dipeptidyl peptidase 4 (DPP4) in central nervous system (CNS) disorders, which of the following statements best reflects its clinical relevance to delirium or delirium-related conditions? ",
            "answer": "A",
            "pmid": [
                "pmid35771831",
                "pmid29353063",
                "pmid25723507",
                "pmid2524220",
                "pmid39773090",
                "pmid31574089",
                "pmid7916159",
                "pmid38566855",
                "pmid20309566",
                "pmid24557038"
            ]
        }
    }
}